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Class I and II genes from the major histocompatibility complex are routinely typed as a
screening prior to solid organ and haematopoietic stem cell transplants, and have been
linked to susceptibility to many diseases and hypersensitivity reactions to some drugs.
Sequenced based typing is the definitive means of typing a person’s HLA alleles to high
resolution. The development of second generation sequencers beginning with the GS-FLX
from Life Sciences, provided the impetus to develop HLA allele callers to deal with this
new data. For this thesis, two HLA allele callers were developed, the first based on the
expected error pattern for the GS-FLX sequencer and the second based on clustering.
The high cost of a sequencing run can be shared by multiplexing many samples together.
This thesis examined GS-FLX sequencing data for the exons encoding the binding pocket
at pooling rates of 768 samples per run of Class I genes and 384 samples per run of Class
I and II genes. At these high rates of pooling, the sequencing cost per sample is low, but
there is a risk that some samples may not receive adequate coverage.
Almost all discordant calls occurred at low minimum coverage, and 99% concordance
was achieved when the minimum coverage exceeded three. Overall concordance at all
levels of coverage exceeded 90% for the samples with Class I and II data. None of the
“High” confidence calls made by either allele caller, were discordant due to call errors.
Analysis of 23 samples sequenced on a single MiSeq run, suggests that this platform
has the potential to outperform the GS-FLX as a sequencing platform for HLA-typing.
The clustering algorithm also showed great promise as a tool for resolving mixtures of
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A, C, G, T Adenine, Cytosine, Guanine and Thymine, nucleic acids
ASHI American Society for Histocompatibility and Immunogenetics [1]
cDNA Complementary DNA, double stranded DNA synthesised from RNA
DNA Deoxyribonucleic acid
emPCR Emulsion PCR
HLA Human leukocyte antigen
HV1 / HV2 Hypervariable region 1 and 2 respectively in the mitochondrial DNA
IIID The Institute of Immunology and Infectious Diseases
KIR Killer cell immunoglobulin like receptor
MHC Major histocompatibility complex
MID Multiplexing identifier tag
mtDNA Mitochondrial DNA
nucDNA Nuclear DNA
PCR Polymerase chain reaction used to amplify DNA molecules
QAP Quality assurance program (see UCLA)
RNA Ribonucleic acid
rCRS Revised Cambridge reference sequence of the Mitochondrial DNA
SNP Single nucleotide polymorphism




This thesis will examine the development of a high throughput HLA typing methodology
based on GS-FLX sequencing of DNA starting material. The aim was to provide an
allele caller that could call data from multiplexed samples, pooled at a ratio that would
make this method considerably cheaper than typing based on Sanger sequencing. As
such it was decided to base the typing on the exons that encode the peptide binding
pocket of the HLA molecules, as this ensures at least 4 digit genotypic resolution and is
the standard level of resolution generated by Sanger sequencing based HLA typing at
most HLA typing laboratories [3], including the Institute for Immunology and Infectious
Diseases (IIID), where this research was conducted.
Specifically, the thesis will concentrate on the bioinformatic processing of the sequencing
data to call alleles for HLA class I (A, B and C) and class II (DPB1, DQB1, DRB1, DRB3,
DRB4 and DRB5) genes from GS-FLX sequencing of DNA. The large and important
laboratory component of preparing and sequencing the samples is beyond the scope of
this thesis. The thesis concludes by testing one of the allele callers developed on MiSeq
sequencing data and applying some of the lessons learnt from HLA typing to resolving




The aim is to provide allele calling algorithms that coupled with highly multiplexed
sequencing of key exons using second generation sequencing can produce allele calls:
1. Concordant with the alleles present as long as those alleles are represented in the
reference database.
2. Resolved to the highest level possible based on the exons sequenced.
3. Cheaply.
4. Quickly.
One key aspect in providing results quickly and cheaply is the amount of human input
required for calling the alleles from the sequence data. To support that need and also
reduce the effect of user expertise, all allele calls reported in this thesis have no user
editing.
1.2. Overview
This chapter presents an overview of the topic and summarises the material presented in
each chapter.
Chapter 2 provides background information on biology and sequencing. It begins
with an overview of basic genetics, followed by the history of sequencing, ending with
second generation sequencing and FLX 454 sequencing. After this the Human Leukocyte
Antigen (HLA) is introduced. This includes an introduction into the importance of
this region and methods of typing HLA genes carried by a person. It concludes with a
summary of reported research into HLA typing from FLX 454 sequencing data. Most of
this research been published during the candidature of this thesis and offers alternative
methods of accomplishing the same goal as this thesis achieves.
Chapter 3 places the allele callers developed in this thesis in context. It discusses
some of the important aspects of the HLA reference database and laboratory pipeline
2
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developed to provide sequencing data for HLA allele calling. This chapter does not go
into detail of the laboratory method, because that large and important body of work
was not carried out by the author of this thesis. Instead it explains decisions on how and
why samples were pooled. These decisions are important for the costing of HLA typing
and the scale of typing required to recover the investment on equipment and reagents.
Chapter 4 details the algorithms used in two allele callers developed during this project.
The first allele caller is based on grouping sequences together by their flow sequences,
based on the expectation that the most common errors in GS-FLX sequencing are related
to homopolymers. The second allele caller, only assumes that the errors are close to
random and groups the reads by clustering.
Chapter 5 uses a subset of the data that was used to validate the two allele callers to
choose the best parameter values to be used in the calling algorithms. These parameter
values are used for warnings related to low coverage and preferential amplification, and
parameters used for separating the groups of reads. Additionally, criteria are chosen to
classify the confidence of the calls made.
Chapter 6 validates the allele callers using two datasets. The first, was made available
by the Broad Institute of MIT and Harvard and contained 318 samples with GS-FLX
data for class I alleles only. The second dataset was produced at the IIID by sequencing
UCLA QAP samples [2].
Chapter 7 tests the allele caller based on clustering on sequencing data from the MiSeq.
Twenty three samples were pooled in a MiSeq run. This produced more data per sample
than was required for calling. Therefore, excerpts of the data were taken to estimate how
many samples should be tested per run in follow-up studies.
Chapter 8 applies some of the techniques developed in this thesis to a forensic
application. Artefacts recovered from crime scenes may contain traces of the victim,
offender and other people. Techniques from this thesis are used to separate sequences of
the hyper-variable I region of mitochondria sequenced using the FLX 454. It demonstrates
how low frequency variants can be recovered from a pool of samples.
Chapter 9 concludes the thesis, summarising the research and making recommendations
for further work.
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2. Background
There is a huge diversity of life on planet earth, but amongst this diversity there are
commonalities that define living objects. Koshland [4] identified ”Program” as the
first of these common elements. The program code for an organism is its genome.
Deoxyribonucleic acid (DNA) carries the program that encodes the blueprint to build
and maintain living organisms. Within the genome of a complex organism, such as a
human being, there are many elements. Indeed, the function of all of the elements of
the genome is a mystery that is still being unravelled [5, 6]. A small component of the
genome, which has been studied extensively is genes. Genes make up between one and
two percent of the human genome [7–9]. This small fraction of the genome accounts for
just over 20,000 protein encoding genes in the human genome [6, 10].
2.1. DNA and genetics
Avery et al. [11] identified DNA as the material that carried genetic instructions. Watson
& Crick [12] described the structure of DNA as being a double helix comprised of two
strands of nucleic acids joined by complementary purine and pyrimidine bases. The
nucleotides on these strands encode the genome, which includes genes and other structures
that provide the blueprint for building proteins [13], which are important macro molecules
in all life forms. Additionally, as part of the DNA of an organism, the traits are passed
between generations. The manifestation of these traits is called the phenotype of an
individual. Gregor Mendel demonstrated the inheritance of traits, plus the importance
of dominant and recessive genes in the 16th century. He reported that the traits of
descendants were determined by the traits carried by their parents and grandparents.
The one to one link between traits and genes has been dismissed due to it being an
oversimplification of a more complex system. Many traits are the result of more than
one gene. Genes can produce different proteins through alternative splicing, and the
5
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encoding for genes can overlap, even to the point that genes can be contained within
other genes [14].
2.1.1. Protein encoding
The building blocks for encoding proteins are the nucleotides on the DNA strands. In
DNA there are four nucleotides, Adenine, Cytosine, Guanine and Thymine (A, C, Gand
T). These nucleotides are combined into groups of three, called codons. Each three
nucleotides or codon encode for an amino acid. The genetic code includes redundancy.
There are 64 different encodings for a codon, but for most organisms, only twenty
amino acids are encoded. Additional amino acids can be formed by post-translational
modification [15]. Therefore, for many amino acids there is more than one encoding.
Changes in codon sequences that produce the same amino acid are called synonymous
and those which cause a change are called non-synonymous. The reading frame defines
which nucleotides on the DNA strand represent the start of codons. A change in the
coding sequence for a molecule, may or may not change the amino acids encoded. If the
change is in the first or second positions of a codon, it is likely to change the amino acid
encoded. However, a change in the third position in a codon often will not change the
amino acid encoded.
Another change that can occur in the nucleotide sequence is the insertion or deletion
of nucleotides. If these insertions or deletions are a multiple of three nucleotides, it will
result in the insertion or removal of amino acids from the encoded protein. However,
insertion or deletion of nucleotides that are not an exact multiple of three will effectively
change the reading frame from that point onwards, and hence change the coding of all
amino acids from that point forward in the molecule. Often this will result in a premature
stop codon and a dysfunctional molecule [16].
From the preceding discussion, it can be seen that changes in the nucleotide sequence
encoding a protein can have many effects on the protein produced. The effects range from
no change for synonymous substitutions, small effects for non-synonymous substitutions
that don’t change the folding of the protein molecule, major changes and potentially
non-functional molecules for changes that change folding or change the reading frame.
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The gene sequence is called the genotype. By linking phenotypes to genotypes, it is
possible to predict the traits of an individual by knowing their genotype or gene sequence.
2.2. Human leukocyte antigen (HLA)
One area of great interest in knowing a person’s phenotype is the HLA types a person
exhibits. A person’s HLA types refers to which alleles of the HLA genes they are carrying.
This thesis is concerned with the classical class I genes (HLA-A, HLA-B and HLA-C) and
the beta molecules of the classical class II genes (HLA-DP, HLA-DQ and HLA-DR). These
genes are contained in the class I and class II regions of the Major Histocompatibility
Complex [17].
The Major Histocompatibility Complex (MHC) was first discovered in the mouse in
1936 [18]. In a series of experiments, Gorer [19–21] examined the immunological responses
of groups of highly inbred mice to human serum, rabbit serum and mouse tumours. Klein
[18] attributes Gorer’s work as being the seed for future growth of our understanding of
the MHC. More than 30 years later, the MHC was discovered in humans [22].
In humans, the term HLA is used to describe both the MHC region and the class I
and class II loci within the region [23]. To avoid confusion, this thesis will use the term
MHC to refer to the region and HLA to refer to the HLA class I and class II genes. The
MHC region is located on chromosome 6 in humans and represents one of the most gene
rich and polymorphic regions in the human genome [24]. The classical MHC is a region
of 3.6 megabases and is divided into three sections. class II is the most centromeric, then
class III, and class I is the most telomeric [24]. In the extended MHC, which covers 7.6
megabases, both the class I and class II regions have been extended [25]. Included in the
MHC region are the HLA class I and II genes, which are the most polymorphic human
genes [24]. The class I genes HLA-A, HLA-B and HLA-C all have over 2,000 known
allelic variants and the class II gene HLA-DRB1 has over 1,500 known allelic variants [3].
Sets of these genes are frequently inherited as a block due to their close proximity. For
example, Begovich et al. [26] reported that DRB1, DQA1 and DQB1 are inherited as a
block, but meiotic recombination was possible between DQB1 and DPB1. Additionally
there is evidence of linkage disequilibrium. For example, recombination events in the
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HLA class I region occur at a rate of approximately one fifth the average rate per meiotic
event [27–29].
2.2.1. Function
The MHC complex contains over 200 genes that provide a variety of functionality with
many of them being immunological [17, 24]. The HLA class I genes (reviewed by Rock &
Goldberg [30]) and class II genes (reviewed by Bryant & Ploegh [31]) have an important
role in the presentation of intracellular and extracellular antigens respectively. These
antigens are potentially bound by receptors on T cells [32] in processes that are key to
the adaptive immune system.
HLA types have also been shown to be related to many diseases (see reviews by
Dawkins et al. [23] and Thorsby [33]). In autoimmune diseases, the mechanisms that
prevent self reactive lymphocytes from destroying components of our own body break
down (reviewed by Goodnow et al. [34]), and some of these lymphocytes become activated,
leading to the destruction of the body cell types that they recognise [35]. HLA types
have been associated with autoimmune disease, for example, in multiple sclerosis [36],
Type I diabetes [37] and ankylosing spondylitis [38]. Some HLA types provide protection
against certain diseases, with the risk of contracting the disease diminished in individuals
with these HLA types, for example, in severe malaria [39] and hepatitis B [40].
As the name Major Histocompatibility Complex suggests, the initial function of this
region to be identified was the effect it had on the tolerance of tissue grafts or organ
transplants [17]. Matching classical class I and class II HLA types between donors and
recipients has been shown to improve the success rates of transplantation, for example,
kidney transplants [41, 42]. Matching has also been shown to reduce the rate of failure of
engraftment and late graft failure for bone marrow transplants [43], and reduce mortality,
rejection and graft versus host disease after haematopoietic stem cell transplantation [44,
45].
For some drugs, hypersensitivity reactions can be associated with the HLA type of
the patient receiving the drug (reviewed by Phillips & Mallal [46]). A drug hypersens-
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itivity reaction is an adverse reaction to a drug that is not predictable based on the
pharmaceutical action of the drug.
There are unidentified genes in the MHC region that affect body odour [47]. This
change in odour has been shown to be detectable in both mice and humans [47, 48].
Furthermore, it has been demonstrated that there is a mate preference for individuals
with differing HLA types,
2.3. Nucleotide sequencing
The links from DNA sequence to proteins and hence function makes knowledge of the
sequence a powerful diagnostic and predictive tool for biological function. The term
sequencing is hereafter used to describe determining the sequence of nucleotides on a
nucleic acid strand.
2.3.1. History
In the 1970’s, discoveries were made in sequencing that led to technologies that dominated
sequencing for three decades and are still important today. Sanger & Coulson [49] reported
the plus minus method of sequencing in 1975. This was followed two years later by
two important new methods. Chemical cleavage sequencing is based on sequencing by
destruction of the molecule being sequenced [50]. However, due to its hazardous chemical
requirements and requirement for large amounts of DNA, it was rarely used and was
overshadowed by another sequencing method unveiled in the same year [51]. Sanger et al.
[52], built upon the weaknesses of the plus minus method to release Sanger sequencing,
also known as chain terminator sequencing or dideoxy sequencing. This method in its
commercially developed form [53] became the mainstay of sequencing until late in the first
decade of the 21st century, when the next generation of sequencers began to dominate
the field.
The first human genome project used Sanger sequencing [53]. It began in 1990 and
took more than a decade [54].
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In the late 1980’s, sequencing by hybridisation was developed [55]. This method was
not widely used due to a number of issues including the high number of oligonucleotides
required, the need to optimise conditions for these oligonucleotides and the inability
to deal with repetitive regions [51]. Sequencing by hybridisation proved important for
known SNP (single nucleotide polymorphism) detection [56] and as a starting point for
future sequencing technologies [57].
In 1998, a method for real-time sequencing of DNA using detection of pyrophosphate
release was published [58]. The method uses sequencing by synthesis which is where
nucleotides are incorporated into growing DNA strands [59]. Pyrosequencing is the
detection and analysis of luminescence when pyrophosphate is released when a nucleotide
is incorporated into the DNA strand [58, 60]. This method can be used for SNP analysis,
tag sequencing and whole genome sequencing [60]. The main type of error associated
with pyrosequencing is in sequencing homopolymeric regions. When analysing the
luminescence produced by the incorporation of multiple identical nucleotides, there is
ambiguity as to how many nucleotides have been incorporated due to the non-linear light
response which is produced [58].
2.3.2. Second generation sequencers
New technologies that allowed the miniaturisation and parallelisation of sequencing
reactions led to a whole new generation of sequencers. These were initially called next
generation sequencers, but with another generation of sequencers being developed, they
are now commonly referred to as second generation sequencers. Second generation
sequencers have several advantages over Sanger sequencing. The largest advantage is the
amount of data that can be generated per run, the cost per base sequenced, and even
when considering the long run times, the amount of data per unit of time.
In 2005, 454 Life Sciences published the first paper about the first of the second
generation sequencers [61]. The paper describes the operation of the initial 454 Life
Sciences second generation sequencer (Roche 454 Life Sciences, Branford, USA) and
presents data for the successful sequencing and de novo assembly of the Mycoplasma
genitalium genome. The 454 Life Sciences second generation sequencer is based on
highly parallel pyrosequencing at a pico litre scale on a fibre optic slide. The process for
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sequencing starts with selecting and isolating the DNA to be sequenced. The selected
DNA is ligated to adaptors and then separated into single strands, which are bound to
beads in conditions favouring one strand per bead. The beads are then covered in an
emulsion droplet and an emulsion PCR is carried out to amplify the strands connected to
the beads. The emulsion is then broken, the DNA is denatured and the beads containing
single stranded DNA are then loaded into wells on a fibre optic plate, one bead per
well. The sequencing then takes place using a pyrosequencing technique optimised for
the small well volume. Nucleotides are flowed sequentially over the plate, with each
nucleotide flow separated by a washing step. When nucleotides are incorporated onto the
beads, inorganic pyrophosphate is released producing photons of light. The amount of
light generated is a function of the number of nucleotides incorporated. A CCD camera
captures the light emissions for each flow. Following the actual sequencing reaction,
the data is processed in two steps. First, the images are processed to calculate the
light intensity for each nucleotide flow for each well. Second, the light level signals are
analysed to calculate the sequence for each bead on the plate. Signal processing includes
background subtraction, elimination of wells not containing beads, normalisation and
correction for carry forward or incomplete extension for beads that lose synchronisation.
The sequence for a bead is called a read and reads are filtered to remove those which
do not have the correct key, have too few incorporations, have too many incorporations
suggesting more than one strand attached to the bead or have low quality. For the
Mycoplasma genitalium genome, the sequencer was able to produce almost half a million
reads, with an average read length of 108 bases, yielding 53 million bases of data, 47
million of which had high quality scores. The original chemistry for the 454 Life Sciences
second generation sequencer generated reads with a read length of 100 to 150 base pairs.
This was extended to 400 to 500 base pairs with the release of the GS-FLX Titanium
system in 2008 [62]. The current GS-FLX Plus which utilises advances in titanium
chemistry has median read lengths of 700 bases with maximum read lengths up to 1000
bases [63]. A smaller sequencer called the GS Junior (Roche 454 Life Sciences, Branford,
USA), allows a plate one eighth the size of a standard FLX plate to be sequenced [64].
Error rates
Huse et al. [65] found the GS20 system (Roche 454 Life Sciences, Branford, USA), to have
an error rate of 0.49 percent. Thirty-nine percent of errors corresponded to homopolymer
effects. Insertions were the most common error followed by deletions. Lind et al. [66] used
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the GS-FLX (Roche 454 Life Sciences, Branford, USA) for sequencing of HLA alleles.
The sequences were compared to known reference HLA alleles and an average error rate
of 1.1 percent was observed, however this included both sequencing and misalignment
errors. Sequencing errors were mainly insertions or deletions and the rate of error was
higher at the end of a read. The GS-FLX Titanium technology was found by Gilles et al.
[67] to have a mean error rate of 0.534 percent for short sequences. Insertions were again
found to be the most common error followed by deletions. Longer sequences were found
to have higher error rates. Niklas et al. [68] used the GS Junior, titanium chemistry for
sequencing of HLA. A total error rate of 0.18 percent was identified which consisted of
50 percent insertion errors, 22 percent deletion errors and 28 percent substitution errors.
Homopolymers were more likely to be associated with errors than single bases and a
longer length of homopolymer correlated with a decrease in accuracy.
2.3.3. Other second generation sequencers
Some of the second generation sequencers available apart from the 454 Life Sciences
sequencers are the Illumina Genome Annalyzer (Illumina, San Diego, USA), Applied
Biosystems SOLiD Sequencer (Life Technologies, Carlsbad, USA) and Ion Torrent (Life
Technologies, Carlsbad, USA). Illumina and SOLiD were released in 2006 and 2007
respectively and Ion Torrent was released in 2010 [59].
The Illumina platform is based on sequencing by synthesis using reversible dye
terminators [59]. A smaller version of the Illumina platform called the MiSeq (Illumina,
San Diego, USA) was released in 2011, which is a bench top version of the full platform
[62]. Its major error type is substitutions [59]. The initial version of Illumina had read
lengths of 25 to 35 bases [69]. These have now been extended to up to 300 base pair
paired end reads on the MiSeq [59]. Illumina has been by far the most successful of the
second generation sequencing platforms.
The SOLiD platform is based on sequencing by chained ligation [59]. It has the shortest
read lengths and claims to have the greatest accuracy of the second generation sequencers
[62]. Its major error type is substitutions [59]. The initial version of the SOLiD platform
had read lengths of 35 base pairs with an accuracy of 99.8 percent [62]. This has been
improved to read lengths of 75 base pairs [59].
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The Ion Torrent platform uses electric detection of sequencing by synthesis on a semi-
conductor chip rather than optic detection as with other second generation sequencers.
Its major error type is indels [59]. Currently, there are two sequencing versions available.
The Ion PGM System (Life Technologies, Carlsbad, USA) has a choice of three chips
providing varying amounts of data in either 200 or 400 base pair reads [70]. The Ion
Proton System (Life Technologies, Carlsbad, USA) is a version which can provide more
data but has a read length of up to 200 bases [70].
2.3.4. Third generation sequencers
Third generation sequencers are single molecule sequencers. One advantage of a single
molecule sequencer over a second generation sequencer is that amplification is not required,
so any associated issues caused by amplification are avoided. Problems with amplification
may include amplification errors, amplification not occurring in known ratios where
samples are mixed, the cost associated with amplification techniques, and recombination.
Another advantage of single molecule sequencing is that only minimal quantities of DNA
are required [59].
The first single molecule sequencer to be released was the Heliscope sequencer system
(Helicos Biosciences, Cambridge, USA), in 2008. This platform is based on sequencing
by synthesis using reversible single-dye termination. The limitations of this sequencer
are its high raw read error rates and its short read length of approximately 32 bases. Its
main error type is deletions [59].
The PacBio sequencer (Pacific Biosciences, Menlo Park, USA) was first presented
in Science in 2009 [71]. This platform involves immobilising DNA polymerase by a
zero-mode waveguide [59]. It claims to provide average read lengths of greater than
10,000 base pairs and may be able to achieve read lengths in excess of 40,000 base pairs
[72]. The advantages of this sequencer are that it has fast sequencing reaction runs, but
is currently limited by its high raw read error rates. Its main error type is indels which
is mainly due to its failure to detect all incorporations [59]. Jiao et al. [73] found the
error rate of their sequencing pipeline to be 2.5%, for circular consensus sequences. With
20.5 percent of circular consensus sequences having more than 5 percent errors. They
found the errors were concentrated in the 3’ and 5’ ends of the reads, and the central
portion of the reads to have better calling accuracy.
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Nanopore sequencing is a more recent addition to the third generation sequencers.
This type of sequencing is based on ionic current shifts when DNA is passed through a
nanopore in a membrane. The potential advantages of this type of sequencing are that it
requires minimal sample preparation and produces long read lengths in real time [59].
Using the MinION sequencer to sequence the HLA-A, HLA-B and CYP2DS genes, at
best 63 percent of the reads mapped to the reference genes [74]. Deletions were the most
common error and the overall mapping accuracy was less than 75 percent, i.e. the error
rate exceeded 25 percent.
2.4. HLA typing
The typing of HLA genes was historically based on serologic or cellular assays [reviewed by
75]. As knowledge of HLA increased, it became apparent that the number of alleles was
large and finding biological reagents to differentiate all alleles was infeasible. Important
functional phenotypic data can be mapped to the genotypes, so that typing by genotype
stills yields the important functional characteristics. Typing was initially based on amino
acid sequencing and comparative peptide mapping [76–81]. Currently, most sequence
based typing uses nucleotide sequencing. The sequence used for typing can be obtained
in several ways. The most obvious is to sequence the whole gene for each chromosome
separately. Each unique gene sequence represents an allele. Separating the chromosomes
to allow individual sequencing is difficult and expensive therefore other techniques were
developed that were cheaper. New techniques fill niches including cost, time required for
results, equipment required and the resolution of results required. For example, typing
based on key exonic sequences may be achieved more cheaply than full gene sequencing,
but there is a reduction in calling resolution.
2.4.1. HLA typing from second generation sequencing data
Second generation sequencers were an obvious tool to be utilised for sequence based
HLA typing. The ability to generate a large amount of data, where each read was
effectively the clone of part of one allele, meant that the opportunity existed to type
samples more quickly, cheaply and with less ambiguity than sequence based typing based
on Sanger sequencing. The ability to resolve phase errors that occurred within a read
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length, reduced ambiguity and eliminated the need for resolving primers. GS-FLX was
the first platform to be used for HLA typing due to its greater read lengths. Read length
was important for resolving phase errors, and to allow exon based typing to be carried
out without shearing amplicons before sequencing. This was important from a cost
perspective, because it allowed samples to be tagged with unique identifiers during the
amplification step to facilitate pooling [82]. As the other sequencing platforms increased
their read lengths, they have successfully been used for HLA typing.
The first papers describing successful HLA typing based on second generation sequen-
cing data were published in 2009 [83, 84]. Bentley et al. [83] presented methodology
which became the blue print that the majority of subsequent papers followed. Sample
identifiers and sequencing adaptors were attached during the amplification of exons by
using tagged primers in PCRs. This eliminated the library preparation step, and hence
reduced the cost of the typing. A total of 14 exons were amplified, which allowed typing
of HLA A, B, C, DPB1, DQA1, DQB1 and DRB1. The primers used for DRB1 also
amplified reads for DRB3, DRB4 and DRB5, but these reads were not used. The calling
of alleles was carried out using Conexio Genomics’ HLA genotyping software (Conexio
Genomics, Fremantle, Australia).
The use of Conexio Genomics’ software is also described by Erlich [85]. Assign software
(Conexio Genomics, Fremantle, Australia) calls alleles by aligning reads against a reference
sequence. Possible alleles are those that have reads that are an exact match for the
exons analysed. Reads that do not exactly match a known allele are not used in calling.
However, these reads can be manually edited. Manual editing can also be used to disable
low frequency reads that match other alleles. It is recommended that a minimum of 50
reads is used per amplicon to call alleles. The ATF version of Assign can be used for
next generation sequence data and Sanger sequence data, whereas the SBT version can
only use Sanger sequence data.
The study presented by Bentley et al. [83] demonstrated that 48 samples could be
sequenced on a single GS-FLX run for seven loci, plus an additional 3 loci when data
from HLA DRB3, DRB4 and DRB5 were analysed. For 24 samples, they demonstrated
99.4% concordance of allele calls with previously known results. Approximately half of
the calls required manual editing.
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This methodology has been reused sometimes with adaption in several studies. The
methodology was validated across eight sites [86] with each site typing the same 20
samples. The concordance of results varied from 95.3% to 99.4% across the eight sites.
The overall concordance was 97.2%. The methodology has been used to examine the
HLA profiles of subjects with follicular lymphoma [87], type I diabetes [88] and healthy
Saudis [89]. Danzer et al. [90] adapted the method to form a largely automated pipeline
where samples could be typed in 30 hours, with less than one quarter of that time being
hands on. The methodology has been further developed to use the Fluidigm Access Array
System (Fluidigm, South San Francisco, USA) [91]. This reduced the sample volumes
required and improves automation for typing large cohorts.
The Assign software has also been used to call alleles based on full gene sequence
[66]. Up to four samples were pooled on one eighth of a GS-FLX plate. These samples
comprised of sheared full length HLA A, B and C genes, and exon 2, intron 2 and exon 3
of HLA DQB1 and DRB1. With this arrangement, 100% of the amplified region was
covered and 100% of the alleles called were concordant with the known results.
There have also been several alternative methodologies for HLA allele calling that do
not use the Assign ATF software. The first of these was reported by Gabriel et al. [84].
They amplified exons 1, 2, 3 and 4 of the genes HLA A and B with tagged primers that
included sample identifiers and the sequencing adaptors. The sample tags allowed eight
samples to be pooled in a single sequencing run, and attaching the sequencing adaptors
during amplification negated the need to do a library preparation before sequencing.
After sequencing, reads were aligned, then clustered using a correction for flowgrams. The
consensuses of the clusters were exported and analysed with Assign SBT software. The
results of their analysis had 100% concordance with known results and had an average
coverage of 1000 reads.
Lank et al. [92] were the first to report HLA typing based on second generation
sequencing of RNA. RNA was extracted from cultured cell lines and converted to cDNA.
A single pair of primers were designed to amplify a 581 base pair amplicon that covered
all of exon 2 and 3 for class I genes. The primers were tagged with MID tags to allow
48 samples to be run in a single sequencing lane. The tagged primers also included
the library A or B adaptors. Sequencing was carried out using the GS-FLX titanium
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chemistry. Allele calling was accomplished by aligning the reads against all known A,
B and C alleles. Sequences that aligned perfectly or only had single base insertions or
deletions were kept for further analysis. Alleles were called if they had forward and
reverse reads perfectly aligned. Using this technique, the only calling problems for 48
samples, were the failure to amplify one sample and the failure to identify a null allele.
Erlich et al. [82] reported two methods of pooling samples, that allowed up to 720
samples to be sequenced for HLA-A, B and C in a single GS-FLX run. They also
developed their own HLA allele calling software. For each possible allele combination, it
calculated the posterior probability that the combination could produce the sequenced
reads. The allele pair with the highest probability was chosen as the allele call. The
sequencing preparation method of including MID tags in the primers resulted in 98.6
percent concordance for 95 samples sequenced on one eighth of a GS-FLX sequencing
run for HLA-A, B and C.
An alternative commercial solution to calling alleles was used by Grumbt et al. [93].
They used SeqHLA 454 software (JSI medical Systems, Ettenheim, Germany). Using
this software they were able to call alleles for three loci HLA A, B and DRB1, when 475
samples were pooled in a single GS-FLX titanium chemistry sequencing run. Alternatively,
up to 192 samples could be typed in a single sequencing run for five loci, HLA A, B, C,
DQB1 and DRB1. They recommend coverage of at least 10 error free reads per allele, or
a total of 50 reads coverage for each exon.
2.4.2. HLA typing from third generation sequencing data
Lind et al. [94] sequenced full length HLA class I genes using the PacBio RS sequencer
(Pacific Biosciences, Menlo Park, USA). Two samples were amplified at HLA-A, -B and
-C loci and the pooled libraries were run on six SMRT cells. The average read length for
a 90 minute sequencing was 2,244 bases. The total average error rate was 16 percent
with 10.5 percent insertion errors, 4.6 percent deletion errors and 0.9 percent substitution
errors.
Ranade et al. [95] used PacBio RSII sequencing technology (Pacific Biosciences, Menlo
Park, USA) to analyse HLA class I genes HLA-A, B and C in eight different samples.
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These were sequenced on a single SMRT cell. The sequences were typed using GenDx
NGS engine HLA-typing software (GenDX, Utrecht, The Netherlands). The authors
concluded that the long read lengths achievable by the PacBio RSII make it well suited to
analysing HLA loci. Concordance ranged from 88-100 percent for all HLA loci analysed,
with amplification imbalance the primary cause of missed calls.
At this early stage of development of the MinION sequencer, an attempt to call HLA-A
and HLA-B alleles was unsuccessful [74]. This was despite coverage of approximately
1000X, and the authors attributed the discordant calls to high error rates during
sequencing.
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This thesis is concerned with the development of algorithms for calling HLA alleles from
second generation sequencing data, and these algorithms and their application will be
detailed in the following chapters. To achieve the goal of using the techniques developed
in this study to provide well resolved and concordant allele calls quickly and cheaply, this
thesis must form one component of a larger system. This chapter will describe two of the
other components of this system at a high level, with the sole purpose of locating the
work of this thesis in the big picture view. The inclusion of this chapter is not intended
to lay claim to any of the large body of important research done in other components of
the larger system.
The two other components that will be discussed are the IMGT HLA reference database
[3], and the development of the laboratory pipeline to generate the sequencing data.
3.1. IMGT HLA reference database
Sequence based typing requires matching the sequence(s) for a sample against a reference
set of known sequences. The alleles for the sample are those with matching sequences in
the reference database. If the gene is only partially sequenced, there may be ambiguity
because more than one allele in the reference database may match the incomplete sequence.
Clearly an obvious step in developing a sequence based typing method is to choose and
assess the reference database.
ln the work reported in this thesis the IMGT HLA database [3] was used to provide
the reference sequences for HLA allele calling. This database has been a repository
for HLA and associated gene reference data for several decades. As of the 3.19 release
of the database, in January 2015, 9,437 class I alleles and 3,105 class II alleles have
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been described. The HLA genes typed in this thesis are those with the majority of the











Table 3.1.: Number of reference alleles in the IMGT HLA database for the HLA genes
called in this thesis
3.1.1. HLA reference coverage
Most of the alleles in the database have incomplete gene sequences. The incomplete
reference sequences follow the same patterns, with the exons encoding the binding pockets,
exons 2 and 3 for class I and exon 2 for class II being completely covered for nearly all
alleles. For class I reference alleles, less than 30% of alleles have a complete sequence
for exon 4 in addition to exon 2 and 3 data. The next most commonly covered features
in the references are the other exons for less than 15% of alleles, then the introns and
finally the UTR regions (See for example Figure 3.1). For class II references alleles after
exon 2, the next most common feature to be sequenced is exon 3 which is covered in
less than 15% of alleles, followed by the other exons in less than 10% of alleles, and
very few reference alleles have sequences for the introns or UTR regions (see for example
Figure 3.2).
The majority of HLA typing strategies are based on exon 2 and 3 for the class I genes
and exon 2 for the class II genes [3]. This conforms well with the data in the reference
database. However, typing based only on the exons that encode the binding pocket will
result in calls made with ambiguity, whereas two or more alleles have the same binding
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Figure 3.1.: Coverage of the HLA-B gene by the reference alleles in the IMGT HLA
database release 3.14
pocket encoding but differ in other exons or non coding regions. The application using
the called alleles will determine whether that ambiguity needs to be resolved.
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Figure 3.2.: Coverage of the HLA-DRB1 gene by the reference alleles in the IMGT HLA
database release 3.14
3.2. Sample preparation and sequencing in the
laboratory
In order to produce the sequencing data to be used for allele calling, many steps need to
be completed in the laboratory. The combination of these steps is hereafter referred to
as a pipeline. There is considerable flexibility in customising the steps taken and hence
scope for different pipelines to be developed. The pipeline needs to achieve the following:
• Selection of the DNA/RNA that encodes the parts of the gene to be used for calling
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from the genomic DNA.
• Amplification or enrichment of DNA.
• Quantification of the amount of DNA.
• Tagging the DNA with multiplexing tags.
• Pooling of tagged DNA.
• Ligation of library adaptors to the DNA.
• Sequencer specific amplification. This is emPCR for GS-FLX and bridge amplifica-
tion for MiSeq.
• Sequencing.
3.2.1. Institute of Immunology and Infectious Diseases pipeline
The pipeline used at the Institute of Immunology and Infectious Diseases (IIID) used a
PCR to select and amplify the exons encoding the binding pocket of the HLA molecules.
The primers used in the PCR were tagged with an 11 base MID tag to allow reads to be
linked to the subjects [96]. After PCR cleanup, the products were pooled two ways. First,
the PCR products for all exons to be sequenced for each subject were pooled, with the
pooling ratios dependent upon the amplicon lengths. Second, the pooled PCR products
for each subject were pooled together, with the ratios for each subject dependent upon
the MID tag used for the subject. Following this, the pooled samples went through the
standard library preparation for the sequencing technology to be used, to attach the
sequencing adaptors onto the amplicons. For GS-FLX, this was followed by emPCR and
sequencing. When using the MiSeq for sequencing, the library preparation was followed
by cluster generation and sequencing.
The development of this pipeline is the result of some key decisions, which then needed
to be implemented in the laboratory. The following is a discussion on some of those key
decisions, and why the above pipeline was chosen over the alternatives.
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3.2.2. Typing strategy
It was decided to base the HLA typing on the sequences of the exons encoding the binding
pocket of the HLA molecule. These are exons 2 and 3 for class I genes, HLA-A, HLA-B
and HLA-C, and exon 2 of the class II genes HLA-DPB1, HLA-DQB1, and HLA-DRB1,
3, 4 and 5. The binding pocket is the most important part of the molecule in determining
function, except in the rare case of null alleles where the location of the part of sequence
causing lack of expression varies between alleles. The binding pocket encoding exons also
have the best coverage in the reference database (Section 3.1.1), therefore give the best
discrimination between alleles per region sequenced.
For HLA-QB1, the primers chosen for amplifying exon 2, did not give complete coverage
of the exon. Therefore, to improve resolution of the typing exon 3 was also sequenced.
Again the primer design, did not yield complete sequence for this exon.
Sequencing specified exons allows multiplexing tags to be added during amplification.
Finally, by sequencing just the binding pocket exons, more samples can be combined in
a single sequencing run, reducing the sequencing cost per sample. These reasons drove
the development of the allele callers, producing potentially simpler solutions than would
be required to handle full length sequencing.
3.2.3. Multiplexing identifier tagging
Multiplexing identifier (MID) tags were added during the PCR used to select and amplify
the exons encoding the binding pockets of the HLA alleles (Section 3.2.2). This was
achieved by appending the MID tags onto the primer sequence [82]. To enable 48 samples
to be sequenced per GS-FLX lane, 48 different primer pairs were required per amplicon,
one per MID tag. Adding the MID tags onto the primers made them approximately
31 bases in length. The alternative to applying the MID tags during the PCR was to
apply them during the library preparation. In that case, a separate library would be
required for each sample which would greatly increase the per sample sequencing cost.
The advantage of applying MID tags during the library preparation was that only a single
primer pair was required per amplicon and the primers would be approximately 20 bases
in length. This would result in a reduction in the upfront cost. However, the reduction
in upfront cost was not as important to IIID as the increased library preparation costs,
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as they were able to spread that cost over thousands of samples, making it much cheaper
overall than creating a library for each sample.
3.2.4. Library adaptors
Library adaptors were ligated onto the pooled PCR products so that one library was
produced per lane that contained the PCR products for class I and class II alleles of 48
samples. An alternative to this was including the library adaptors in the tagged primers
[83]. This added 19 bases to the length of the tagged primer. The advantage of including
the library adaptors in the tagged primer was the elimination of the library preparation
step. However, this option was not chosen for two reasons. First, the very long primers
required purification and hence were much more expensive. Second, the primers could
only be used with the GS-FLX family of sequencers. In this case, IIID decided that
the additional upfront cost of the longer primers was not warranted to avoid the cost of
preparing one library per 48 samples, with the additional disadvantage of locking the
primers to a single sequencing technology.
Not locking the MID tagged primers to a single sequencing technology resulted in the
discovery of two more advantages of ligating library adaptors during a library preparation
step. When sequencing on MiSeq, the opportunity also existed to attach sequencing
adaptors and multiplexing identifiers during PCR amplification using tagged primers.
However, the MiSeq sequencer does not divide the sequencing plate into lanes in the way
the GS-FLX does. This meant that to sequence 384 samples in a single sequencing run
would require 384 unique identifiers, in contrast to the 48 unique identifiers required in a
GS-FLX run with 8 lanes to handle 384 samples. Therefore, in order to sequence the
same number of samples in a MiSeq run as a GS-FLX run would require eight times the
upfront investment in primers. This additional investment was avoided by producing
a library for each pool of 48 samples. If required, this would also allow more than 384
samples to be pooled by simply producing more libraries of 48 pooled samples. The
second advantage of doing a library preparation for each pool of samples was that the
Illumina multiplexing identifiers could be varied between runs. For example, one run may
have used identifiers 1 to 8 and the next run could use identifiers 9 to 16. This allowed
for easy identification of between run contamination. The disadvantage of using the
MID tagged primers was that 11 bases of the sequence data was used for multiplexing,
whereas, using the MiSeq multiplexing tags only did not use any of the sequence data for
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multiplexing. This effectively reduced the overlap of the paired ends by 11 bases.
3.3. Outcome
The allele callers developed in this thesis along with the laboratory methods overviewed
in this chapter have gained ASHI accreditation [1]. In excess of 6,000 samples have been
typed for HLA class I and class II. The samples have come from five continents, Africa,
Asia, Australia, Europe and North America.
3.4. Costs
No costings are provided in this thesis for two reasons. First, the suppliers of the kits and
reagents used in much of the laboratory work do not make their prices openly available.
Therefore, the costs levied on one lab may differ to those for another lab. Second, the
calculation of costs for HLA typing are complicated, with several large upfront costs,
such as sequencers and other laboratory equipment, plus investment in reagents such as
primers. In addition to this are reagents and kits required by the pipeline for each batch
of samples. Finally, there is the large cost of labour. Labour costs exist in management
/ administration, laboratory work, analysis and reporting. In the initial studies that
verified that second generation sequencers were capable of producing sequencing data
suitable for HLA typing [83, 84], the sequencing costs per sample would have been high.
However, when a large number of samples, e.g. 384, are multiplexed in a single GS-FLX
or MiSeq sequencing run, the cost of labour rather than the cost of the sequencing run is
the largest component of the HLA typing cost.
The amount IIID charges clients for HLA typing based on GS-FLX sequencing is
approximately one third the amount they were charging for typing based on Sanger
sequencing. This decrease in costs is largely due to the elimination of the need for
resolving primers to reduce phase ambiguity and a reduction in the time required for
checking the results. Therefore, this price reduction is accompanied by a large increase
in throughput.
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Calling HLA alleles from sequence data is basically a simple matching task. The sequenced
reads come from a gene and those reads will represent the sequence of the gene, with
the addition of some errors. To call alleles, the best estimate of the gene sequences are
matched against the IMGT HLA database of known allele sequences [3]. This thesis
matches sequences against known exon 2 and exon 3 sequences for class I genes HLA-A,
B and C, and the class II gene HLA-DQB1, and known exon 2 sequences for the class II
genes HLA-DPB1, and DRB1, 3, 4 and 5.
Errors are when the sequenced read does not exactly match the sequence of one of the
alleles being sequenced. Errors can be introduced in several phases, with the key ones
being PCR amplification and sequencing.
During PCR amplification, four issues can arise. These are, preferential amplification,
off-target amplification, recombination and transcription errors. In preferential amplifica-
tion, one allele is amplified much more than the other allele, resulting in an imbalance in
the number of sequenced reads for each allele. In the extreme, there will be no reads
for one of the alleles, resulting in an allele not being called. Off-target amplification
results from the amplification primers binding to other sites on the genome and hence
amplifying the wrong section of the genome. This may result in closely related pseudo
genes being amplified along with the target genes. A recombination event results in an
amplicon being formed during more than one amplification cycle or template switching in
the same amplification cycle. The recombinant amplicon may be formed as a partial copy
of one allele during the first cycle and a copy of the remainder of the other allele during
a subsequent cycle. As a result, any reads from that amplicon will have one end that has
the SNPs associated with one allele and the other end with SNPs associated with the
other allele
1
. Transcription errors are rare errors, whereby when copying a transcript,
1The only amplicons that are considered as recombinants are those that partially match both alleles.
It is not possible to recognise recombinants formed between two molecules of the same allele.
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the wrong base is incorporated.
Sequencing errors vary between platforms [59]. For pyrosequencing based sequencers
such as GS-FLX, the predominant sequencing errors are insertions and deletions in
homopolymer runs. For Illumina based platforms, insertions and deletions are almost
eliminated, and substitutions are the main error.
Two allele callers have been implemented. The first allele caller is called “Allele caller
based on expectation” and was designed based on the error patterns of the GS-FLX.
As such it is suited to calling alleles from reads from any platform with a similar error
pattern, but is poorly suited to calling alleles from sequencers with different error patterns.
The second allele caller is called “Allele caller based on clustering”. This allele caller is
suited to reads from any next generation sequencing platform where the reads are long
enough to cover the exons used for calling.
4.1. Example format
The discussion of how the two allele callers work will depend heavily on examples.
Rather than explaining how to interpret each figure using captions, a convention is used
throughout the examples. The conventions are as follows:
1. Presentation of the two sequences to be separated, a and b. Nucleotide indices are
presented above the sequences, with the background for an index shaded in yellow
if the sequences are not equivalent at that index.
2. Presention of the sequence data, which consists of 12 reads. The reads in the
example are short to make it easier to follow. In reality, there may be hundreds of
reads, all covering a region 270 or 276 bases long. When the reads are presented,
they will be shown with one read spelt out in full on the top row. The rest of the
reads will be shown as a combination of dots and nucleotides. A dot represents
that the read matches the read on the top row at that position and a spelt out
nucleotide represents a change between the read and the read on the top row. The
index positions for the nucleotides are written above the table of reads, and the
read numbers are written to the left of the reads table. A yellow background for an
index indicates that not all reads are equivalent at that index. A white background
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for a read indicates that it is from sequence a, and a grey background indicates the
read is from sequence b.
3. Presention of the reads in flow sequence format. These are only shown for examples
of the allele caller based on expectation. Flow sequence format is presenting the
nucleotide flows that would be incorporated during sequencing for the sequence.
For example, the sequence ATCCGTTT, is represented as the flow sequence
ATCGT. The incorporation indices are at the top, followed by a row of the
nucleotides that are incorporated. If there is any variation in the flow sequence
between reads at an index, the background of the index is shaded yellow. The read
numbers are written to the left of the read incorporations table. If a flow sequence
incorporates the base from the first row, a dot is shown. If the flow from the top
line is not incorporated for that read, a dash is shown. A white background for flow
sequence indicates the read was from sequence a and a grey background indicates
the read was from sequence b.
4. Presention of flow groups. These are only shown for examples of the allele caller
based on expectation. Flow groups are formed by grouping reads with the same
flow sequence. For each group, the read numbers that make up the group are
shown, and a consensus is calculated.
5. Presention of the reads in incorporations format. This is shown for all examples
in the read caller by clustering, but only when required in the allele caller by
expectation. Incorporations format, is presenting the number of each specified
nucleotide at that point in the sequence. For example, the sequence ATCCGTTT,
is represented in incorporations as the flow sequence ATCGT and incorporations
1,1,2,1,3, that is, one A, followed by one T, two Cs, one G and finally three Ts.
The incorporation indices are at the top, followed by a row of the nucleotides
that are incorporated. If there is any variation in the number of incorporations
between reads at an index, the background of the index is shaded yellow. The read
numbers are written to the left of the read incorporations table. The number of
incorporations of each nucleotide are all written as digits for the first read, but
subsequent reads use a dot where their incorporation matches that of the top
read and a digit if it doesn’t match the top read. A white background for read
incorporations indicates the read was from sequence a and a grey background
indicates the read was from sequence b.
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6. Presentation of the coefficients of determination. This is shown for all examples
in the read caller by clustering, but only when required in the allele caller by
expectation. Calculate the R2 between each pair of incorporations indices. The
coefficients are multiplied by ten and rounded to the nearest whole number. This
is to make visualisation easier and is only done in the thesis to improve readability,
it is not done in the actual algorithm. Additionally, the values are colour coded to
enhance the visibility of higher values (Figure 4.1).
10 Correlation with self is not relevant.
- At least one of the indices has no variation so no correlation coefficient can be calculated.










10 Perfect correlation between the indices.
Figure 4.1.: Key for coefficients of determination
4.2. Allele caller based on expectation
The allele caller based on expectation is designed to call alleles provided its expectations
of the reads to call alleles are met. These are:
• Reads cover the exons to be used for calling alleles. Reads that do not fully cover
the exon are discarded.
• Sequencing errors are predominantly due to homopolymer insertions or deletions.
• There will be enough reads to call the alleles after reads with substitution errors in
the exons are ignored.
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These expectations are based on reported read lengths, error rates and types of errors and
the amplicons chosen for sequencing. Calling alleles is based only on the exon sequences.
Therefore, any errors that occur outside of the exon sequence will not have an affect on
allele calling, unless the errors are in the MID or primer sequences, which cause the reads
to be discarded from the analysis.
4.2.1. Illustration of the algorithm
Based on the expectation that most reads will only contain homopolymer insertions
or deletions within the region used to call alleles, reads can be grouped based on their
flow sequences. A flow sequence is the sequence of flows for which one or more bases is
incorporated into the synthesised fragment during sequencing. This is best explained
using a simple example. For the sequence ATTCTGGGACC, the following flows
will be incorporated A, T, C, T, G, A, C, with the bases incorporated being one A,
followed by two Ts, one C, one T, three Gs, one A and finally 2 Cs. The flow sequence
is thus, ATCTGAC. By converting sequences into flow sequences, it is easy to group
reads that are the same except for homopolymer differences. For example, the reads
ATTCTGGGACC, ATTCTGGACC and ATTCTGGGGACC are all different,
but all have the same flow ATCTGAC, with the difference being the number of Gs
incorporated, three, two and four, for the three reads respectively.
For each exon to be used to call alleles, there will exist a set of reads and the makeup
of those reads will be dependent upon the alleles of the subject being sequenced. The
three scenarios to be examined are:
• The two alleles have the same exon sequence.
• The two alleles have exon sequences which are different and have different flow
sequences.
• The two alleles have exon sequences which are different, but have the same flow
sequences.
The three scenarios will first be examined separately, but the same algorithm handles all
three cases.
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Same exon sequence for both alleles
This will arise when the subject is homozygous for the locus being called, or when the
subject has two alleles which both have the same sequence for the exon (Figure 4.2). In
this case, the set of sequenced reads can be divided into three independent subsets:
1. Reads with no sequencing errors in the exon sequence (Figure 4.3 reads 1, 3, 6, 7
and 10). These match the sequence and flow sequence of the alleles being called.
2. Reads with only homopolymer indels errors in the exon sequence (Figure 4.3 reads
2, 4, 5, 8, 9 and 12). These match the flow sequence of the alleles being called, but
not the sequence.
3. Reads with at least one substitution error or one non-homopolymer insertion or
deletion in the exon sequence (Figure 4.3 read 11). Additionally, these reads may
also include homopolymer indels, but these will not effect their grouping. These
reads neither match the sequence nor flow sequence of the alleles being called.
Sequences
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
a & b C C T G G A A C A T T G G C G T T T
Reads
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
1 C C T G G A A - C A T T - G G - C G - T T T - 1
2 • • • • • • • - • • • • - • • G • • - • • • T 2
3 • • • • • • • - • • • • - • • - • • - • • • - 1
4 • • • • • • • - • • • • T • • - • • - • • • - 2
5 • • • • • • • - • • • • - • • - • • - • • - - 2
6 • • • • • • • - • • • • - • • - • • - • • • - 1
7 • • • • • • • - • • • • - • • - • • - • • • - 1
8 • • • • • • - - • • • • - • • - • • - • • • - 2
9 • - • • • • • - • • • • - • • - • • G • • • - 2
10 • • • • • • • - • • • • - • • - • • - • • • - 1
11 • • • • • • • - • G • • - • • - • • - • • • - 3
12 • • • • • • • A • • • • - • • - • • - • • • T 2
Flow patterns
1 2 3 4 5 6 7 8 9 10 11 12
C T G A C A G T G C G T
1 • • • • • • - • • • • •
2 • • • • • • - • • • • •
3 • • • • • • - • • • • •
4 • • • • • • - • • • • •
5 • • • • • • - • • • • •
6 • • • • • • - • • • • •
7 • • • • • • - • • • • •
8 • • • • • • - • • • • •
9 • • • • • • - • • • • •
10 • • • • • • - • • • • •
11 • • • • • - • • • • • •
12 • • • • • • - • • • • •
Flow pattern    Reads Consensus
   1 to 10C T G A C A T G C G T 12 C C T G G A A C A T T G G
   8C T G A C G T G C G T C C T G G A A C G T T G G
Figure 4.2.: Alleles with the same exon sequences
By grouping reads by their flow sequences (Figure 4.4), reads with no sequencing errors
and those with only homopolymer indels form one set, whilst those with substitutions
and/or non-homopolymer indels form one or more sets each representing different errors.
Based on the expectations, most of the reads will be in the set with the correct flow
sequence, and the set(s) with incorrect flow sequences will be small. Furthermore, the
flow sequence of the first set will match the flow sequence of the alleles being called and
except in the case where more than half of the reads have the same homopolymer error,
the consensus of the set will match the sequence of the alleles being called. In contrast,
errors that change the flow sequence in most cases will produce a flow sequence and/or a
consensus sequence that doesn’t match that of any known alleles in the database.
In the example, two sets were formed (Figure 4.5). The first contained 11 reads and
the consensus of this set matched the sequence of the alleles (Figure 4.2). The second set
contained a single read. This read was the only read with a substitution error.
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Sequences
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
a & b C C T G G A A C A T T G G C G T T T
Reads
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
1 C C T G G A A - C A T T - G G - C G - T T T - 1
2 • • • • • • • - • • • • - • • G • • - • • • T 2
3 • • • • • • • - • • • • - • • - • • - • • • - 1
4 • • • • • • • - • • • • T • • - • • - • • • - 2
5 • • • • • • • - • • • • - • • - • • - • • - - 2
6 • • • • • • • - • • • • - • • - • • - • • • - 1
7 • • • • • • • - • • • • - • • - • • - • • • - 1
8 • • • • • • - - • • • • - • • - • • - • • • - 2
9 • - • • • • • - • • • • - • • - • • G • • • - 2
10 • • • • • • • - • • • • - • • - • • - • • • - 1
11 • • • • • • • - • G • • - • • - • • - • • • - 3
12 • • • • • • • A • • • • - • • - • • - • • • T 2
Flow patterns
1 2 3 4 5 6 7 8 9 10 11 12
C T G A C A G T G C G T
1 • • • • • • - • • • • •
2 • • • • • • - • • • • •
3 • • • • • • - • • • • •
4 • • • • • • - • • • • •
5 • • • • • • - • • • • •
6 • • • • • • - • • • • •
7 • • • • • • - • • • • •
8 • • • • • • - • • • • •
9 • • • • • • - • • • • •
10 • • • • • • - • • • • •
11 • • • • • - • • • • • •
12 • • • • • • - • • • • •
Flow pattern    Reads Consensus
   1 to 10C T G A C A T G C G T 12 C C T G G A A C A T T G G
   8C T G A C G T G C G T C C T G G A A C G T T G G
Figure 4.3.: Example reads from alleles with the same exon sequences
Sequences
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
a & b C C T G G A A C A T T G G C G T T T
Reads
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
1 C C T G G A A - C A T T - G G - C G - T T T - 1
2 • • • • • • • - • • • • - • • G • • - • • • T 2
3 • • • • • • • - • • • • - • • - • • - • • • - 1
4 • • • • • • • - • • • • T • • - • • - • • • - 2
5 • • • • • • • - • • • • - • • - • • - • • - - 2
6 • • • • • • • - • • • • - • • - • • - • • • - 1
7 • • • • • • • - • • • • - • • - • • - • • • - 1
8 • • • • • • - - • • • • - • • - • • - • • • - 2
9 • - • • • • • - • • • • - • • - • • G • • • - 2
10 • • • • • • • - • • • • - • • - • • - • • • - 1
11 • • • • • • • - • G • • - • • - • • - • • • - 3
12 • • • • • • • A • • • • - • • - • • - • • • T 2
Flow patterns
1 2 3 4 5 6 7 8 9 10 11 12
C T G A C A G T G C G T
1 • • • • • • - • • • • •
2 • • • • • • - • • • • •
3 • • • • • • - • • • • •
4 • • • • • • - • • • • •
5 • • • • • • - • • • • •
6 • • • • • • - • • • • •
7 • • • • • • - • • • • •
8 • • • • • • - • • • • •
9 • • • • • • - • • • • •
10 • • • • • • - • • • • •
11 • • • • • - • • • • • •
12 • • • • • • - • • • • •
Flow pattern    Reads Consensus
   1 to 10C T G A C A T G C G T 12 C C T G G A A C A T T G G
   8C T G A C G T G C G T C C T G G A A C G T T G G
Figure 4.4.: Example flow sequences from alleles with the same exon sequences
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ReadsFlow pattern
1 to 10 & 121 C T G A C A T G C G T
112 C T G A C G T G C G T
Consensus
1 C C T G G A A C A T T G G C G T T T
2 C C T G G A A C G T T G G C G T T T
Figure 4.5.: Example flow groups and consensuses from alleles with the same exon
sequences
Two different exon sequences with different flows
This is the most common pattern that will occur for subjects that are heterozygous for
the locus being called (Figure 4.6). In this case the set of sequenced reads can be divided
into seven subsets:
1. Allele 1 reads with no sequencing errors in the exon sequence (Figure 4.7 reads 1
and 7). These match the sequence and flow sequence of allele 1.
2. Allele 1 reads with only homopolymer indels errors in the exon sequence (Figure 4.7
reads 2, 4 and 11). These match the flow sequence of allele 1, but not the sequence.
3. Allele 1 reads with at least one substitution error or one non-homopolymer insertion
or deletion in the exon sequence (Figure 4.7 read 9). Additionally, these reads may
also have homopolymer indels, but these will not effect their grouping. These reads
neither match the sequence nor flow sequence of allele 1.
4. Allele 2 reads with no sequencing errors in the exon sequence (Figure 4.7 reads 3
and 5). These match the sequence and flow sequence of allele 2.
5. Allele 2 reads with only homopolymer indels errors in the exon sequence (Figure 4.7
reads 8 and 12). These match the flow sequence of allele 2, but not the sequence.
6. Allele 2 reads with at least one substitution error or one non-homopolymer insertion
or deletion in the exon sequence (Figure 4.7 read 6). Additionally, these reads may
also have homopolymer indels, but these will not effect their grouping. These reads
neither match the sequence nor flow sequence of allele 2.
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7. Reads which have a sequence which is a recombination of the sequences from allele 1
and allele 2 (Figure 4.7 read 10). These sequences do not match the sequence of
either allele, and in the majority of cases, will not match the flow sequence of either
allele either. These reads may or may not contain other errors.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
a C C T G G A A C A T T G G C G T T T
b T C T G G A A C A T T G G G G T T T
Figure 4.6.: Alleles with the different exon sequences
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1 C C T G G A A - C A T T G G C G T T T -
2 • • • • • • • - • • • • • • • • • • - -
3 T • • • • • • - • • • • • • G • • • • -
4 • • • • • • • - • • • • • • • • • • • T
5 T • • • • • • - • • • • • • G • • • • -
6 T • • • • • G - • • • • • • G - • • • -
7 • • • • • • • - • • • • • • • • • • • -
8 T • • • • • • A • • • • • • G • • • • -
9 • • • • • • • - • • • • • • T • • • • -
10 • • • • • • • - • • • • • • G • • • • -
11 • • • • • • - - • • • • • • • • • • • -
12 T • • • • • • - • • • • • • G • • • - -
Figure 4.7.: Example reads from alleles with different exon sequences
This scenario effectively represents a duplication of what occurs when the alleles share
the same exon sequence, with the possible complication of recombinant reads. Again,
reads are grouped by their flow sequences (Figure 4.8) and the consensus calculated for
each flow group (Figure 4.9). The expectation is for two larger groups with flow sequences
and consensuses matching known alleles, and smaller groups representing errors and/or
recombinants with flow sequences and/or consensus sequences that in most cases will
not match any known alleles in the database. In the unusual example that errors or
recombination form reads which match a known allele, there will be more than two sets
of reads matching known alleles.
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In the example, five sets were formed (Figure 4.9). The first contained five reads and
the consensus of this set matched the sequence of allele 1 (Figure 4.6. The second set
contained a four reads and the consensus of this set matched the sequence of allele 2
(Figure 4.6. Sets three and four each had a single read and were formed from reads that
had substitution errors. Set five had a single read, which was a recombinant between the
two allele sequences.
T C T G A G C A T G T C G T
1 - • • • • - • • • • - • • •
2 - • • • • - • • • • - • • •
3 • • • • • - • • • • - - - •
4 - • • • • - • • • • - • • •
5 • • • • • - • • • • - - - •
6 • • • • • • • • • • - - - •
7 - • • • • - • • • • - • • •
8 • • • • • - • • • • - - - •
9 - • • • • - • • • • • - • •
10 - • • • • - • • • • - - - •
11 - • • • • - • • • • - • • •
12 • • • • • - • • • • - - - •
Figure 4.8.: Example flow sequences from alleles with different exon sequences
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ReadsFlow pattern
1 C T G A C A T G C G T 1, 2, 4, 7 & 11
2 T C T G A C A T G T 3, 5, 8 & 12
3 T C T G A G C A T G T 6
4 C T G A C A T G T G T 9
5 C T G A C A T G T 10
Consensus
1 C C T G G A A C A T T G G C G T T T
2 T C T G G A A C A T T G G G G T T T
3 T C T G G A G C A T T G G G T T T
4 C C T G G A A C A T T G G T G T T T
5 C C T G G A A C A T T G G G G T T T
Figure 4.9.: Example flow groups and consensuses from alleles with different exon
sequences
Two different exon sequences with the same flows
This is a possible but unusual pattern that will occur for some subjects that are
heterozygous for the locus being called (Figure 4.10). In this case the set of sequenced
reads will divide into nine subsets:
1. Allele 1 reads with no sequencing errors in the exon sequence (Figure 4.11 reads
1 and 9). These match the sequence and flow sequence of allele 1, and the flow
sequence of allele 2.
2. Allele 1 reads with only homopolymer indels errors in the exon sequence (Figure 4.11
reads 2 and 4). These match the flow sequence of allele 1 and allele 2, but not the
sequence of allele 1.
3. Allele 1 reads with at least one substitution error or one non-homopolymer insertion
or deletion in the exon sequence (Figure 4.11 read 11). Additionally, these reads
may also have homopolymer indels, but these will not effect their grouping. These
reads neither match the sequence nor flow sequence of allele 1 or allele 2.
4. Allele 2 reads with no sequencing errors in the exon sequence (Figure 4.11 reads
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3 and 6). These match the sequence and flow sequence of allele 2, and the flow
sequence of allele 1.
5. Allele 2 reads with only homopolymer indels errors in the exon sequence (Figure 4.11
read 5). These match the flow sequence of allele 2 and allele 1, but not the sequence
of allele 2.
6. Allele 2 reads with at least one substitution error or one non-homopolymer insertion
or deletion in the exon sequence (Figure 4.11 read 8). Additionally, these reads
may also have homopolymer indels, but these will not effect their grouping. These
reads neither match the sequence nor flow sequence of allele 2 or allele 1.
7. Reads which have a sequence which is a recombination of the sequences from allele 1
and allele 2, but have no other sequencing errors (Figure 4.11 read 10). These will
not match the sequence of either allele, but will match the flow sequence of both
alleles.
8. Reads which have a sequence which is a recombination of the sequences from
allele 1 and allele 2, and have other homopolymer indels errors in the exon sequence
(Figure 4.11 read 7). These will not match the sequence of either allele, but will
match the flow sequence of both alleles.
9. Reads which have a sequence which is a recombination of the sequences from allele 1
and allele 2, and have at least one substitution error or one non-homopolymer
insertion or deletion in the exon sequence (Figure 4.11 read 12). Additionally, these
reads may also have homopolymer indels, but these will not effect their grouping.
These reads will match neither the sequence nor flow sequence of either allele.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
a C C T G G A A C A T T G G C G T T T
b C T T G G A A C A T T G C C G T T T
Figure 4.10.: Alleles with the different exon sequences that have the same flow pattern
This is the most complicated scenario. After grouping the reads by flow patterns
(Figure 4.12), items 1, 2, 4, 5, 7 and 8 will form one large flow group, with small flow
groups being formed by the other errors (Figure 4.13). As with the first two scenarios,
the consensuses of the smaller flow groups will generally not match the sequences of
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
1 C C T G G - A A - C A - T T - G G - C G - T T T -
2 • • • • • - G • - • • - • • - • • G • • - • • - -
3 • T • • • - • • - • • - • • - • C - • • - • • • -
4 • • • • • - • • - • • - • • - • • - • • • • • • -
5 • T • • • - • • - • • - • • - • C - • • - • • • T
6 • T • • • - • • - • • - • • - • C - • • - • • • -
7 • • • • • - • • - • • A • • T • C - • • - • • • -
8 • T • • • - • • - A • - • • - • C - • • - • • • -
9 • • • • • - • • - • • - • • - • • - • • - • • • -
10 • • • • • - • • - • • - • • - • C - • • - • • • -
11 • • • • • G • • - • T - • • - • • - • • - • • • -
12 • T • • T - • A - • • - • • - • • - • • - • • • -
Figure 4.11.: Example reads from alleles with different exon sequences that have the
same flow pattern
known alleles. However, the consensus of the large group can-not be used to identify the
two different alleles that it represents. Instead, the larger flow group must be split into
at least two groups, that match the two alleles.
Splitting is accomplished using correlations to determine patterns. First, the number
of bases incorporated for each flow index in the flow pattern is calculated (Figure 4.14).
The coefficient of determination is calculated from incorporations for all reads in a flow
group for each pair of flow indices (Figure 4.15). All indices that are well correlated with
another index and have at least two well represented patterns are key indices for splitting
the reads into smaller flow groups (Figure 4.16). After the flow group has been split into
smaller groups the consensuses of all groups are calculated (Figure 4.17). The process of
splitting may also form other small flow groups that represent errors.
In the example, the reads were initially split into four groups (Figure 4.13). The
first group contained nine reads, but its consensus did not match either of the allele
sequences (Figure 4.10). Groups two and three each formed from a single read that had
a substitution error, one from the first allele and the other from the second allele. The
last group was formed from a recombinant that also contained a substitution error. After
splitting group one, four sub groups were formed. The consensuses for the sub groups
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1 2 3 4 5 6 7 8 9 10 11 12
C T G T A C A T G C G T
1 • • • - • • • • • • • •
2 • • • - • • • • • • • •
3 • • • - • • • • • • • •
4 • • • - • • • • • • • •
5 • • • - • • • • • • • •
6 • • • - • • • • • • • •
7 • • • - • • • • • • • •
8 • • • - • - - • • • • •
9 • • • - • • • • • • • •
10 • • • - • • • • • • • •
11 • • • - • • - • • • • •
12 • • • • • • • • • • • •
Figure 4.12.: Example flow sequences from alleles with different exon sequences that have
the same flow pattern
Flow pattern Reads
1 to 7, 9 & 101 C T G A C A T G C G T
2 C T G A T G C G T 8
3 C T G A C T G C G T 11
4 C T G T A C A T G C G T 12
Consensus
1 C C T G G A A C A T T G G C C G T T T
2 C T T G G A A A A T T G C C G T T T
3 C C T G G G A A C T T T G G C G T T T
4 C T T G T A A C A T T G G C G T T T
Figure 4.13.: Example flow groups and consensuses from alleles with different exon
sequences that have the same flow pattern
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one and three matched the sequences of allele one and two respectively (Figure 4.10).
Sub group two consisted of a single read that originated from allele one, but failed to
be grouped in sub group one because it had a homopolymer insertion error in one of
the key indices. Sub group four contained two recombinant reads, one of which had
homopolymer errors.
1 2 3 4 5 6 7 8 9 10 11
C T G A C A T G C G T
1 2 1 2 2 1 1 2 2 1 1 3
2 • • 3 1 • • • 3 • • 2
3 1 2 • • • • • 1 2 • •
4 • • • • • • • • • 2 •
5 1 2 • • • • • 1 2 • 4
6 1 2 • • • • • 1 2 • •
7 • • • • • 2 • 1 2 • •
9 • • • • • • • • • • •
10 • • • • • • • 1 2 • •
Figure 4.14.: Incorporations for reads from the group to be split
1 2 3 4 5 6 7 8 9 10 11
C T G A C A T G C G T
1 C 10 1 1 - 1 - 3 4 1 3
2 T 10 1 1 - 1 - 3 4 1 3
3 G 1 1 10 - 0 - 6 2 0 6
4 A 1 1 10 - 0 - 6 2 0 6
5 C - - - - - - - - - -
6 A 1 1 0 0 - - 1 1 0 0
7 T - - - - - - - - - -
8 G 3 3 6 6 - 1 - 8 1 5
9 C 4 4 2 2 - 1 - 8 2 2
10 G 1 1 0 0 - 0 - 1 2 0
11 T 3 3 6 6 - 0 - 5 2 0
Figure 4.15.: Coefficients of determination for reads from the group to be split
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61 2 2 1 2
31 2
83 4 2 2 1
13 1
38 9 2 1 2
13 1
51 2
Figure 4.16.: Incorporation patterns at well correlated indices
Correlated indices
Reads1 2 8 9
1 2 1 2 1 1, 4 & 9
2 2 1 3 1 2
3 1 2 1 2 3, 5 & 6
4 2 1 1 2 7 & 10
Consensus
1 C C T G G A A C A T T G G C G T T T
2 C C T G G G A C A T T G G G C G T T T
3 C T T G G A A A A T T G C C G T T T
4 C C T G G A A C A A T T T G C C G T T T
Figure 4.17.: Consensuses for sub groups of the group that was split
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4.2.2. Algorithm
Based on the three scenarios presented (Section 4.2.1) the following steps are carried
out to predict the most likely allele pairs for each locus tested for each sample in the
sequencing run.
1. For each lane - Separate reads by MID tags
During amplification, the DNA is amplified with primers tagged with an 11 base
MID tag. Each sample pooled in the same lane has a different MID tag, but the
same MID tag is used for all amplifications for that sample. Therefore, separating
the reads into groups that represent the samples is simply a matter of sorting the
reads by their first 11 bases. Read groups that have the first eleven bases matching
known MID tags are assigned to the sample that was amplified with that MID tag.
MID tags are all at least four nucleotides different from other MID tags and the
differences are substitutions. Therefore, it is extremely improbable that one MID
tag will match another MID tag due to sequencing errors. Furthermore, because
the MID tag is at the front of the read, the errors should be low. Any reads where
the first 11 bases do not match an expected MID tag exactly are discarded.
2. For each MID tag - Separate reads by primer sequence
The sequence immediately following the MID tag in the reads should match one of
the primers used for amplification. These primers identify which gene and which
exon within the gene is being amplified. Reads are sorted into those matching the
known primer pairs, again by matching the expected sequences exactly. Reads with
any errors in the primer region are discarded. For HLA-A, B, C, DPB1 and DQB1,
the primer sequences uniquely identify the gene. However, for HLA-DRB1, DRB3,
DRB4 and DRB5, the same primer pair is used to amplify exon 2 of whichever of
the four genes that are present.
3. For each locus - Align reads from appropriate primer to exon sequences
Subsequent to separating the reads, each locus of each sample is analysed separately.
HLA-A, B, C, DPB1 and DQB1 alleles are called by analysing the reads assigned
to the primers for those genes. For the HLA-DRB genes, the same set of reads is
analysed four times, once for each possible gene.
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The first step in the analysis is to align each of the reads in the set to a reference
allele (Table 4.1). A Gotoh pairwise aligner with a gap opening penalty of 10, a
gap extension penalty of 4, a mismatch penalty of 5 and a match score of 4 is used
to align the reads. Reads that do not cover all bases of an exon are discarded.












Table 4.1.: HLA reference alleles
HLA-A Exon 2 reference HLA-A Exon 3 reference
Figure 4.18.: Trimming reads to exon boundaries
4. Calculate flow patterns and flow incorporations for trimmed reads
The flow patterns can be calculated by replacing all homopolymer runs in the read
with a single nucleotide, or by taking the first nucleotide from each homopolymer
44
4. HLA allele callers
run, including runs of a single nucleotide. Flow incorporations are the number of
times each flow nucleotide is incorporated in the sequence. The read is described
by and stored in two related structures, the flow pattern and the incorporations
(Figure 4.19).
5. Group reads by flow pattern
Reads are then separated into flow groups based on their flow patterns. This means
that not only will reads that are exactly the same over the trimmed region be
grouped together, but also reads that have the same flow sequence, but different
incorporations. In the extreme, this means that AAAGTT would be grouped
with reads as divergent as AGGGGT and AGTTTTT. However, in practice,
because all reads come from real alleles and error rates are low, they tend to be
very similar. The changes in incorporations that commonly occur between real
alleles with the same flow sequence, tend to occur in pairs to avoid phase shifts.
For example, the mock sequences AGG TCA GTA and AGT TCA GTA with
a pair of incorporation changes, are much more likely than AGG TCA GTA
and AGG TTC AGT A, because the single incorporation change in the second
example has caused a phase shift for the third codon and all subsequent codons.
6. Calculate correlated indices for each flow group
To determine whether it is likely that a flow group represents more than one
exon sequence, correlations are calculated between all flow indices. A pair of flow
indices is considered sufficiently correlated if the correlation coefficient exceeds
the minimum correlation required and there are two patterns each with at least a
threshold number of reads. In the example (Figure 4.16), the minimum correlation
required is R2 ≥ 0.7 and the minimum number of reads for a pattern is 3. Based
on these rules, in order to split a pair of alleles that have the same flow for one of
their exons, there must be at least twice the threshold number of reads for that
exon in order to identify both alleles, i.e. at least six reads in this example. With
less than this number of reads, it is not possible to split it into two groups each
containing at least the threshold number of reads.
7. If there are well correlated indices - Group reads by patterns at correlated indices
Once the well correlated indices that have two or more groups with enough reads
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Sequences
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
a C C T G G A A C A T T G G C G T T T
b T C T G G A A C A T T G G G G T T T
Reads
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1 C C T G G A A - C A T T G G C G T T T -
2 • • • • • • • - • • • • • • • • • • - -
3 T • • • • • • - • • • • • • G • • • • -
4 • • • • • • • - • • • • • • • • • • • T
5 T • • • • • • - • • • • • • G • • • • -
6 T • • • • • • - • • • • • • G - • • • -
7 • • • • • • • - • • • • • • • • • • • -
8 T • • • • • • A • • • • • • G • • • • -
9 • • • • • • • - • • • • • • • • • • • -
10 • • • • • • • - • • • • • • G • • • • -
11 • • • • • • - - • • • • • • • • • • • -
12 T • • • • • • - • • • • • • G • • • - -
IncorporationsFlows
1 C T G A C A T G C G T 2 1 2 2 1 1 2 2 1 1 3
2 C T G A C A T G C G T 2 1 2 2 1 1 2 2 1 1 3
3 T C T G A C A T G T 1 1 1 2 2 1 1 2 4 3
4 C T G A C A T G C G T 2 1 2 2 1 1 2 2 1 1 4
5 T C T G A C A T G T 1 1 1 2 2 1 1 2 4 3
6 T C T G A C A T G T 1 1 1 2 2 1 1 2 3 3
7 C T G A C A T G C G T 2 1 2 2 1 1 2 2 1 1 3
8 T C T G A C A T G T 1 1 1 2 3 1 1 2 4 3
9 C T G A C A T G C G T 2 1 2 2 1 1 2 2 1 1 3
10 C T G A C A T G T 2 1 2 2 1 1 2 4 3
11 C T G A C A T G C G T 2 1 2 1 1 1 2 2 1 1 3
12 T C T G A C A T G T 1 1 1 2 2 1 1 2 4 2
Figure 4.19.: Converting reads to flow patterns and incorporations
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are calculated, they are selected as the only parts of the reads that can be used
to separate the reads into groups. Even if an index occurs in more than one well
represented correlation pair, it is only counted once. In the example, indices, 1 & 2
and 8 & 9 both have at least two well represented patterns, so the larger pattern for
forming the groups is created based on indices 1, 2, 8 and 9 (Figure 4.16). Indices 3
and 4 are not part of the larger pattern, despite being perfectly correlated because
they had one well represented pattern. Based on the selected indices, the reads can
be divided into four groups (Figure 4.17). Groups 1 and 3 represent the two alleles,
group 2 is the result of sequencing errors at one of the indices used to split the flow
group, and group 4 is a recombinant between 1 and 3.
8. Calculate consensus sequences for each flow group
The consensus is calculated as a majority rules consensus. It is calculated by
rounding the average incorporations at each flow index to the nearest integer and
then reconstructing the sequence from the flow and average incorporations. For
example, the flow ACG with three reads with the following incorporations 1-2-1,
1-1-1, and 1-2-2, will have average incorporations of 1-1.67-1.33, which rounds to
1-2-1. The consensuses is then one A followed by two Cs and finally one G, or
ACCG.
9. Calculate all possible alleles that have flows matching a flow group for all exons
sequenced
All alleles from the IMGT database [3] are examined as possible candidates to
match the flow groups. For each possible allele the flow pattern for each sequenced
exon is calculated and compared to the flow patterns from the flow groups. All
alleles that have matching flow patterns for all sequenced exons are flagged as
candidate alleles.
10. Calculate all possible pairs of alleles from the alleles in the previous step
All possible combinations of candidate alleles are then calculated. This includes
homozygous combinations. Therefore, if there were three candidate alleles X, Y
and Z, there would be six possible combinations: XX; XY; XZ; YY; YZ and ZZ.
11. Rank the possible pairs of alleles
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To determine which of all of the possible allele combinations is the best allele pair,
all allele pairs are ranked based on six ranking methods. Only allele pairs which
are ranked first in at least one ranking method are considered to be possibly the
best allele pair. The ranking methods are:
• Coverage
Rank based on: Total amount of reads used to call both alleles; then the
minimum number of reads for any exon used to call both alleles; then the
maximum number of incorporation differences between the read consensus and
the allele sequence; and finally by the total number of incorporation differences
between all exon consensus sequences and the allocated allele exon sequences.
• Consensus errors
Rank based on: the maximum number of incorporation differences between the
read consensus and the allele sequence; then the total number of incorporation
differences between all exon consensus sequences and the allocated allele exon
sequences; then the total amount of reads used to call both alleles; and finally
the minimum number of reads for any exon used to call both alleles.
• Average read errors
Rank based on: the maximum average number of incorporation differences
between the reads for an exon and the allele sequence; then the sum total of
the average number of incorporation differences between the reads for an exon
and the allocated allele exon sequences; then the total amount of reads used
to call both alleles; and finally the minimum number of reads for any exon
used to call both alleles.
• Warning counts
Rank based on the number of warnings raised for the allele pair call. Warnings
are allocated for:
– Less than a threshold number of reads for an exon.
– Reads for an exon shared between both alleles called.
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– The number of reads used to call an exon are less than a set of reads for
the same exon that are not used to call either allele for this gene.
– Possible primer bias, due to the difference in reads for an exon to call one
allele versus the other allele. A warning is raised if the ratio of reads used
by the two alleles for the exon exceeds a threshold.
– Incorporation differences between the called allele sequence and the exon
consensus sequence from the reads used to call the allele. For example, if
the consensus is AGGCAGT and the assigned reference has a sequence
of AGCAGT, the incorporation difference is one, because the consensus
has one more G than the assigned reference allele.
• Common and well documented allele (CWD) counts
Rank based on: The number of common alleles and then the number of well
documented alleles [97]. If two allele pairs are equivalent, except for a phasing
difference between the exonic sequences, they are both ranked with the CWD
score of the highest ranking pair. For example, the exon 2 and 3 sequences for
the allele pair HLA-C*07:01:01:01 plus HLA-C*07:02:01:01 are the same as
for the allele pair HLA-C*07:19 plus HLA-C*07:27:01. However, the pairing
between exon 2 and exon 3 sequences is different. For these two allele pairs,
HLA-C*07:01:01:01 plus HLA-C*07:02:01:01 has two common alleles, whereas
HLA-C*07:19 plus HLA-C*07:27:01 has two well documented alleles. Without
phasing data between exon 2 and exon 3, or sequence data from other parts
of the gene, there is no way to distinguish between these pairings and thus,
they should be ranked equally. Hence both pairs, in this example, are ranked
as if they have two common alleles.
• Rankings
Rank based on the sum of all of the other rankings (See Table 4.2 for an
example).
12. Report the best ranking allele pair and any other high ranking allele pairs as
alternative options
All possible allele pairs are then ranked based on the number of number one rankings
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Pair Cov CE RE Warn CWD Sum Rank
1 1 1 1 1 2 6 1
2 2 2 2 3 1 10 2
3 2 3 3 2 1 11 3
Table 4.2.: Calculating the rankings ranking based on other rankings
(Cov = Coverage ranking, CE = Consensus error ranking, RE = Read error ranking, Warn = Warnings ranking, CWD
= Common and Well Documented allele count ranking, Sum = sum of previous five columns, Rank = Rankings ranking)
they achieved across the six ranking categories. Allele pairs that did not achieve at
least one first ranking are not reported. The allele pair(s) with the most number
one rankings are given a “Yes” rating, unless they achieve less than four number
one ratings, in which case it is rated as “Maybe”. Allele pairs are also rated as
“Maybe” if they are within two first rankings of the best allele pair. All other allele
pairs are given a “No” rating. In addition to a rating as to whether the allele caller
rates the allele pair as the best option, a rating is given as to the confidence rating
of the call. An allele pair may be the best possible call the caller can make, but
it may still not appear to be a very good call. For example, if a sample is called
homozygous for a locus based on one read for each exon, there is a high likelihood
it is going to be an incorrect call. The thresholds for values used to call the alleles
that are used to set use recommended to “High”, “Medium” and “Low” will be
derived based on a subset of the data analysed.
13. Create an aligned file including the reads, primers and possible alleles
When a person inspects the allele calls, most of the calls on a good run will have a
single allele pair with a “Yes” rating for use best call, which is made with “High”
confidence and no warnings, and all other allele pairs with “No” ratings for best
call. These calls can be accepted with confidence. However, in the case where
there are “Maybe” ratings for best call, or the best calls have “Medium” or “Low”
confidence, warnings or homozygosity, the user will need to investigate the call
further. One important step of further investigation is to look at the aligned reads.
Preempting this requirement, the software does an alignment of the reads against a
reference for that locus, and also aligns the primers used and exon sequences from
all possible alleles.
All calls used in this thesis are the highest ranked “Yes” or “Maybe” classified
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allele pair. That is no human interpretation has been used. Human intervention
can improve the quality of calls, but has been excluded from this thesis to make
the results more transparent and 100% repeatable. When the caller is used by the
IIID staff, two people independently check the results, which often involves using
these alignments.
4.3. Allele caller based on clustering
The second allele caller breaks the challenge of calling alleles into separating the reads
for each exon into groups, one for each allele, and then calculating the consensus of
the groups and matching those to known alleles. Separating reads into groups can be
viewed as forming groups where the variation between reads within the group is less
than the variation between groups. This is essentially a clustering exercise, which leaves
three decisions to be made. First, which clustering algorithm to use. Second, how to
calculate distances between reads and finally, how to know whether the clusters formed
are suitable groups to represent the alleles.
4.3.1. Clustering algorithm
In most cases, the reads being separated for an exon will represent two groups. This will
occur when the subject is heterozygous for that locus and no off-target reads are amplified
by the primers for the exon. In some cases, the reads will all belong to the same group.
This represents either the subject being homozygous for that locus, or being heterozygous
but having two alleles that have the same sequence for the exon being analysed, or one
allele dropping out and not having any reads present for analysis. In some cases, three or
more groups may be formed. The first example of this is for reads captured by the DRB
primers. These reads may be from DRB1, 3, 4 or 5, or from other DRB genes not being
called. Therefore, depending on the genotype of the subject, there may be between one
group and four groups. For example, HLA-DRB1*01:01:01G homozygous, with no DRB3,
4 or 5 genes has a single group, and HLA-DRB1*03:01:01G + HLA-DRB1*04:01:01G +
HLA-DRB3*01:01:01 + HLA-DRB4*01:01:01 has four groups. If the primer amplifies
some off-target genes, this number may increase. Good primer design can minimise the
amplification of off-target genes. It has been observed in the sequencing data used in
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this thesis that primers for HLA-DRB1, 3, 4 and 5, also can amplify HLA-DRB7, and
HLA-B rarely also amply HLA-C at low levels. Not knowing how many groups the reads
need to be clustered into represents a challenge for the clustering algorithm, with many
algorithms requiring the number of groups as an input parameter, [see for example 98].
To overcome this, either the clustering method that calculates the number of groups
must be used, or the clustering can be run several times, each with a different number of
expected groups, and then a method used to choose the best clustering output. This
thesis chose the later option, choosing clustering by affinity propagation [99].
4.3.2. Distances between reads
A simple distance calculation would be to perform a pairwise alignment between each
pair of reads and set the distance to the number of mismatches between the aligned pair.
This is called the Hamming distance, but has not been chosen for this thesis because it
treats all mismatches equally. A mismatch caused by an error in the sequencing pipeline
is always scored the same as a mismatch due to a true difference between sequences. The
method used in this thesis aims to weight differences based on their pattern of occurrence
across the whole dataset, the argument being that looking at read pairs in isolation
misses valuable data that can be used to better estimate the distance.
This is best illustrated using simple examples. In the examples, the dataset consists of
a mixture of two distinct sequences. The method is not limited to two sequences, but
using just two sequences simplifies the examples.
When examining a set of reads sequenced from a mixture of two unknown sequences, a
and b, three factors influence how difficult it is to separate the reads into those matching
a and those matching b:
Number of differences between a and b It is easier to differentiate between a and b
if there are multiple differences between the sequences. At the extreme, a single
difference is the smallest distinction between two different sequences. This single
difference may be a substitution or an indel. An indel is an insertion in one sequence
with respect to the other which could also be viewed as a deletion in one sequence
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with respect to the other. Note that in coding regions, a single insertion or deletion
will cause a change in reading frame from that point in the sequence onwards.
Number of reads of a and b A large number of reads from each sequence is ideal when
trying to identify the original sequences. However, there may be a low number of
reads from one of the sequences, due to differences in original template numbers of
the two sequences, preferential amplification of one sequence over the other, or poor
sequencing of one sequence. If there are a small number of reads in total, it is likely
that one sequence will not have enough reads present to be identified unless the
sequences are mixed in fairly even proportions. The more reads that are present,
the greater the chance of recovering low frequency sequences from mixtures.
Number of errors in the sequenced reads Errors in the sequenced reads make the
identification of the original sequence more difficult. It may be impossible to
reconstruct the original sequence(s), if the errors are systematic and frequent
enough. The errors can stem from a number of sources, including:
1. Damaged template material.
2. Amplification transcription errors.
3. Recombination during amplification.
4. Errors during sequencing.
The easiest scenario is where there are a large number of differences between a and b,
a large number of reads match each sequence and there are few errors. In practice, the
situation will often be more difficult and potentially impossible when one or more of the
factors is not ideal. For example, if a sequence present at low frequency has only a single
difference from the sequence forming the majority of the sample, it may be impossible to
determine whether the reads belong to a single sequence or two distinct sequences. The
likelihood of being able to isolate the two sequences is also dependent upon whether the
difference between them matches the error profile of the sequencing platform.
The following examples show the effects of multiple versus single substitution and
single indel differences, and the effects of errors. Separate examples are not presented
to show the effects of low numbers of reads representing one of the sequences. Rather
53
4. HLA allele callers
the effect low numbers of reads have will be discussed as part of the other examples.
The example of a single substitution difference between sequences with errors will be
extended to show the difference in distances calculated using the methodology from this
thesis versus calculating distances based on the Hamming distance between aligned read
pairs. This example is chosen because it represents the most difficult challenge that can
be reliably answered using GS-FLX sequencing. At the conclusion of this example, the
effects of multiple differences and indels will be discussed.
Multiple differences between a and b with NO errors
The sequences, a and b, are 21 nucleotides long, and have four differences (Figure 4.20).
The differences are at indices 4, 10, 11 and 17. All four differences are substitutions.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
a G A C C T G G A A C A T T A G C G T T T A
b G A C T T G G A A A C T T A G C A T T T A
Figure 4.20.: Reads for alleles, with multiple differences
The reads from the sequencing data for sequences a and b show the differences as an
easily recognised pattern (Figure 4.21). Reads 1, 2, 5, 6, 9 and 11 are from sequence a
and reads 3, 4, 7, 8, 10 and 12 are from sequence b. Looking at the reads, the following
are easy to see:
1. There are several SNPs relative to the fully spelt out read on the top row.
2. The SNPs are present at the indices that differentiate sequence a, from sequence b
(4, 10, 11 and 17).
3. The SNPs occur in repeating patterns. These patterns can be used to separate
the reads into two groups. The patterns at indices 4, 10, 11 and 17 are CCAG or
TACA.
These observations seem obvious, but things are only so clear because there are no
errors.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
1 G A C C T G G A A C A T T A G C G T T T A
2 • • • • • • • • • • • • • • • • • • • • •
3 • • • T • • • • • A C • • • • • A • • • •
4 • • • T • • • • • A C • • • • • A • • • •
5 • • • • • • • • • • • • • • • • • • • • •
6 • • • • • • • • • • • • • • • • • • • • •
7 • • • T • • • • • A C • • • • • A • • • •
8 • • • T • • • • • A C • • • • • A • • • •
9 • • • • • • • • • • • • • • • • • • • • •
10 • • • T • • • • • A C • • • • • A • • • •
11 • • • • • • • • • • • • • • • • • • • • •
12 • • • T • • • • • A C • • • • • A • • • •
Figure 4.21.: Reads for alleles, with multiple differences and no sequencing errors
Converting the reads to incorporations does not hinder the observation of patterns
(Figure 4.22). Looking at the incorporations for the reads, the following are easy to see:
1. There are six indices at which the incorporations vary between reads (3, 4, 6, 8, 13
and 14).
2. The change in incorporations occur in repeating patterns with the incorporations
at indices 3, 4, 6, 8, 13, and 14, either 2, 1, 2, 1, 1, 0, or 1, 2, 3, 0, 0, 1.
The coefficients of determination for this example show perfect correlations between
each pair of indices where both indices change (indices 3, ,4, 6, 8, 13 and 14) and no
coefficient of determination can be calculated for all other pair of indices (Figure 4.23).
All of the patterns recognised for this example are not dependent upon the ratio of
the number of reads for each sequence. In this example, there were six reads for each
sequence. However, it would have been possible to see two sequences even if there had
only been a single read for one sequence and eleven reads for the other sequence. The
single read for the minor species would have appeared as an ”odd read out” in both the
reads view and the incorporations view. Furthermore, the coefficients of variation would
be unchanged from the example presented. Even at this extremely unbalanced ratio of
read for the sequences, it would appear clear that the single read was different from the
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
G A C T G A C A T A G C G A T A
1 1 1 2 1 2 2 1 1 2 1 1 1 1 0 3 1
2 • • • • • • • • • • • • • • • •
3 • • 1 2 • 3 • 0 • • • • 0 1 • •
4 • • 1 2 • 3 • 0 • • • • 0 1 • •
5 • • • • • • • • • • • • • • • •
6 • • • • • • • • • • • • • • • •
7 • • 1 2 • 3 • 0 • • • • 0 1 • •
8 • • 1 2 • 3 • 0 • • • • 0 1 • •
9 • • • • • • • • • • • • • • • •
10 • • 1 2 • 3 • 0 • • • • 0 1 • •
11 • • • • • • • • • • • • • • • •
12 • • 1 2 • 3 • 0 • • • • 0 1 • •
Figure 4.22.: Incorporations for alleles, with multiple differences and no sequencing errors
other eleven reads.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
1 - - - - - - - - - - - - - - - -
2 - - - - - - - - - - - - - - - -
3 - - 10 10 - 10 - 10 - - - - 10 10 - -
4 - - 10 10 - 10 - 10 - - - - 10 10 - -
5 - - - - - - - - - - - - - - - -
6 - - 10 10 - 10 - 10 - - - - 10 10 - -
7 - - - - - - - - - - - - - - - -
8 - - 10 10 - 10 - 10 - - - - 10 10 - -
9 - - - - - - - - - - - - - - - -
10 - - - - - - - - - - - - - - - -
11 - - - - - - - - - - - - - - - -
12 - - - - - - - - - - - - - - - -
13 - - 10 10 - 10 - 10 - - - - 10 10 - -
14 - - 10 10 - 10 - 10 - - - - 10 10 - -
15 - - - - - - - - - - - - - - - -
16 - - - - - - - - - - - - - - - -
Figure 4.23.: Coefficients of determination for read incorporations for sequences with
multiple differences and no sequencing errors
A single substitution between a and b with NO errors
The sequences, a and b, are 21 nucleotides long, and differ at only a single substitution
at index 8 (Figure 4.24).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
a G A C C T G G A A C A T T A G C G T T T A
b G A C C T G G G A C A T T A G C G T T T A
Figure 4.24.: Sequences for alleles, with a single substitution difference
The reads from the sequencing data for sequences a and b show a clear pattern
(Figure 4.25). Looking at the reads, the following are easy to see:
1. Reads either match the top read exactly or differ only at a single SNP site.
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2. All reads that have a SNP have it at index 8.
Again these observations seem obvious, because there are no errors.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
1 G A C C T G G A A C A T T A G C G T T T A
2 • • • • • • • G • • • • • • • • • • • • •
3 • • • • • • • • • • • • • • • • • • • • •
4 • • • • • • • • • • • • • • • • • • • • •
5 • • • • • • • G • • • • • • • • • • • • •
6 • • • • • • • • • • • • • • • • • • • • •
7 • • • • • • • G • • • • • • • • • • • • •
8 • • • • • • • • • • • • • • • • • • • • •
9 • • • • • • • G • • • • • • • • • • • • •
10 • • • • • • • G • • • • • • • • • • • • •
11 • • • • • • • • • • • • • • • • • • • • •
12 • • • • • • • G • • • • • • • • • • • • •
Figure 4.25.: Reads for alleles, with a single substitution difference and no sequencing
errors
Converting the reads to incorporations does not hinder the observation of patterns
(Figure 4.26). Looking at the incorporations for the reads, the following are easy to see:
1. There are two indices at which the incorporations vary between reads (five and
six).
2. The change in incorporations occur in repeating patterns with the incorporations
at indices five and six, either 2, 2, or 3, 1.
The coefficients of determination for this example show perfect correlations between
indices five and six, and no coefficient of determination can be calculated for all other
pair of indices (Figure 4.27).
All of the patterns recognised for this example are not dependent upon the ratio of
the number of reads for each sequence. In this example, there were six reads for each
sequence. It would have been possible to see two sequences even if there had only been a
single read for one sequence and eleven reads for the other sequence. The single read for
58
4. HLA allele callers
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
G A C T G A C A T A G C G T A
1 1 1 2 1 2 2 1 1 2 1 1 1 1 3 4
2 • • • • 3 1 • • • • • • • • •
3 • • • • • • • • • • • • • • •
4 • • • • • • • • • • • • • • •
5 • • • • 3 1 • • • • • • • • •
6 • • • • • • • • • • • • • • •
7 • • • • 3 1 • • • • • • • • •
8 • • • • • • • • • • • • • • •
9 • • • • 3 1 • • • • • • • • •
10 • • • • 3 1 • • • • • • • • •
11 • • • • • • • • • • • • • • •
12 • • • • 3 1 • • • • • • • • •
Figure 4.26.: Incorporations for alleles, with a single substitution and no sequencing
errors
the minor species would have appeared as an ”odd read out” in both the reads view and
the incorporations view. Furthermore, the coefficients of variation would be unchanged
from the example presented. However, at this extremely unbalanced ratio of reads for the
sequences, the odd read out is so similar to the other reads that it could not be classified
as being from a different sequence to the other reads with confidence.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 - - - - - - - - - - - - - - -
2 - - - - - - - - - - - - - - -
3 - - - - - - - - - - - - - - -
4 - - - - - - - - - - - - - - -
5 - - - - 10 10 - - - - - - - - -
6 - - - - 10 10 - - - - - - - - -
7 - - - - - - - - - - - - - - -
8 - - - - - - - - - - - - - - -
9 - - - - - - - - - - - - - - -
10 - - - - - - - - - - - - - - -
11 - - - - - - - - - - - - - - -
12 - - - - - - - - - - - - - - -
13 - - - - - - - - - - - - - - -
14 - - - - - - - - - - - - - - -
15 - - - - - - - - - - - - - - -
Figure 4.27.: Coefficients of determination for read incorporations for sequences with a
single substitution difference and no sequencing errors
A single deletion / insertion difference between a and b with NO errors
The sequences, a and b, are 21 nucleotides long, and differ at index 12 where sequence
b has a deletion compared to sequence a, or it could be viewed that sequence a has an
insertion compared to sequence b (Figure 4.28).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
a G A C C T G G A A C A T T A G C G T T T A
b G A C C T G G A A C A - T A G C G T T T A
Figure 4.28.: Sequences for alleles, with a single indel difference
Reads from the sequencing data for sequences a and b show the difference as an easily
recognised pattern (Figure 4.29). Looking at the reads, the following are easy to see:
1. Reads either match the top read exactly or differ only by a deletion at a single site.
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2. All reads that have a deletion have it at index 12
Again these observations seem obvious, because there are no errors.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
1 G A C C T G G A A C A T T A G C G T T T A
2 • • • • • • • • • • • • • • • • • • • • •
3 • • • • • • • • • • • - • • • • • • • • •
4 • • • • • • • • • • • - • • • • • • • • •
5 • • • • • • • • • • • - • • • • • • • • •
6 • • • • • • • • • • • • • • • • • • • • •
7 • • • • • • • • • • • • • • • • • • • • •
8 • • • • • • • • • • • • • • • • • • • • •
9 • • • • • • • • • • • - • • • • • • • • •
10 • • • • • • • • • • • • • • • • • • • • •
11 • • • • • • • • • • • - • • • • • • • • •
12 • • • • • • • • • • • - • • • • • • • • •
Figure 4.29.: Reads for alleles, with a single indel and no sequencing errors
Converting the reads to incorporations does not hinder the observation of patterns
(Figure 4.30). Looking at the incorporations for the reads, the following are easy to see:
1. There is a single index at which the incorporations vary between reads (9).
The coefficients of determination for this example show that no coefficient of determin-
ation can be calculated for all pairs of indices (Figure 4.31). This is because only a single
index has variation. In order for coefficients of determination to be calculated, there
must be at least two indices that have variation. That is, in order to identify indices of
variation between sequences, the two sequences must differ by at least two indels or at
least one substitution. Combinations of indels and substitutions will also be detectable.
All of the patterns recognised for this example are not dependent upon the ratio of
the number of reads for each sequence. In this example, there were six reads for each
sequence. It would have been possible to see two sequences even if there had only been a
single read for one sequence and eleven reads for the other sequence. The single read for
the minor species would have appeared as an ”odd read out” in both the reads view and
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
G A C T G A C A T A G C G T A
1 1 1 2 1 2 2 1 1 2 1 1 1 1 3 1
2 • • • • • • • • • • • • • • •
3 • • • • • • • • 1 • • • • • •
4 • • • • • • • • 1 • • • • • •
5 • • • • • • • • 1 • • • • • •
6 • • • • • • • • • • • • • • •
7 • • • • • • • • • • • • • • •
8 • • • • • • • • • • • • • • •
9 • • • • • • • • 1 • • • • • •
10 • • • • • • • • • • • • • • •
11 • • • • • • • • 1 • • • • • •
12 • • • • • • • • 1 • • • • • •
Figure 4.30.: Incorporations for alleles, with a single indel and no sequencing errors
the incorporations view. Furthermore, the coefficients of variation can-not be calculated
for reads only differing at a single index site, regardless of the ratio of the reads for
each sequence. At this extremely unbalanced ratio of reads for the sequences, the odd
read out is so similar to the other reads that it could not be classified as being from a
different sequence to the other reads with confidence. The identification of reads from two
sequences only differing by a single indel can only be based on a count and percentage of
reads threshold required to give confidence that the indels are real. This threshold will
be dependent upon the sequencing pipeline. For example, the cutoff would be higher
when using a sequencing platform such as GS-FLX that has a higher indel sequencing
error rate than a platform such as Illumina MiSeq which has few indel sequencing errors.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 - - - - - - - - - - - - - - -
2 - - - - - - - - - - - - - - -
3 - - - - - - - - - - - - - - -
4 - - - - - - - - - - - - - - -
5 - - - - - - - - - - - - - - -
6 - - - - - - - - - - - - - - -
7 - - - - - - - - - - - - - - -
8 - - - - - - - - - - - - - - -
9 - - - - - - - - 10 - - - - - -
10 - - - - - - - - - - - - - - -
11 - - - - - - - - - - - - - - -
12 - - - - - - - - - - - - - - -
13 - - - - - - - - - - - - - - -
14 - - - - - - - - - - - - - - -
15 - - - - - - - - - - - - - - -
Figure 4.31.: Coefficients of determination for read incorporations for sequences with a
single index difference and no sequencing errors
Summary of the examples with NO errors
In the three examples presented so far, the three views presented; reads, incorporations,
and coefficients of determination, all offer useful data for separating the reads into two
groups representing the a and b sequences. Their uses can be summarised as follows:
• Reads view: patterns can be seen visually and the distance between a pair of reads
could be calculated as the number of indices at which the reads differ. This will
work for all three examples. However, if there is a major imbalance in the ratio of
reads, this method will not be able to separate reads from sequences differing at a
single nucleotide, with confidence.
• Incorporations view: patterns can be seen visually and the distance between a pair
of reads could be calculated as the sum of the differences in incorporations at the
indices at which the reads differ. This will work for all three examples. However, if
there is a major imbalance in the ratio of reads, this method will not be able to
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separate reads from sequences differing at a single nucleotide, with confidence.
• Coefficients of determination: The incorporation indices that are different between
the sequences are perfectly correlated with each other in the examples that two or
more variable indices exist. However, this measure is incapable of identifying the
variable index in the example that only had a single indel difference between the
sequences to be separated. Additionally, this metric was unchanged by the ratio of
reads belonging to each sequence.
Based on these trivial examples, where there are no sequencing errors, separating
the reads into groups representing the sequences they represent is an easy classification
exercise where the reads are grouped by the sequence or incorporation pattern. It would
also be possible to calculate the distances between reads or their incorporations and
then group the reads using clustering, but that would offer no advantage when there
are no errors. The incorporations view offers no advantages over the reads view and the
coefficients of determination do not offer anything that could not be derived from the
reads or incorporations view.
Multiple differences between a and b with sequencing errors
The sequences a and b, are the same as used in the example for multiple differences
and no sequencing errors (Figure 4.20). Similarly, the reads used are the same as in
that example (Figure 4.21). However, six insertion errors, six deletion errors and six
substitution errors have been added (Figure 4.32). This represents an average of 1.5
errors per read. Additionally, read 9 is a recombinant of sequence a and b. Examining
the reads with errors, the following can be observed:
1. There are a lot of SNPs relative to the fully spelt out read on the top row.
2. There are several insertions and deletions relative to the fully spelt out read on the
top row.
3. There are 16 indices that are variable between the reads. Four of these are due to
differences between the sequences and twelve are a result of errors.
4. A repeating pattern of SNPs at indices 4, 12, 13 and 19 is still discernible.
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5. It is difficult to tell whether repeated errors, such as the homopolymer insertion at
index 20 are patterns.
6. The addition of errors has made the trivial example of Figure 4.21 much more
challenging.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
1 G A C C T - G G - A A C A T T A G C G - T T T A
2 • • • • • G • • A • • • • • • • • • • - - • • •
3 • G • T • - • • - • • A C • • • • • A - • • • •
4 • • • T • - • A - • • A C • • • • • A T • • • •
5 • • • • • - • • - - • • • • • • • • • - • • • •
6 • • • • C - - • - • • • • • • • • T • T • • • •
7 • • • T • - • • - • • A C C • • • • A - • • • •
8 • • • T • G • • - • • A C • • • • • A - • • • •
9 • • • • • - • • - • • • • • • • • • • - • • • •
10 • • • T • - • • - • • A C - • • • • A - - • • •
11 • • • • • - • • - - • • • • • • • • • - • • A •
12 • • • • • - • • - • • • • • • • • • A T • • • •
Figure 4.32.: Reads for alleles, with multiple differences and sequencing errors
Converting the reads to incorporations does not make the patterns easier to visualise
(Figure 4.33). Looking at the incorporations, the following can be observed:
1. Patterns are no longer obvious in the figure.
2. There are now 15 variable indices in the read incorporations. Nine of these indices
are due to errors.
3. Errors are also present at the indices that represent true differences between the
sequences.
4. With careful observation, a repeating pattern at indices 3, 4, 6, 8, 14 and 15 is still
discernible.
5. It is not clear whether differences between reads are the result of substitutions,
insertions or deletions.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
G A C T G A C A T A G T C G A T A
1 1 1 2 1 2 2 1 1 2 1 1 0 1 1 0 3 1
2 • • • • 3 3 • • • • • • • • • 2 •
3 2 0 1 2 • 3 • 0 • • • • • 0 1 • •
4 • • 1 2 1 4 • 0 • • • • • 0 1 4 •
5 • • • • • 1 • • • • • • • • • • •
6 • • 3 0 1 • • • • • • 1 0 • • 4 •
7 • • 1 2 • 3 2 0 1 • • • • 0 1 • •
8 • • 1 2 3 3 • 0 • • • • • 0 1 • •
9 • • • • • • • • • • • • • • • • •
10 • • 1 2 • 3 • 0 1 • • • • 0 1 2 •
11 • • • • • 1 • • • • • • • • • 2 2
12 • • • • • • • • • • • • • 0 1 4 •
Figure 4.33.: Incorporations for alleles, with multiple differences and sequencing errors
The coefficients of determination for this example show that scores can be calculated for
all pairs of indices, except pairs involving indices 10 or 11 which are constant (Figure 4.34).
Examining the scores for coefficients of determination, the following can be seen:
1. There are perfect correlations between four pairs of indices.
2. There are many completely uncorrelated pairs of indices.
3. Two of the perfectly correlated pairs of indices are due to errors. These are between
indices 1 and 2, and between indices 12 and 13.
4. The other two perfect correlations are between indices 3 and 4, and indices 14 and
15, which represent true differences between the sequences.
5. The other correlation pairs that represent true differences between the sequences
have scores between 5 and 8 inclusive.
6. Other scores due to errors vary between 0 and 5 inclusive.
An important point to remember when examining this example is that reads from
a and b make up roughly equal proportions of the total reads. There are six reads
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
1 10 10 1 1 0 0 0 1 0 - - 0 0 1 1 0 0
2 10 10 1 1 0 0 0 1 0 - - 0 0 1 1 0 0
3 1 1 10 10 1 5 1 8 2 - - 4 4 6 6 0 0
4 1 1 10 10 1 5 1 8 2 - - 4 4 6 6 0 0
5 0 0 1 1 10 0 0 0 0 - - 3 3 0 0 4 0
6 0 0 5 5 0 10 0 6 1 - - 0 0 5 5 0 2
7 0 0 1 1 0 0 10 1 5 - - 0 0 1 1 0 0
8 1 1 8 8 0 6 1 10 3 - - 1 1 7 7 0 1
9 0 0 2 2 0 1 5 3 10 - - 0 0 2 2 1 0
10 - - - - - - - - - - - - - - - - -
11 - - - - - - - - - - - - - - - - -
12 0 0 4 4 3 0 0 1 0 - - 10 10 1 1 2 0
13 0 0 4 4 3 0 0 1 0 - - 10 10 1 1 2 0
14 1 1 6 6 0 5 1 7 2 - - 1 1 10 10 1 1
15 1 1 6 6 0 5 1 7 2 - - 1 1 10 10 1 1
16 0 0 0 0 4 0 0 0 1 - - 2 2 1 1 10 2
17 0 0 0 0 0 2 0 1 0 - - 0 0 1 1 2 10
Figure 4.34.: Coefficients of determination for alleles, with multiple differences and
sequencing errors
for sequence a, five reads for sequence b, and one recombinant read. The challenge
of separating reads becomes more challenging when the number of reads for the two
sequences are highly disproportionate. In section 4.3.2 it was possible to confidently
isolate even a single read as representing a different sequence to the other reads. When
errors are added, the ability to identify a single read as representing a different sequence
than the rest of the sequences is dependent upon the number of errors and the number
of differences between the sequences. When there were no errors, the coefficients of
determination were unaffected by the ratio of reads for each sequence. This is not the
case when errors are introduced. Errors at the indices that differentiate the sequences
change the coefficient of determination for all pairs of indices including the error affected
index. The change will be greatest when the number of errors at an index is high or the
number of true SNPs or indels at an index is low. Furthermore, in the case that a single
read is isolated to represent a separate sequence, that read may not exactly match the
sequence it represents due to errors. It is clear that when we combine errors with uneven
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representation of the sequences, visually separating the reads or categorising them based
on their sequence may fail to identify minor variants.
A single substitution between a and b with sequencing errors
The sequences, a and b, are the same as used in the example for a single substitution
difference and no sequencing errors (Figure 4.24). Similarly, the reads used are the same
as in that example (Figure 4.25). However, six insertion errors, six deletion errors and
six substitution errors have been added (Figure 4.35). This represents an average of 1.5
errors per read. It is not possible to tell whether any of the reads are recombinants when
only a single difference exists between the sequences. When examining the reads with
errors, the following can be observed:
1. There are a lot of SNPs relative to the fully spelt out read on the top row.
2. There are several insertions and deletions relative to the fully spelt out read on the
top row.
3. There are 13 indices that are variable between the reads. One of these is due to a
substitution difference between the sequences and twelve are a result of errors.
4. A repeating pattern of SNPs at index 10 is still discernible.
5. It is difficult to tell whether repeated errors, such as the homopolymer insertion at
index 20 is a pattern.
6. The addition of errors has made the trivial example of Figure 4.25 much more
challenging.
Converting the reads to incorporations does not make the patterns easier to visualise
(Figure 4.36). Looking at the incorporations, the following can be observed:
1. Patterns are not obvious in the figure.
2. There are now 13 variable indices in the read incorporations. Eleven of these indices
are due to errors.
3. Errors are also present at the indices that represent true differences between the
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sequences.
4. With careful observation, a repeating pattern at indices 5 and 6 is still discernible.
5. It is not clear whether differences between reads are the result of substitutions,
insertions or deletions.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
1 G A - C C T G G - A A C A T T A G C G - T T T A
2 • • C • • • • • - G • • • • • • • • • - - • • •
3 • G - • • • • • A • • • • • • • • • • - • • A •
4 • • - • • • • • - - • • • • • • • • • T • • • •
5 • • - • • • • • - G • • • • • • • • • - • • • •
6 • • - • • • • • - • • • • • A • • • • T • • • •
7 • • - • • • • • - G • • • • • • • • • - • • • •
8 • • - • • • • • - • • • • - • • • • • - • • • •
9 • • - A • • • • - G • • • • • • • • • - • • • •
10 • • - • • • - • - G • • • • • C • • • - - • • •
11 • • C • • • • • - • • • • • • • • G • - • • • •
12 • • - • • • • • - G • • • - • • • • • T • • • •
Figure 4.35.: Reads for alleles, with a single substitution difference with errors
The coefficients of determination for this example show that scores can be calculated
for all pairs of indices, except pairs involving indices 4, 7 or 8, which are constant
(Figure 4.37). When examining the scores for coefficients of determination, the following
can be seen:
1. There are perfect correlations between four pairs of indices.
2. There are many completely uncorrelated pairs of indices.
3. All perfectly correlated index pairs are due to errors.
4. The correlation pair that represents true differences between the sequences has a
score of 6.
5. Other scores due to errors vary between 0 and 5 inclusive.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
G A C T G A C A T A C G C G T A
1 1 1 2 1 2 2 1 1 2 1 0 1 1 1 3 1
2 • • 3 • 3 1 • • • • • • • • 2 •
3 2 0 • • • 3 • • • • • • • • 2 2
4 • • • • • 1 • • • • • • • • 4 •
5 • • • • 3 1 • • • • • • • • • •
6 • • • • • • • • 1 2 • • • • 4 •
7 • • • • 3 1 • • • • • • • • • •
8 • • • • • • • • 1 • • • • • • •
9 • 2 1 • 3 1 • • • • • • • • • •
10 • • • • • 1 • • • 0 1 • • • 2 •
11 • • 3 • • • • • • • • 3 0 0 • •
12 • • • • 4 0 • • 1 • • • • • 4 •
Figure 4.36.: Incorporations for alleles, with a single substitution difference and
sequencing errors
In this example, there are six reads for each sequence. It is clear that if the number of
reads for one sequence was very low, then it would not be possible to tell whether the
reads came from a second sequence or were just reads with sequencing errors from the
first sequence. It is clear that in order to visually identify a minority sequence when
there is only a single substitution difference from the majority species, there needs to be
more reads for the minority species than for the case where there are multiple differences
between the sequences. Additionally, the coefficients of determination will be impacted
more by errors when there are a small number of reads representing one sequence.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
1 10 5 0 - 1 4 - - 0 0 0 0 0 0 2 10
2 5 10 2 - 1 3 - - 0 0 0 0 0 0 1 5
3 0 2 10 - 0 0 - - 0 0 0 3 3 3 1 0
4 - - - - - - - - - - - - - - - -
5 1 1 0 - 10 6 - - 0 0 1 1 1 1 0 1
6 4 3 0 - 6 10 - - 0 1 0 1 1 1 1 4
7 - - - - - - - - - - - - - - - -
8 - - - - - - - - - - - - - - - -
9 0 0 0 - 0 0 - - 10 2 0 0 0 0 3 0
10 0 0 0 - 0 1 - - 2 10 5 0 0 0 3 0
11 0 0 0 - 1 0 - - 0 5 10 0 0 0 2 0
12 0 0 3 - 1 1 - - 0 0 0 10 10 10 0 0
13 0 0 3 - 1 1 - - 0 0 0 10 10 10 0 0
14 0 0 3 - 1 1 - - 0 0 0 10 10 10 0 0
15 2 1 1 - 0 1 - - 3 3 2 0 0 0 10 2
16 10 5 0 - 1 4 - - 0 0 0 0 0 0 2 10
Figure 4.37.: Coefficients of determination for alleles, with a single substitution difference
and sequencing errors
A single deletion / insertion difference between a and b with sequencing errors
The sequences, a and b, are the same as used in the example for a single indel difference
and no sequencing errors (Figure 4.28). Similarly, the reads used are the same as in
that example (Figure 4.29). However, six insertion errors, six deletion errors and six
substitution errors have been added (Figure 4.38). This represents an average of 1.5
errors per read. It is not possible to tell whether any of the reads are recombinants when
only a single difference exists between the sequences. When examining the reads with
errors, the following can be observed:
1. There are a lot of SNPs relative to the fully spelt out read on the top row.
2. There are several insertions and deletions relative to the fully spelt out read on the
top row.
3. There are 13 indices that are variable between the reads. One of these is due to an
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indel difference between the sequences and twelve are a result of errors.
4. A repeating pattern of SNPs at index 14 is still discernible.
5. It is difficult to tell whether repeated errors, such as the homopolymer insertion at
index 20 is a pattern.
6. The addition of errors has made the trivial example of Figure 4.29 much more
challenging.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
1 G A - C C T G G - A A C A T T A G C G - T T T A
2 • • - • • • • A - • • • • • • • • • • - • • A •
3 • • C • • • • • - • • • • - • • • • • - • • • •
4 • • - • • • • • - • • • • - • • • • • T • • • •
5 • • - • • C • • A • • • • - • • • • • - • • • •
6 • • - • • • - • - • • • • • • • • • • - - • • •
7 • • - • • • • • - • • • • • • • • • • - • • • •
8 • • - • • • • • A • • • • • • • T • • T • • • •
9 • • - - • • • • - - • • • - • • • • • - • • • •
10 • • - • • • • • - G • • • - A • • • • - • • • •
11 • • - • • • • • - • • • • - • • • • • - - • • •
12 • • - • • • • • - • • • • - • • • • • T • • • •
Figure 4.38.: Reads for alleles, with a single indel difference with errors
Converting the reads to incorporations does not make the patterns easier to visualise
(Figure 4.39). When looking at the incorporations, the following can be observed:
1. Patterns are no longer obvious in the figure.
2. There are now 10 variable indices in the read incorporations. Nine of these indices
are due to errors.
3. Errors are also present at the index that represent true differences between the
sequences.
4. A repeating pattern at index 9 is still discernible.
72
4. HLA allele callers
5. It is not clear whether differences between reads are the result of substitutions,
insertions or deletions.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
G A C T G A C A T A G T C G T A
1 1 1 2 1 2 2 1 1 2 1 1 0 1 1 3 1
2 • • • • 1 3 • • • • • • • • 2 2
3 • • 3 • • • • • 1 • • • • • • •
4 • • • • • • • • 1 • • • • • 4 •
5 • • 3 0 • 3 • • 1 • • • • • • •
6 • • • • 1 • • • • • • • • • 2 •
7 • • • • • • • • • • • • • • • •
8 • • • • • 3 • • • • 0 1 • • 4 •
9 • • 1 • • 1 • • 1 • • • • • • •
10 • • • • 3 1 • • 0 2 • • • • • •
11 • • • • • • • • 1 • • • • • 2 •
12 • • • • • • • • 1 • • • • • 4 •
Figure 4.39.: Incorporations for alleles, with a single indel difference and sequencing
errors
The coefficients of determination for this example show scores can be calculated for all
pairs of indices, except pairs involving indices 1, 2, 7, 8, 13, or 14, which are constant
(Figure 4.40). When examining the scores for coefficients of determination, the following
can be seen:
1. There is a perfect correlation between one pair of indices.
2. There are many completely uncorrelated pairs of indices.
3. The perfectly correlated index pair is due to errors.
4. Other scores due to errors vary between 0 and 5 inclusive.
In this example, there are six reads for each sequence. It is clear that if the number of
reads for one sequence was very low, then it would not be possible to tell whether the
reads came from a second sequence or were just reads with sequencing errors from the
first sequence. It is clear that in order to visually identify a minority sequence when
there is only a single indel difference from the majority species, there needs to be more
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
1 - - - - - - - - - - - - - - - -
2 - - - - - - - - - - - - - - - -
3 - - 10 3 0 3 - - 0 0 0 0 - - 0 0
4 - - 3 10 0 2 - - 0 0 0 0 - - 0 0
5 - - 0 0 10 3 - - 5 4 0 0 - - 2 3
6 - - 3 2 3 10 - - 3 3 2 2 - - 0 2
7 - - - - - - - - - - - - - - - -
8 - - - - - - - - - - - - - - - -
9 - - 0 0 5 3 - - 10 4 1 1 - - 0 1
10 - - 0 0 4 3 - - 4 10 0 0 - - 0 0
11 - - 0 0 0 2 - - 1 0 10 10 - - 2 0
12 - - 0 0 0 2 - - 1 0 10 10 - - 2 0
13 - - - - - - - - - - - - - - - -
14 - - - - - - - - - - - - - - - -
15 - - 0 0 2 0 - - 0 0 2 2 - - 10 2
16 - - 0 0 3 2 - - 1 0 0 0 - - 2 10
Figure 4.40.: Coefficients of determination for alleles, with a single indel difference and
sequencing errors
reads for the minority species than for the other two examples.
Summary of the examples with errors
Adding errors to the first three examples has changed them from being a trivial sorting
task into a challenging task, that in the case of single substitutions or indels, may be
impossible when one of the sequences has few reads representing it. The problem with
the three views can be summarised as follows:
• Reads view: errors occurring at the indices that are true differences between the
sequences plus common errors at other indices, make the patterns hard to see. This
is exacerbated when there are less differences between the sequences and when
there is an imbalance in the number of reads representing each sequence. It is no
longer possible to simply separate the reads based on their sequences, due to errors.
Errors will also distort the distance calculation. However, with sufficient reads
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representing each sequence, the most common SNPs belong to true differences
between the reads.
• Incorporations view: has the same strengths and weaknesses as the reads view.
• Coefficients of determination: no longer have perfect correlations to identify the
indices that represent true differences between the sequences. Furthermore, some
perfect correlations are produced as the result of errors. However, as a general
rule, the scores for pairs of indices that are true difference indices, are higher than
those for indices that only differ due to errors. As was the case when there were no
errors, the coefficients of determination can not be used to identify the index that
differentiates two sequences differing by only a single indel.
Acting alone, the views are unable to do better than calculating a Hamming distance
between each pair of reads. Additionally, the problem can be further complicated by
having mixtures with an unknown number of components, i.e. one, two or more. Finding
the correct patterns in an unknown set of reads with errors, when at least one of the
sequences is present as a minor component, is a far more difficult task than the first
trivial example.
4.3.3. Distance calculation
The key to calculating more accurate distances is combining the incorporations view and
coefficients of determination. This is possible because they are based on the same indices.
The data to be combined are:
1. When sufficient reads represent each sequence, the most common SNPs which
translate into the most common changes in incorporation represent true differences
between the sequences.
2. Generally, the highest coefficients of determination occur for pairs of indices that
represent true differences.
3. The incorporations view can be used to calculate distances between pairs of reads.
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These distances can be the input for a clustering algorithm to group the reads.
The challenge is to use the incorporations data to eliminate false positives in the
coefficients of determination data. The remaining well correlated indices then identify
which indices should be used to calculate the distances between read pairs. This is best
illustrated by examining the data from the examples already presented. In Figure 4.34,
18 pairs of indices had a coefficient of determination score of 5 or higher. Fifteen of
these pairs represent pairs of indices that are different in the sequences, and the other
three are due to errors. The patterns present at each pair of indices can be viewed in
Figure 4.33. These data have been extracted and are presented for the index pairs of
interest (Figure 4.41). Looking at the data, it is clear that the difference between the
index pairs with high coefficients of determination that are due to errors, and those due
to true differences between the sequences, is the allocation of the reads to the patterns.
When an error causes a high coefficient of determination score, it is a result of an error
occurring in isolation in an area conserved between the two sequences. True differences
between the sequences in the example presented have two patterns, each with at least
three reads representing them. Additionally, in order for the two patterns to cause a high
coefficient of determination score, they must be complementary. That is, the patterns are
not conserved at either index. For example, patterns of 2 1 and 1 0 are complementary,
but patterns of 2 1 and 2 3 are not complementary because they are conserved at the
first index. This again brings up the caveat that the key indices can only be identified
when the frequency of differences due to the minor sequence exceed the frequency of
difference due to errors at a specific index. The differences between sequences will always
cause a difference in reads at the same indices, except when there is an error at that
point. Errors will generally be distributed across a range of indices. Systematic errors
that always occur at the same index, e.g. a PCR transcription error that occurs early in
the PCR amplification, can not be discriminated from minor variants, especially if there
is a need to differentiate between sequences that only have a single difference.
If the sequences vary at multiple indices, then the presence of a pattern extending
over multiple indices can be used to lower the threshold. This is assuming that errors
do not systematically appear across multiple indices. When examining the data for the
multiple differences between sequences with errors data again, it can be seen that the
scores for coefficient of determination are five or greater between all pairs of indices that
are different between the a and b sequences. If we extend the patterns to more than two
indices, where all the indices are sufficiently correlated with each other, the threshold of
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Sheet6
Page 1
Index 1 Index 2 Score P1 # P2 # P3 # P4 # P5 # P6 #
1 2 10 1 1 11 2 0 1
3 4 10 2 1 6 1 2 5 3 0 1
3 6 5 1 3 4 2 2 3 2 1 2 2 3 1 1 4 1 3 2 1
3 8 8 2 1 6 1 0 5 3 1 1
3 14 6 2 1 5 1 0 5 3 1 1 2 0 1
3 15 6 2 0 5 1 1 5 3 0 1 2 1 1
4 6 5 2 3 4 1 2 3 1 1 2 1 3 1 2 4 1 0 2 1
4 8 8 1 1 6 2 0 5 0 1 1
4 14 6 1 1 5 2 0 5 1 0 1 0 1 1
4 15 6 1 0 5 2 1 5 1 1 1 0 0 1
6 8 6 2 1 4 3 0 4 1 1 2 3 1 1 4 0 1
6 14 5 3 0 4 2 1 3 1 1 2 3 1 1 4 0 1 2 0 1
6 15 5 3 1 4 2 0 3 1 0 2 3 0 1 4 1 1 2 1 1
7 9 5 1 2 10 1 1 1 2 1 1
8 14 7 1 1 6 0 0 5 1 0 1
8 15 7 1 0 6 0 1 5 1 1 1
12 13 10 0 1 11 1 0 1
14 15 10 1 0 6 0 1 6
Figure 4.41.: Incorporation patterns and their counts for index pairs with a coefficient of
determination score of 5 or greater, for reads from sequences with multiple
differences. Scores due to errors have a grey background. Counts greater
than two are coloured blue, and counts of two or less are coloured pink. P1-
P6 are the patterns present at the index pair and the following # columns
are the counts for how often the pattern occurs in the 12 reads.
the number of reads matching a pattern can be lowered. In this example, there are no
groups of indices greater than two caused by errors where all the indices are sufficiently
correlated. However, examining the four indices 3, 4, 6 and 8, yields two patterns with
multiple reads. There are three reads with the pattern 2 1 2 1 and four reads with the
pattern 1 2 3 0. As the length of patterns increases, the chance of the indices all being
sufficiently correlated, and two or more patterns existing due to random errors, decreases.
Therefore, the threshold for the number of reads for a pattern to be accepted, can be
lowered. It is not possible to differentiate true sequence differences from systematic errors
using this method.
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Using the two cutoffs, coefficient of determination score of at least five and at least
two complementary patterns represented by three or more reads, the key indices for
this example are 3, 4, 6, 8, 14 and 15. The distances between all pairs of reads can
be calculated from the incorporations view (Figure 4.33).The distance is the sum of
differences in incorporations at the key indices (Equation 4.1). The distances are






d is the distance between read 1 and read 2,
i is index,
K is the set of key indices,
R1Inc is the vector of incorporations for read 1,
R2Inc is the vector of incorporations for read 2.
Equation 4.1.: Distance calculation based on incorporations and key indices
1 2 3 4 5 6 7 8 9 10 11 12
1 0 1 6 7 1 2 6 6 0 6 1 2
2 1 0 5 6 2 3 5 5 1 5 2 3
3 6 5 0 1 7 8 0 0 6 0 7 4
4 7 6 1 0 8 9 1 1 7 1 8 5
5 1 2 7 8 0 3 7 7 1 7 0 3
6 2 3 8 9 3 0 8 8 2 8 3 4
7 6 5 0 1 7 8 0 0 6 0 7 4
8 6 5 0 1 7 8 0 0 6 0 7 4
9 0 1 6 7 1 2 6 6 0 6 1 2
10 6 5 0 1 7 8 0 0 6 0 7 4
11 1 2 7 8 0 3 7 7 1 7 0 3
12 2 3 4 5 3 4 4 4 2 4 3 0
a a b b a a b b a b a a/b
1 2 3 4 5 6 7 8 9 10 11 12
1 0 4 7 8 2 5 7 7 1 8 2 4
2 4 0 10 11 5 8 10 8 4 9 5 7
3 7 10 0 4 8 11 3 3 7 4 8 7
4 8 11 4 0 9 10 4 4 8 5 9 6
5 2 5 8 9 0 6 8 8 2 9 1 5
6 5 8 11 10 6 0 11 11 5 12 6 6
7 7 10 3 4 8 11 0 3 7 3 8 7
8 7 8 3 4 8 11 3 0 7 4 8 7
9 1 4 7 8 2 5 7 7 0 8 2 4
10 8 9 4 5 9 12 3 4 8 0 9 8
11 2 5 8 9 1 6 8 8 2 9 0 5
12 4 7 7 6 5 6 7 7 4 8 5 0
(a) Incorporations at key indices
1 2 3 4 5 6 7 8 9 10 11 12
1 0 1 6 7 1 2 6 6 0 6 1 2
2 1 0 5 6 2 3 5 5 1 5 2 3
3 6 5 0 1 7 8 0 0 6 0 7 4
4 7 6 1 0 8 9 1 1 7 1 8 5
5 1 2 7 8 0 3 7 7 1 7 0 3
6 2 3 8 9 3 0 8 8 2 8 3 4
7 6 5 0 1 7 8 0 0 6 0 7 4
8 6 5 0 1 7 8 0 0 6 0 7 4
9 0 1 6 7 1 2 6 6 0 6 1 2
10 6 5 0 1 7 8 0 0 6 0 7 4
11 1 2 7 8 0 3 7 7 1 7 0 3
12 2 3 4 5 3 4 4 4 2 4 3 0
a a b b a a b b a b a a/b
1 2 3 4 5 6 7 8 9 10 11 12
1 0 4 7 8 2 5 7 7 1 8 2 4
2 4 0 10 11 5 8 10 8 4 9 5 7
3 7 10 0 4 8 11 3 3 7 4 8 7
4 8 11 4 0 9 10 4 4 8 5 9 6
5 2 5 8 9 0 6 8 8 2 9 1 5
6 5 8 11 10 6 0 11 11 5 12 6 6
7 7 10 3 4 8 11 0 3 7 3 8 7
8 7 8 3 4 8 11 3 0 7 4 8 7
9 1 4 7 8 2 5 7 7 0 8 2 4
10 8 9 4 5 9 12 3 4 8 0 9 8
11 2 5 8 9 1 6 8 8 2 9 0 5
12 4 7 7 6 5 6 7 7 4 8 5 0
(b) Hamming
Figure 4.42.: Distances between each read pair. White background is for reads from
sequence a, grey background is for reads from sequence b and a red
background is for recombinant reads. For the distance between reads
from different sequences, the background colour will be a mix of the colours
from the two sequences, e.g. distances between reads from a and b sequences
will have a pale grey background. All distances from self have been omitted
because they are meaningless.
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For all read pairs, the distance is shorter when calculated with Equation 4.1 than by
using the Hamming distance. This is because the increase in distance caused by errors at
indices that do not differentiate the two sequences, are included in the Hamming distance.
These increases in distance occur across all read pairs, reducing the ratio of distances
between reads representing the same sequence to distances between reads representing
different sequences. When using distances calculated using Equation 4.1, reads from
sequence a are at worst 3 units apart, reads from sequence b are at worst 1 unit apart
and reads from sequence a are at the closest 5 units away from reads in sequence b. This
contrasts with the Hamming method where reads from sequence a are at worst 8 units
apart, reads from sequence b are at worst 5 units apart and reads from sequence a are at
the closest 7 units away from reads in sequence b. For both methods, the recombinant
read will complicate the separation of the reads into their originating sequences. In both
cases, it is closer to sequence a than sequence b.
4.3.4. Clustering
Once the distances between each read pair have been calculated, the reads can be
clustered using a clustering algorithm. Clustering was calculated using clustering by
affinity propagation [99]. Affinity propagation has been used for a range of applications
[99]. For this application, it has the advantage that the number of clusters produced
does not have to be specified, rather it is determined by the data being clustered and the
initial preferences values. The algorithm requires two matrices of data to be supplied.
First, the similarities represent how similar the data to be clustered are to each other.
Second, the preferences represent how likely a data point will be preferred as an exemplar
that represents a cluster. Frey & Dueck [99] recommend setting the initial preferences to
the minimum similarity, to find a small number of clusters in the data. Increasing the
preferences increases the probability that a read will be chosen as an exemplar.
For this thesis all reads that are zero distance apart are grouped together. This means
they have the same number of incorporations at all of the key indices and form larger
groups than just combining reads which are exactly the same. Clustering is then carried
out on the groups of reads.
Similarities are calculated as minus the distance between groups of reads squared
(Equation 4.2).
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Preferences are calculated based on the minimum similarity and the group sizes. If a
group has a large number of reads, it is assumed to be more likely to represent
a true sequence than a group with a small number of reads, and hence is given
a preference score to reflect that (Equation 4.3). The ratio of group size to total
number of reads ensures that for different datasets with different numbers of reads,
the preference for a group of reads will be the same in each dataset when the group
makes up the same proportion of the total dataset. This ratio is multiplied by
10,000 to ensure the output of the logarithm remains positive, for all groups sizes
that contain at least 0.01% of the total reads. With 10,000 as the constant, a ten
folds difference between group sizes results in a 25% change in preference value.
S = −d2
where:
S is the similarity between two groups of reads,
d is the distance between the two groups of reads.
Equation 4.2.: Similarities between two groups of reads












P is the preference for a group of reads,
Smin is the minimum similarity score,
G is the number of reads in the group,
T is the total number of reads, 10, 000 is a normalisation factor,
Equation 4.3.: Preferences score for a group of reads
4.3.5. Cluster suitability
When splitting the reads into groups, two options exist. The first is to do the split in
a single step, and the second is to split the reads into groups, then take the reads in
each group and split them again. The second method is preferred in this work, due
to the potential imbalance in the distance between reads for each group. For example,
when examining the reads for exon two of DRB of a subject that is heterozygous for
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HLA-DRB1 with a single HLA-DRB3 allele, the HLA-DRB1 alleles are much more similar
to each other than they are to the HLA-DRB3 allele. This represents a challenge for the
clustering algorithm, with two possible outcomes being, the separation of reads into two
groups, one representing HLA-DRB1 and the other HLA-DRB3, or the separation of
the reads into three groups, one for each allele. To overcome the potentially incomplete
clustering, each group formed is then clustered again to determine whether it can be
split further. Clustering continues for all groups formed until the clustering algorithm
only produces a single cluster and hence no further clustering is possible. At this point,
the cluster is deemed suitable, as it is homogeneous enough that it can no longer be split,
and thus should represent a single allele.
4.3.6. Algorithm
The algorithm begins with the first four steps from the allele caller based on expectation
(Section 4.2.2). Next, the following two steps are repeated until no further clusters are
formed:
1. Calculate the distance between each pair of reads in the group (Section 4.3.3)
2. Cluster the reads based on the distance pairs (Section 4.3.4)
After this, the consensus of each cluster is calculated. Finally, steps 9-13 of the clustering
based on expectation algorithm are completed (Section 4.2.2).
81
5. HLA allele caller parameter values
Parameters are values that are inputs to the calling algorithms, which can change the
output of the algorithms. The best way to set these parameters is using the experience
of calling alleles and determining which values work best.
Parameters were selected based on analysis of allele calls for a training data set of 50
samples that had been previously typed at IIID based on Sanger sequencing data, and
were subsequently sequenced using GS-FLX Titanium chemistry by the Broad Institute
of MIT and Harvard, Cambridge, Massachusetts, USA. The Broad Institute sequenced
exons 2 and 3 for the class I alleles HLA-A, HLA-B and HLA-C. Each sequencing lane
contained 94 samples plus controls, and was run on an eight lane plate. These samples
were a subset of the samples used to test the allele callers (Chapter 6).
In addition to comparing the results for concordance with previous results, the quality
of the sequencing was also assessed. The sequencing data was aligned against the
previously called reference sequences of the alleles. Reads were assigned to the exon
sequences of one of the known reference alleles, assigned as a recombinant, or discarded.
Reads were discarded if they had an incorrect primer sequence, did not completely cover
an exon or did not align with at least an 85% match to one of known reference allele
exon sequences. This allowed the initial testing of the allele callers to accurately assign
“Low” confidence calls to poor quality data. Failure of the allele caller to call alleles
correctly when there are no reads for that allele must not be considered as a failure of
the allele caller. This process can-not be done routinely, because it requires the actual
alleles of the sample to be known, but is useful during the parameter evaluation phase to
allow confidence scores to be assigned based on an assessment of the reads, to identify
potentially poor quality read data.
The parameter values derived during this chapter are used for the remainder of the
thesis. This is ideal for datasets closely related to the training dataset. Datasets less
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closely matched to the training dataset will test the robustness of the parameters chosen.
5.1. Calling parameters
The two allele callers each have parameters that can change the allele calls made. Many
of these parameters are either overlapping or have analogs in the other caller.
The allele caller based on expectation has five input parameters:
1. The correlation cutoff used to split reads from a group with the same flow pattern.
2. The minimum number of reads for each pattern when two alleles have the same
flow pattern.
3. Warning cutoff for allele calls with low coverage.
4. Warning cutoff for ratio of reads for preferential amplification.
5. A set of criteria for assessing the quality of the call.
The allele caller based on correlation has seven input parameters:
1. The quality score for read flow incorporations to be included in calculations.
2. The correlation coefficient to determine key correlation indices for a single flow
change in incorporations.
3. The count of reads required to have a pattern in order to determine key indices for
a single flow change in incorporations.
4. The count of reads required to have a pattern in order to determine key indices for
two correlated flow change in incorporations.
5. The count of reads required to have a pattern in order to determine key indices for
three correlated flow change in incorporations.
6. Warning cutoff for allele calls with low coverage.
7. Warning cutoff for ratio of reads for preferential amplification.
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8. A set of criteria for assessing the quality of the call.
5.1.1. Parameters to split flow groups
It is possible for a pair of alleles to have the same flow sequence for an exon, but different
sequences for that exon. Groups within the flow group are identified by identifying
incorporation pairs that are well correlated and which split the flow group into at least
two subsets, each with at least a threshold number of reads. This means of splitting is a
simplified version of the identification of key indices in the allele calling by clustering
algorithm. This simplified method can be used because within a flow group, the sequences
are all very similar and the number of indices different between the two groups within a
flow group will be small. Therefore, there is no need to try to identify groups of more
than two indices that are correlated. Furthermore, because there is no clustering step
following the split, reads which have errors at the indices identified for splitting are not
going to be grouped with the reads with no errors at these indices. This is preferable
in the situation where there are generally only two or four indices that have different
incorporations between the two alleles, because an error in one of those positions will
make it difficult to decide which group the read belongs in. In contrast, the identification
of key indices needs to be able to deal with a range of key indices counts, from 2 to in
excess of 40. When the number of key indices is large, it is expected more reads may
have errors at one or more key indices. However, when there are errors at key indices,
clustering should be able to correctly partition the reads based on distances calculated
from all of the key indices discovered.
None of the first 50 samples have two alleles with equivalent flows for an exon but
different sequences for that same exon. Therefore, it was decided to use the correlation
coefficient and read count threshold for pairs from the key indices parameter analysis.
The rationale was that the key indices parameter needed to be sensitive enough to detect
a single pair of expected key indices between two closely related alleles. This is the same
sensitivity as is required for splitting flow groups.
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5.1.2. Warning count for low coverage
Minimum coverage was plotted for correct and incorrect calls for the first 50 Broad
samples. The coverage used is not the number of reads that map to the exons, rather
the number of reads that were used by the caller. For example, the allele caller based on
expectation does not use any reads that have substitution errors in the exon sequence,
and hence will generally not use all of the reads. Both algorithms had very high failure
rates when the minimum coverage used for calling was low and high success when the
minimum coverage used for calling was higher (Figure 5.1). For the caller based on
clustering, 95% of the incorrect calls were made when the minimum coverage used for
calling was 4 or less, and 95% of the correct calls were when the minimum coverage
was greater than 4. The caller based on expectation had 90% of its incorrect calls when
the minimum coverage was 4 or less and 86% of its correct calls when the minimum
coverage exceeded 4. Therefore, four was chosen as the minimum coverage level for which
a warning was issued.
5.1.3. Warning for preferential amplification
The preferential amplification ratio is the maximum ratio between the number of reads
used to call each allele for both exons. For example, if the first allele used 20 reads for
exon 2 and 30 reads for exon 3, and the second allele used 15 reads for exon 2 and 10
reads for exon 3, the preferential amplification ratio is 3 from exon 3, which is greater
than the ratio 1.33 for exon 2. In both allele callers, the majority of both correct and
incorrect calls occurred for low preferential amplification ratios (Figure 5.2). Although
there was not the stark contrast between successful and unsuccessful calls that was seen
for low coverage, a warning based on preferential amplification was still included. A high
preferential amplification is indicative of either, a problem with the PCR for the allele
pair being called, the calling of an allele from a small percentage of the reads with a
consistent error, or calling of an allele for a minor contamination. These are all major
issues the user needs to be informed about. The warning level chosen was a preferential
amplification level of 4, which was close to the 95 percentile for correct calls for both
allele callers (Figure 5.2).
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Expectation concordant Expectation discordant Clustering concordant Clustering discordant
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Figure 5.1.: Cumulative proportion of concordant and discordant samples set 1
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Expectation concordant Expectation discordant Clustering concordant Clustering discordant
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Figure 5.2.: Cumulative proportion of concordant and discordant samples set 2
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5.1.4. Key indices parameters
The quality score, correlation coefficient, and read count thresholds are all used to
determine the key indices for the distance calculation. It is difficult to set and assess
these parameters individually as they act in concert to identify the key indices. Therefore,
a set of 350 combinations of correlation coefficients and read count thresholds was
tested for each of 5 different quality scores. For each test, the key indices calculated for
each sample were compared with those expected based on the known exon sequences.
Specifically, the percentage of expected key indices and the number of off target key
indices, were recorded. For the 50 samples tested, for three loci and two exons per loci,
203 sample loci had reads for both alleles, 11 of which were homozygous.
Confidence in identifying key indices with extremely low coverage is problematic, as
can be seen in Table 5.1, where three samples had less than 50% of their key indices
identified for any combination of quality score, coefficient of determination and read
count thresholds. Therefore, a threshold of three reads minimum coverage was used to
make the dataset easier to interpret. All 11 homozygous samples had greater than two
reads, and 163 of the heterozygous samples had more than two reads for each exon. This
choice does not automatically preclude key indices being discovered when the coverage
for an allele is two or lower.
Detection rate Q10 Q15 Q20 Q25 Q30
All 179 177 174 163 155
≥90% 189 189 186 179 173
≥80% 189 189 188 185 179
≥50% 189 189 189 189 188
>0 192 192 192 192 192
0 11 11 11 11 11
0 expected 11 11 11 11 11
Table 5.1.: Best detection rate of expected key indices for five quality score cutoffs, across
all combinations of coefficients of determination and count thresholds
Ideally, calculation of the key indices would identify all of the expected key indices and
no off-target indices. However, in practice this is not possible. For example, samples with
very few reads combined with the possibility of errors in the key indices for some of those
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reads, may prevent those sites being detected. Alternatively, the capture of off-target
reads may cause many off-target indices to be identified and indeed, this is desirable so
that the off-target reads can be clustered in groups away from the on-target reads. This
means that for each sample, we have a known set of key indices, of which we want to
identify as many as possible. We may also have an unknown set of off-target key indices
which we would like to identify, and we have another set of off-target indices caused by
errors in the reads that we want to minimise, and ideally eliminate. As the known key
indices are required to differentiate reads between the two alleles, it was chosen as the
highest priority in choosing a set of parameters.
From these sets of results the parameters were chosen as follows:
Proportion of expected key indices For each quality score tested, the percentage of
samples meeting detection of known key indices thresholds was calculated as
the highest value across all of the correlation coefficient / read count threshold
combinations (Table 5.2). There was no combination of parameters able to detect
all of the key indices for all of the samples. The best results were for quality scores
Q10 and Q15, where 156 of the 163 heterozygous samples had all of their key
indices identified. For these quality thresholds, all of the heterozygous samples had
at least 90% of their key indices identified. Based on these values, it was decided
to use Q15 as the quality threshold. Q15 was chosen in preference to Q10, which
delivered equivalent results, because it will provide cleaner data. Furthermore, the
benchmark for choosing the other parameters was set at identifying at least 90% of
the expected key indices for all samples with more than two reads per allele.
Proportion of unexpected key indices The proportion of unexpected correlations was
calculated as the ratio of unexpected key indices discovered to expected key indices
discovered. For example, if a pair of alleles was expected to have 13 key indices
and 12 of these were discovered, but also 6 other key indices were discovered, the
proportion of unexpected would be 50%. Of the 350 combinations of read count
thresholds and correlation coefficients tested for Q15, 166 achieved identification of
90% or more of the expected key indices for all samples with more than two reads per
allele. For these 166 parameter sets, the lowest proportion of unexpected key indices
identified was calculated (Table 5.3). These were higher than the lowest numbers
calculated for all possible parameter combinations, because stricter parameter sets
are able to reduce the number of unexpected key correlations detected, but at the
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Detection rate Q10 Q15 Q20 Q25 Q30
All 156 156 154 151 146
≥90% 163 163 162 160 159
≥80% 163 163 163 161 161
≥50% 163 163 163 163 163
>0 163 163 163 163 163
0 11 11 11 11 11
0 expected 11 11 11 11 11
Table 5.2.: Best detection rate of expected key indices for five quality score cutoffs and
samples with at least three reads per allele exon, across all combinations of
coefficients of determination and count thresholds
expense of also missing some expected key correlations. Only one parameter set
achieved the lowest proportion of key indices in all categories. This was: coefficient
of determination = 0.7, read count threshold 2 = 4, read count threshold 3 = 4
and read count threshold 4 = 2. The read count thresholds mean that for two
alleles only different at two or three key indices, at least four reads are required for
each allele. If the two alleles differ at four or more key indices, these indices can
be detected when there are at least two reads per allele. Alleles with only a single
read will not be detected. This loss is compensated for by the best performance
in identifying the expected key indices and minimising unexpected key indices in
samples with more than two reads per allele, which ideally should always be the
case.
5.2. Criteria for assessing the confidence in the call
Based on the two algorithms described (Chapter 4) and the other parameter values
derived (Section 5.1), allele calls were made for training samples. Each sample was
given a grade as to whether or not it was concordant with the previous sequence based
typing, based on Sanger sequencing calls. It was not expected that all samples would be
concordant for all loci, because the sequencing data had variable coverage. For each set
of calls, the proportion of correct calls and the proportion of incorrect calls was plotted
against the minimum coverage for the allele pair (Figure 5.3). The minimum coverage
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Table 5.3.: Best ratio of unexpected key indices to detected key indices, across all
combinations of coefficients of determination and count thresholds that
detected ≥90% of expected key indices for all samples
was calculated as the minimum of the count of reads assigned to each exon for each
allele, when the reads were mapped against the known reference allele exon sequences. It
is clear from the plots that nearly all of the discordant calls occur when there is zero
or very low coverage of at least one exon for at least one allele, and there are very few
concordant calls with these levels of coverage.
Expectation concordant Expectation discordant Clustering concordant Clustering discordant











(a) Zoomed in on low coverages











(b) Showing all coverages
Figure 5.3.: Cumulative proportion of concordant and discordant samples versus coverage
for both allele callers
This was not an unexpected finding. The challenge is to find a set of criteria that can
be used to identify a call as potentially unreliable, when the number of reads belonging
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to each allele in the sample is not known.
For the training data the proportion of concordant and discordant calls was plotted
against the following (Figures 5.1 and 5.2):
• Warning count.
• Number of first rankings.
• Minimum coverage for the assigned alleles, not based on the real minimum coverage
of the actual alleles.
• Total coverage.
• Maximum number of unused reads.
• Number of exons with the same sequence for both alleles.
• Maximum average read flow error.
• Total average read flow error.
• Maximum consensus flow error.
• Total consensus flow error.
• Number of options assigned ”Yes” or ”Maybe” status.
• Primer bias.
From these plots, it was clear that some of the values were better determinants than
others, but none were as good as knowing the actual minimum number of reads. Therefore,
a combination of criteria were used to assign “High”, “Medium” and “Low” confidence
levels to the calls. The patterns were very similar for both allele callers. With the best
predictors of discordant calls being the same for both callers. Therefore, the same criteria
were chosen for both callers.
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Calls were allocated a “Low” confidence if:
• Warning count ≥5.
• Number of first rankings ≤3.
• Minimum coverage ≤2.
• Maximum consensus flow error ≥2.
Calls were allocated a “Medium” confidence if:
• They were not “Low” confidence
• They had at least one exon that was the same for both alleles
• They had at least two results that were given “Yes” or “Maybe” as their rank for
best allele pair
Calls that were not “Low” or “Medium” confidence were allocated a “High” confidence.
These confidence ratings do not affect the allele pairs called, but rather give the user a
suggestion as to how to interpret the results.
93
6. HLA allele caller validation using
GS-FLX
Two sets of GS-FLX HLA sequence data were used to validate the HLA allele callers.
1. A set of 318 samples
1
that had been previously typed at IIID based on Sanger
sequencing data, were sequenced using GS-FLX Titanium chemistry by the Broad
Institute in 2011. They sequenced exons 2 and 3 for the class I alleles HLA-A,
HLA-B and HLA-C. Ninety-four samples plus controls were sequenced per lane on
an eight lane plate.
2. Quality assurance program (QAP) samples from UCLA Immunogenetics Center [2]
have been sequenced at IIID using the GS-FLX sequencer with Titanium chemistry.
Forty-eight samples were sequenced per lane on an eight lane plate. As part of the
QAP program, the results for class I and II alleles were available after completion
of the program. This dataset contained reads for 96 UCLA samples, many of which
were run multiple times. In total, 220 sequencings were carried out, across 10
sequencing runs. Seven of these runs used the GS-FLX sequencer and three used
the GS Junior sequencer. One of the runs on the GS-FLX had samples spread
across four lanes. In all cases, the number of samples per lane was 48, with the
balance of the samples made up by non QAP samples, that were not included
in this analysis. Many of these runs were workups for laboratory techniques to
maximise lab throughput and minimise sequencing costs. The runs were carried out
between 2012 and 2014, with the loci sequenced varying between runs (Table 6.1).
1The original dataset had 320 samples, but the reads from two of the samples were a very poor match
for the previously typed alleles across multiple loci. This suggested a potential sample mixup, so
these samples were excluded from the analysis
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Run Date Lane Sequencer Count Loci
1 20/11/2012 7 GS-FLX 6 A, B, C, DRB
2 08/01/2013 3 GS-FLX+ 12 A, B, C, DRB
3 19/03/2013 3 GS-FLX 6 A, B, C, DPB1, DRB
3 19/03/2013 4 GS-FLX 36 A, B, C, DRB
3 19/03/2013 7 GS-FLX 6 A, B, C, DPB1, DRB
3 19/03/2013 8 GS-FLX 36 A, B, C, DRB
4 24/07/2013 8 GS-FLX+ 18 A, B, C, DPB1, DQB1, DRB
5 05/08/2013 4 GS-FLX 18 A, B, C, DPB1, DQB1, DRB
6 06/03/2014 - GS Junior 18 A, B, C, DPB1, DQB1, DRB
7 07/05/2014 3 GS-FLX+ 6 A, B, C, DPB1, DQB1, DRB
8 18/06/2014 - GS Junior 46 A, B, C, DPB1, DQB1, DRB
9 15/08/2014 - GS Junior 6 A, B, C, DPB1, DQB1, DRB
10 22/10/2014 8 GS-FLX 6 A, B, C, DPB1, DQB1, DRB
Table 6.1.: QAP sequencing runs
For each dataset, the sequences for the samples were analysed with both allele callers.
The results from the callers were then compared with the results previously obtained.
These were the results based on Sanger sequencing for the Broad samples, and the UCLA
typing results for the QAP samples.
For the Broad data, in addition to comparing the results for concordance with previous
results, the sequencing data was aligned against the reference sequences of the previously
called alleles. This was done for the Broad data, to ensure that the first 50 samples
which were used to estimate parameters were representative of the relationship between
low coverage and discordant calls.
6.1. Results
The two datasets will be presented separately. First, the Broad sample data, followed by
the QAP sample data.
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6.1.1. Broad comparison
Detailed results for the Broad dataset are presented in Appendix A.
The Broad results were divided into two groups, the training dataset of 50 samples
that were used in the parameter value selection and the test dataset made up of the
remaining 268 samples. Clearly, the parameters chosen should produce good results for
the training dataset. If similarly good results could be achieved for the test dataset, it
would show that the parameters are robust enough for a wider range input data.
Both allele callers had a strong relationship between discordance and actual coverage
for the training dataset (Figure 5.3) and the test dataset (Figure 6.1). In the test dataset,
approximately 70% of the discordant calls for the allele caller based on expectation and
50 % of the discordant calls for the allele caller based on clustering occurred when the
actual minimum exon coverage was zero. In other words, for both allele callers, at least
half of their discordant calls occurred when the sample data did not have any reads for at
least one exon of at least one of the alleles. For both callers almost all of the discordant
calls were made when the minimum coverage was less than three. On the other hand the
majority of concordant calls for both allele callers were when the minimum coverage was
greater than three reads.
There were 7 loci in the training dataset (Table 6.2) and 49 loci in the test dataset
(Table 6.3) that had no reads. Furthermore, 55 of the 150 loci for the training dataset
and 210 or the 804 loci for the test dataset did not have reads present for both exons
for both alleles. The dropouts occurred for all three loci, with HLA-C having the most
dropouts and HLA-B having the least. Both allele callers made more calls than the
number of loci that had all exons covered, and neither managed concordance for all loci
that had all exons covered.
The allele caller based on expectation made concordant calls for 85 loci in the training
dataset, which is 56.6% of the total loci or 89.5% of the loci that had reads for all exons.
For the test dataset, 70.8% of the total calls were concordant, or 95.8% of the calls for
loci which had reads for all exons were concordant. Additionally, 25.4% of the calls made
for the training data and 13.1% of the calls for the test dataset were discordant.
For the allele caller based on clustering, 50.7% of the total loci for the training dataset
and 67.0% of the test dataset were concordant. This was equivalent to 80% of the
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HLA-A HLA-B HLA-C Total
Sample count 50 50 50 150
Reads 47 49 47 143
All exons covered 32 35 28 95
Expectation call 37 41 36 114
Expectation concordant 27 31 27 85
Clustering call 31 35 31 97
Clustering concordant 25 26 25 76
Table 6.2.: Concordance of both allele callers of the training dataset
HLA-A HLA-B HLA-C Total
Sample count 268 268 268 804
Reads 255 255 245 755
All exons covered 190 227 177 594
Expectation call 215 241 199 655
Expectation concordant 179 222 168 569
Clustering call 202 231 185 618
Clustering concordant 170 219 150 539
Table 6.3.: Concordance of both allele callers of test dataset
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Expectation concordant Expectation discordant Clustering concordant Clustering discordant











(a) Zoomed in on low coverages











(b) Showing all coverages
Figure 6.1.: Cumulative proportion of concordant and discordant samples versus actual
minimum coverage for both allele callers for test dataset
covered loci for the training dataset and 90.7% of the covered loci for the test dataset.
Additionally, 21.6% of the calls for the training dataset and 12.8% of the calls for the
test dataset were discordant.
Most of the discordant calls had “Low” confidence for both allele callers for both
the training dataset (Table 6.4) and the test dataset. For the allele caller based on
expectation, 83% of the discordant calls for the training dataset and 84% of the discordant
calls for the test dataset had “Low” confidence. For the allele caller based on clustering,
81% of the discordant calls for the training dataset and 90% of the discordant calls for
the test dataset had “Low” confidence.
The majority of calls with medium confidence has at least one exon with the same
sequence for both alleles calls (Table 6.6 and Table 6.7). Only one discordant medium
confidence call for each allele caller did not have an exon with the same sequence for
each allele.
Only one discordant call was made with “High” confidence by each allele caller. For
both allele callers, this call was for the HLA-B locus for the same sample (Table 6.8).
The allele calling from the previous typing and the two allele callers under test agreed
on one of the two alleles B*58:01:01G. The other allele call had the same exon 2 for
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Low 10 (12%) 24 (83%) 1 (1%) 17 (81%)
Medium 5 (6%) 4 (14%) 5 (7%) 3 (14%)
High 70 (82%) 1 (3%) 70 (92%) 1 (5%)
All 85 29 76 21











Low 39 (7%) 72 (84%) 9 (2%) 71 (90%)
Medium 61 (11%) 14 (16%) 58 (11%) 8 (10%)
High 469 (82%) 0 (0%) 472 (88%) 0 (0%)
All 569 86 539 79









Same exon 5 1 5 2
Multiple options 0 1 0 0
Both 0 2 0 1
All 5 4 5 3









Same exon 55 11 57 7
Multiple options 4 0 1 1
Both 2 3 0 0
All 61 14 58 8
Table 6.7.: Breakdown of “Medium” confidence calls in test dataset
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both B*51:01:01G and B*51:173Q, and exon 3 has a single mismatch at position 31.
Examination of the reads shows that both allele callers used at least 100 reads for both
exons to call the B*51:173Q allele and that none of the exon 3 read sequences matched
B*51:01:01G at position 31. The allele B*51:173Q was added to the IMGT reference
database [3] in March 2014 [100], so would not have been available when the calls based
on Sanger sequencing were made.
Caller Allele 1 Allele 2
Sanger + Assign B*51:01:01G B*58:01:01G
Expectation B*51:173Q B*58:01:01G
Clustering B*51:173Q B*58:01:01G
Table 6.8.: Discordant alleles called with “High” confidence for the training dataset
6.1.2. QAP comparison
Detailed results for the QAP dataset are presented in Appendix B.
The QAP results represent analysis of sequencing data from 13 lanes spread across
10 sequencing runs. Therefore, the presentation of results will either present data for
all QAP samples, QAP samples by run or QAP samples by lane. There was a large
variation in the number of reads passing all of the Roche software quality filters, with
the highest yield of 131,128 reads more than doubling the lowest yield of 62,740 reads
(Table 6.9). Median read lengths were also variable, ranging from 343 to 494 bases.
Across all lanes of data for all runs, the concordance was 95% for the allele caller
based on expectation and 93% for the allele caller based on clustering (Table 6.10). For
both allele callers, the concordance was less than 20% for lane 7 of the third run. For
this lane, both callers only called 6 of the 38 sample loci, with the allele caller based on
expectation being concordant for all six calls, and the allele caller based on clustering
being concordant for five calls and discordant for one call. All other lanes are concordant
for at least 90% of the actual alleles. Discordance was similar for both callers, with 2%
and 3% of the discordant calls made by the callers based on expectation and clustering
respectively.
Approximately 85% of the concordant calls made with both allele callers were made
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1 7 180,201 174,275 131,128 440
2 3 174,580 168,192 93,200 415
3 3 180,522 175,940 122,651 397
3 4 160,411 154,557 116,406 415
3 7 132,941 126,613 89,028 410
3 8 142,663 134,107 86,866 399
4 8 142,720 138,482 66,082 396
5 4 176,312 169,111 109,306 494
6 - 1831,52 172,234 100,629 415
7 3 139,405 131,023 86,154 391
8 - 176,753 169,367 62,740 476
9 - 147,379 136,861 71,469 454
10 8 176,307 170,191 123,504 343
Table 6.9.: Run parameters for the QAP sequencing runs
with “High” confidence (Table 6.11). Four percent of the concordant calls calls made with
“Low” confidence and eleven percent of the concordant calls were made with “Medium”
confidence for both allele callers. The majority of discordant calls for both allele callers
were made with “Low” confidence, and only one discordant calls was made with “High”
confidence.
When the calls were made with “High” confidence, there were no discordant calls
for the allele caller by expectation and one discordant call by the allele caller based on
clustering (Table 6.13). Across all of the samples, 81% of the actual alleles are called
concordantly with “High” confidence by the allele caller based on expectation and 79%
by the allele caller based on clustering. However, there is large variation for both callers.
The allele caller based on expectation had “High” confidence calls with concordances
ranging from 11% to 91%, and the allele caller based on clustering had “High” confidence
calls with concordances ranging from 13% to 91%.
The only “High” confidence call that was discordant was made by the allele caller based
on clustering. The call made from that data by the allele caller based on expectation
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1 7 32 31 (97%) 3 (9%) 31 (97%) 1 (3%)
2 3 66 60 (91%) 0 (0%) 60 (91%) 0 (0%)
3 3 38 36 (95%) 2 (5%) 36 (95%) 2 (5%)
3 7 38 6 (16%) 0 (0%) 5 (13%) 1 (17%)
3 4 198 195 (98%) 5 (3%) 196 (99%) 3 (2%)
3 8 198 197 (99%) 1 (1%) 195 (98%) 3 (2%)
4 8 132 131 (99%) 1 (1%) 131 (99%) 1 (1%)
5 4 132 125 (95%) 6 (5%) 119 (90%) 10 (8%)
6 - 136 136 (100%) 0 (0%) 134 (99%) 1 (1%)
7 3 45 43 (96%) 1 (2%) 42 (93%) 2 (5%)
8 - 340 322 (95%) 12 (4%) 312 (92%) 12 (4%)
9 - 43 42 (98%) 2 (5%) 40 (93%) 2 (5%)
10 8 45 43 (96%) 2 (4%) 43 (96%) 1 (2%)
All - 1443 1367 (95%) 35 (2%) 1344 (93%) 39 (3%)










Low 51 (4%) 21 (60%) 58 (4%) 29 (74%)
Medium 144 (11%) 14 (40%) 142 (11%) 9 (23%)
High 1172 (86%) 0 (0%) 1144 (85%) 1 (3%)
All 1367 35 1344 39
Table 6.11.: Concordance of both allele callers by call confidence level of QAP samples
Caller Allele 1 Allele 2




Table 6.12.: Discordant alleles called with “High” confidence for the QAP samples
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was also incorrect, but called with “Medium” confidence. The “Medium” confidence call
was made, because there were two well ranked calls, the second of which was the correct
call. This sample was also tested in two other lanes, and for those lanes the correct call
was made by both allele callers. The discordant call was comprised of one allele that
matched one of the known alleles. The second allele matched the other known allele for
exon 2, but had 14 differences in exon 3. Examination of the reads for the discordant
sample showed that for exon 2 the reads matched the sequences of A*02:06:01G and
A*02:01:01G which has the same exon 2 sequence as A*02:65. The majority of the exon
3 reads matched the sequence for A*02:06:01G which has the same exon 3 sequence as
A*02:01:01G, but there were two other minor components. One of the minor components
matched A*02:65 and the other was consistent with A*24. When examining the reads
for the other two lanes that had the same sample, there was no reads matching A*02:65










1 7 32 27 (84%) 0 (0%) 27 (84%) 0 (0%)
2 3 66 56 (85%) 0 (0%) 51 (77%) 0 (0%)
3 3 38 32 (84%) 0 (0%) 24 (63%) 0 (0%)
3 7 38 4 (11%) 0 (0%) 5 (13%) 0 (0%)
3 4 198 181 (91%) 0 (0%) 180 (91%) 0 (0%)
3 8 198 178 (90%) 0 (0%) 169 (85%) 0 (0%)
4 8 132 112 (85%) 0 (0%) 113 (86%) 0 (0%)
5 4 132 86 (65%) 0 (0%) 83 (63%) 0 (0%)
6 - 136 116 (85%) 0 (0%) 120 (88%) 0 (0%)
7 3 45 39 (87%) 0 (0%) 39 (87%) 0 (0%)
8 - 340 275 (81%) 0 (0%) 275 (81%) 1 (0.4%)
9 - 43 31 (72%) 0 (0%) 30 (70%) 0 (0%)
10 8 45 35 (78%) 0 (0%) 28 (62%) 0 (0%)
All - 1443 1172 (81%) 0 (0%) 1144 (79%) 1 (0.1%)
Table 6.13.: Concordance for “High” confidence calls of both allele callers for QAP
samples
On average, less than 10% of the calls made with “Medium” confidence were discordant
for both allele callers (Table 6.14). For both callers, approximately 10% of the concordance
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with the actual results was made with calls of “Medium” confidence. Most of the calls
made with “Medium” confidence had at least one exon that was the same for both alleles
(Table 6.15). For the allele caller based on expectation, all calls made with multiple
options that had at least one exon in common between the alleles, were discordant (4/4).
Additionally, 5 of the 21 calls made with “Medium” confidence, and where multiple
options existed without any shared exon sequences, were discordant. For the allele caller
based on clustering, all of the discordant calls were for alleles that shared at least one
exon sequence, and there were no discordant calls where there were multiple options that










1 7 32 4 (13%) 1 (20%) 4 (13%) 1 (20%)
2 3 66 4 (6%) 0 (0%) 6 (9%) 0 (0%)
3 3 38 2 (5%) 2 (50%) 4 (11%) 1 (20%)
3 7 38 1 (3%) 0 (0%) 0 (0%) 0 (0%)
3 4 198 13 (7%) 2 (13%) 13 (7%) 0 (0%)
3 8 198 13 (7%) 0 (0%) 15 (8%) 1 (6%)
4 8 132 19 (14%) 1 (5%) 18 (14%) 0 (0%)
5 4 132 23 (17%) 0 (0%) 21 (16%) 0 (0%)
6 - 136 13 (10%) 0 (0%) 11 (8%) 1 (8%)
7 3 45 4 (9%) 0 (0%) 3 (7%) 1 (25%)
8 - 340 32 (9%) 7 (18%) 31 (9%) 4 (11%)
9 - 43 11 (26%) 0 (0%) 9 (21%) 0 (0%)
10 8 45 5 (11%) 1 (17%) 7 (16%) 0 (0%)
All - 1443 144 (10%) 14 (9%) 142 (10%) 9 (6%)
Table 6.14.: Concordance for “Medium” confidence calls of both allele callers for QAP
samples
For both allele callers, 4% of the loci were called concordantly when the confidence
in the call is “Low”. Approximately one third of the calls made with “Low” confidence
were discordant.
More than 90% of the actual alleles were called concordantly by the allele caller based
on expectation for all loci. HLA-DRB1 and HLA-DRB3 had the lowest concordances of
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Same exon 128 5 120 9
Multiple options 16 5 22 0
Both 0 4 0 0
Total 144 14 142 9










1 7 32 0 (0%) 2 (100%) 0 (0%) 0 (0%)
2 3 66 0 (0%) 0 (0%) 3 (5%) 0 (0%)
3 3 38 2 (5%) 0 (0%) 8 (21%) 1 (11%)
3 7 38 1 (3%) 0 (0%) 0 (0%) 1 (100%)
3 4 198 1 (1%) 3 (75%) 3 (2%) 3 (50%)
3 8 198 6 (3%) 1 (14%) 11 (6%) 2 (15%)
4 8 132 0 (0%) 0 (0%) 0 (0%) 1 (100%)
5 4 132 16 (12%) 6 (27%) 15 (11%) 10 (40%)
6 - 136 7 (5%) 0 (0%) 3 (2%) 0 (0%)
7 3 45 0 (0%) 1 (100%) 0 (0%) 1 (100%)
8 - 340 15 (4%) 5 (25%) 6 (2%) 7 (54%)
9 - 43 0 (0%) 2 (100%) 1 (2%) 2 (67%)
10 8 45 3 (7%) 1 (25%) 8 (18%) 1 (11%)
All - 1443 51 (4%) 21 (29%) 58 (4%) 29 (33%)
Table 6.16.: Concordance for “Low” confidence calls of both allele callers for QAP samples
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92%. HLA-DRB1 also had the highest discordance, with 5% of the calls being discordant.
For the allele caller based on clustering, all loci except HLA-DRB3 were called with
greater than 90% concordance. For HLA-DRB3, the concordance was 88%. HLA-DQB1
and HLA-DRB1 were the loci with highest discordance for the allele caller based on












A 220 206 (94%) 7 (3%) 206 (94%) 6 (3%)
B 220 211 (96%) 2 (1%) 209 (95%) 4 (2%)
C 220 209 (95%) 3 (1%) 206 (94%) 3 (1%)
DPB1 128 122 (95%) 2 (2%) 123 (96%) 0 (0%)
DQB1 118 116 (98%) 2 (2%) 110 (93%) 8 (7%)
DRB1 220 203 (92%) 10 (5%) 200 (91%) 13 (6%)
DRB3 156 144 (92%) 3 (2%) 137 (88%) 3 (2%)
DRB4 104 101 (97%) 4 (4%) 99 (95%) 2 (2%)
DRB5 57 55 (96%) 2 (4%) 54 (95%) 0 (0%)
All 1443 1367 (95%) 35 (2%) 1344 (93%) 39 (3%)
Table 6.17.: Concordance by locus of both allele callers for QAP samples
6.2. Discussion
In an ideal situation, only a single read covering each exon of each allele for each loci
would be required to call the alleles. However, calling is made much more challenging by
amplification errors including translation errors, recombination, off target amplification
and preferential amplification, along with sequencing errors. The key to overcoming these
errors is to have sufficient good reads that the signal can be extracted from the noise.
The Broad dataset, had minimum exon coverages ranging from 0 to 299 reads (Figure
6.1). Therefore, it proved to be an excellent test for the two allele callers developed. As
expected concordance was high when the coverage was high and discordance peaked as
the minimum coverage approached and reached zero. Overall the concordance for both
the training and test datasets for both allele callers are much lower than those reported
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in the literature for other allele callers [83, 84, 86, 92, 93, 95]. The concordance for the
QAP samples was higher and approached the levels reported in the literature. The lower
concordance rates for the Broad dataset, reflect the challenging nature of some of the
samples in the dataset, which is what was needed to test the limits of the callers.
Erlich [85] recommended at least 50 reads per locus to call HLA alleles, and early
papers published often exceeded that. For example, Gabriel et al. [84] had an average
coverage of 1000 reads per locus. The much lower coverage levels seen in this study were
the result of much more ambitious sample counts per sequencing run. Early studies used
48 or less samples per sequencing run [83, 84, 86]. Lank et al. [92] ran the equivalent of
384 samples per run for HLA class I only, and Erlich et al. [82] ran 768 samples for HLA
class I only in a single sequencing run. Grumbt et al. [93] could run 192 samples for 5
loci in a single run. The Broad dataset used the methodology and sample density from
Erlich et al. [82] and was sequenced at a similar time. This is double the density of any
other publication. Similarly, the QAP samples were loaded at 384 samples per run for 6
loci. Furthermore, many of these runs were workups for laboratory processes, with the
QAP samples acting as positive controls.
Each allele pair called was given confidence rating of “Low”, “Medium” or “High”.
Only one “High” confidence call was discordant with the originally called data in each of
the datasets. For the Broad dataset, this was probably due to an incorrect call from the
Sanger data because the allele in the sample was not present in the reference database
when the original call was made. The discordant call made at “High” confidence in the
QAP dataset was probably due to a low level contamination in the PCR product for
exon 3. For both Broad datasets tested, the “Low” confidence calls included at least 80%
of the discordant calls and at most 12% of the concordant calls. However, for the QAP
samples, at least 23% of discordant calls were made with “Medium” confidence. The
majority of “Medium” confidence calls for all datasets and both allele callers had at least
one exon sequence in common between the two alleles called, or were homozygous. These
calls also formed the majority of the discordant “Medium” confidence calls. Homozygous
calls represent a challenge in interpretation, in that a homozygous call can be the correct
call as evidenced by the concordant homozygous calls, but it may also occur due to
allelic drop out. When high confidence is required in the results, true homozygosity can
be confirmed by using a different typing method or an alternative set of amplification
primers.
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6.3. Conclusion
The combination of the allele callers developed in this thesis (Chapter 4) and the
parameter values chosen based on a training dataset (Chapter 5) has resulted in two
robust allele callers. The allele callers performed equally well for the training dataset
and a test dataset, both derived by splitting the larger Broad dataset. Furthermore, the
overall concordance was higher when tested on the unrelated QAP samples.
Although the concordance of calling for these datasets is lower than reported for
other callers in the literature, this can be attributed to much lower read coverage. Low
read coverage, especially less than three reads per exon per allele strongly determines
discordance. To combat discordant calls, the allele callers developed report a call
confidence level. At “High” call confidence, no unexplained discordance occurred. For all
data tested, the majority of discordant calls occurred for “Low” confidence calls.
The ability of the caller to identify calls with “High” confidence of being concordant,
enables it to be used in conjunction with high numbers of samples sequenced per run.
This reduces sequencing costs and makes HLA typing more affordable.
108
7. HLA allele calling from MiSeq data
7.1. Introduction
At the commencement of this thesis, the GS-FLX with titanium chemistry was the obvious
platform to provide sequencing data because of its read lengths. During the last five years,
read lengths for many platforms have increased, and now there are other next generation
sequencing platforms with sufficiently long read lengths to use the methods developed in
this thesis. Specifically, the Illumina MiSeq with overlapping paired end reads and the
Ion Torrent PGM using 400 base pair chips, are second generation sequencing platforms
that could be used. Additionally, third generation sequencing platforms offer much longer
read lengths.
The MiSeq platform can produce up to 15Gb of data per run for 300 base pair paired
end reads, this equates to 25,000,000 read pairs [101]. Choosing primers to produce
amplicon sizes less than twice the read length, allows overlap at the end of the pairs so
that the two reads in the pair can be merged to yield a single read covering the whole
amplicon.
Data from a single MiSeq run of 23 HLA samples was made available by IIID to be
used in this thesis. This data enabled the allele caller based on clustering (Section 4.3) to
be tested on a different source of sequencing data. The allele caller based on expectation
(Section 4.2.2) was not tested on this data, because the assumption that the predominant
sequencing errors would be homopolymer indels is not satisfied by MiSeq data, which has
predominantly substitution errors. Additionally, by examining different sized excerpts of
the data, the number of samples that could be typed in a single run was estimated.
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7.2. Methodology
A pool of 23 samples that had previously been sequenced on the GS-FLX platform
was sequenced using the MiSeq. These samples were tagged with eleven base MID
primers during PCR amplification, rather than using the MiSeq library multiplexing
tags. This had the disadvantage that the eleven base MID tag used part of the read
length. However, it allowed a previously prepared sample pool to be used and reduced
the library preparation cost for the sequencing run. The sample pool was sequenced
using 310 base pair, paired end sequencing by Illumina Australia and New Zealand.
The run produced 24,290,089 read pairs, which equates to more than one million reads
per sample on average. It was expected that this was a lot more reads than would be
required to call the alleles. Therefore, 12 excerpts of reads were taken from the read pairs
produced. The 12 excerpts were 4 repetitions of each of 100,000, 200,000 and 500,000
read pairs (Table 7.1). For each repetition, the three excerpts overlapped, i.e. the 100,000
read pair excerpt was a subset of the 200,000 read pair excerpt, which in turn was a
subset of the 500,000 read pair excerpt. There was no overlap of reads between the
repetitions. The step of creating excerpts was only done because this pilot study data
only sequenced a small set of samples, and would not normally be carried out.
Excerpt Start End Length
1 100,001 200,000 100,000
2 1 200,000 200,000
3 1 500,000 500,000
4 2,500,001 2,600,000 100,000
5 2,500,001 2,700,000 200,000
6 2,500,001 3,000,000 500,000
7 5,000,001 2,600,000 100,000
8 5,000,001 2,700,000 200,000
9 5,000,001 3,000,000 500,000
10 7,500,001 7,600,000 100,000
11 7,500,001 7,700,000 200,000
12 7,500,001 8,000,000 500,000
Table 7.1.: Excerpts used to test HLA allele calling from MiSeq
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For each excerpt, the reads were split into pools based on the MID sequence. For each
pool, the reads were split into locus pools based on the primer sequence at the start of
the read. These steps are the same as when calling alleles from GS-FLX data for either
allele caller.
The next step is a deviation from the previous methods, and is required to merge
the paired end reads to form a single read covering the amplicon. For each exon to be
sequenced, the primers were chosen to form an amplicon that was short enough that
the paired end reads would overlap in the middle (Figure 7.1). The read sequence of
the amplicon was thus a combination of the both of the paired ends. To merge the
overlapping parts of the paired ends, both ends were first aligned against a reference
sequence (Table 4.1) using a pairwise aligner.
For the part of the reference sequence covered by both ends of the pair, for each
reference index in the overlapping region, the merged result was chosen as follows:
Both ends have the same insertion Use the insertion bases and the highest quality score
from the two ends.
Only one read has an insertion The insertion is ignored.
Both ends have insertions but they don’t match The insertions are ignored.
Both ends have a deletion No base is added for that index.
One end has a deletion The base from the other end is used along with its quality score.
Both ends agree The agreed base is used with the highest quality score.
Each end has a different base The base with the highest quality score is used.
Once the reads have been merged, they are analysed in the same way as was done
for the GS-FLX reads, i.e. the only modifications made to the allele caller based on
clustering, were analysing excerpts of the data and the need to merge the paired ends to
form read sequences that covered the exons.
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Figure 7.1.: Overlapping MiSeq paired end reads covering an exon
7.3. Results
Detailed results for the MiSeq dataset are presented in Appendix C.
Across the four repetitions of each excerpt size, the average concordances were 96%,
98% and 99% for the 100,000, 200,000 and 500,000 reads respectively (Table 7.2). On
average, 3%, 2% and 1% of the calls were discordant for the 100,000, 200,000 and 500,000
excerpt sizes respectively. For all excerpt sizes, most of the calls were made at “Medium”
or “High” confidence.
For the 200,000 and 500,000 read excerpts, more than 80% of the calls were made with
“High” confidence, and one of these calls was discordant. For the 100,000 read excerpts,
on average 78% of the calls were made with “High” confidence and only one of these
calls was discordant.
The discordant call for the 100,000 read excerpt, had one allele in common with the
expected result (Table 7.3). The other allele, C*07:73, had the same exon 3 sequence as
the actual allele, C*07:01:01G, but a single SNP different for exon 2. The correct call
was made, but had a “No” ranking for the best allele call, so was not considered as an
option. There were 19 reads in the cluster for exon 2 for the discordant allele, and 16
reads for exon 2 for the concordant call. Examination of the reads, does not support a
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Excerpt Confidence Concordant Discordant
100,000 Low 3 (0%) 3 (50%)
100,000 Medium 115 (17%) 16 (12%)
100,000 High 533 (78%) 1 (0.2%)
100,000 All 651 (96%) 20 (3%)
200,000 Low 1 (0%) 0 (0%)
200,000 Medium 115 (17%) 13 (10%)
200,000 High 550 (81%) 0 (0%)
200,000 All 666 (98%) 13 (2%)
500,000 Low 1 (0%) 0 (0%)
500,000 Medium 115 (17%) 4 (3%)
500,000 High 559 (82%) 1 (0.2%)
500,000 All 675 (99%) 5 (1%)
Table 7.2.: MiSeq concordance for three excerpt sizes
systematic sequencing error causing the erroneous call. Concordant calls were made for
this sample locus for the other eleven excerpt repetitions.
The discordant call for the 500,000 read excerpt, should have been homozygous, but
a second erroneous allele was also called (Table 7.3). The sample was homozygous
for HLA-DRB1*03:01:01G, and thus was expected to have two HLA-DRB3 alleles,
i.e. was truly homozygous for HLA-DRB3 also. The false allele called for HLA-
DRB3 appears to be a low level recombinant between HLA-DRB1*03:01:01G and HLA-
DRB3*01:01:02G. Examination of the reads supported that reads consistent with this
were present. Examination of other excerpts also confirmed the presence of recombinants.
However, all 11 other excerpts produced concordant results.
Excerpt Allele 1 Allele 2
Actual 100,000 C*04:01:01G C*07:01:01G
Called 100,000 C*04:01:01G C*07:73
Actual 500,000 DRB3*01:01:02G DRB3*01:01:02G
Called 500,000 DRB3*01:01:02G DRB3*01:14
Table 7.3.: Discordant alleles called with “High” confidence for the MiSeq samples
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Calls made with “Medium” confidence provided concordant calls for 17% of the loci,
for all excerpt sizes (Table 7.2). The percentage of calls made with “Medium” confidence
that were discordant ranged from 12% for the excerpts with 100,000 reads, through 10%
for the 200,000 read excerpts, to 4% for the 500,000 read excerpts. Across all excerpt
sizes, the most common reason for calling with “Medium” confidence was both alleles
for the loci having at least one exon sequence the same (Table 7.4). There were no calls
that were allocated “Medium” confidence, based on having multiple options alone. The
only “Medium” confidence calls that had multiple options, also had at least one exon in
common between the alleles called, and all of these calls were discordant.
Concordant Discordant
Same exon 345 26
Linked homozygous 0 1
Multiple options 0 0
Both 0 7
All 345 33
Table 7.4.: Breakdown of medium confidence calls MiSeq
The largest excerpt size tested, 500,000 reads, had five loci which were discordant
(Table 7.2)). One sample locus was called with “High” confidence and was discordant
(Table 7.3). The other four sample loci were called with “Medium” confidence and were
the four repetitions from a single sample loci (Table 7.5). This sample was also discordant
in all repetitions for both other excerpt sizes, whereas the sample that was discordant in
only one repetition was not discordant in any repetitions for both other excerpt sizes.
Seven of the twelve excerpts had multiple options and all had one exon sequence in
common between the two called alleles. Hence, this sample loci was the source of all
seven discordant calls made with “Medium” confidence, having both multiple options and
at least one common exon sequence between the alleles (Table 7.4). When the second
option was called, it was concordant with the actual results.
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Match Allele 1 Allele 2
Concordant A*02:01:01G A*32:01:01G
Discordant A*02:01:01G A*02:65
Table 7.5.: Discordant alleles called with 500,000 read excerpts for the MiSeq samples
7.4. Discussion
Concordance for the 23 samples, called 12 times, ranged from 96% for excepts of 100,000
reads to 99% for excerpts of 500,000 reads. These concordances are similar to levels
reported by other HLA allele calling from second generation sequencing data pipelines
[83, 84, 86, 92, 93, 95]. With 500,000 reads used to call 23 samples, a sequencing run of
24,000,000 reads may be capable of calling alleles for more than 1,000 samples for class I
HLA-A, HLA-B and HLA-C, and class II HLA-DPB1, HLA-DQB1 and HLA-DRB1, 3, 4
and 5. This is more than has been reported for any other study. However, in practice,
the number of samples sequenced in a run may be limited by other factors, such as how
many samples are available to be tested in a batch. By using the MID tagged primers
used to prepare the samples used in this run, large numbers of samples may be pooled in
a single run by using two sets of multiplexing tags. For example, 16 MiSeq multiplexing
tags, each wrapping 48 samples tagged with 11 base MID tags, would allow 768 samples
to be pooled in a single run. This comes at the expense of losing 11 bases from the read
length.
Two issues were found with the results for the MiSeq allele calls. First, there were two
calls made with “High” confidence which were discordant. The first was made with the
smallest excerpt size and appeared to be the result of a clustering error, as the reads did
not support the call. The second was made from the largest excerpt size and appeared
to be the result of a low level recombinant between an HLA-DRB1 exon sequence and
an HLA-DRB3 exon sequence. Both of these discordant calls were only made once from
the 12 excerpts tested. The second issue was that one sample locus was discordant for
all repetitions of all excerpt sizes. In 7 of the 12 excerpts tested the concordant allele
combination was given as a second option.
These two issues highlight the potential problems of transferring an algorithm and
parameter values from one sequencing technology to another. This is also supported by
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the loss of functionality of the “Low” confidence allele calls. For the GS-FLX sequencing
data (Table 6.4 and Table 6.11) the majority of discordant calls were called with “Low”
confidence, however for the MiSeq data only 3 out of 38 discordant calls were made with
“Low” confidence.
Three options exist which may potentially improve the calling and the assignment of
call confidence levels for MiSeq data. First, when more MiSeq data becomes available,
the choice of parameter values and criteria for assigning confidence levels should be based
on Miseq training data rather than GS-FLX training data. Second, no quality filtering
of reads was done prior to using reads in this test, i.e. all reads were used in the analysis,
but bases with quality scores below Q15 (Section 5.1.4) were excluded. Developing a set
of quality metrics that could exclude reads with low average quality or too many low
quality bases, may improve the clustering. Finally, new warnings need to be investigated,
for example, detection of potential recombinants. Recombinants are not a product of
the sequencing platform, but with generally larger numbers of reads used for calling, low
level recombinants are more likely to be detected and called as alleles.
7.5. Conclusion
The level of concordance achieved by this pilot study is impressive when considering that
the allele caller was developed for and had parameter values chosen based on a different
sequencing platform. Potentially, using training data and confidence criteria based on a
body of MiSeq training data combined with quality filtering on the reads may improve
concordance.
The amount of data produced in a single MiSeq run gives the potential to sequence a
large number of samples per run, or to add additional areas to be sequenced for each
sample.
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8. Resolving mitochondrial DNA
mixtures
8.1. Introduction
Forensic examination may identify the perpetrator(s) of a crime through many artefacts
and traces left at the scene or transferred from the victim(s) to the offender(s) or
vice versa. These include, fingerprints, personal items e.g. strands of clothing, and
biological specimens including blood, saliva, hair, skin cells or semen. DNA can be
extracted from the biological specimens and this can be matched to the victim(s),
offender(s) and other parties. There are two types of DNA and both may be used to
aid in identification of individuals. Nuclear DNA (nucDNA) is the most commonly
used DNA in forensic applications [102]. Analysis of short tandem repeats (STR) and
single nucleotide polymorphisms (SNP) are the most common methods used in nucDNA
analysis [103]. Mitochondrial DNA (mtDNA) is the second type of DNA. If both types
of DNA are readily available, nucDNA is used in preference to mtDNA because it has
higher potential to uniquely identify individuals [103].
Mitochondrial DNA has several important differences to nucDNA that make it a better
option in some circumstances. A cell has two copies of nucDNA, but may have several
thousand copies of mtDNA [104] and thus mtDNA is more likely to be recovered from
small samples. Additionally, mtDNA is better preserved than nucDNA, because it has a
circular structure and therefore has no ends, protecting it from exonucleases. As a result,
mtDNA can be used for specimens where it is no longer possible to recover nucDNA of
suitable quality for analysis, see Hatsch et al. [105] and Sudoyo et al. [106] for examples.
Mitochondrial DNA is maternally inherited and thus siblings and their maternally linked
relatives share the same mtDNA. This has advantages, in that a maternally linked relative
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may provide matching material for a person who is unavailable to supply samples, see
Sudoyo et al. [106] for an example . There are also disadvantages, in that mtDNA can-not
be used to discriminate between maternally related relatives [107]. The mitochondrial
genome is just over sixteen and a half thousand bases long [108], and forensic analysis
normally concentrates on one or two hyper-variable regions, hyper-variable region one
(HV1) and two (HV2) being 341 and 267 bases long respectively [102]. Therefore, the
amount of variation possible in this region is much less than for the nucDNA, which
is over 200,000 times larger. Budowle et al. [109] found in the analysis of eight ethnic
groups that the probability of a random match within the same ethnic group ranged
from 0.52 percent to 2.5 percent. They found the average number of differences between
individuals in HV1 and HV2 combined in the same ethnic grouping varied between 7.2
for French caucasians to 14.1 for African Americans. Between group average number
of differences varied between 7.6 for French vs US caucasians to 15.3 for Africans vs
Hispanics.
Heteroplasmy has been observed in mtDNA. In heteroplasmy, an individual may
have more than one sequence for their mtDNA with two types of variation observed
[110]. Length heteroplasmy occurs where a homopolymer region (a stretch with the
same nucleotide repeated) of the sequence will have insertions or deletions of the same
nucleotide. Substitution heteroplasmy is where the heteroplasmic variant has a single
SNP difference from the dominant sequence. As technology improves, heteroplasmy is
detected more often [107]. Heteroplasmy is most commonly a single base change from
the dominant sequence, but may involve two or three changes [111]. Matching both the
dominant sequence and heteroplasmic variants will provide additional confidence of a
match [102, 110]. However, in the unusual case that only highly degraded samples are
available, and that only heteroplasmic variants can be recovered, the case of a match
will be weakened [110].
A major challenge in forensic sample analysis, is that samples may include DNA
from two or more individuals. In the past, resolving has been carried out for nucDNA
using Sanger sequencing technology and a variety of statistical tests, see Weir et al.
[112], Curran et al. [113], Ladd et al. [114] and Kelly et al. [115] for examples. There is
conjecture in the literature of the reliability of this technique and how it can be impacted
by cognitive bias [116–118]. Krane et al. [119] recommend keeping the transfer of other
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evidence to the minimum required at each step of DNA analysis. Homer et al. [120] have
used thousands of SNPs on a microarray to determine if an individual was part of a
mixture. They compared the distance of the individual from the SNPs in the mixture to
the distance of the individual from a reference population. Using this technique they were
able to confirm the presence of individuals in populations of over 40 subjects, and detect
individuals when they contributed less than one percent of the DNA in the mixture.
Three different techniques have been reported to examine mixtures of mtDNA. Hall
et al. [121] used polymerase chain reaction (PCR) followed by desolvation and direct
analysis using electrospray ionisation mass spectrometry to resolve mixtures of two
subjects. In mixtures where the smaller component was present at one percent, the
smaller component was not detectable, at five percent the resolution was not reliable and
at 25 percent resolution was automatable. A single sample with 10 percent was resolvable
with manual interrogation. Egeland & Salas [122] presented a statistical framework
for analysing mixtures using Sanger sequencing data. Sanger sequencing data has a
resolution of detecting mixtures of approximately 5-20 percent, is unable to resolve phase
between differences reducing the strength of the conclusions and fails when a mixture
contains sequences of different lengths [107]. In an attempt to solve these issues, Holland
et al. [107] used the FLX GS junior sequencer to examine HV1 mixtures of two subjects.
They were able to detect mixtures when the subjects were pooled at the ratio 1:250.
They did not attempt to resolve the mixtures and stated that recombination would be a
major issue in mixture resolution.
The challenge addressed by this chapter is mixture resolution of mtDNA samples,
to either supplement existing nucDNA mixture resolution data or stand alone in cases
where nucDNA analysis is not available. The analysis aims to be as automated as
possible to avoid problems of cognitive bias. Additionally, the method will attempt to
resolve components at lower levels than are possible using current techniques and resolve
mixtures of more than two samples.
Resolving mitochondria into that belonging to potentially different individuals was
chosen as an extension to the algorithms developed in this thesis for HLA typing because
it presents several of the same challenges. However, it is a more difficult problem and
that added difficulty demonstrates the applicability of this thesis to a broader domain.
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As with HLA typing, the challenge is to split a pool of sequence reads into buckets, where
each bucket represents a unique entity. In HLA typing, the buckets represent reads from
a single allele and in mitochondrial sorting, the buckets represent reads from a single
subject. In both cases, the problem is made more difficult by sequencing errors, non
uniform bucket sizes, recombination and an unknown number of buckets. For HLA, the
non-uniformity of bucket sizes is due to problems in the sequencing pipeline, such as
preferential amplification of one allele over the other whereas, for mitochondrial sorting,
there will also be marked differences in the amount of material sequenced for each subject.
In HLA typing, the subject will have one or two different alleles for the HLA-A, B,
C, DPB1, DQB1 and DRB1 genes, and zero, one or two alleles for the HLA-DRB3,
DRB4 and DRB5 genes with the number of DRB3, DRB4 and DRB5 alleles related
to which DRB1 alleles were present. However, with mitochondrial sorting, there is no
prior information to determine how many subjects are present. A further complication is
that the mitochondrial sequence within the hyper-variable region is known to exhibit
heteroplasmy, that is the sequence for one individual will contain variations. Finally,
in HLA typing a large database of known HLA sequences can be used to validate that
known alleles are being called, but for mitochondrial sequencing there is not a set of
known mitochondrial sequences that have to be matched. Even in the case that the
victim’s and suspect’s sequences are known, the analysis would be blinded to these.
8.2. Methodology
The sequencing data used in this chapter was provided by IIID. The experimental design
for the sequencing runs and the laboratory work to obtain the sequences were not part
of this thesis. This material is being presented here to provide the background for the
data analysed.
One GS junior run and a partial GS-FLX run of sequencing data were used for
this section. Both runs included samples for the hyper-variable 1 (HV1) region of
mitochondrial DNA. The subjects sequenced in the two runs were all different.
The first sequencing run pooled the DNA of two subjects, amplified the HV1 region
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using PCR and then pooled this sample with two HIV samples unrelated to this project
and sequenced them on a GS-junior run. The three samples were all MID tagged to
facilitate their separation post sequencing. Only the reads with the MID tag for the
HV1 region were analysed in this project. When pooling the DNA, the first subject
was present at 100 times the amount of the second subject. For these subjects, Sanger
sequencing had been carried out previously to obtain the sequences of the HV1 region.
The second sequencing run used three lanes each covering one eighth of a plate of
a GS-FLX sequencing run. For this run, four subjects were used and the pooling was
carried out at three stages. In all cases, the pooling was in the ratio 1000:100:10:1. The
first pooling, pooled cells, the second pooling, pooled DNA and the third pooling, pooled
PCR products. The subjects were also sequenced individually. In all cases, pooled or
unpooled, the samples for sequencing went through the process: cells, extract DNA, PCR
amplification of the HV1 region, apply MID tags, pool for sequencing, sequence using
the FLX 454 titanium chemistry, separate samples by MID tag and finally, analysis. The
first lane contained three of the samples MID tagged to act as control information. The
second lane contained the cell pool and the DNA pool, each MID tagged. The final lane
contained the PCR products pool and the final individual sample, each MID tagged.
Figure 8.1 illustrates the sample preparation and sequencing setup.
After sequencing, the sequence data was separated into the data for each sample using
the MID tags. Each sample was then analysed using a modified version of the algorithm
presented in Section 4.3. The modifications were:
• The revised Cambridge reference sequence (rCRS) (Andrews et al. 1999) was used
to trim the reads to the HV1 region. All reads were pairwise aligned to the HV1
sequence and only reads that completely covered the HV1 region were used in the
subsequent analysis.
• After clustering, the consensuses for each cluster were assumed to represent the
HV1 sequence of one of the components of the mixture, i.e steps 9-13 of algorithm
1 (ref 1.2.3) are not required.
• Only one level of clustering was carried out. This is because the samples run on
the GS-FLX sequencing run exhibited such a high level of homopolymer variation
that subsequent clusterings served only to split clusters based on sequencing errors.
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Cells 1 Cells 2 Cells 3 Cells 4
DNA extraction











Seq 1 Seq 2 Seq 3 Seq 4 Seq 5 Seq 6 Seq 7
Lane 1 Lane 3Lane 2
Figure 8.1.: Experimental design for mitochondria sequencing run two.
8.3. Results
Results will be presented as a figure showing SNPs in the recovered clusters with respect
to the revised Cambridge Reference Sequence (rCRS). The rCRS indices at which the
SNPs occur will be shown at the top of the figure. For sequencing run two, where seven
sets of clusters are to be compared, the same set of indices is used for all seven figures,
to make comparison between the figures easier. The cluster name, number of reads and
proportion of reads are displayed on the left hand side. Finally, the SNPs are shown in
the main part of the figure. SNPs are colour coded A(green), C(blue), G(black) T(red),
deletion (pink) and mixtures (purple). Insertions are shown with the background shaded
and the font colour white.
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8.3.1. Sequencing run one
The GS Junior run produced over 150,000 reads that passed all the sequencing software
filters and had a mean read length of 440 bases (Table 8.1). After MID separation there
were a total of 67,915 reads assigned to the mitochondrial DNA mixture, of which 58,108
(85.6%) covered the HV1 region.
Raw wells 208,790
Key pass wells 198,059
Passed filter wells 152,934
Mean read length 440
Table 8.1.: Run parameters for the first mitochondrial sequencing run
The Sanger sequencing control data showed 14 differences between the reference





























































































SS-1 A T C T T T C T C
SS-2 M T Y T T
C-1 56528 97.3% A T C T T T C T C
C-2 1005 1.7% A T C T T T C T C A C C
C-3 575 1.0% - T T T
Figure 8.2.: Sequence variation between reference and recovered sequences from
sequencing run one.
Three clusters were found (Figure 8.2).
Cluster 1 The largest cluster, which contained 97.3% of the reads was an exact match
to the Sanger sequence for the major component of the mixture.
Cluster 2 The second largest cluster contained 1.7% of the reads. It was a match for the
first cluster except that it had three insertions. These insertions were located close
together, within a 15 base stretch, and did not insert into long homopolymer runs.
Cluster 3 The smallest cluster contained 1.0% of the reads. It was a match for the
Sanger sequence representing the minor component of the mixture except for a
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deletion from a run of five C’s and the cluster consensuses was pure at both of
the mixture sites in the Sanger sequence. Examining the reads for the cluster, the
deletion was present in 54.1% of the reads, and there was no evidence of a mixture
at either position indicated by the Sanger sequencing, with all reads matching the
cluster consensus at these positions.
In total there were 57,533 reads in clusters one and two combined and 575 reads in
cluster three. This is almost an exact match to the pooling ratio of 100:1.
8.3.2. Sequencing run two
The number of reads that passed all of the Roche software filters varied between 118,520
for lane 2 to 157,209 for lane 1 (Table 8.2). The median read lengths were almost identical
for the three lanes, but there was a large discrepancy in the average read lengths. Lanes
2 and 3 had similar average read lengths to the first run, but lane 1 was over 40 bases
shorter (Table 8.1 and Table 8.2).
Lane 1 Lane 2 Lane 3
Raw wells 197,734 154,239 158,178
Key pass wells 185,889 140,218 146,034
Passed filter wells 157,209 118,520 126,895
Mean read length 394 445 456
Median read length 497 499 496
Table 8.2.: Run parameters for the second mitochondrial sequencing run
Each subject was sequenced individually to provide the reference data to check the
resolving of the pools. These individual subject samples were put through the same
clustering algorithm as the pools.
Sample 1 had 56,502 reads, of which 20,012 (35.4%) covered the HV1 region, suggesting
two thirds of the reads were too short to cover the region of interest. The reads covering
HV1, split into 4 clusters (Figure 8.3). The first cluster contained 92.9% of the reads,
and had two homopolymer deletions and one insertion compared to the rCRS. The other
clusters all have multiple differences compared to the first cluster.
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C1-1 18598 92.9% G C C - - C C C
C1-2 1196 6.0% G C C A C T C C C C C C
C1-3 69 0.3% G C C C C
C1-4 149 0.7% G C C C C C
Figure 8.3.: Sequence variation between recovered sequences from cells 1 in sequencing
run two.
Sample 2 had 60,091 reads, of which 46,134 (76.8%) covered the HV1 region, these
were split into 7 clusters (Figure 8.4). The clusters were all very similar apart from the
two smallest clusters which together contained 0.4% of the reads. The majority of true
reads were in clusters that only differed by homopolymer deletions and in the region
16,187 to 16,192. This region is centred around a T, which in the rCRS is preceded by
five Cs and followed by four Cs. The clusters have the T preceded by one, two, three or


















































































































































































C2-1 21093 45.7% A - - T C T T T C T C
C2-2 20003 43.4% A T C T T T C T C
C2-3 2127 4.6% A - - T C T T T C T C
C2-4 2262 4.9% A - T C T T T C T C
C2-5 461 1.0% A T C T T C T C
C2-6 100 0.2% - - T C T T T C C T C
C2-7 88 0.2% G - T T C T C
Figure 8.4.: Sequence variation between recovered sequences from cells 2 in sequencing
run two.
Sample 3 had 36,890 reads of which 26,403 (71.6%) covered the HV1 region. These
were then split into 5 clusters (Figure 8.5). The first four clusters contain 99.8% of the
reads and only differ by homopolymer deletions and the location of the T in the region
16,187 to 16,192.
Sample 4 had 69,260 reads of which 60,989 (88.1%) covered the HV1 region. These
were split into 4 clusters (Figure 8.6). The first 3 clusters contained 99.9% of the reads
and only differed by homopolymer insertions or deletions.
The cells pool had 78.803 reads of which 62,247 (79.0%) covered the HV1 region. These
were split into 15 clusters (Figure 8.7). None of the cluster consensuses matched the
consensuses of the unpooled components. Indices 16,055, 16,071, 16,162, 16,166 and
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C3-1 11872 45.0% - - G G C C
C3-2 12535 47.5% - - G G C C
C3-3 991 3.8% - T C G G C C
C3-4 956 3.6% - G G C C
C3-5 49 0.2% G - G G C C



















































































































































































C4-1 35418 58.1% - C
C4-2 25249 41.4% - - C
C4-3 270 0.4% C A A - C
C4-4 52 0.1% C A - C
Figure 8.6.: Sequence variation between recovered sequences from cells 4 in sequencing
run two.
16,169 featured in all clusters in this pool, but were poorly represented in the unpooled
components. Therefore, ignoring these indices and homopolymer deletions, led to a good
agreement with the component’s clusters. All clusters except 8, 11, 12, 13 and 15 could
then be matched to one of the components. The percentage of reads attributable to each
component were cells 1 - 0%, cells 2 - 1.2%, cells 3 - 7.6% and cells 4 - 87.7%. After no
reads were recovered for the cells 1 component, the reads for the cells pool was examined
and it was found that there were 14 reads or 0.02% of the total matching the SNP pattern
for the cells 1 component.
The DNA pool had 36,611 reads of which 26,886 (73.4%) covered the HV1 region,
these were split into 10 clusters (Figure 8.8). None of the cluster consensuses matched
the consensuses of the unpooled components. Indices 16,055, 16,071, 16,162, 16,166 and
16,169 featured in all clusters in this pool, but were poorly represented in the unpooled
components. Therefore, ignoring these indices and homopolymer deletions, led to a
good agreement with the component’s clusters. All clusters except 8 and 10 could then
be matched to one of the components. The percentage of reads attributable to each
component were cells 1 - 0%, cells 2 - 1.3%, cells 3 - 8.5% and cells 4 - 89.3%. After no
reads were recovered for the cells 1 component, the reads for the cells pool was examined
and it was found that there were 10 reads or 0.04% of the total reads matching the SNP
pattern for the cells 1 component.
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Cell-1 3131 5.0% C C C A - C
Cell-2 22912 36.8% C C - - C
Cell-3 20497 32.9% A - - C
Cell-4 2129 3.4% A - - G G C C
Cell-5 6017 9.7% A - - C
Cell-6 130 0.2% C A - - T C T T T C T C
Cell-7 2638 4.2% C C C A - G G C C
Cell-8 591 0.9% A - - G G
Cell-9 356 0.6% A A - T C T T T C T C
Cell-10 2084 3.3% C - - C
Cell-11 460 0.7% C C C A - C C
Cell-12 393 0.6% C C C A - G G
Cell-13 548 0.9% A - - C C C
Cell-14 266 0.4% C A - T C T T T C T C
Cell-15 95 0.2% C C A - A C C



















































































































































































DNA-1 12193 45.4% C C - C
DNA-2 2375 8.8% A C
DNA-3 1552 5.8% C C C A C
DNA-4 7865 29.3% A - C
DNA-5 194 0.7% C A - T C T T T C T C
DNA-6 1330 4.9% C C C A G G C C
DNA-7 966 3.6% A G G - C C
DNA-8 211 0.8% C C C A C C
DNA-9 158 0.6% A A T C T T T C T C
DNA-10 42 0.2% C C A C C
Figure 8.8.: Sequence variation between recovered sequences from DNA pool in sequencing
run two.
The PCR pool had 55,249 reads of which 45,324 (82.0%) covered the HV1 region,
these were split into 5 clusters (Figure 8.9). Two of the cluster consensuses matched
the consensuses of the unpooled components. Indices 16,166 and 16,169 featured in one
cluster in this pool, but were poorly represented in the unpooled components. Therefore,
ignoring these indices and homopolymer deletions, led to a good agreement with the
component’s clusters. All clusters could then be matched to one of the components. The
percentage of reads attributable to each component were cells 1 - 0%, cells 2 - 0.7%, cells
3 - 7.6% and cells 4 - 91.8%. After no reads were recovered for the cells 1 component,
the reads for the cells pool was examined and it was found that there were 12 reads or
0.03% of the total reads matching the SNP pattern for the cells 1 component.
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PCR-1 1791 4.0% - - G G C C
PCR-2 22192 49.0% - - - C
PCR-3 19406 42.8% - C
PCR-4 1621 3.6% C A - G G C C
PCR-5 314 0.7% A T T T C T C
Figure 8.9.: Sequence variation between recovered sequences from PCR pool in sequencing
run two.
8.4. Discussion
8.4.1. Sequencing run one
The two mixture sites in the minority Sanger sequence were not supported by the FLX
sequence data. This may have been due to different primers, the sequencing technologies
or PCR artefacts. Excluding the two mixtures present in the minority reference sequence,
there were twelve differences between two references. As this was just for the HV1
region, this represents a relatively easy separation when compared to a mean difference
count of less than eight for HV1 and HV2 for French caucasians versus US caucasians.
However, the clustering proved very successful with this challenge with the only deviation
from a perfect split being a deletion present in just over half of the reads for the minor
component in a five base homopolymer run, and a variant of the major component. The
variant may be due to heteroplasmy or sequencing errors.
8.4.2. Sequencing run two
The clusters formed from the unpooled samples showed that the majority of the variation
seen in these samples was due to changes in homopolymer runs. If these changes were
due to length heteroplasmy, it would have been expected that the same clusters would
have been recovered from the pools. However, although clusters were recovered from the
pools that resembled the unpooled clusters, only two clusters from the pools were exact
matches to the unpooled clusters. Both of these were in the PCR pool. Instead, different
homopolymer insertion and deletion sites showed up in the pooled clusters. In the second
lane, which contained the cells pool and the DNA pool, there were some changes which
occurred more frequently in this lane than the other two lanes. There were C insertions
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at 16,055 and 16,071, an A insertion at 16,162 and a change from five As preceding
three Cs followed by two As to four As preceding three Cs followed by three As in the
region 16,162 to 16,171. Some of these changes were seen in clusters totalling 0.5% of the
reads in the 4th cell sample and the 16,162 to 16,171 region affected one small cluster in
the PCR pool. This contrasts with the cells and DNA pools where at least one of these
issues was seen in every cluster.
It is unclear why there were so many problems with homopolymers in this run.
Contrasting this run with the first run, where only a single homopolymer problem was
noted, yields the following differences:
• Different samples.
• Two samples on the first sequencing run versus one or four samples on the second
sequencing run.
• Different sequencer.
• Different sequencing platform GS-junior versus GS-FLX.
• The pooled sample in the first sequencing run was MID tagged and pooled with
two unrelated samples whereas, the second sequencing run had three lanes with
the same amplicon from different samples. This would mean when a homopolymer
run was reached, the whole lane would be signalling a high luminescence at the
same time. Perhaps the sensor may have been saturated.
A second issue was the loss of reads originating from the cells 1 sample. These reads
may have been lost due to incorrect pooling or poor sequencing. It is unlikely that the
pooling was the issue, because the reads were very underrepresented in all three pools,
so three pooling errors would had to have occurred. From the sequencing perspective,
when the cells 1 sample was unpooled, only 35.4% of the sequenced reads covered the
HV1 region. This was less than half of the ratio recovered for all other samples.
Despite these two issues, the clusters from the pools could be assigned back to their
original components. This then verified that the pooling ratios were roughly correct.
However, this would be insufficient for a real forensic examination.
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8.5. Conclusion
This chapter developed a method for resolving mixtures of mitochondrial DNA based on
the HV1 sequence. A theoretical example demonstrated why this method was better able
to estimate the distances between reads, by identifying key indices to use for the distance
calculation. The method was then tested using two runs of FLX sequencing data.
The results from the first sequencing run were very promising suggesting that the
method could be used to resolve a mixture of two components where the ratio of the
components was 100:1. The second sequencing run attempted to resolve a mixture of
four components pooled in the ratio 1000:100:10:1. This run was less successful and
two reasons were identified for the lack of success. First, the second sequencing run had
a large number of homopolymer issues compared to the first run. Second, the minor
component in the mixture appeared to sequence poorly, thus the ratio of its reads was
much lower than expected, and as a result it was not recovered from the mixture.
The results in this chapter are promising enough to suggest this methodology may
have the potential for further development in this field. The major issue to be addressed
is dealing with homopolymer errors. From past experience, some GS-FLX runs exhibit
a higher than usual proportion of homopolymer errors, and when the same library is
run again the problems do no recur. If repeating the run does not overcome the high
proportion of homopolymer errors, there are two other options to tackle this issue. First,
a different sequencing platform, such as MiSeq, which doesn’t have a high error rate in
homopolymer regions could be used. Alternatively, a new library formed from pooling
the mitochondrial sample in a lane with other unrelated samples, may be tried to reduce
the uniformity of the sample being sequenced.
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9. Conclusion
This thesis developed two HLA allele callers, one based on expectations of the GS-FLX
sequencing data and the other based on clustering. Both callers were developed to call
alleles from GS-FLX data, where reads covered the exons encoding the binding pocket. In
addition to calling HLA alleles from GS-FLX data, the clustering caller was used to call
HLA alleles from MiSeq paired end read data with no modifications to the allele caller,
but a preprocessing step to merge the paired ends was added. To test the versatility of
the clustering methodology it was also used to resolve mitochondrial mixtures.
9.1. Key findings
The key findings and tools developed as part of this dissertation were:
• Both allele callers were capable of making concordant calls from GS-FLX sequencing
provided sufficient reads were available for each exon of each allele.
• Criteria was developed to act as a surrogate for knowing the number of reads
covering each exon. These criteria classified calls as “Low”, “Medium” and “High”
confidence.
• “High” confidence calls were consistently concordant with known alleles. There
were only two exceptions and both were not due to the allele calling. In one case,
the known allele was probably wrong due to the sample appearing to contain
an allele that was added to the reference database six years after the allele was
originally called. In the second case, the sample appeared to be contaminated.
• The majority of “Medium” confidence calls had at least one exon sequence in
common between the two alleles. These calls were often concordant, but to ensure
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that the call was not a result of dropout of one allele during PCR amplification, an
alternative method of calling, or different PCR primers, would be required.
• Calling HLA alleles from MiSeq data was up to 99% concordant.
• The presence of discordant calls made with “High” confidence on MiSeq data
suggests parameters and criteria for determining call confidence should be updated
when changing the allele calling platform.
• A mitochondrial mixture in the ratio 100:1 was successfully resolved.
• The attempt to resolve a more complex mixture was less successful. This was due
to large numbers of homopolymer errors.
These findings suggest that the aim of the thesis has been achieved. The allele callers
developed in this thesis coupled with highly multiplexed sequencing of key exons using
second generation sequencing can produce allele calls which are:
1. Concordant with the alleles present, as long as those alleles are represented in the
reference database.
2. Resolved to the highest level possible based on the exons sequenced.
3. Delivered in an affordable way.
4. Reported with a rapid turnaround time.
9.2. Further work
The tools developed in this thesis can be applied to other domains where the aim
is to separate sequence reads into two or more groups. The HLA allele callers have
demonstrated the capability of these tools for domains in which there are up to two
categories. This would be relevant for calling alleles in other highly variable genes, such
as KIR. The tools have been applied to separating a larger and unknown number of
categories in the mitochondrial chapter. This also may have broader applications. Some
examples of how the work presented in this thesis may be extended are:
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• Adding exons to those used in calling. In this thesis, called was based on the
exons encoding the binding pockets for the HLA genes. By adding more exon
sequences, alleles may be called with less ambiguity. The algorithms developed in
this thesis do not aim to produce the full gene sequence for each allele. Such an
algorithm would require a different preparation of material for sequencing. This
would increase the cost of typing, because less samples could be multiplexed in
a sequencing run and no multiplexing could be done using tagged primers. As a
result, full gene sequencing is a complementary rather than a competing method
to that used in this thesis, providing better resolution at a higher cost.
• Optimisation of the parameters and confidence criteria for MiSeq paired end data.
This will require more MiSeq paired end data than was available for this thesis.
Furthermore, additional insight into warnings required for MiSeq may feedback to
make allele calling from GS-FLX data more robust.
• Further testing of mitochondrial DNA mixture resolution. First, mitochondrial
data should be multiplexed and sequenced with other unrelated samples. Second,
the method could be tested on other sequencing platforms, such as the MiSeq.
Finally, hypervariable region II could be added to the analysis.
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A. Allele calls from Broad sequencing data
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B1 A*03:01:01G 206 174 A*23:01 414 157 A*03:01:01G A*23:01:01G A*03:01:01G A*23:01:01G
B1 B*35:01:01 492 367 B*57:03:01 440 299 B*35:01:01G B*57:03:01 B*35:01:01G B*57:03:01
B1 C*04:01:01G 243 313 C*08:02 442 245 C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
B2 B*15:10 4 1 B*42:01:01 0 0 B*15:10:01 B*15:10:01
B2 C*03:04:02 2 2 C*17:01 2 0 C*03:04:02 C*03:04:02
B3 B*15:17:01G 4 3 B*49:01:01 4 2 B*15:17:01G B*15:17:01G
B3 C*05:01 1 3 C*07:01:01G 3 0 C*05:01:01G C*05:01:01G
B4 B*41:01:01 9 2 B*45:01:01G 0 1 B*41:01:01 B*41:01:01 B*41:01:01 B*41:01:02
B4 C*07:01:01G 4 2 C*16:01 3 0 C*07:01:01G C*07:16
B5 A*30:02:01G 82 57 A*68:02:01 123 81 A*30:02:01G A*68:02:01G A*30:02:01G A*68:02:01G
B5 B*15:10 245 150 B*57:03:01 254 174 B*15:10:01 B*57:03:01 B*15:10:01 B*57:03:01
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B5 C*03:02:01G 183 135 C*18:01:01G 91 172 C*03:02:01G C*18:01:01G C*03:02:01G C*18:01:01G
B6 A*33:03:01G 4 12 A*74:01:01G 7 4 A*33:03:01G A*74:01:01G A*33:03:01G A*74:01:01G
B6 B*15:03 6 5 B*35:01:01 13 8 B*15:03:01G B*35:01:01G B*15:03:01G B*35:01:01G
B6 C*02:10 21 4 C*04:01:01G 17 6 C*02:10 C*04:01:01G C*02:10 C*02:10
B7 A*23:01 6 2 A*32:01:01 2 1 A*23:01:01G A*32:01:01G
B7 C*04:01:01G 2 0 C*07:01:01G 2 3 C*07:01:01G C*07:01:01G C*07:01:31 C*07:296
B8 A*03:01:01G 21 11 A*68:01:01 38 29 A*03:01:01G A*68:01:01G A*03:01:01G A*68:01:01G
B8 B*18:01:01G 62 22 B*58:02 41 39 B*18:01:01G B*58:02 B*18:01:01G B*58:02
B8 C*05:01:01 5 9 C*06:02:01G 5 7 C*05:01:01G C*06:02:01G C*05:01:01G C*06:02:01G
B9 A*02:01:01G 2 7 A*74:01:01G 2 2 A*02:416 A*74:01:01G A*02:416 A*74:01:01G
B9 B*15:16 5 1 B*58:02 1 3 B*15:16:01 B*15:16:01 B*15:222 B*15:222
B10 A*03:01:01G 31 9 A*33:03:01G 19 23 A*03:01:01G A*33:03:01G A*03:01:01G A*33:03:01G
B10 B*52:01:02 48 25 B*58:01:01 49 29 B*52:01:02 B*58:01:01G B*52:01:02 B*58:01:01G
B10 C*03:02:01G 31 22 C*16:01 42 24 C*03:02:01G C*16:01:01G C*03:02:01G C*16:01:01G
B11 B*07:05 0 0 B*13:02:01G 9 2 B*13:02:01G B*13:58 B*13:02:06 B*13:02:07
B12 A*23:01 4 2 A*30:01:01 0 2 A*23:01:10 A*23:01:10 A*23:01:10 A*23:01:10
B12 B*15:03 3 1 B*42:01:01 3 3 B*15:03:01G B*42:01:01 B*15:132 B*15:253
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B13 A*11:01:01G 30 13 A*33:03:01G 11 15 A*11:01:01G A*33:51 A*11:01:01G A*33:03:01G
B13 B*35:01:01 59 41 B*40:12 73 35 B*35:01:01G B*40:12 B*35:01:01G B*40:12
B13 C*02:10 1 36 C*15:05:01G 25 53 C*02:10 C*15:05:01G C*15:19 C*15:22
B14 A*03:01:01G 0 2 A*23:01 1 0 A*03:152 A*03:152
B15 A*29:02:01 3 6 A*29:02:01 3 6 A*29:02:01G A*29:02:01G A*29:02:01G A*29:52
B15 B*15:03 1 3 B*78:01:01 3 1 B*15:03:01G B*15:03:01G
B15 C*02:10 3 2 C*16:01 3 3 C*02:10 C*16:01:01G C*02:10 C*16:01:01G
B16 A*33:03:01G 0 4 A*68:02:01 2 2 A*68:02:01G A*68:02:01G A*68:67 A*68:78
B16 B*15:10 3 2 B*57:03:01 3 1 B*15:10:01 B*57:03:01
B17 A*23:01 279 146 A*23:01 279 146 A*23:01:01G A*23:01:01G A*23:01:01G A*23:01:01G
B17 B*15:16 226 27 B*18:01:01G 264 35 B*15:16:01 B*18:01:01G B*15:16:01 B*18:01:01G
B17 C*02:10 111 137 C*14:02:01G 142 208 C*02:10 C*14:02:01G C*02:10 C*14:02:01G
B18 A*23:01 217 75 A*68:02:01 133 137 A*23:01:01G A*68:02:01G A*23:01:01G A*68:02:01G
B18 B*15:10 290 174 B*58:02 298 204 B*15:10:01 B*58:02 B*15:10:01 B*58:02
B18 C*03:04:02 177 173 C*06:02:01G 173 145 C*03:04:02 C*06:02:01G C*03:04:02 C*06:02:01G
B19 A*29:02:01 29 18 A*30:02:01G 36 16 A*29:02:01G A*30:02:01G A*29:02:01G A*30:02:01G
B19 B*08:01 31 33 B*49:01:01 52 32 B*08:01:01G B*49:01:01G B*08:01:01G B*49:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B19 C*07:01:01G 53 66 C*07:01:01G 53 66 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
B20 A*33:03:01G 68 109 A*34:02:01 255 95 A*33:03:01G A*34:02:01 A*33:03:01G A*34:02:01
B20 B*08:01 300 154 B*35:01:01 280 203 B*08:01:01G B*35:01:01G B*08:01:01G B*35:01:01G
B20 C*03:04:01 143 132 C*04:01:01G 69 187 C*03:04:01G C*04:01:01G C*03:04:01G C*04:01:01G
B21 A*02:01:01G 203 80 A*33:01:01 22 42 A*02:01:01G A*33:01:01 A*02:01:01G A*33:01:01
B21 B*51:01:01G 163 110 B*58:01:01 159 89 B*51:173Q B*58:01:01G B*51:173Q B*58:01:01G
B21 C*07:01:01G 121 43 C*18:01:01G 42 88 C*07:01:01G C*18:01:01G C*07:01:01G C*18:01:01G
B22 A*02:02 12 1 A*30:01:01 3 5 A*30:01:01G A*30:01:01G A*30:01:01G A*30:62
B22 B*44:03:01G 22 11 B*45:01:01G 28 5 B*44:03:01G B*45:01:01G B*44:03:01G B*44:188
B22 C*04:07 0 9 C*06:02:01G 7 10 C*06:02:01G C*18:01:01G C*06:02:01G C*18:01:01G
B23 B*44:03:01G 4 3 B*53:01:01 5 2 B*44:03:01G B*53:01:01G B*44:03:01G B*44:03:12
B24 C*03:04:01 0 1 C*07:02:01G 2 1 C*07:02:01G C*07:02:01G C*07:169 C*07:17:01
B25 A*01:01:01 172 130 A*34:02:01 184 130 A*01:01:01G A*34:02:01 A*01:01:01G A*34:02:01
B25 B*08:01 340 210 B*53:01:01 457 256 B*08:01:01G B*53:01:01G B*08:01:01G B*53:01:01G
B25 C*04:01:01G 153 284 C*07:01:01G 277 259 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
B26 A*30:01:01 27 47 A*30:02:01G 28 36 A*30:01:01G A*30:02:01G A*30:01:01G A*30:02:01G
B26 B*42:01:01 44 28 B*45:01:01G 121 22 B*42:01:01 B*45:01:01G B*42:01:01 B*45:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B26 C*16:01:01 48 22 C*17:01 78 14 C*16:01:01G C*17:01:01G C*16:01:01G C*17:01:01G
B27 B*44:03:01G 1 1 B*53:01:01 5 0 B*44:03:01G B*44:03:01G
B28 A*29:02:01 57 48 A*30:01:01 62 38 A*29:02:01G A*30:01:01G A*29:02:01G A*30:01:01G
B28 B*42:01:01 107 92 B*44:03:01G 138 113 B*42:01:01 B*44:03:01G B*42:01:01 B*44:03:01G
B28 C*16:01 33 95 C*17:01 64 77 C*16:01:01G C*17:01:01G C*16:01:01G C*17:01:01G
B29 A*03:01:01G 220 130 A*33:01:01 73 125 A*03:01:01G A*33:01:01 A*03:01:01G A*33:01:01
B29 B*58:02 392 266 B*81:01:01G 357 247 B*58:02 B*81:01:01G B*58:02 B*81:01:01G
B29 C*04:01:01G 49 514 C*18:01:01G 77 514 C*04:01:01G C*18:01:01G C*04:01:01G C*18:01:01G
B30 A*30:01:01 159 94 A*68:02:01 144 81 A*30:01:01G A*68:02:01G A*30:01:01G A*68:02:01G
B30 B*15:37 428 248 B*42:01:01 378 212 B*15:37 B*42:01:01 B*15:37 B*42:01:01
B30 C*03:04:02 8 179 C*17:01 51 177 C*03:04:02 C*17:01:01G C*03:04:02 C*17:01:01G
B31 A*01:01:01 2 1 A*30:01:01 1 0 A*01:01:01G A*01:01:21
B31 B*08:01 4 9 B*42:01:01 6 9 B*08:01:01G B*42:01:01 B*42:01:01 B*42:01:01
B31 C*07:01:01G 2 2 C*17:01 7 1 C*07:01:01G C*17:01:01G C*17:01:01G C*17:01:11
B32 A*01:02 57 70 A*30:02:01G 56 57 A*01:02 A*30:02:01G A*01:02 A*30:02:01G
B32 B*15:10 160 103 B*42:01:01 121 94 B*15:10:01 B*42:01:01 B*15:10:01 B*42:01:01
B32 C*03:04:02 88 59 C*17:01 112 77 C*03:04:02 C*17:01:01G C*03:04:02 C*17:01:01G
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B33 A*68:02:01 15 3 A*74:01:01G 9 3 A*68:02:01G A*74:01:01G
B33 B*45:01:01G 43 18 B*53:01:01 36 19 B*45:01:01G B*53:01:01G B*45:01:01G B*53:01:01G
B33 C*04:01:01G 7 3 C*16:01 16 3 C*04:01:01G C*16:01:01G C*04:01:01G C*16:01:01G
B34 B*53:01:01 3 4 B*58:01:01 0 0 B*53:01:01G B*53:01:01G B*53:01:01G B*53:20
B34 C*04:01:01G 0 0 C*07:01:01G 2 2 C*07:01:01G C*07:01:01G
B35 A*30:02:01G 101 62 A*66:02 92 104 A*30:02:01G A*66:02 A*30:02:01G A*66:02
B35 B*35:01:01 296 329 B*58:01:01 281 329 B*35:01:01G B*58:01:01G B*35:01:01G B*58:01:01G
B35 C*03:02:01G 155 105 C*04:01:01G 88 177 C*03:02:01G C*04:01:01G C*03:02:01G C*04:01:01G
B36 A*01:01:01 80 41 A*30:01:01 101 38 A*01:01:01G A*30:01:01G A*01:01:01G A*30:01:01G
B36 B*42:01:01 167 96 B*56:01:01 213 90 B*42:01:01 B*56:01:01G B*42:01:01 B*56:01:01G
B36 C*01:02:01G 85 103 C*17:01 131 70 C*01:02:01G C*17:01:01G C*01:02:01G C*17:01:01G
B37 A*02:05 9 16 A*30:01:01 6 4 A*02:05:01G A*02:05:01G A*02:05:01G A*02:05:01G
B37 B*35:01:01 32 10 B*44:03:01G 39 29 B*35:01:01G B*44:03:01G B*35:01:01G B*44:03:01G
B37 C*04:01:01G 26 47 C*04:01:01G 26 47 C*04:01:01G C*04:01:01G C*04:01:01G C*04:01:01G
B38 A*23:01 3 3 A*30:02:01G 1 1 A*23:01:01G A*23:01:01G
B39 B*45:01:01G 2 1 B*58:02 0 0 B*45:01:01G B*45:01:01G
B40 A*03:01:01G 144 107 A*66:01:01G 261 203 A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B40 B*37:01:01 505 268 B*39:10:01 402 228 B*37:01:01G B*39:10:01 B*37:01:01G B*39:10:01
B40 C*08:02 252 274 C*12:03:01 271 189 C*08:02:01G C*12:03:01G C*08:02:01G C*12:03:01G
B41 A*03:01:01G 142 121 A*30:01:01 197 86 A*03:01:01G A*30:01:01G A*03:01:01G A*30:01:01G
B41 B*07:05 375 208 B*55:01:01 461 236 B*07:05:01G B*55:01:01G B*07:05:01G B*55:01:01G
B41 C*03:03:01G 285 202 C*15:05:01G 287 387 C*03:03:01G C*15:05:01G C*03:03:01G C*15:05:01G
B42 A*02:01:01G 37 25 A*02:02 32 18 A*02:01:01G A*02:02:01 A*02:01:01G A*02:02:01
B42 B*45:01:01G 32 17 B*57:03:01 14 20 B*45:01:01G B*57:03:01 B*45:01:01G B*57:03:01
B42 C*04:01:01G 5 22 C*16:01 16 24 C*04:01:01G C*16:01:01G C*04:01:01G C*16:01:01G
B43 A*01:01:01 17 4 A*33:03:01G 5 8 A*01:01:01G A*33:03:01G A*01:01:01G A*33:03:01G
B43 B*15:16 44 24 B*37:01:01 52 22 B*15:16:01 B*37:01:01G B*15:16:01 B*37:01:01G
B43 C*06:02:01G 1 28 C*14:02:01G 0 42 C*06:02:01G C*06:02:01G
B44 A*03:01:01G 132 92 A*11:01:01G 91 76 A*03:01:01G A*11:01:01G A*03:01:01G A*11:01:01G
B44 B*44:03:01G 280 191 B*55:01:01 298 148 B*44:03:01G B*55:01:01G B*44:03:01G B*55:01:01G
B44 C*03:03:01G 74 140 C*16:01 62 121 C*03:03:01G C*16:01:01G C*03:03:01G C*16:01:01G
B45 A*23:01 0 1 A*34:02:01 2 1 A*34:02:01 A*34:02:01
B46 A*23:01 10 12 A*68:01:01 17 12 A*23:01:01G A*68:01:01G A*23:01:01G A*68:01:01G
B46 B*42:01:01 161 41 B*58:02 312 41 B*42:01:01 B*58:02 B*42:01:01 B*58:02
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B46 C*06:02:01G 5 35 C*17:01 30 21 C*12:04:01 C*17:01:01G C*06:02:01G C*17:01:01G
B47 A*30:01:01 149 48 A*68:02:01 212 86 A*30:01:01G A*68:02:01G A*30:01:01G A*68:02:01G
B47 B*15:03 397 188 B*53:01:01 393 222 B*15:03:01G B*53:01:01G B*15:03:01G B*53:01:01G
B47 C*02:10 274 271 C*04:01:01G 293 253 C*02:10 C*04:01:01G C*02:10 C*04:01:01G
B48 B*40:01:01G 15 3 B*45:01:01G 15 2 B*40:01:01G B*45:01:01G B*40:01:01G B*45:01:01G
B48 C*03:04:01 1 6 C*16:01 3 3 C*03:04:01G C*16:01:01G C*16:28 C*16:39:01
B49 A*33:03:01G 9 37 A*36:01 36 20 A*33:03:01G A*36:01 A*33:03:01G A*36:01
B49 B*07:05 36 28 B*35:01:01 49 30 B*07:05:01G B*35:01:01G B*07:05:01G B*35:01:01G
B49 C*04:01:01G 19 19 C*15:05:01G 57 22 C*04:01:01G C*15:05:01G C*04:01:01G C*15:05:01G
B50 B*07:05 0 0 B*08:01 0 0 B*08:79 B*08:79
B51 A*30:01:01 433 284 A*30:01:01 433 284 A*30:01:01G A*30:01:01G A*30:01:01G A*30:01:01G
B51 B*15:10 472 204 B*52:01:02 442 217 B*15:10:01 B*52:01:02 B*15:10:01 B*52:01:02
B51 C*03:04:02 302 209 C*16:01 298 183 C*03:04:02 C*16:01:01G C*03:04:02 C*16:01:01G
B52 A*03:01:01G 254 123 A*33:03:01G 89 132 A*03:01:01G A*33:03:01G A*03:01:01G A*33:03:01G
B52 B*14:02 226 234 B*15:10 467 282 B*14:02:01 B*15:10:01 B*14:02:01 B*15:10:01
B52 C*03:04:02 194 129 C*08:02 179 188 C*03:04:02 C*08:02:01G C*03:04:02 C*08:02:01G
B53 A*23:01 106 36 A*30:01:01 85 35 A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B53 B*07:02:01G 154 91 B*42:02 146 105 B*07:02:01G B*42:02 B*07:02:01G B*42:02
B53 C*07:02:01G 109 61 C*17:01 119 82 C*07:02:01G C*17:01:01G C*07:02:01G C*17:01:01G
B54 A*23:01 48 29 A*30:01:01G 26 26 A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
B54 B*41:02:01 107 108 B*42:01:01 85 108 B*41:02:01 B*42:01:01 B*41:02:01 B*42:01:01
B54 C*17:01 90 109 C*17:01 90 109 C*17:01:01G C*17:01:01G C*17:01:01G C*17:01:01G
B55 A*29:02:01 1 0 A*34:02:01 7 1 A*34:02:01 A*34:02:01 A*34:02:01 A*34:02:01
B55 B*07:02:01G 10 3 B*07:02:01G 10 3 B*07:02:01G B*07:02:01G B*07:02:01G B*07:02:13
B55 C*07:01:01G 5 4 C*07:01:01G 5 4 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
B56 A*02:01:01G 187 110 A*29:02:01 71 68 A*02:01:01G A*29:02:01G A*02:01:01G A*29:02:01G
B56 B*45:01:01G 237 159 B*53:01:01 239 167 B*45:01:01G B*53:01:01G B*45:01:01G B*53:01:01G
B56 C*04:01:01G 84 132 C*16:01 151 130 C*04:01:01G C*16:01:01G C*04:01:01G C*16:01:01G
B57 A*01:01:01 2 1 A*68:02:01 0 0 A*01:01:01G A*01:01:01G
B57 B*57:01:01G 0 0 B*81:01:01G 2 4 B*81:01:01G B*81:01:01G
B58 A*02:01:01G 263 85 A*02:02 264 117 A*02:01:01G A*02:02:01 A*02:01:01G A*02:02:01
B58 B*45:01:01G 372 236 B*58:02 325 269 B*45:01:01G B*58:02 B*45:01:01G B*58:02
B58 C*06:02:01G 75 186 C*16:01:01 105 163 C*06:02:01G C*16:01:01G C*06:02:01G C*16:01:01G
B59 A*23:01 1 1 A*23:01 1 1 A*23:01:01G A*23:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B60 A*03:01:01G 54 34 A*68:02:01 75 58 A*03:01:01G A*68:02:01G A*03:01:01G A*68:02:01G
B60 B*53:01:01 152 88 B*57:03:01 144 93 B*53:01:01G B*57:03:01 B*53:01:01G B*57:03:01
B60 C*04:01:01G 0 68 C*07:01:01G 1 33 C*07:01:01G C*07:01:01G
B61 A*23:01 6 3 A*30:01:01 7 4 A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
B61 B*07:02:01G 29 14 B*42:01:01 29 10 B*07:02:01G B*42:01:01 B*07:02:01G B*42:01:01
B62 A*23:01 25 16 A*74:01:01G 14 20 A*23:01:01G A*74:01:01G A*23:01:01G A*74:01:01G
B62 B*14:02 43 31 B*53:01:01 60 24 B*14:02:01 B*53:01:01G B*14:02:01 B*53:01:01G
B62 C*04:01:01G 14 44 C*08:02 28 29 C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
B63 A*29:02:01 120 89 A*68:01:01 230 131 A*29:02:01G A*68:01:01G A*29:02:01G A*68:01:01G
B63 B*44:03:01G 355 231 B*51:01:01G 405 288 B*44:03:01G B*51:01:01G B*44:03:01G B*51:01:01G
B63 C*05:01:01G 137 232 C*14:10 56 260 C*05:01:01G C*14:10 C*05:01:01G C*14:10
B64 A*02:02 259 165 A*30:01:01 149 142 A*02:02:01 A*30:01:01G A*02:02:01 A*30:01:01G
B64 B*42:01:01 363 183 B*57:01:01G 375 228 B*42:01:01 B*57:01:01G B*42:01:01 B*57:01:01G
B64 C*07:01:01G 168 198 C*17:01 136 125 C*07:01:01G C*17:01:01G C*07:01:01G C*17:01:01G
B65 C*16:01 0 0 C*17:01 2 1 C*17:01:01G C*17:01:01G
B66 A*03:01:01G 159 160 A*23:01 253 149 A*03:01:01G A*23:01:01G A*03:01:01G A*23:01:01G
B66 B*42:01:01 472 284 B*44:03:01G 449 262 B*42:01:01 B*44:03:01G B*42:01:01 B*44:03:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B66 C*04:01:01G 145 382 C*17:01 458 190 C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
B67 B*35:01:01 1 0 B*44:02:01G 1 1 B*44:02:01G B*44:02:01G
B67 C*04:01:01G 3 0 C*05:01 2 2 C*05:01:01G C*05:01:01G
B68 A*23:01 232 80 A*30:02:01G 141 113 A*23:01:01G A*30:02:01G A*23:01:01G A*30:02:01G
B68 B*13:02:01G 278 212 B*58:01:01 294 252 B*13:02:01G B*58:01:01G B*13:02:01G B*58:01:01G
B68 C*03:02:01G 163 115 C*06:02:01G 110 113 C*03:02:01G C*06:02:01G C*03:02:01G C*06:02:01G
B69 A*02:01:01G 4 0 A*68:02:01 3 5 A*02:73 A*68:02:01G A*02:73 A*68:02:01G
B69 B*45:01:01G 5 1 B*57:03:01 1 2 B*57:03:01 B*57:03:01
B69 C*07:01:01G 6 3 C*16:01 1 3 C*07:01:01G C*16:01:01G
B70 A*68:02:01 27 18 A*68:02:01 27 18 A*68:02:01G A*68:02:01G A*68:02:01G A*68:02:01G
B70 B*07:02:01G 56 16 B*42:01:01 56 17 B*07:02:01G B*42:01:01 B*07:02:01G B*42:01:01
B70 C*15:05:01G 9 23 C*17:01 24 8 C*15:05:01G C*17:01:01G C*15:05:01G C*17:01:01G
B71 B*53:01:01 3 0 B*58:02 2 1 B*58:02 B*58:02
B72 B*08:01 3 2 B*44:03:01G 1 2 B*08:01:01G B*44:54 B*08:44 B*44:03:01G
B72 C*04:01:01G 3 2 C*04:01:01G 3 2 C*04:01:01G C*04:01:01G
B73 A*02:02 40 18 A*29:02:01 16 10 A*02:02:01 A*29:02:01G A*02:02:01 A*29:02:01G
B73 B*51:01:01G 42 29 B*53:01:01 67 24 B*51:01:01G B*53:01:01G B*51:01:01G B*53:01:01G
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B73 C*04:01:01G 12 21 C*16:01 29 26 C*04:01:01G C*16:01:01G C*04:01:01G C*16:01:01G
B74 A*01:02 11 7 A*03:01:01G 4 6 A*01:02 A*03:01:01G A*01:02 A*03:63
B74 B*15:03 18 15 B*53:01:01 19 12 B*15:03:01G B*53:01:01G B*15:03:01G B*53:01:01G
B74 C*02:10 15 15 C*04:01:01G 30 17 C*02:10 C*04:01:01G C*02:10 C*04:01:01G
B75 B*35:01:01 1 1 B*42:02 0 0 B*35:218 B*35:218
B75 C*04:01:01G 0 1 C*17:01 2 1 C*17:01:01G C*17:01:01G C*17:01:09 C*17:01:11
B76 A*02:01:01G 317 173 A*23:01:01G 255 103 A*02:01:01G A*23:01:01G A*02:01:01G A*23:01:01G
B76 B*08:01:01G 298 145 B*53:01:01 604 201 B*08:01:01G B*53:01:01G B*08:01:01G B*53:01:01G
B76 C*07:02:01G 27 77 C*08:02:01G 30 117 C*07:02:01G C*08:02:01G C*07:02:01G C*08:02:01G
B77 A*23:01 334 170 A*30:02:01G 210 131 A*23:01:01G A*30:02:01G A*23:01:01G A*30:02:01G
B77 B*15:03 445 266 B*57:03:01 451 284 B*15:03:01G B*57:03:01 B*15:03:01G B*57:03:01
B77 C*02:10 289 332 C*18:01:01G 311 324 C*02:10 C*18:01:01G C*02:10 C*18:01:01G
B78 A*23:01 2 0 A*30:02:01G 1 2 A*30:02:01G A*30:02:01G
B79 A*23:01 136 85 A*30:02:01G 105 87 A*23:01:01G A*30:02:01G A*23:01:01G A*30:02:01G
B79 B*35:01:01 83 114 B*49:01:01 110 102 B*35:01:01G B*49:01:01G B*35:01:01G B*49:01:01G
B79 C*04:01:01G 62 112 C*07:01:01G 177 101 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
B80 A*23:01 64 13 A*33:01:01 6 17 A*23:01:01G A*33:01:01 A*23:01:01G A*33:01:01
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B80 B*53:01:01 19 31 B*57:03:01 21 17 B*53:01:01G B*57:03:01 B*53:01:01G B*57:03:01
B80 C*04:01:01G 20 34 C*18:01:01G 28 34 C*04:01:01G C*18:01:01G C*04:01:01G C*18:01:01G
B81 A*02:01:01G 124 63 A*33:03:01G 28 37 A*02:01:01G A*33:03:01G A*02:01:01G A*33:03:01G
B81 B*37:01:01 71 34 B*41:02:01 83 37 B*37:01:01G B*41:02:01 B*37:01:01G B*41:02:01
B81 C*02:10 12 28 C*17:01 117 23 C*02:10 C*17:01:01G C*02:10 C*17:01:01G
B82 B*15:10 0 0 B*18:01:01G 0 0 B*18:101 B*18:101
B83 A*23:01 10 4 A*68:02:01 17 11 A*23:01:01G A*68:02:01G A*23:01:01G A*68:02:01G
B83 B*15:03 16 14 B*58:01:01 9 10 B*15:03:01G B*58:01:01G B*15:03:01G B*58:01:01G
B83 C*02:10 1 4 C*07:01:01G 5 6 C*02:10 C*07:01:01G C*07:277 C*07:313
B84 A*26:01:01 139 115 A*36:01 165 82 A*26:01:01G A*36:01 A*26:01:01G A*36:01
B84 B*08:01 146 114 B*57:03:01 164 110 B*08:01:01G B*57:03:01 B*08:01:01G B*57:03:01
B84 C*03:04:01 121 122 C*07:01:01G 258 123 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
B85 A*03:01:01G 130 123 A*23:01 171 129 A*03:01:01G A*23:01:01G A*03:01:01G A*23:01:01G
B85 B*15:16 212 75 B*45:01:01G 200 124 B*15:16:01 B*45:01:01G B*15:16:01 B*45:01:01G
B85 C*04:01:01G 124 121 C*16:01 129 90 C*04:01:01G C*16:01:01G C*04:01:01G C*16:01:01G
B86 A*24:02:01G 375 206 A*24:02:01G 375 206 A*24:02:01G A*24:02:01G A*24:02:01G A*24:02:01G
B86 B*15:01:01G 158 114 B*57:01:01G 155 104 B*15:01:01G B*57:01:01G B*15:01:01G B*57:01:01G
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B86 C*01:02:01G 161 110 C*06:02:01G 220 124 C*01:02:01G C*06:02:01G C*01:02:01G C*06:02:01G
B87 A*23:01 132 53 A*32:01:01 104 64 A*23:01:01G A*32:01:01G A*23:01:01G A*32:01:01G
B87 B*44:02:01G 74 91 B*53:01:01 95 133 B*44:02:01G B*53:01:01G B*44:02:01G B*53:01:01G
B87 C*04:01:01G 67 71 C*05:01 96 55 C*04:01:01G C*05:01:01G C*04:01:01G C*05:01:01G
B88 A*33:03:01G 1 8 A*36:01 14 1 A*33:03:01G A*36:01
B88 B*42:01:01 7 6 B*53:01:01 14 6 B*42:01:01 B*53:01:01G B*42:01:01 B*53:01:01G
B88 C*04:01:01G 1 5 C*17:01 18 4 C*04:01:01G C*17:01:01G C*17:01:09 C*17:01:11
B89 B*14:01 0 0 B*49:01:01 3 2 B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
B90 A*23:01 14 5 A*74:01:01G 10 11 A*23:01:01G A*74:01:01G A*23:01:01G A*74:01:01G
B90 B*07:05 15 29 B*58:02 26 13 B*07:05:01G B*58:02 B*07:05:01G B*58:02
B90 C*06:02:01G 17 10 C*07:02:01G 18 13 C*06:02:01G C*07:02:01G C*06:02:01G C*07:02:01G
B91 A*30:02:01G 10 4 A*36:01 16 8 A*30:02:01G A*36:01 A*30:02:01G A*36:01
B91 B*15:03 7 7 B*53:01:01 15 15 B*15:03:01G B*53:01:01G B*15:03:01G B*53:01:01G
B91 C*04:01:01G 35 16 C*04:01:01G 35 16 C*04:01:01G C*04:01:01G C*04:01:01G C*04:01:01G
B92 A*34:02:01 2 2 A*68:02:01 4 6 A*68:02:01G A*68:27:01 A*68:02:01G A*68:27:01
B92 B*35:01:01 5 5 B*81:01:01G 3 5 B*35:01:01G B*48:06 B*35:01:01G B*48:06
B92 C*16:01 8 4 C*18:01:01G 7 4 C*16:01:01G C*18:01:01G C*16:01:01G C*18:01:01G
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B93 A*30:01:01G 170 103 A*32:01:01 163 117 A*30:01:01G A*32:01:01G A*30:01:01G A*32:01:01G
B93 B*35:01:01 235 99 B*42:02 167 92 B*35:01:01G B*42:02 B*35:01:01G B*42:02
B93 C*04:01:01G 23 43 C*17:01 92 31 C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
B94 A*36:01 119 104 A*68:02:01 167 127 A*36:01 A*68:02:01G A*36:01 A*68:02:01G
B94 B*53:01:01 174 336 B*58:01:01 176 336 B*53:01:01G B*58:01:01G B*53:01:01G B*58:01:01G
B94 C*03:02:01G 150 121 C*07:01:01G 211 127 C*03:02:01G C*07:01:01G C*03:02:01G C*07:01:01G
B95 A*02:01:01G 9 13 A*24:02:01G 15 6 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
B95 B*15:01:01G 10 6 B*40:01:01G 25 11 B*15:01:01G B*40:01:01G B*15:01:01G B*40:01:01G
B95 C*03:04:01 19 15 C*03:04:01 19 15 C*03:04:01G C*03:04:01G C*03:04:01G C*03:04:01G
B96 A*24:02:01G 15 17 A*24:02:01G 15 17 A*24:02:01G A*24:02:01G A*24:02:01G A*24:02:01G
B96 B*13:02:01G 3 8 B*55:01:01 5 11 B*13:02:01G B*55:01:01G B*13:02:06 B*13:02:07
B96 C*03:03:01G 4 5 C*06:02:01G 2 7 C*03:03:01G C*06:02:01G C*06:19 C*06:79N
B97 A*01:01:01G 0 0 A*29:02:01G 2 3 A*69:01 A*69:01
B97 B*08:01:01G 0 0 B*15:01:01G 0 0 B*35:08:01 B*35:08:01 B*35:156 B*35:176
B98 A*01:01:01 82 108 A*24:02:01G 116 94 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
B98 B*07:02:01G 81 103 B*57:01:01G 115 114 B*07:02:01G B*57:01:01G B*07:02:01G B*57:01:01G
B98 C*06:02:01G 70 83 C*07:02:01G 127 69 C*06:02:01G C*07:02:01G C*06:02:01G C*07:02:01G
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B99 A*23:01:01G 48 16 A*24:02:01G 48 14 A*23:01:01G A*24:02:01G A*23:01:01G A*24:02:01G
B99 B*15:01:01G 17 23 B*51:01:01G 10 24 B*15:01:01G B*51:01:01G B*15:01:01G B*51:01:01G
B99 C*03:03:01G 8 10 C*15:02:01G 14 9 C*03:03:01G C*15:02:01G C*03:03:01G C*15:02:01G
B100 A*02:01:01G 138 187 A*11:01:01G 92 113 A*02:01:01G A*11:01:01G A*02:01:01G A*11:01:01G
B100 B*08:01 79 0 B*15:18 233 2 B*15:18:01G B*15:18:01G
B100 C*07:01:01G 69 99 C*07:04:01G 46 98 C*07:01:01G C*07:04:01G C*07:01:01G C*07:04:01G
B101 A*02:01:01G 89 189 A*68:01:02G 78 217 A*02:01:01G A*68:01:02G A*02:01:01G A*68:01:02G
B101 B*44:02:01G 125 122 B*51:01:01G 111 157 B*44:02:01G B*51:01:01G B*44:02:01G B*51:01:01G
B101 C*05:01 44 133 C*14:02:01G 6 86 C*05:01:01G C*14:02:01G C*05:01:01G C*14:02:01G
B102 A*02:01:01G 65 63 A*24:02:01G 39 29 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
B102 B*44:02:01G 119 76 B*44:02:01G 119 76 B*44:02:01G B*44:02:01G B*44:02:01G B*44:02:01G
B102 C*05:01 12 17 C*07:04:01G 21 22 C*05:01:01G C*07:04:01G C*05:01:01G C*07:04:01G
B103 A*24:02:01G 150 98 A*26:01:01 110 162 A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
B103 B*27:05:02G 105 124 B*44:02:01G 110 112 B*27:05:02G B*44:02:01G B*27:05:02G B*44:02:01G
B103 C*02:02:02G 45 57 C*05:01 113 76 C*02:02:02G C*05:01:01G C*02:02:02G C*05:01:01G
B104 A*02:01:01G 102 98 A*68:02:01 50 82 A*02:01:01G A*68:02:01G A*02:01:01G A*68:02:01G
B104 B*14:02 96 54 B*44:02:01G 82 62 B*14:02:01 B*44:02:01G B*14:02:01 B*44:02:01G
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B104 C*05:01 57 79 C*08:02 60 79 C*05:01:01G C*08:02:01G C*05:01:01G C*08:02:01G
B105 A*26:01:01 133 79 A*31:01:02G 21 92 A*26:01:01G A*31:01:02G A*26:01:01G A*31:01:02G
B105 B*14:01 88 67 B*15:01:01G 78 51 B*14:01:01 B*15:01:01G B*14:01:01 B*15:01:01G
B105 C*03:03:01G 51 51 C*08:02 43 70 C*03:03:01G C*08:02:01G C*03:03:01G C*08:02:01G
B106 A*02:01:01G 47 61 A*25:01:01G 13 74 A*02:01:01G A*25:01:01G A*02:01:01G A*25:01:01G
B106 B*18:01:01G 78 60 B*49:01:01 78 46 B*18:01:01G B*49:01:01G B*18:01:01G B*49:01:01G
B106 C*07:01:01G 28 42 C*12:03:01 11 51 C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
B107 A*01:01:01 155 121 A*03:02 177 149 A*01:01:01G A*03:02:01 A*01:01:01G A*03:02:01
B107 B*08:01 139 142 B*49:01:01 184 125 B*08:01:01G B*49:01:01G B*08:01:01G B*49:01:01G
B107 C*07:01:01G 239 223 C*07:01:01G 239 223 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
B108 A*03:01:01G 74 46 A*24:02:01G 88 50 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
B108 B*35:03:01 97 55 B*40:01:01G 120 74 B*35:03:01G B*40:01:01G B*35:03:01G B*40:01:01G
B108 C*03:04:01 55 19 C*04:01:01G 2 14 C*03:04:01G C*04:01:01G C*03:04:01G C*04:01:01G
B109 A*11:01:01G 3 2 A*32:01:01 7 2 A*11:01:01G A*32:01:01G A*32:01:01G A*32:01:12
B109 B*35:01:01 2 2 B*40:02:01 0 0 B*35:01:01G B*35:01:01G B*35:01:10 B*35:210
B110 A*01:01:01 22 62 A*24:02:01G 26 41 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
B110 B*15:24 92 72 B*57:01:01G 90 66 B*15:24:01 B*57:01:01G B*15:24:01 B*57:01:01G
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B110 C*03:03:01G 66 44 C*06:02:01G 70 34 C*03:03:01G C*06:02:01G C*03:03:01G C*06:02:01G
B111 A*02:01:01G 28 39 A*29:02:01 10 34 A*02:01:01G A*29:02:01G A*02:01:01G A*29:02:01G
B111 B*44:02:01G 51 26 B*44:03:01G 51 24 B*44:02:01G B*44:03:01G B*44:02:01G B*44:03:01G
B111 C*05:01 18 27 C*16:01 27 15 C*05:01:01G C*16:01:01G C*05:01:01G C*16:01:01G
B112 A*02:01:01G 25 51 A*29:02:01 13 40 A*02:01:01G A*29:02:01G A*02:01:01G A*29:02:01G
B112 B*15:01:01G 85 82 B*45:01:01G 82 107 B*15:01:01G B*45:01:01G B*15:01:01G B*45:01:01G
B112 C*03:03:01G 74 47 C*06:02:01G 50 55 C*03:03:01G C*06:02:01G C*03:03:01G C*06:02:01G
B113 A*03:01:01G 1 35 A*24:02:01G 1 28 A*03:01:01G A*03:01:01G
B113 B*35:01:01 50 61 B*44:02:01G 62 47 B*35:01:01G B*44:02:01G B*35:01:01G B*44:02:01G
B113 C*04:01:01G 3 3 C*05:01 22 2 C*04:01:01G C*05:01:01G C*05:09:01 C*05:20
B114 A*01:01:01 17 41 A*02:01:01G 38 67 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
B114 B*44:02:01G 75 58 B*57:01:01G 64 47 B*44:02:01G B*57:01:01G B*44:02:01G B*57:01:01G
B114 C*06:02:01G 24 39 C*07:04:01G 49 45 C*06:02:01G C*07:04:01G C*06:02:01G C*07:04:01G
B115 A*02:01:01G 30 29 A*26:01:01 17 32 A*02:01:01G A*26:01:01G A*02:01:01G A*26:01:01G
B115 B*07:02:01G 31 14 B*07:02:01G 31 14 B*07:02:01G B*07:02:01G B*07:02:01G B*07:02:01G
B115 C*07:02:01G 48 86 C*07:02:01G 48 86 C*07:02:01G C*07:02:01G C*07:02:01G C*07:02:01G
B116 A*01:01:01 19 13 A*26:01:01 25 27 A*01:01:01G A*26:01:01G A*01:01:01G A*26:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B116 B*08:01 44 9 B*37:01:01 62 8 B*08:01:01G B*37:01:01G B*08:01:01G B*37:01:01G
B116 C*06:02:01G 55 4 C*07:02:01G 60 1 C*06:02:01G C*06:02:01G C*06:02:01G C*06:93
B117 A*11:01:01G 2 49 A*68:01:02G 3 54 A*11:01:01G A*68:01:02G A*68:01:22 A*68:01:27
B117 B*44:02:01G 72 92 B*51:01:01G 107 59 B*44:02:01G B*51:01:01G B*44:02:01G B*51:01:01G
B117 C*07:04:01G 16 33 C*15:02:01G 21 104 C*07:04:01G C*15:02:01G C*07:04:01G C*15:02:01G
B118 A*03:01:01G 2 6 A*24:02:01G 3 1 A*03:152 A*03:22:01 A*03:01:01G A*03:152
B118 B*07:02:01G 19 4 B*44:03:01G 23 4 B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
B118 C*03:03:01G 2 5 C*07:02:01G 3 4 C*03:03:01G C*07:02:01G C*03:158 C*03:214
B119 A*02:01:01G 3 15 A*68:01:02G 0 18 A*02:01:01G A*02:01:01G A*02:275 A*02:343
B119 B*27:05:02G 41 12 B*44:02:01G 31 30 B*27:05:02G B*44:02:01G B*27:05:02G B*44:02:01G
B119 C*01:02:01G 6 25 C*07:04:01G 33 42 C*01:02:01G C*07:04:01G C*01:02:01G C*07:04:01G
B120 A*02:01:01G 39 73 A*02:01:01G 39 73 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
B120 B*18:01:01G 61 55 B*39:06:02 74 41 B*18:01:01G B*39:06:02 B*18:01:01G B*39:06:02
B120 C*07:01:01G 42 54 C*07:02:01G 26 62 C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
B121 A*29:01:01G 7 15 A*30:01:01 14 13 A*29:01:01G A*30:01:01G A*29:01:01G A*30:01:01G
B121 B*13:02:01G 40 9 B*58:01:01 57 11 B*13:02:01G B*58:01:01G B*13:02:01G B*58:01:01G
B121 C*03:02:01G 15 29 C*06:02:01G 17 16 C*03:02:01G C*06:02:01G C*03:02:01G C*06:02:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B122 A*01:01:01 25 64 A*31:01:02G 4 79 A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
B122 B*07:02:01G 61 102 B*56:01:01 79 79 B*07:02:01G B*56:01:01G B*07:02:01G B*56:01:01G
B122 C*01:02:01G 0 70 C*07:02:01G 21 59 C*07:02:01G C*07:02:01G C*07:169 C*07:17:01
B123 A*03:01:01G 28 131 A*03:01:01G 28 131 A*03:01:01G A*03:01:01G A*03:01:01G A*03:01:01G
B123 B*07:02:01G 83 73 B*08:01 78 61 B*07:02:01G B*08:01:01G B*07:02:01G B*08:01:01G
B123 C*07:02:01G 25 45 C*16:01 21 36 C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
B124 A*02:01:01G 53 44 A*03:01:01G 18 48 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B124 B*27:05:02G 36 65 B*40:02:01 66 83 B*27:05:02G B*40:02:01G B*27:05:02G B*40:02:01G
B124 C*01:02:01G 36 59 C*02:02:02G 7 54 C*01:02:01G C*02:02:02G C*01:02:01G C*02:02:02G
B125 A*25:01:01G 12 24 A*29:02:01 9 14 A*25:01:01G A*29:02:01G A*25:01:01G A*29:02:01G
B125 B*18:01:01G 19 5 B*44:03:01G 16 6 B*18:01:01G B*44:03:01G B*18:01:01G B*44:03:01G
B125 C*12:03:01 15 5 C*16:01 10 1 C*12:03:01G C*12:98 C*12:03:01G C*12:98
B126 A*02:01:01G 26 18 A*03:01:01G 15 20 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B126 B*40:01:01G 30 11 B*44:02:01G 24 13 B*40:01:01G B*44:02:01G B*40:01:01G B*44:02:01G
B126 C*03:04:01 2 6 C*07:04:01G 5 5 C*03:04:01G C*07:04:01G C*03:04:01G C*07:04:01G
B127 A*01:01:01 39 109 A*01:01:01 39 109 A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
B127 B*08:01 162 161 B*08:01 162 161 B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B127 C*07:01:01G 158 144 C*07:01:01G 158 144 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
B128 A*03:01:01G 19 45 A*24:02:01G 21 38 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
B128 B*07:02:01G 74 102 B*44:02:01G 72 69 B*07:02:01G B*44:02:01G B*07:02:01G B*44:02:01G
B128 C*05:01 8 59 C*07:02:01G 22 59 C*05:01:01G C*07:02:01G C*05:01:01G C*07:02:01G
B129 A*01:01:01 4 45 A*03:01:01G 11 32 A*01:01:01G A*03:01:01G A*01:01:01G A*03:01:01G
B129 B*07:02:01G 55 0 B*35:08:01 0 0 B*35:08:01 B*35:08:01
B129 C*04:01:01G 31 38 C*07:02:01G 70 49 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
B130 A*02:01:01G 55 61 A*24:02:01G 50 41 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
B130 B*14:02 62 65 B*35:03:01 76 68 B*14:02:01 B*35:03:01G B*14:02:01 B*35:03:01G
B130 C*02:02:02G 50 72 C*04:01:01G 64 55 C*02:02:02G C*04:01:01G C*02:02:02G C*04:01:01G
B131 A*03:01:01G 24 40 A*11:01:01G 17 40 A*03:01:01G A*11:01:01G A*03:01:01G A*11:01:01G
B131 B*35:01:01 50 53 B*51:01:01G 49 34 B*35:01:01G B*51:01:01G B*35:01:01G B*51:01:01G
B131 C*04:01:01G 18 32 C*15:02:01G 36 54 C*04:01:01G C*15:02:01G C*04:01:01G C*15:02:01G
B132 A*02:01:01G 17 43 A*11:01:01G 8 21 A*02:01:01G A*11:01:01G A*02:01:01G A*11:01:01G
B132 B*27:05:03 42 38 B*40:01:01G 61 34 B*27:05:03 B*40:01:01G B*27:05:03 B*40:01:01G
B133 A*24:02:01G 53 135 A*24:02:01G 53 135 A*24:02:01G A*24:02:01G A*24:02:01G A*24:02:01G
B133 B*07:02:01G 73 56 B*35:01:01 75 57 B*07:02:01G B*35:01:01G B*07:02:01G B*35:01:01G
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B133 C*04:01:01G 17 37 C*07:02:01G 35 62 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
B134 A*02:01:01G 40 74 A*30:02:01G 10 59 A*02:01:01G A*30:02:01G A*02:01:01G A*30:02:01G
B134 B*41:01:01 99 83 B*51:01:01G 91 104 B*41:01:01 B*51:01:01G B*41:01:01 B*51:01:01G
B134 C*16:02 62 90 C*17:01 99 69 C*16:02:01G C*17:01:01G C*16:02:01G C*17:01:01G
B135 A*11:01:01G 19 31 A*24:02:01G 16 38 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
B135 B*07:02:01G 50 79 B*35:01:01 80 74 B*07:02:01G B*35:01:01G B*07:02:01G B*35:01:01G
B135 C*04:01:01G 28 59 C*07:02:01G 68 50 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
B136 A*01:01:01 2 25 A*03:01:01G 6 31 A*01:01:01G A*03:01:01G A*01:01:63 A*03:01:01G
B136 B*07:02:01G 38 50 B*44:02:01G 50 43 B*07:02:01G B*44:02:01G B*07:02:01G B*44:02:01G
B136 C*05:01:01 4 26 C*07:02:01G 9 24 C*05:01:01G C*07:02:01G C*05:01:01G C*07:02:01G
B137 A*01:01:01 5 61 A*24:02:01G 8 37 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
B137 B*08:01 90 80 B*40:01:01G 141 83 B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
B137 C*03:04:01 54 87 C*07:01:01G 72 85 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
B138 A*03:01:01G 1 14 A*24:02:01G 7 15 A*03:152 A*24:02:01G A*03:152 A*24:63
B138 B*07:02:01G 80 22 B*15:17:01G 118 28 B*07:02:01G B*15:17:01G B*07:02:01G B*15:17:01G
B139 A*01:01:01 1 59 A*02:01:01G 11 73 A*02:01:01G A*02:01:01G A*02:275 A*02:343
B139 B*08:01 75 68 B*40:01:01G 104 81 B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B139 C*03:04:01 14 36 C*07:01:01G 36 51 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
B140 A*03:01:01G 15 11 A*32:01:01 43 12 A*03:01:01G A*32:01:01G A*03:01:01G A*32:01:01G
B140 B*35:01:01 159 82 B*35:01:01 159 82 B*35:01:01G B*35:01:01G B*35:01:01G B*35:01:01G
B140 C*04:01:01G 2 51 C*04:01:01G 2 51 C*04:01:01G C*04:01:01G C*04:01:01G C*04:01:12
B141 A*01:01:01 3 33 A*25:01:01G 4 59 A*25:01:01G A*25:01:01G A*25:01:01G A*25:01:01G
B141 B*18:01:01G 79 62 B*38:01:01 75 45 B*18:01:01G B*38:01:01 B*18:01:01G B*38:01:01
B141 C*06:02:01G 7 37 C*12:03:01 2 51 C*06:02:01G C*06:02:38 C*06:02:38 C*12:03:08
B142 A*01:01:01 33 46 A*68:01:02G 47 59 A*01:01:01G A*68:01:02G A*01:01:01G A*68:01:02G
B142 B*44:02:01G 191 58 B*44:03:01G 191 54 B*44:02:01G B*44:03:01G B*44:02:01G B*44:03:01G
B142 C*07:04:01G 67 79 C*16:01 52 47 C*07:04:01G C*16:01:01G C*07:04:01G C*16:01:01G
B143 A*01:01:01 22 70 A*11:01:01G 18 66 A*01:01:01G A*11:01:01G A*01:01:01G A*11:01:01G
B143 B*08:01 80 52 B*35:01:01 93 80 B*08:01:01G B*35:01:01G B*08:01:01G B*35:01:01G
B143 C*04:01:01G 23 67 C*07:01:01G 65 79 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
B144 A*02:01:01G 5 34 A*03:01:01G 1 43 A*02:01:01G A*03:89 A*02:01:01G A*03:89
B144 B*15:01:01G 89 74 B*40:01:01G 116 88 B*15:01:01G B*40:01:01G B*15:01:01G B*40:01:01G
B145 A*02:01:01G 9 83 A*29:02:01 5 79 A*02:01:01G A*29:02:01G A*02:01:01G A*29:02:01G
B145 B*07:02:01G 127 139 B*44:03:01G 117 105 B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B145 C*07:02:01G 92 107 C*16:01 32 85 C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
B146 A*01:01:01 1 108 A*01:01:01 1 108 A*01:01:01G A*01:01:01G
B146 B*08:01 84 78 B*57:01:01G 105 93 B*08:01:01G B*57:01:01G B*08:01:01G B*57:01:01G
B146 C*06:02:01G 34 49 C*07:01:01G 56 38 C*06:02:01G C*07:01:01G C*06:02:01G C*07:01:01G
B147 A*23:01 58 12 A*29:02:01 30 29 A*23:01:01G A*29:02:01G A*23:01:01G A*29:02:01G
B147 B*35:08:01 60 14 B*44:03:01G 51 21 B*35:08:01 B*44:03:01G B*35:08:01 B*44:03:01G
B147 C*04:01:01G 2 3 C*16:01 5 5 C*04:01:01G C*16:01:01G C*04:173N C*16:01:01G
B148 A*03:01:01G 13 20 A*11:01:01G 6 22 A*03:01:01G A*11:01:01G A*03:01:01G A*11:01:01G
B148 B*14:02 39 24 B*35:01:01 50 24 B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
B148 C*04:01:01G 0 2 C*08:02 1 3 C*08:02:01G C*08:02:01G
B149 A*01:01:01 33 30 A*24:02:01G 27 14 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
B149 B*07:02:01G 59 29 B*44:02:01G 55 39 B*07:02:01G B*44:02:01G B*07:02:01G B*44:02:01G
B149 C*05:06 19 15 C*07:02:01G 39 5 C*05:06 C*07:02:01G C*05:06 C*07:02:01G
B150 B*07:02:01G 82 48 B*08:01 63 41 B*07:02:01G B*08:01:01G B*07:02:01G B*08:01:01G
B150 C*07:01:01G 48 25 C*07:02:01G 36 36 C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
B151 A*01:01:01 32 36 A*24:02:01G 36 5 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
B151 B*08:01 44 44 B*15:01:01G 87 57 B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B151 C*03:03:01G 22 58 C*07:01:01G 70 51 C*03:03:01G C*07:01:01G C*03:03:01G C*07:01:01G
B152 A*03:01:01G 0 16 A*32:01:01 1 14 A*32:01:01G A*32:01:01G
B152 B*07:02:01G 25 14 B*14:02 33 11 B*07:02:01G B*14:02:01 B*07:02:01G B*14:02:01
B152 C*07:02:01G 17 22 C*08:02 8 27 C*07:02:01G C*08:02:01G C*07:02:01G C*08:02:01G
B153 A*03:01:01G 37 28 A*11:01:01G 30 15 A*03:01:01G A*11:01:01G A*03:01:01G A*11:01:01G
B153 B*51:01:01G 137 91 B*51:01:01G 137 91 B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
B153 C*01:02:01G 0 8 C*15:02:01G 3 15 C*15:02:01G C*15:102 C*15:102 C*15:85
B154 A*01:01:01 0 15 A*24:02:01G 3 6 A*24:02:58 A*24:222N A*24:02:58 A*24:02:58
B154 B*35:08:01 64 21 B*51:01:01G 55 23 B*35:08:01 B*51:01:01G B*35:08:01 B*51:01:01G
B154 C*04:01:01G 1 5 C*15:02:01G 1 11 C*04:01:01G C*15:02:01G C*15:02:01G C*15:85
B155 A*24:02:01G 42 52 A*24:02:01G 42 52 A*24:02:01G A*24:02:01G A*24:02:01G A*24:02:01G
B155 B*35:03:01 48 37 B*51:09:01 51 51 B*35:03:01G B*51:09:01 B*35:03:01G B*51:09:01
B155 C*01:02:01G 1 29 C*04:01:01G 0 18 C*01:02:01G C*01:02:01G
B156 A*03:01:01G 9 14 A*30:04:01 13 17 A*03:01:01G A*30:04:01G A*03:01:01G A*30:04:01G
B156 B*07:02:01G 35 19 B*35:01:01 39 16 B*07:02:01G B*35:01:01G B*07:02:01G B*35:01:01G
B156 C*04:01:01G 0 2 C*07:02:01G 2 4 C*07:02:01G C*07:02:01G
B157 A*01:01:01 7 63 A*02:01:01G 22 38 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B157 B*07:02:01G 143 99 B*08:01 110 74 B*07:02:01G B*08:01:01G B*07:02:01G B*08:01:01G
B157 C*07:01:01G 88 79 C*07:02:01G 99 74 C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
B158 B*40:02:01 83 70 B*44:02:01G 34 54 B*40:02:01G B*44:02:01G B*40:02:01G B*44:02:01G
B159 A*01:01:01 5 47 A*26:01:01 2 66 A*01:01:01G A*26:01:01G A*01:01:01G A*26:105
B159 B*08:01 57 63 B*27:05:02G 74 87 B*08:01:01G B*27:05:02G B*08:01:01G B*27:05:02G
B159 C*01:02:01G 57 43 C*07:01:01G 83 57 C*01:02:01G C*07:01:01G C*01:02:01G C*07:01:01G
B160 A*02:01:01G 39 8 A*11:01:01G 11 10 A*02:01:01G A*11:01:01G A*02:01:01G A*11:01:01G
B160 B*35:03:01 61 19 B*57:01:01G 56 31 B*35:03:01G B*57:01:01G B*35:03:01G B*57:01:01G
B160 C*04:01:01G 3 1 C*06:02:01G 6 8 C*04:01:01G C*06:02:01G C*06:02:01G C*06:71
B161 A*02:01:01G 4 87 A*24:02:01G 1 48 A*02:01:01G A*02:17:01G A*02:01:31 A*02:19
B161 B*15:01:01G 107 58 B*18:01:01G 81 59 B*15:01:01G B*18:01:01G B*15:01:01G B*18:01:01G
B161 C*03:04:01 2 34 C*05:01 0 45 C*03:04:01G C*03:04:01G C*03:04:17 C*03:109
B162 A*25:01:01G 10 89 A*31:01:02G 2 63 A*25:01:01G A*25:01:01G A*25:01:01G A*25:01:01G
B162 B*15:01:01G 86 59 B*18:01:01G 88 58 B*15:01:01G B*18:01:01G B*15:01:01G B*18:01:01G
B162 C*03:03:01G 5 53 C*12:03:01 8 40 C*03:03:01G C*12:03:01G C*03:03:01G C*12:03:01G
B163 A*02:01:01G 1 30 A*03:01:01G 1 15 A*02:01:01G A*03:01:01G A*02:01:108 A*03:89
B163 B*39:06:02 38 6 B*44:02:01G 54 1 B*39:06:02 B*39:06:02 B*39:06:02 B*39:06:02
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B164 B*07:02:01G 27 2 B*51:01:01G 0 0 B*07:02:01G B*07:02:01G B*07:151:01 B*07:67N
B165 B*35:03:01 124 86 B*44:02:01G 75 90 B*35:03:01G B*44:02:01G B*35:03:01G B*44:02:01G
B165 C*04:01:01G 48 74 C*05:01 92 94 C*04:01:01G C*05:01:01G C*04:01:01G C*05:01:01G
B166 A*01:01:01 9 30 A*02:01:01G 6 50 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
B166 B*08:01 75 42 B*44:02:01G 83 54 B*08:01:01G B*44:02:01G B*08:01:01G B*44:02:01G
B166 C*05:01 3 19 C*07:01:01G 1 7 C*05:01:01G C*07:01:01G C*05:09:01 C*05:20
B167 A*03:01:01G 1 32 A*30:01:01 0 34 A*03:01:01G A*03:01:01G
B167 B*13:02:01G 46 41 B*35:01:01 71 56 B*13:02:01G B*35:01:01G B*13:02:01G B*35:01:01G
B167 C*04:01:01G 46 28 C*06:02:01G 92 17 C*04:01:01G C*06:02:01G C*04:01:01G C*06:02:01G
B168 A*02:01:01G 57 58 A*24:02:01G 47 34 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
B168 B*07:02:01G 61 80 B*49:01:01 87 52 B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
B168 C*07:01:01G 71 54 C*07:02:01G 75 59 C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
B169 A*01:01:01 22 36 A*02:01:01G 16 55 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
B169 B*07:02:01G 92 70 B*08:01 53 44 B*07:02:01G B*08:01:01G B*07:02:01G B*08:01:01G
B169 C*07:01:01G 74 41 C*07:02:01G 75 53 C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
B170 B*15:18 89 47 B*51:01:01G 50 47 B*15:18:01G B*51:01:01G B*15:18:01G B*51:01:01G
B170 C*07:04:01G 7 13 C*15:02:01G 0 34 C*07:04:01G C*07:04:01G C*07:199:01 C*07:338
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B171 B*14:02:01 128 83 B*14:02:01 128 83 B*14:02:01 B*14:02:01 B*14:02:01 B*14:02:01
B171 C*08:02:01G 3 43 C*08:02:01G 3 43 C*08:02:01G C*08:02:01G C*08:02:01G C*08:02:08
B172 A*02:01:01G 7 0 A*30:01:01 3 19 A*30:01:01G A*30:01:01G
B172 B*15:01:01G 83 43 B*15:17:01G 52 43 B*15:01:01G B*15:17:01G B*15:01:01G B*15:17:01G
B172 C*03:04:01 3 26 C*07:01:01G 12 15 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
B173 A*03:01:01G 19 37 A*30:01:01 15 32 A*03:01:01G A*30:01:01G A*03:01:01G A*30:01:01G
B173 B*13:02:01G 43 26 B*15:01:01G 144 123 B*13:02:01G B*15:01:01G B*13:02:01G B*15:01:01G
B173 C*03:03:01G 46 92 C*06:02:01G 46 89 C*03:03:01G C*06:02:01G C*03:03:01G C*06:02:01G
B174 A*01:01:01 37 21 A*02:01:01G 63 20 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
B174 B*35:01:01 216 79 B*35:03:01 216 80 B*35:01:01G B*35:03:01G B*35:01:01G B*35:03:01G
B174 C*04:01:01G 44 56 C*12:03:01 56 39 C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
B175 B*08:01 25 26 B*44:03:01G 21 25 B*08:01:01G B*44:03:01G B*08:01:01G B*44:03:01G
B175 C*04:01:01G 30 18 C*07:01:01G 42 31 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
B176 A*11:01:01G 16 13 A*24:02:01G 26 14 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
B176 B*27:05:02G 44 23 B*35:01:01 33 31 B*27:05:02G B*35:01:01G B*27:05:02G B*35:01:01G
B177 B*07:02:01G 227 123 B*07:02:01G 227 123 B*07:02:01G B*07:02:01G B*07:02:01G B*07:02:01G
B177 C*07:02:01G 135 37 C*07:02:01G 135 37 C*07:02:01G C*07:02:01G C*07:02:01G C*07:02:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B178 A*24:02:01G 60 32 A*25:01:01G 40 56 A*24:02:01G A*25:01:01G A*24:02:01G A*25:01:01G
B178 B*08:01 77 69 B*18:01:01G 132 69 B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
B179 A*01:01:01 16 17 A*02:01:01G 35 54 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
B179 B*07:02:01G 37 48 B*57:01:01G 62 63 B*07:02:01G B*57:01:01G B*07:02:01G B*57:01:01G
B179 C*06:02:01G 1 17 C*07:02:01G 2 19 C*06:02:01G C*07:76:02 C*06:17 C*07:49
B180 B*51:01:01G 65 54 B*57:01:01G 59 61 B*51:01:01G B*57:01:01G B*51:01:01G B*57:01:01G
B181 A*02:01:01G 6 1 A*33:03:01G 0 28 A*02:152 A*02:152 A*02:152 A*02:152
B181 B*07:02:01G 44 49 B*44:02:01G 56 51 B*07:02:01G B*44:02:01G B*07:02:01G B*44:02:01G
B181 C*05:01:01G 22 31 C*07:02:01G 13 30 C*05:01:01G C*07:02:01G C*05:01:01G C*07:02:01G
B182 A*02:01:01G 61 70 A*23:01 22 26 A*02:01:01G A*23:01:01G A*02:01:01G A*23:01:01G
B182 B*08:01 77 81 B*15:01:01G 93 54 B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
B182 C*03:04:01 23 56 C*07:01:01G 27 54 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
B183 A*24:02:01G 116 13 A*24:03:01G 0 4 A*24:02:01G A*24:02:01G A*24:02:01G A*24:02:01G
B183 B*35:01:01 117 75 B*40:02:01G 102 56 B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
B183 C*03:04:01 46 54 C*04:01:01G 63 79 C*03:04:01G C*04:01:01G C*03:04:01G C*04:01:01G
B184 A*02:01:01G 29 35 A*03:01:01G 9 23 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B184 B*15:01:01G 65 20 B*57:01:01G 62 44 B*15:01:01G B*57:01:01G B*15:01:01G B*57:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B184 C*03:04:01 1 13 C*06:02:01G 0 11 C*03:140 C*03:140
B185 A*11:01:01G 35 45 A*29:02:01 17 76 A*11:01:01G A*29:02:01G A*11:01:01G A*29:02:01G
B185 B*15:18 118 80 B*44:03:01G 109 68 B*15:18:01G B*44:03:01G B*15:18:01G B*44:03:01G
B185 C*07:04:01G 63 34 C*16:01:01 56 29 C*07:04:01G C*16:01:01G C*07:04:01G C*16:01:01G
B186 A*26:01:01 59 8 A*68:01:01 18 20 A*26:01:01G A*68:01:01G A*26:01:01G A*68:01:01G
B186 B*27:05:02G 33 43 B*35:01:01 57 42 B*27:05:02G B*35:01:01G B*27:05:02G B*35:01:01G
B187 A*02:01:01G 70 95 A*03:01:01G 49 66 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B187 B*07:02:01G 209 148 B*07:02:01G 209 148 B*07:02:01G B*07:02:01G B*07:02:01G B*07:02:01G
B187 C*07:02:01G 110 123 C*07:02:01G 110 123 C*07:02:01G C*07:02:01G C*07:02:01G C*07:02:01G
B188 A*02:01:01G 21 72 A*68:01:01 37 65 A*02:01:01G A*68:01:01G A*02:01:01G A*68:01:01G
B188 B*15:01:01G 98 47 B*35:03:01 83 61 B*15:01:01G B*35:03:01G B*15:01:01G B*35:03:01G
B188 C*03:04:01 23 63 C*04:01:01G 10 57 C*03:04:01G C*04:01:01G C*03:04:01G C*04:01:01G
B189 A*01:01:01 21 53 A*31:01:02G 6 51 A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
B189 B*14:02 74 81 B*40:01:01G 118 75 B*14:02:01 B*40:01:01G B*14:02:01 B*40:01:01G
B189 C*07:02:01G 52 64 C*08:02 12 74 C*07:02:01G C*08:02:01G C*07:02:01G C*08:02:01G
B190 A*01:01:01 6 129 A*31:01:02G 6 105 A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
B190 B*35:03:01 122 92 B*52:01:01 111 130 B*35:03:01G B*52:01:01G B*35:03:01G B*52:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B190 C*03:04:01 85 77 C*12:02:01G 76 85 C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
B191 A*01:01:01 87 69 A*01:01:01 87 69 A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
B191 B*08:01 140 66 B*08:01 140 66 B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
B191 C*07:01:01G 84 43 C*07:01:01G 84 43 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
B192 A*01:01:01 10 21 A*24:02:01G 6 23 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
B192 B*08:01 40 16 B*49:01:01 35 29 B*08:01:01G B*49:01:01G B*08:01:01G B*49:01:01G
B192 C*07:01:01G 44 60 C*07:01:01G 44 60 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
B193 A*03:01:01G 20 25 A*03:01:01G 20 25 A*03:01:01G A*03:01:01G A*03:01:01G A*03:01:01G
B193 B*08:01 60 38 B*35:03:01 71 42 B*08:01:01G B*35:03:01G B*08:01:01G B*35:03:01G
B193 C*07:01:01G 14 11 C*15:02:01G 1 20 C*07:01:01G C*07:01:01G C*07:277 C*07:313
B194 A*02:01:01G 55 39 A*02:01:01G 55 39 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
B194 B*15:01:01G 45 29 B*51:01:01G 46 33 B*15:01:01G B*51:01:01G B*15:01:01G B*51:01:01G
B195 A*02:01:01G 42 19 A*03:01:01G 17 12 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B195 B*07:02:01G 64 33 B*07:02:01G 64 33 B*07:02:01G B*37:07 B*07:02:01G B*07:02:01G
B195 C*07:02:01G 11 3 C*07:02:01G 11 3 C*07:02:01G C*07:02:01G C*07:02:01G C*07:13
B196 B*08:01 44 82 B*40:01:01G 113 63 B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
B197 A*02:01:01G 85 96 A*30:01:01G 18 70 A*02:01:01G A*30:01:01G A*02:01:01G A*30:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B197 B*13:02:01G 183 170 B*13:02:01G 183 170 B*13:02:01G B*13:02:01G B*13:02:01G B*13:02:01G
B197 C*06:02:01G 68 67 C*07:02:01G 83 63 C*06:02:01G C*07:02:01G C*06:02:01G C*07:02:01G
B198 A*01:01:01 19 66 A*02:01:01G 55 105 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
B198 B*08:01 79 34 B*44:02:01G 68 50 B*08:01:01G B*44:02:01G B*08:01:01G B*44:02:01G
B198 C*05:01 22 50 C*07:01:01G 57 32 C*05:01:01G C*07:01:01G C*05:01:01G C*07:01:01G
B199 A*03:01:01G 13 22 A*11:01:01G 7 23 A*03:01:01G A*11:01:01G A*03:01:01G A*11:01:01G
B199 B*27:05:02G 50 8 B*35:01:01 59 11 B*27:05:02G B*35:01:01G B*27:05:02G B*35:01:01G
B200 A*01:01:01 27 11 A*29:01:01G 15 11 A*01:01:01G A*29:01:01G A*01:01:01G A*29:01:01G
B200 B*07:05 92 67 B*35:02:01 92 84 B*07:05:01G B*35:02:01G B*07:05:01G B*35:02:01G
B200 C*04:01:01G 32 69 C*15:05:01G 63 81 C*04:01:01G C*15:05:01G C*04:01:01G C*15:05:01G
B201 A*02:01:01G 160 260 A*02:01:01G 160 260 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
B201 B*07:02:01G 114 102 B*15:01:01G 139 93 B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
B201 C*03:03:01G 58 64 C*07:02:01G 77 68 C*03:03:01G C*07:02:01G C*03:03:01G C*07:02:01G
B202 A*02:01:01G 187 169 A*02:01:01G 187 169 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
B202 B*08:01 60 57 B*40:01:01G 95 61 B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
B202 C*03:04:01 12 49 C*07:01:01G 151 53 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
B203 A*02:02 3 92 A*03:12 2 47 A*02:05:01G A*03:01:01G A*03:01:33 A*03:01:41
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B203 B*14:01 25 59 B*35:08:01 96 64 B*14:01:01 B*35:08:01 B*14:01:01 B*35:08:01
B204 A*02:01:01G 50 36 A*68:02:01 32 35 A*02:01:01G A*68:02:01G A*02:01:01G A*68:02:01G
B204 B*14:02 43 41 B*51:01:01G 83 32 B*14:02:01 B*51:01:01G B*14:02:01 B*51:01:01G
B205 A*02:01:01G 0 0 A*23:01 2 10 A*23:01:01G A*23:01:01G A*23:01:01G A*23:38N
B205 B*44:02:01G 32 41 B*50:02 43 36 B*44:02:01G B*50:02 B*44:02:01G B*50:02
B205 C*05:01:01 9 23 C*06:02:01G 12 12 C*05:01:01G C*06:02:01G C*05:01:01G C*06:02:01G
B206 A*02:01:01G 54 72 A*24:02:01G 36 48 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
B206 B*27:02:01 110 69 B*35:03:01 95 39 B*27:02:01 B*35:03:01G B*27:02:01 B*35:03:01G
B207 A*03:01:01G 2 2 A*25:01:01G 0 47 A*03:01:01G A*03:01:01G A*03:01:33 A*03:01:41
B207 B*44:02:01G 42 25 B*55:01:01 43 18 B*44:02:01G B*55:01:01G B*44:02:01G B*55:01:01G
B207 C*03:03:01G 2 9 C*05:01:01 4 19 C*05:01:01G C*05:01:01G C*05:01:01G C*05:01:01G
B208 A*02:01:01G 15 85 A*03:01:01G 10 61 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B208 B*07:02:01G 105 33 B*41:02:01 113 42 B*07:02:01G B*41:02:01 B*07:02:01G B*41:02:01
B208 C*07:02:01G 7 80 C*17:01 8 42 C*07:02:01G C*17:01:01G C*07:02:01G C*17:01:01G
B209 B*37:01:01 30 1 B*38:01:01 26 6 B*37:01:01G B*38:01:01 B*38:01:01 B*38:01:01
B210 A*02:01:01G 15 26 A*66:01:01G 9 19 A*02:01:01G A*66:01:01G A*02:01:01G A*66:01:01G
B210 B*40:01:01G 150 40 B*41:02:01 150 15 B*40:01:01G B*41:02:01 B*40:01:01G B*41:02:01
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B211 A*01:01:01 23 27 A*02:01:01G 26 14 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
B211 B*44:02:01G 83 91 B*57:01:01G 106 78 B*44:02:01G B*57:01:01G B*44:02:01G B*57:01:01G
B211 C*05:01:01 38 47 C*06:02:01G 46 28 C*05:01:01G C*06:02:01G C*05:01:01G C*06:02:01G
B212 A*01:01:01 0 66 A*23:01 5 62 A*23:01:01G A*23:01:01G A*23:02 A*23:38N
B212 B*08:01 54 65 B*44:03:01G 91 61 B*08:01:01G B*44:03:01G B*08:01:01G B*44:03:01G
B212 C*04:01:01G 6 53 C*07:01:01G 71 52 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
B213 A*02:01:01G 29 52 A*24:02:01G 17 14 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
B213 B*35:03:01 67 31 B*44:02:01G 34 38 B*35:03:01G B*44:02:01G B*35:03:01G B*44:02:01G
B213 C*04:01:01G 10 13 C*05:01 7 10 C*04:01:01G C*05:01:01G C*04:01:01G C*05:01:01G
B214 B*15:01:01G 64 35 B*52:01:01 35 35 B*15:01:01G B*52:01:01G B*15:01:01G B*52:01:01G
B214 C*03:03:01G 0 15 C*12:02:01G 2 9 C*12:02:01G C*12:02:01G C*12:124 C*12:84N
B215 A*02:01:01G 19 44 A*11:01:01G 10 30 A*02:01:01G A*11:01:01G A*02:01:01G A*11:01:01G
B215 B*08:01 12 12 B*35:01:01 39 15 B*08:01:01G B*35:01:01G B*08:01:01G B*35:01:01G
B215 C*04:01:01G 0 16 C*07:01:01G 2 20 C*07:01:01G C*07:01:01G C*07:115 C*07:188
B216 A*02:01:01G 57 88 A*02:01:01G 57 88 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
B216 B*08:01 41 35 B*40:01:01G 49 24 B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
B216 C*03:04:01 4 6 C*07:01:01G 10 9 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B217 A*03:02 27 27 A*68:01:02G 52 87 A*03:02:01 A*68:01:02G A*03:02:01 A*68:01:02G
B217 B*18:01:01G 94 31 B*44:02:01G 71 60 B*18:01:01G B*44:02:01G B*18:01:01G B*44:02:01G
B217 C*07:04:01G 32 40 C*12:03:01 7 28 C*07:04:01G C*12:03:01G C*07:04:01G C*12:03:01G
B218 A*03:01:01G 2 13 A*24:02:01G 0 8 A*03:01:01G A*03:01:01G
B218 B*44:03:01G 17 11 B*49:01:01 39 27 B*44:03:01G B*49:01:01G B*44:03:01G B*49:01:01G
B218 C*07:01:01G 2 2 C*16:01 1 1 C*07:01:01G C*16:01:01G
B219 A*01:01:01 0 8 A*02:01:01G 20 21 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
B219 B*27:05:02G 43 20 B*37:01:01 60 30 B*27:05:02G B*37:01:01G B*27:05:02G B*37:01:01G
B219 C*01:02:01G 2 10 C*06:02:01G 4 11 C*01:02:01G C*01:02:01G C*06:02:01G C*06:02:01G
B220 A*24:02:01G 19 47 A*32:01:01 15 67 A*24:02:01G A*32:01:01G A*24:02:01G A*32:01:01G
B220 B*08:01 180 53 B*08:01 180 53 B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
B220 C*07:01:01G 1 28 C*07:01:01G 1 28 C*07:01:01G C*07:01:01G
B221 A*02:01:01G 48 30 A*32:01:01 38 24 A*02:01:01G A*32:01:01G A*02:01:01G A*32:01:01G
B221 B*45:01:01G 51 36 B*55:01:01 56 32 B*45:01:01G B*55:01:01G B*45:01:01G B*55:01:01G
B222 A*03:01:01G 13 50 A*24:02:01G 52 33 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
B222 B*07:02:01G 67 61 B*15:01:01G 79 73 B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
B222 C*03:03:01G 38 34 C*07:02:01G 49 30 C*03:03:01G C*07:02:01G C*03:03:01G C*07:02:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B223 A*33:01:01 0 5 A*69:01 2 27 A*69:01 A*69:01 A*69:01 A*69:01
B223 B*14:02 46 2 B*35:08:01 70 1 B*14:02:01 B*35:08:01 B*35:188 B*35:188
B224 A*02:06:01G 8 5 A*33:01:01 1 0 A*02:06:01G A*02:06:01G A*02:06:01G A*02:06:01G
B224 B*44:03:01G 80 7 B*51:01:01G 79 10 B*44:03:01G B*51:01:01G B*44:03:01G B*51:01:01G
B225 A*02:01:01G 122 160 A*11:01:01G 86 100 A*02:01:01G A*11:01:01G A*02:01:01G A*11:01:01G
B225 B*35:01:01 151 120 B*44:03:01G 160 109 B*35:01:01G B*44:03:01G B*35:01:01G B*44:03:01G
B225 C*02:02:02G 25 61 C*04:01:01G 21 84 C*02:02:02G C*04:01:01G C*02:02:02G C*04:01:01G
B226 A*24:02:01G 22 65 A*36:01 5 74 A*24:02:01G A*36:01 A*24:02:01G A*36:01
B226 B*14:02 76 61 B*52:01:01 107 72 B*14:02:01 B*52:01:01G B*14:02:01 B*52:01:01G
B226 C*08:02 30 25 C*12:02:01G 32 37 C*08:02:01G C*12:02:01G C*08:02:01G C*12:02:01G
B227 A*02:01:01G 12 61 A*11:01:01G 12 29 A*02:01:01G A*11:01:01G A*02:01:01G A*11:01:01G
B227 B*18:01:01G 222 67 B*18:01:01G 222 67 B*18:01:01G B*18:01:01G B*18:01:01G B*18:01:01G
B227 C*01:02:01G 17 34 C*07:01:01G 42 32 C*01:02:01G C*07:01:01G C*01:02:01G C*07:01:01G
B228 A*02:01:01G 141 134 A*30:01:01G 40 86 A*02:01:01G A*30:01:01G A*02:01:01G A*30:01:01G
B228 B*08:01 81 77 B*39:06:02 112 66 B*08:01:01G B*39:06:02 B*08:01:01G B*39:06:02
B228 C*07:01:01G 214 50 C*12:03:01 15 62 C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
B229 A*02:01:01G 78 95 A*23:01 23 63 A*02:01:01G A*23:01:01G A*02:01:01G A*23:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B229 B*44:03:01G 106 70 B*49:01:01 108 46 B*44:03:01G B*49:01:01G B*44:03:01G B*49:01:01G
B229 C*07:01:01G 199 71 C*16:02 8 71 C*07:01:01G C*16:02:01G C*07:277 C*07:313
B230 B*14:02 38 53 B*57:03:01 92 43 B*14:02:01 B*57:03:01 B*14:02:01 B*57:03:01
B230 C*07:01:01G 14 12 C*08:02 0 14 C*07:01:01G C*07:01:01G C*07:277 C*07:313
B231 A*01:01:01 6 73 A*11:01:01G 10 57 A*01:01:01G A*11:01:01G A*01:01:01G A*11:01:01G
B231 B*35:01:01 102 113 B*51:01:01G 129 58 B*35:01:01G B*51:01:01G B*35:01:01G B*51:01:01G
B231 C*04:01:01G 4 43 C*15:02:01G 12 81 C*04:01:01G C*15:02:01G C*04:01:01G C*15:02:01G
B232 A*24:02:01G 3 0 A*32:01:01 6 2 A*32:01:01G A*32:01:01G A*32:23 A*32:38
B232 B*40:01:01G 69 28 B*44:02:01G 57 19 B*40:01:01G B*44:02:01G B*40:01:01G B*44:02:01G
B232 C*03:03:01G 1 8 C*05:01:01 0 13 C*03:03:01G C*03:03:01G
B233 A*02:01:01G 54 77 A*03:01:01G 39 80 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B233 B*44:02:01G 112 77 B*57:03:01 95 64 B*44:02:01G B*57:03:01 B*44:02:01G B*57:03:01
B233 C*05:01 51 112 C*18:01:01G 64 70 C*05:01:01G C*18:01:01G C*05:01:01G C*18:01:01G
B234 A*02:06:01G 55 89 A*23:01 30 55 A*02:06:01G A*23:01:01G A*02:06:01G A*23:01:01G
B234 B*39:08 91 67 B*41:01:01 92 62 B*39:08 B*41:01:01 B*39:08 B*41:01:01
B234 C*07:02:01G 30 36 C*17:01 40 20 C*07:02:01G C*17:01:01G C*07:02:01G C*17:01:01G
B235 B*08:01 27 25 B*35:12:01 19 22 B*08:01:01G B*35:12:01 B*08:01:01G B*35:12:01
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B235 C*04:01:01G 9 26 C*07:01:01G 31 8 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
B236 A*02:01:01G 54 58 A*11:01:01G 25 22 A*02:01:01G A*11:01:01G A*02:01:01G A*11:01:01G
B236 B*13:02:01G 54 32 B*52:01:01 63 37 B*13:02:01G B*52:01:01G B*13:02:01G B*52:01:01G
B237 A*24:02:01G 45 0 A*68:02:01 54 129 A*68:02:01G A*68:02:01G A*68:67 A*68:78
B237 B*14:02 113 89 B*35:12:01 153 82 B*14:02:01 B*35:12:01 B*14:02:01 B*35:12:01
B237 C*04:01:01G 27 53 C*08:02 34 84 C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
B238 A*02:06:01G 87 133 A*23:01 60 79 A*02:06:01G A*23:01:01G A*02:06:01G A*23:01:01G
B238 B*27:05:02G 115 96 B*35:01:01 146 99 B*27:05:02G B*35:01:01G B*27:05:02G B*35:01:01G
B239 A*02:01:01G 9 23 A*30:01:01 1 9 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
B239 B*15:10 18 10 B*40:01:01G 14 9 B*15:10:01 B*40:01:01G B*15:10:01 B*40:01:01G
B240 B*35:12:01 78 57 B*40:02:01 87 80 B*35:12:01 B*40:02:01G B*35:12:01 B*40:02:01G
B241 A*02:01:01G 58 38 A*02:44 23 22 A*02:01:01G A*02:44 A*02:01:01G A*02:44
B241 B*40:02:01 82 23 B*58:01:01 85 28 B*40:02:01G B*58:01:01G B*40:02:01G B*58:01:01G
B242 B*39:05:01 5 8 B*51:01:01G 31 8 B*39:05:01 B*51:01:01G B*39:05:01 B*51:01:01G
B243 A*02:01:01G 48 65 A*03:01:01G 27 51 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B243 B*07:02:01G 100 45 B*14:02 110 56 B*07:02:01G B*14:02:01 B*07:02:01G B*14:02:01
B243 C*07:02:01G 5 42 C*08:02 0 31 C*07:02:01G C*07:41 C*07:02:01G C*07:41
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B244 A*02:01:01G 1 36 A*02:20:01 1 0 A*02:01:01G A*02:01:01G
B244 B*07:02:01G 10 16 B*58:01:01 33 17 B*07:02:01G B*58:01:01G B*07:02:01G B*58:01:01G
B244 C*07:01:01G 0 6 C*07:02:01G 2 13 C*07:02:01G C*07:27:01 C*07:02:43 C*07:27:01
B245 A*24:02:01G 61 65 A*24:23 61 87 A*24:02:01G A*24:23 A*24:02:01G A*24:23
B245 B*37:01:01 150 90 B*40:01:01G 115 38 B*37:01:01G B*40:01:01G B*37:01:01G B*40:01:01G
B245 C*03:04:01 4 54 C*06:02:01G 3 51 C*03:04:01G C*06:02:01G C*03:04:01G C*06:02:01G
B246 A*29:02:01 1 2 A*30:02:01G 1 0 A*29:02:01G A*29:02:01G
B246 B*18:01:01G 10 2 B*44:03:01G 12 0 B*18:01:01G B*18:01:01G B*18:01:10 B*18:92
B247 A*11:01:01G 3 96 A*31:01:02G 2 61 A*11:01:01G A*31:01:02G A*11:01:01G A*31:01:02G
B247 B*27:05:02G 124 39 B*40:02:01G 105 43 B*27:05:02G B*40:02:01G B*27:05:02G B*40:02:01G
B247 C*01:02:01G 19 42 C*03:06 12 55 C*01:02:01G C*03:06 C*01:02:01G C*03:06
B248 A*24:02:01G 44 19 A*31:01:02G 14 40 A*24:02:01G A*31:01:02G A*24:02:01G A*31:01:02G
B248 B*27:05:02G 73 22 B*39:01:01 73 25 B*27:05:02G B*39:01:01G B*27:05:02G B*39:01:01G
B249 A*24:02:01G 35 78 A*24:02:01G 35 78 A*24:02:01G A*24:02:01G A*24:02:01G A*24:02:01G
B249 B*35:01:01 96 100 B*40:02:01G 127 82 B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
B249 C*03:04:01 75 48 C*03:05 75 42 C*03:04:01G C*03:05 C*03:04:01G C*03:05
B250 A*02:01:01G 9 137 A*29:02:01 4 98 A*02:01:01G A*29:02:01G A*02:01:01G A*29:02:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B250 B*42:01:01 123 117 B*52:01:01 153 121 B*42:01:01 B*52:01:01G B*42:01:01 B*52:01:01G
B250 C*12:02:01G 59 77 C*17:01 148 99 C*12:02:01G C*17:01:01G C*12:02:01G C*17:01:01G
B251 A*02:01:01G 70 85 A*68:01:02G 44 36 A*02:01:01G A*68:01:02G A*02:01:01G A*68:01:02G
B251 B*51:01:01G 134 117 B*51:01:01G 134 117 B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
B251 C*02:02:02G 5 29 C*14:02:01G 4 29 C*02:02:02G C*14:02:01G C*02:02:02G C*14:02:01G
B252 B*13:02:01G 87 43 B*14:02 101 55 B*13:02:01G B*14:02:01 B*13:02:01G B*14:02:01
B252 C*06:02:01G 5 36 C*08:02:01G 1 30 C*06:02:01G C*08:02:01G C*06:02:09 C*06:123
B253 A*01:01:01 9 28 A*02:01:01G 20 34 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
B253 B*40:02:01 40 5 B*57:01:01G 16 2 B*40:02:01G B*57:01:01G B*40:02:01G B*57:01:01G
B254 A*24:02:01G 22 16 A*68:02:01 14 71 A*24:02:01G A*68:02:01G A*24:02:01G A*68:02:01G
B254 B*48:01:01 44 38 B*58:01:01 51 29 B*48:01:01G B*58:01:01G B*48:01:01G B*58:01:01G
B254 C*07:01:01G 5 2 C*08:01:01G 0 8 C*07:01:01G C*07:01:01G C*07:01:31 C*07:296
B255 A*30:01:01 46 51 A*33:01:01 30 45 A*30:01:01G A*33:01:01 A*30:01:01G A*33:01:01
B255 B*42:01:01 68 35 B*53:01:01 103 32 B*42:01:01 B*53:01:01G B*42:01:01 B*53:01:01G
B256 A*02:05 12 10 A*11:01:01G 0 6 A*02:05:01G A*02:05:01G A*02:359 A*02:413
B256 B*35:03:01 12 24 B*50:01:01 61 5 B*35:03:01G B*50:01:01G B*35:03:01G B*50:01:01G
B257 A*03:01:01G 56 28 A*31:01:02G 19 28 A*03:01:01G A*31:01:02G A*03:01:01G A*31:01:02G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B257 B*07:02:01G 89 71 B*51:02:01 99 56 B*07:02:01G B*51:02:01 B*07:02:01G B*51:02:01
B258 A*24:02:01G 61 41 A*26:01:01 29 56 A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
B258 B*35:43:01 113 78 B*38:01:01 83 57 B*35:43:01G B*38:01:01 B*35:43:01G B*38:01:01
B258 C*01:02:01G 45 58 C*12:03:01 57 44 C*01:02:01G C*12:03:01G C*01:02:01G C*12:03:01G
B259 A*03:01:01G 89 74 A*24:02:01G 139 61 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
B259 B*18:01:01G 110 93 B*81:01:01G 113 99 B*18:01:01G B*81:01:01G B*18:01:01G B*81:01:01G
B259 C*08:04 137 55 C*12:03:01 146 44 C*08:04:01 C*12:03:01G C*08:04:01 C*12:03:01G
B260 A*03:01:01G 71 48 A*68:01:02G 123 78 A*03:01:01G A*68:01:02G A*03:01:01G A*68:01:02G
B260 B*07:02:01G 73 106 B*44:02:01G 104 85 B*07:02:01G B*44:02:01G B*07:02:01G B*44:02:01G
B260 C*07:02:01G 100 83 C*07:04:01G 86 50 C*07:02:01G C*07:04:01G C*07:02:01G C*07:04:01G
B261 A*02:06:01G 88 43 A*68:01:01 49 53 A*02:06:01G A*68:01:01G A*02:06:01G A*68:01:01G
B261 B*15:18 75 72 B*39:05:01 58 51 B*15:18:01G B*39:05:01 B*15:18:01G B*39:05:01
B261 C*07:02:01G 47 20 C*07:04:01G 46 17 C*07:02:01G C*07:04:01G C*07:02:01G C*07:04:01G
B262 A*02:01:01G 113 67 A*30:01:01 45 47 A*02:01:01G A*30:01:01G A*02:01:01G A*30:01:01G
B262 B*14:02 64 47 B*42:01:01 54 41 B*14:02:01 B*42:01:01 B*14:02:01 B*42:01:01
B262 C*08:02 32 39 C*17:01 72 19 C*08:02:01G C*17:01:01G C*08:02:01G C*17:01:01G
B263 B*42:02 1 0 B*55:01:01 2 1 B*55:01:01G B*55:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B264 A*03:01:01G 79 85 A*32:01:01 116 89 A*03:01:01G A*32:01:01G A*03:01:01G A*32:01:01G
B264 B*07:02:01G 75 129 B*41:02:01 91 78 B*07:02:01G B*41:02:01 B*07:02:01G B*41:02:01
B264 C*07:02:01G 62 13 C*17:01 121 21 C*07:02:01G C*17:01:01G C*07:02:01G C*17:01:01G
B265 A*32:01:01 19 16 A*68:02:01 20 21 A*32:01:01G A*68:02:01G A*32:01:01G A*68:02:01G
B265 B*27:05:02G 17 15 B*49:01:01 49 13 B*27:05:02G B*49:01:01G B*27:05:02G B*49:01:01G
B265 C*01:02:01G 0 15 C*07:01:01G 18 13 C*07:01:01G C*07:01:01G C*07:277 C*07:313
B266 A*02:01:01G 35 18 A*03:01:01G 17 11 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B266 B*07:02:01G 15 13 B*35:17:01 34 11 B*07:02:01G B*35:17:01 B*07:02:01G B*35:17:01
B266 C*04:01:01G 3 0 C*07:02:01G 10 1 C*07:02:01G C*07:02:01G
B267 A*24:25 28 32 A*34:01:01 63 64 A*24:25 A*34:01:01 A*24:25 A*34:01:01
B267 B*15:35 70 27 B*48:01:01 66 35 B*15:35 B*48:01:01G B*15:35 B*48:01:01G
B267 C*07:02:01G 31 22 C*08:01:01G 26 21 C*07:02:01G C*08:01:01G C*07:02:01G C*08:01:01G
B268 A*03:01:01G 9 37 A*11:01:01G 7 31 A*03:01:01G A*11:01:01G A*03:01:01G A*11:01:01G
B268 B*07:02:01G 28 11 B*38:01:01 28 40 B*07:02:01G B*38:01:01 B*07:02:01G B*38:01:01
B269 A*03:01:01G 80 82 A*03:01:01G 80 82 A*03:01:01G A*03:01:01G A*03:01:01G A*03:01:01G
B269 B*07:02:01G 31 29 B*49:01:01 55 24 B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
B269 C*07:01:01G 37 23 C*07:02:01G 24 38 C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B270 A*02:06:01G 32 28 A*68:01:02G 19 32 A*02:06:01G A*68:01:02G A*02:06:01G A*68:01:02G
B270 B*35:17:01 35 12 B*40:02:01 66 17 B*35:17:01 B*40:02:01G B*35:17:01 B*40:02:01G
B270 C*03:03:01G 2 26 C*03:04:01 2 0 C*03:04:01G C*03:04:01G C*03:04:01G C*03:04:01G
B271 A*02:01:01G 197 49 A*29:02:01 60 49 A*02:01:01G A*29:02:01G A*02:01:01G A*29:02:01G
B271 B*15:01:01G 70 34 B*55:01:01 65 26 B*15:01:01G B*55:01:01G B*15:01:01G B*55:01:01G
B271 C*03:03:01G 11 38 C*16:01 31 25 C*03:03:01G C*16:01:01G C*03:03:01G C*16:01:01G
B272 A*31:01:02G 49 115 A*31:01:02G 49 115 A*31:01:02G A*31:01:02G A*31:01:02G A*31:01:02G
B272 B*39:05:01 54 82 B*39:05:01 54 82 B*39:05:01 B*39:05:01 B*39:05:01 B*39:05:01
B272 C*07:02:01G 32 11 C*07:02:01G 32 11 C*07:02:01G C*07:02:01G C*07:02:01G C*07:02:01G
B273 A*01:01:01 90 77 A*31:01:02G 25 67 A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
B273 B*35:02:01 92 95 B*39:05:01 60 58 B*35:02:01G B*39:05:01 B*35:02:01G B*39:05:01
B273 C*04:01:01G 30 37 C*07:02:01G 55 31 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
B274 A*02:01:01G 36 51 A*68:03:01 20 131 A*02:01:01G A*68:03:01 A*02:01:01G A*68:03:01
B274 B*07:02:01G 154 61 B*35:14:01 299 49 B*07:02:01G B*35:14:01 B*07:02:01G B*35:14:01
B274 C*04:01:01G 17 54 C*07:02:01G 60 45 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
B275 A*31:01:02G 40 63 A*32:01:01 148 48 A*31:01:02G A*32:01:01G A*31:01:02G A*32:01:01G
B275 B*35:01:01 159 70 B*51:01:01G 152 58 B*35:01:01G B*51:01:01G B*35:01:01G B*51:01:01G
High confidence Medium confidence Low confidence Discordant call
continued . . .
176
A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B275 C*01:02:01G 10 24 C*15:02:01G 53 62 C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
B276 A*02:01:01G 59 88 A*23:01 34 60 A*02:01:01G A*23:01:01G A*02:01:01G A*23:01:01G
B276 B*39:01:01 122 7 B*50:01:01 152 6 B*39:01:01G B*50:01:01G B*39:01:01G B*50:01:01G
B276 C*06:02:01G 89 26 C*12:03:01 70 19 C*06:02:01G C*12:03:01G C*06:02:01G C*12:03:01G
B277 A*30:01:01G 78 90 A*32:01:01 143 93 A*30:01:01G A*32:01:01G A*30:01:01G A*32:01:01G
B277 B*42:02 85 38 B*53:01:01 121 53 B*42:02 B*53:01:01G B*42:02 B*53:01:01G
B277 C*04:01:01G 27 31 C*17:01 77 24 C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
B278 B*07:02:01G 30 78 B*40:02:01 51 54 B*07:02:01G B*40:02:01G B*07:02:01G B*40:02:01G
B278 C*02:02:02G 24 28 C*07:02:01G 64 16 C*02:02:02G C*07:02:01G C*02:02:02G C*07:02:01G
B279 A*26:01:01 11 24 A*68:02:01 25 37 A*26:01:01G A*68:02:01G A*26:01:01G A*68:02:01G
B279 B*08:01 52 37 B*14:02 67 51 B*08:01:01G B*14:02:01 B*08:01:01G B*14:02:01
B279 C*07:01:01G 74 22 C*08:02 30 15 C*07:01:01G C*08:02:01G C*07:01:01G C*08:02:01G
B280 A*01:01:01 14 24 A*03:01:01G 10 23 A*01:01:01G A*03:01:01G A*01:01:01G A*03:01:01G
B280 B*07:02:01G 31 46 B*51:01:01G 55 40 B*07:02:01G B*51:01:01G B*07:02:01G B*51:01:01G
B280 C*07:02:01G 3 15 C*15:02:01G 3 23 C*07:02:01G C*07:02:01G
B281 B*42:02 47 61 B*44:03:01G 49 88 B*42:02 B*44:03:01G B*42:02 B*44:03:01G
B281 C*04:01:01G 20 28 C*17:01 88 30 C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B282 A*02:01:01G 153 53 A*03:01:01G 85 40 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
B282 B*18:01:01G 16 45 B*35:01:01 32 43 B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
B282 C*04:01:01G 15 41 C*07:01:01G 35 31 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
B283 A*02:02 65 28 A*26:01:01 44 34 A*02:02:01 A*26:01:01G A*02:02:01 A*26:01:01G
B283 B*27:05:02G 23 44 B*53:01:01 46 39 B*27:05:02G B*53:01:01G B*27:05:02G B*53:01:01G
B283 C*04:01:01G 36 18 C*06:08 58 16 C*04:01:01G C*06:08 C*04:01:01G C*06:08
B284 A*30:02:01G 57 24 A*34:02:01 50 32 A*30:02:01G A*34:02:01 A*30:02:01G A*34:02:01
B284 B*53:01:01 41 32 B*57:03:01 40 34 B*53:01:01G B*57:03:01 B*53:01:01G B*57:03:01
B284 C*04:01:01G 22 27 C*18:01:01G 24 27 C*04:01:01G C*18:01:01G C*04:01:01G C*18:01:01G
B285 A*02:05 39 75 A*23:01 54 43 A*02:05:01G A*23:01:01G A*02:05:01G A*23:01:01G
B285 B*45:01:01G 108 68 B*49:01:01G 89 52 B*45:01:01G B*49:01:01G B*45:01:01G B*49:01:01G
B285 C*06:02:01G 24 38 C*07:01:01G 41 45 C*06:02:01G C*07:01:01G C*06:02:01G C*07:01:01G
B286 A*02:02 68 94 A*68:01:01 75 106 A*02:02:01 A*68:01:01G A*02:02:01 A*68:01:01G
B286 B*39:10:01 55 31 B*78:01:01 61 45 B*39:10:01 B*78:01:01 B*39:10:01 B*78:01:01
B286 C*12:03:01 21 20 C*16:01 12 15 C*12:03:01G C*16:01:01G C*12:03:01G C*16:01:01G
B287 A*23:01 85 49 A*32:01:01 85 120 A*23:01:01G A*32:01:01G A*23:01:01G A*32:01:01G
B287 B*14:01 97 77 B*15:03 107 92 B*14:01:01 B*15:03:01G B*14:01:01 B*15:03:01G
High confidence Medium confidence Low confidence Discordant call
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A. Allele calls from Broad sequencing data
. . . Broad results continued
Id Allele 1 Exon 2 Exon 3 Allele 2 Exon 2 Exon 3 Expectation 1 Expectation 2 Clustering 1 Clustering 2
B287 C*02:10 54 19 C*08:02 79 32 C*02:10 C*08:02:01G C*02:10 C*08:02:01G
B288 A*01:01:01 0 68 A*11:01:01G 135 49 A*11:01:01G A*11:01:01G A*11:02:01G A*11:59
B288 B*08:01 57 31 B*35:01:01 79 31 B*08:01:01G B*35:01:01G B*08:01:01G B*35:01:01G
B288 C*04:01:01G 14 26 C*07:01:01G 68 21 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
B289 A*02:01:01G 118 91 A*33:01:01 8 64 A*02:01:01G A*33:01:01 A*02:01:01G A*33:01:01
B289 B*39:10:01 74 54 B*78:01:01 87 53 B*39:10:01 B*78:01:01 B*39:10:01 B*78:01:01
B289 C*12:03:01 125 15 C*16:01 117 11 C*12:03:01G C*16:01:01G C*12:03:01G C*16:01:01G
B290 A*23:01 84 53 A*68:01:01 71 108 A*23:01:01G A*68:01:01G A*23:01:01G A*68:01:01G
B290 B*57:03:01 65 37 B*58:02 72 67 B*57:03:01 B*58:02 B*57:03:01 B*58:02
B2901 C*06:02:01G 19 14 C*07:01:01G 54 11 C*06:02:01G C*07:01:01G C*06:02:01G C*07:01:01G
Table A.1.: Allele calls for the Broad dataset. Allele 1 and Allele 2 are the calls made from Sanger sequencing. Exon 2 and 3 are the number of
FLX 454 reads covering each exon for each of the two alleles. Expectation 1 and 2 are the allele calls made from the FLX 454 data
using the allele caller based on expectation. Clustering 1 and 2 are the allele calls made from the FLX 454 data using the allele caller
based on clustering. The font color of allele calls represents ’High’, ’Medium’ and ’Low’ confidence calls, and background shading
represents discordance with the Sanger sequencing based calls.
1The original dataset sequenced by the Broad Institute contained 320 samples for which reference allele calls were available. Twenty eight of these samples had no results
called for all loci by both callers, these samples are not shown in this table. Additionally two samples were excluded, due to poor matches across multiple loci, which was
assumed to be due to sample mixup.
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B. Allele calls from UCLA QAP samples
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
1 Q19 A A*11:01 A*74:01 A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
1 Q19 B B*07:02 B*53:01 B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
1 Q19 C C*04:01 C*07:02 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
1 Q19 DRB1 DRB1*04:01 DRB1*13:02 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
1 Q19 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
1 Q19 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
1 Q19 DRB5
1 Q20 A A*02:01 A*32:01 A*02:01:01G A*02:65 A*02:01:01G A*02:65
1 Q20 B B*35:01 B*52:01 B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
1 Q20 C C*03:04 C*12:02 C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
1 Q20 DRB1 DRB1*04:07 DRB1*15:02 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
1 Q20 DRB3
1 Q20 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
1 Q20 DRB5 DRB5*01:02 DRB5*01:02:01G DRB5*01:02:01G
1 Q21 A A*03:01 A*25:01 A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
1 Q21 B B*18:01 B*35:01 B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
1 Q21 C C*04:01 C*12:03 C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
1 Q21 DRB1 DRB1*01:01 DRB1*01:01 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01G
1 Q21 DRB3 DRB3*02:02:01G
1 Q21 DRB4
1 Q21 DRB5
1 Q22 A A*01:01 A*01:01 A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
1 Q22 B B*08:01 B*18:01 B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
1 Q22 C C*07:01 C*07:01 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 Q22 DRB1 DRB1*03:01 DRB1*11:04 DRB1*03:01:01G DRB1*11:04:01 DRB1*03:01:01G DRB1*11:04:01G
1 Q22 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
1 Q22 DRB4
1 Q22 DRB5
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
1 Q23 A A*31:01 A*34:01 A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
1 Q23 B B*13:01 B*49:01 B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
1 Q23 C C*07:01 C*12:03 C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
1 Q23 DRB1 DRB1*01:02 DRB1*14:01 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01G
1 Q23 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
1 Q23 DRB4
1 Q23 DRB5 DRB5*01:01:01
1 Q24 A A*03:01 A*29:02 A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
1 Q24 B B*07:02 B*44:03 B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
1 Q24 C C*07:02 C*16:01 C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
1 Q24 DRB1 DRB1*14:01 DRB1*15:01 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01G DRB1*15:01:01G
1 Q24 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
1 Q24 DRB4
1 Q24 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
2 Q19 A A*11:01 A*74:01 A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
2 Q19 B B*07:02 B*53:01 B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
2 Q19 C C*04:01 C*07:02 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
2 Q19 DRB1 DRB1*04:01 DRB1*13:02 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
2 Q19 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
2 Q19 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
2 Q19 DRB5
2 Q20 A A*02:01 A*32:01 A*02:01:01G A*32:01:01G A*02:01:01G A*32:01:01G
2 Q20 B B*35:01 B*52:01 B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
2 Q20 C C*03:04 C*12:02 C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
2 Q20 DRB1 DRB1*04:07 DRB1*15:02 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
2 Q20 DRB3
2 Q20 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
2 Q20 DRB5 DRB5*01:02 DRB5*01:02:01G DRB5*01:02:01G
2 Q21 A A*03:01 A*25:01 A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
2 Q21 B B*18:01 B*35:01 B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
2 Q21 C C*04:01 C*12:03 C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
2 Q21 DRB1 DRB1*01:01 DRB1*01:01 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
2 Q21 DRB3
2 Q21 DRB4
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
2 Q21 DRB5
2 Q22 A A*01:01 A*01:01 A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
2 Q22 B B*08:01 B*18:01 B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
2 Q22 C C*07:01 C*07:01 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
2 Q22 DRB1 DRB1*03:01 DRB1*11:04 DRB1*03:01:01G DRB1*11:04:01 DRB1*03:01:01i DRB1*11:04:01i
2 Q22 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
2 Q22 DRB4
2 Q22 DRB5
2 Q23 A A*31:01 A*34:01 A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
2 Q23 B B*13:01 B*49:01 B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
2 Q23 C C*07:01 C*12:03 C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
2 Q23 DRB1 DRB1*01:02 DRB1*14:01 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
2 Q23 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
2 Q23 DRB4
2 Q23 DRB5
2 Q24 A A*03:01 A*29:02 A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
2 Q24 B B*07:02 B*44:03 B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
2 Q24 C C*07:02 C*16:01 C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
2 Q24 DRB1 DRB1*14:01 DRB1*15:01 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
2 Q24 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
2 Q24 DRB4
2 Q24 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
2 Q25 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
2 Q25 B B*15:25 B*54:01 B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
2 Q25 C C*01:02 C*04:03 C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
2 Q25 DRB1 DRB1*04:05 DRB1*11:06 DRB1*04:05:01 DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
2 Q25 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
2 Q25 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
2 Q25 DRB5
2 Q26 A A*01:01 A*29:02 A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
2 Q26 B B*44:03 B*58:01 B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
2 Q26 C C*07:01 C*16:01 C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
2 Q26 DRB1 DRB1*07:01 DRB1*11:01 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
2 Q26 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
2 Q26 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
2 Q26 DRB5
2 Q27 A A*02:02 A*30:02 A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
2 Q27 B B*15:03 B*57:02 B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
2 Q27 C C*02:10 C*18:01 C*02:10 C*18:01:01G C*02:10 C*18:01:01G
2 Q27 DRB1 DRB1*07:01 DRB1*10:01 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
2 Q27 DRB3
2 Q27 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
2 Q27 DRB5
2 Q28 A A*68:01 A*68:03 A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
2 Q28 B B*35:01 B*40:02 B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
2 Q28 C C*03:05 C*04:01 C*03:05 C*04:01:01G C*03:05 C*04:01:01G
2 Q28 DRB1 DRB1*04:07 DRB1*14:02 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
2 Q28 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
2 Q28 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
2 Q28 DRB5
2 Q29 A A*02:01 A*31:02 A*02:01:01G A*31:02 A*02:01:01G A*31:02
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
2 Q29 B B*15:15 B*51:01 B*15:15 B*51:01:01G B*15:15 B*51:01:01G
2 Q29 C C*01:02 C*15:02 C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
2 Q29 DRB1 DRB1*04:07 DRB1*08:02 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
2 Q29 DRB3
2 Q29 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
2 Q29 DRB5
2 Q30 A A*23:01 A*30:01
2 Q30 B B*49:01 B*49:01
2 Q30 C C*07:01 C*07:01
2 Q30 DRB1 DRB1*11:01 DRB1*15:01
2 Q30 DRB3 DRB3*02:02
2 Q30 DRB4
2 Q30 DRB5 DRB5*01:01
3 Q31 A A*02:01 A*32:01 A*02:01:01G A*32:01:01G A*02:01:01G A*32:01:01G
3 Q31 B B*27:05 B*73:01 B*27:05:02G B*27:05:02G B*27:05:05 B*27:85
3 Q31 C C*02:02 C*15:05 C*02:02:02G C*15:05:01G C*02:02:02G C*15:05:01G
3 Q31 DPB1 DPB1*02:01 DPB1*03:01 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
3 Q31 DRB1 DRB1*08:04 DRB1*14:02 DRB1*08:04:01 DRB1*14:02:01 DRB1*08:04:01 DRB1*14:02:01
3 Q31 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
3 Q31 DRB4
3 Q31 DRB5
3 Q32 A A*02:01 A*26:01 A*02:01:01G A*26:01:01G A*02:01:01G A*26:01:01G
3 Q32 B B*37:01 B*58:01 B*37:01:01G B*58:01:01G B*37:01:01G B*58:01:01G
3 Q32 C C*03:02 C*06:02 C*03:02:01G C*06:02:01G C*03:02:01G C*06:02:01G
3 Q32 DPB1 DPB1*02:01 DPB1*02:02 DPB1*02:01:02G DPB1*02:02 DPB1*02:01:02G DPB1*02:02
3 Q32 DRB1 DRB1*10:01 DRB1*13:02 DRB1*10:01:01 DRB1*13:02:01 DRB1*10:01:01 DRB1*13:02:01
3 Q32 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
3 Q32 DRB4
3 Q32 DRB5
3 Q33 A A*01:01 A*32:01 A*01:01:01G A*32:01:01G A*01:01:01G A*32:01:01G
3 Q33 B B*08:01 B*15:01 B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
3 Q33 C C*03:03 C*07:01 C*03:03:01G C*07:01:01G C*03:03:01G C*07:01:01G
3 Q33 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
3 Q33 DRB1 DRB1*03:01 DRB1*14:07 DRB1*03:01:01G DRB1*14:07:02 DRB1*03:01:01i DRB1*14:07:02
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
3 Q33 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
3 Q33 DRB4
3 Q33 DRB5
3 Q34 A A*01:01 A*24:02 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
3 Q34 B B*51:01 B*57:01 B*51:01:01G B*57:01:01G B*51:01:01G B*57:01:01G
3 Q34 C C*02:02 C*06:02 C*02:02:02G C*06:02:01G C*02:02:02G C*06:02:01G
3 Q34 DPB1 DPB1*02:01 DPB1*04:02 DPB1*10:01 DPB1*11:01:01 DPB1*10:01 DPB1*11:01:01
3 Q34 DRB1 DRB1*07:01 DRB1*11:01 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
3 Q34 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
3 Q34 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
3 Q34 DRB5
3 Q35 A A*03:01 A*24:02 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
3 Q35 B B*07:02 B*18:01 B*07:02:01G B*18:01:01G B*07:02:01G B*18:01:01G
3 Q35 C C*07:02 C*12:03 C*07:02:01G C*12:03:01G C*07:02:01G C*12:03:01G
3 Q35 DPB1 DPB1*04:01 DPB1*14:01 DPB1*04:01:01G DPB1*14:01 DPB1*04:01:01G DPB1*14:01
3 Q35 DRB1 DRB1*11:04 DRB1*15:01 DRB1*11:04:01 DRB1*15:01:01G DRB1*11:04:01i DRB1*15:01:01i
3 Q35 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
High confidence Medium confidence Low confidence Discordant call
continued . . .
189
B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
3 Q35 DRB4
3 Q35 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
3 Q36 A A*03:01 A*03:01 A*03:01:01G A*03:89 A*03:01:01G A*03:89
3 Q36 B B*14:02 B*35:03 B*14:02:01 B*35:03:01G B*14:02:01 B*35:03:01G
3 Q36 C C*07:02 C*08:02 C*07:02:01G C*08:02:01G C*07:02:01G C*08:02:01G
3 Q36 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
3 Q36 DRB1 DRB1*04:05 DRB1*13:02 DRB1*04:05:01 DRB1*13:02:01 DRB1*04:05:01i DRB1*13:02:01
3 Q36 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
3 Q36 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
3 Q36 DRB5
4 Q31 A A*02:01 A*32:01 A*02:01:01G A*32:01:01G A*02:01:01G A*32:01:01G
4 Q31 B B*27:05 B*73:01 B*27:05:02G B*73:01 B*27:05:05 B*27:85
4 Q31 C C*02:02 C*15:05 C*02:02:02G C*15:05:01G C*02:02:02G C*15:05:01G
4 Q31 DPB1 DPB1*02:01 DPB1*03:01 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
4 Q31 DRB1 DRB1*08:04 DRB1*14:02 DRB1*08:04:01 DRB1*14:02:01 DRB1*08:04:01 DRB1*14:02:01
4 Q31 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
4 Q31 DRB4
High confidence Medium confidence Low confidence Discordant call
continued . . .
190
B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
4 Q31 DRB5
4 Q32 A A*02:01 A*26:01
4 Q32 B B*37:01 B*58:01
4 Q32 C C*03:02 C*06:02
4 Q32 DPB1 DPB1*02:01 DPB1*02:02
4 Q32 DRB1 DRB1*10:01 DRB1*13:02
4 Q32 DRB3 DRB3*03:01
4 Q32 DRB4
4 Q32 DRB5
4 Q33 A A*01:01 A*32:01
4 Q33 B B*08:01 B*15:01
4 Q33 C C*03:03 C*07:01
4 Q33 DPB1 DPB1*02:01 DPB1*04:01
4 Q33 DRB1 DRB1*03:01 DRB1*14:07
4 Q33 DRB3 DRB3*01:01 DRB3*02:02
4 Q33 DRB4
4 Q33 DRB5
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
4 Q34 A A*01:01 A*24:02
4 Q34 B B*51:01 B*57:01
4 Q34 C C*02:02 C*06:02
4 Q34 DPB1 DPB1*02:01 DPB1*04:02
4 Q34 DRB1 DRB1*07:01 DRB1*11:01
4 Q34 DRB3 DRB3*02:02
4 Q34 DRB4 DRB4*01:01
4 Q34 DRB5
4 Q35 A A*03:01 A*24:02
4 Q35 B B*07:02 B*18:01
4 Q35 C C*07:02 C*12:03
4 Q35 DPB1 DPB1*04:01 DPB1*14:01
4 Q35 DRB1 DRB1*11:04 DRB1*15:01
4 Q35 DRB3 DRB3*02:02
4 Q35 DRB4
4 Q35 DRB5 DRB5*01:01
4 Q36 A A*03:01 A*03:01
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
4 Q36 B B*14:02 B*35:03
4 Q36 C C*07:02 C*08:02
4 Q36 DPB1 DPB1*02:01 DPB1*04:01
4 Q36 DRB1 DRB1*04:05 DRB1*13:02
4 Q36 DRB3 DRB3*03:01
4 Q36 DRB4 DRB4*01:01
4 Q36 DRB5
5 Q1 A A*24:02 A*34:01 A*24:02:01G A*34:01:01 A*24:02:01G A*34:01:01
5 Q1 B B*38:02 B*48:01 B*38:02:01G B*48:01:01G B*38:02:01G B*48:01:01G
5 Q1 C C*07:02 C*08:01 C*07:02:01G C*08:01:01G C*07:02:01G C*08:01:01G
5 Q1 DRB1 DRB1*14:06 DRB1*15:02 DRB1*14:06:01 DRB1*15:02:01 DRB1*14:06:01 DRB1*15:02:01
5 Q1 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
5 Q1 DRB4
5 Q1 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
5 Q2 A A*02:06 A*24:02 A*02:06:01G A*24:02:01G A*02:06:01G A*24:02:01G
5 Q2 B B*51:01 B*54:01 B*51:01:01G B*54:01:01G B*51:01:01G B*54:01:01G
5 Q2 C C*01:02 C*14:02 C*01:02:01G C*14:02:01G C*01:02:01G C*14:02:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q2 DRB1 DRB1*04:05 DRB1*14:03 DRB1*04:10:01G DRB1*14:03:01 DRB1*04:05:01i DRB1*14:03:01
5 Q2 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
5 Q2 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q2 DRB5
5 Q3 A A*02:01 A*02:05 A*02:01:01G A*02:05:01G A*02:01:01G A*02:05:01G
5 Q3 B B*35:02 B*51:01 B*35:02:01G B*51:01:01G B*35:02:01G B*51:01:01G
5 Q3 C C*04:01 C*14:02 C*04:01:01G C*14:02:01G C*04:01:01G C*14:02:01G
5 Q3 DRB1 DRB1*11:04 DRB1*11:04 DRB1*11:04:01 DRB1*11:04:01 DRB1*11:04:01i DRB1*11:04:01i
5 Q3 DRB3 DRB3*02:02 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
5 Q3 DRB4
5 Q3 DRB5
5 Q4 A A*30:01 A*33:03 A*30:01:01G A*33:03:01G A*30:01:01G A*33:03:01G
5 Q4 B B*42:01 B*53:01 B*42:01:01 B*53:01:01G B*42:01:01 B*53:01:01G
5 Q4 C C*04:01 C*17:01 C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
5 Q4 DRB1 DRB1*03:02 DRB1*13:02 DRB1*03:02:01 DRB1*13:02:01 DRB1*03:02:01 DRB1*13:02:01
5 Q4 DRB3 DRB3*01:01 DRB3*03:01 DRB3*01:01:02G DRB3*03:01:01G DRB3*01:01:02G DRB3*03:01:01G
5 Q4 DRB4
High confidence Medium confidence Low confidence Discordant call
continued . . .
194
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q4 DRB5
5 Q5 A A*01:02 A*68:02 A*01:02 A*68:02:01G A*01:02 A*68:02:01G
5 Q5 B B*15:10 B*58:02 B*15:10:01 B*58:02 B*15:10:01 B*58:02
5 Q5 C C*03:04 C*06:02 C*03:04:02 C*06:02:01G C*03:04:02 C*06:02:01G
5 Q5 DRB1 DRB1*03:01 DRB1*12:01 DRB1*03:01:01G DRB1*12:01:01G DRB1*03:01:01i DRB1*12:01:01G
5 Q5 DRB3 DRB3*02:02 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
5 Q5 DRB4
5 Q5 DRB5
5 Q6 A A*11:01 A*32:01 A*11:01:01G A*32:01:01G A*11:01:01G A*32:01:01G
5 Q6 B B*35:01 B*41:01 B*35:01:01G B*41:01:01 B*35:01:01G B*41:01:01
5 Q6 C C*04:01 C*07:01 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
5 Q6 DRB1 DRB1*01:01 DRB1*13:05 DRB1*01:01:01G DRB1*13:05:01 DRB1*01:01:01i DRB1*13:05:01
5 Q6 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
5 Q6 DRB4
5 Q6 DRB5
5 Q7 A A*02:06 A*11:02 A*02:06:01G A*11:02:01G A*02:06:01G A*11:02:01G
5 Q7 B B*15:11 B*27:04 B*15:11:01G B*27:04:01G B*15:11:01G B*27:04:01G
High confidence Medium confidence Low confidence Discordant call
continued . . .
195
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q7 C C*03:03 C*12:02 C*03:03:01G C*12:02:01G C*03:03:01G C*12:02:01G
5 Q7 DRB1 DRB1*04:03 DRB1*08:03 DRB1*04:03:01 DRB1*08:03:02 DRB1*04:03:01i DRB1*08:03:02
5 Q7 DRB3
5 Q7 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q7 DRB5
5 Q8 A A*34:01 A*34:01 A*34:01:01 A*34:01:01 A*34:01:01 A*34:01:01
5 Q8 B B*15:21 B*40:01 B*15:21 B*40:01:01G B*15:21 B*40:01:01G
5 Q8 C C*04:03 C*12:03 C*04:03:01 C*12:03:01G C*04:03:01 C*12:03:01G
5 Q8 DRB1 DRB1*04:05 DRB1*15:02 DRB1*04:05:01 DRB1*15:02:01 DRB1*04:05:01i DRB1*15:02:01
5 Q8 DRB3
5 Q8 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q8 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
5 Q9 A A*36:01 A*69:01 A*36:01 A*69:01 A*36:01 A*69:01
5 Q9 B B*07:02 B*55:01 B*07:02:01G B*55:01:01G B*07:02:01G B*55:01:01G
5 Q9 C C*01:02 C*07:02 C*01:02:01G C*07:02:01G C*01:02:01G C*07:02:01G
5 Q9 DRB1 DRB1*11:01 DRB1*15:03 DRB1*11:01:01G DRB1*15:03:01G DRB1*11:01:01i DRB1*15:03:01G
5 Q9 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q9 DRB4 DRB4*01:01:01G DRB4*01:03:03 DRB4*01:03:03
5 Q9 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
5 Q10 A A*02:01 A*23:01 A*02:01:01G A*23:01:01G A*02:01:01G A*23:01:01G
5 Q10 B B*14:01 B*15:01 B*14:01:01 B*15:01:01G B*14:01:01 B*15:01:01G
5 Q10 C C*03:04 C*08:02 C*03:04:01G C*08:02:01G C*03:04:01G C*08:02:01G
5 Q10 DRB1 DRB1*04:01 DRB1*13:01 DRB1*04:01:01 DRB1*13:01:01G DRB1*04:01:01 DRB1*13:01:01i
5 Q10 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
5 Q10 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q10 DRB5
5 Q11 A A*23:01 A*66:02 A*23:01:01G A*66:02 A*23:01:01G A*66:02
5 Q11 B B*42:02 B*57:03 B*42:02 B*57:03:01 B*42:02 B*57:03:01
5 Q11 C C*17:01 C*18:01 C*17:01:01G C*18:01:01G C*17:01:01G C*18:01:01G
5 Q11 DRB1 DRB1*12:01 DRB1*16:02 DRB1*12:01:01G DRB1*16:02:01 DRB1*12:01:01G DRB1*16:02:01
5 Q11 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
5 Q11 DRB4
5 Q11 DRB5 DRB5*02:02 DRB5*02:02:01G DRB5*02:02:01G
5 Q12 A A*29:02 A*68:01 A*29:02:01G A*68:01:02G A*29:02:01G A*68:01:02G
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q12 B B*44:02 B*44:03 B*44:02:01G B*44:03:01G B*44:02:01G B*44:03:01G
5 Q12 C C*07:04 C*16:01 C*07:04:01G C*16:01:01G C*07:04:01G C*16:01:01G
5 Q12 DRB1 DRB1*07:01 DRB1*13:02 DRB1*07:01:01G DRB1*13:02:01 DRB1*07:01:01G DRB1*13:02:01
5 Q12 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
5 Q12 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q12 DRB5
5 Q13 A A*03:01 A*23:01 A*03:01:01G A*23:01:01G A*03:01:01G A*23:01:01G
5 Q13 B B*27:02 B*27:02 B*27:02:01 B*27:02:01 B*27:02:01 B*27:02:01
5 Q13 C C*02:02 C*02:02 C*02:02:02G C*02:02:02G C*02:02:02G C*02:02:02G
5 Q13 DRB1 DRB1*11:04 DRB1*16:01 DRB1*11:04:01 DRB1*16:01:01 DRB1*11:04:01i DRB1*16:01:01
5 Q13 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
5 Q13 DRB4
5 Q13 DRB5 DRB5*02:02 DRB5*02:02:01G DRB5*02:02:01G
5 Q14 A A*01:01 A*03:01 A*03:01:01G A*29:32 A*03:01:01G A*29:32
5 Q14 B B*39:20 B*55:01 B*39:20 B*55:01:01G B*39:20 B*55:01:01G
5 Q14 C C*03:03 C*12:03 C*03:03:01G C*12:03:01G C*03:03:01G C*12:03:01G
5 Q14 DRB1 DRB1*08:04 DRB1*14:01 DRB1*08:04:01 DRB1*14:01:01G DRB1*08:04:01 DRB1*14:01:01i
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q14 DRB3 DRB3*02:02 DRB3*02:01:01G DRB3*02:02:01G DRB3*02:02:01G
5 Q14 DRB4
5 Q14 DRB5
5 Q15 A A*03:01 A*30:04 A*03:01:01G A*30:04:01G A*03:01:01G A*30:04:01G
5 Q15 B B*14:01 B*37:01 B*14:01:01 B*37:01:01G B*14:01:01 B*37:01:01G
5 Q15 C C*06:02 C*08:02 C*06:02:01G C*08:02:01G C*06:02:01G C*08:02:01G
5 Q15 DRB1 DRB1*03:01 DRB1*15:01 DRB1*03:01:01G DRB1*15:01:01G DRB1*03:01:01i DRB1*15:01:01i
5 Q15 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
5 Q15 DRB4
5 Q15 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
5 Q16 A A*30:02 A*34:02 A*30:02:01G A*34:02:01 A*30:02:01G A*34:02:01
5 Q16 B B*49:01 B*53:01 B*49:01:01G B*53:01:01G B*49:01:01G B*53:01:01G
5 Q16 C C*04:01 C*07:01 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
5 Q16 DRB1 DRB1*01:01 DRB1*04:05 DRB1*01:01:02 DRB1*04:05:01 DRB1*01:01:02 DRB1*04:05:01i
5 Q16 DRB3
5 Q16 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q16 DRB5 DRB5*01:01:01
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q17 A A*02:01 A*68:03 A*02:01:01G A*68:03:01 A*02:01:01G A*68:03:01
5 Q17 B B*39:05 B*51:01 B*39:05:01 B*51:01:01G B*39:05:01 B*51:01:01G
5 Q17 C C*02:02 C*07:02 C*02:02:02G C*07:02:01G C*02:02:02G C*07:02:01G
5 Q17 DRB1 DRB1*04:04 DRB1*04:07 DRB1*04:04:01 DRB1*04:07:01G DRB1*04:04:01 DRB1*04:07:01G
5 Q17 DRB3
5 Q17 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
5 Q17 DRB5
5 Q18 A A*02:01 A*29:02 A*02:01:01G A*29:02:01G A*02:01:01G A*29:02:01G
5 Q18 B B*15:30 B*44:03 B*15:30 B*44:03:01G B*15:30 B*44:03:01G
5 Q18 C C*01:02 C*04:01 C*01:02:01G C*04:01:01G C*01:02:01G C*04:01:01G
5 Q18 DRB1 DRB1*01:03 DRB1*04:03 DRB1*01:03 DRB1*04:03:01 DRB1*01:03 DRB1*04:03:01i
5 Q18 DRB3
5 Q18 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q18 DRB5
5 Q19 A A*11:01 A*74:01 A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
5 Q19 B B*07:02 B*53:01 B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
5 Q19 C C*04:01 C*07:02 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q19 DRB1 DRB1*04:01 DRB1*13:02 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
5 Q19 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
5 Q19 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q19 DRB5
5 Q20 A A*02:01 A*32:01 A*02:01:01G A*32:01:01G A*02:01:01G A*32:01:01G
5 Q20 B B*35:01 B*52:01 B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
5 Q20 C C*03:04 C*12:02 C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
5 Q20 DRB1 DRB1*04:07 DRB1*15:02 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
5 Q20 DRB3
5 Q20 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q20 DRB5 DRB5*01:02 DRB5*01:02:01G DRB5*01:02:01G
5 Q21 A A*03:01 A*25:01 A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
5 Q21 B B*18:01 B*35:01 B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
5 Q21 C C*04:01 C*12:03 C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
5 Q21 DRB1 DRB1*01:01 DRB1*01:01 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
5 Q21 DRB3
5 Q21 DRB4
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q21 DRB5
5 Q22 A A*01:01 A*01:01 A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
5 Q22 B B*08:01 B*18:01 B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
5 Q22 C C*07:01 C*07:01 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
5 Q22 DRB1 DRB1*03:01 DRB1*11:04 DRB1*03:01:01G DRB1*11:04:01 DRB1*03:01:01i DRB1*11:04:01i
5 Q22 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
5 Q22 DRB4
5 Q22 DRB5
5 Q23 A A*31:01 A*34:01 A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
5 Q23 B B*13:01 B*49:01 B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
5 Q23 C C*07:01 C*12:03 C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
5 Q23 DRB1 DRB1*01:02 DRB1*14:01 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
5 Q23 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
5 Q23 DRB4
5 Q23 DRB5
5 Q24 A A*03:01 A*29:02 A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
5 Q24 B B*07:02 B*44:03 B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q24 C C*07:02 C*16:01 C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
5 Q24 DRB1 DRB1*14:01 DRB1*15:01 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
5 Q24 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
5 Q24 DRB4
5 Q24 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
5 Q25 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
5 Q25 B B*15:25 B*54:01 B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
5 Q25 C C*01:02 C*04:03 C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
5 Q25 DRB1 DRB1*04:05 DRB1*11:06 DRB1*04:05:01 DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
5 Q25 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
5 Q25 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q25 DRB5
5 Q26 A A*01:01 A*29:02 A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
5 Q26 B B*44:03 B*58:01 B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
5 Q26 C C*07:01 C*16:01 C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
5 Q26 DRB1 DRB1*07:01 DRB1*11:01 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
5 Q26 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q26 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q26 DRB5
5 Q27 A A*02:02 A*30:02 A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
5 Q27 B B*15:03 B*57:02 B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
5 Q27 C C*02:10 C*18:01 C*02:10 C*18:01:01G C*02:10 C*18:01:01G
5 Q27 DRB1 DRB1*07:01 DRB1*10:01 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
5 Q27 DRB3
5 Q27 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q27 DRB5
5 Q28 A A*68:01 A*68:03 A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
5 Q28 B B*35:01 B*40:02 B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
5 Q28 C C*03:05 C*04:01 C*03:05 C*04:01:01G C*03:05 C*04:01:01G
5 Q28 DRB1 DRB1*04:07 DRB1*14:02 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
5 Q28 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
5 Q28 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q28 DRB5
5 Q29 A A*02:01 A*31:02 A*02:01:01G A*31:02 A*02:01:01G A*31:02
High confidence Medium confidence Low confidence Discordant call
continued . . .
204
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q29 B B*15:15 B*51:01 B*15:15 B*51:01:01G B*15:15 B*51:01:01G
5 Q29 C C*01:02 C*15:02 C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
5 Q29 DRB1 DRB1*04:07 DRB1*08:02 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
5 Q29 DRB3
5 Q29 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q29 DRB5
5 Q30 A A*23:01 A*30:01 A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
5 Q30 B B*49:01 B*49:01 B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
5 Q30 C C*07:01 C*07:01 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
5 Q30 DRB1 DRB1*11:01 DRB1*15:01 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
5 Q30 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
5 Q30 DRB4
5 Q30 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
5 Q31 A A*02:01 A*32:01 A*02:01:01G A*32:01:01G A*02:01:01G A*32:01:01G
5 Q31 B B*27:05 B*73:01 B*27:05:02G B*73:01 B*27:05:05 B*27:85
5 Q31 C C*02:02 C*15:05 C*02:02:02G C*15:05:01G C*02:02:02G C*15:05:01G
5 Q31 DRB1 DRB1*08:04 DRB1*14:02 DRB1*08:04:01 DRB1*14:02:01 DRB1*08:04:01 DRB1*14:02:01
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q31 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
5 Q31 DRB4
5 Q31 DRB5
5 Q32 A A*02:01 A*26:01 A*02:01:01G A*26:01:01G A*02:01:01G A*26:01:01G
5 Q32 B B*37:01 B*58:01 B*37:01:01G B*58:01:01G B*37:01:01G B*58:01:01G
5 Q32 C C*03:02 C*06:02 C*03:02:01G C*06:02:01G C*03:02:01G C*06:02:01G
5 Q32 DRB1 DRB1*10:01 DRB1*13:02 DRB1*10:01:01 DRB1*13:02:01 DRB1*10:01:01 DRB1*13:02:01
5 Q32 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
5 Q32 DRB4
5 Q32 DRB5
5 Q33 A A*01:01 A*32:01 A*01:01:01G A*32:01:01G A*01:01:01G A*32:01:01G
5 Q33 B B*08:01 B*15:01 B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
5 Q33 C C*03:03 C*07:01 C*03:03:01G C*07:01:01G C*03:03:01G C*07:01:01G
5 Q33 DRB1 DRB1*03:01 DRB1*14:07 DRB1*03:01:01G DRB1*14:07:02 DRB1*03:01:01i DRB1*14:07:02
5 Q33 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
5 Q33 DRB4
5 Q33 DRB5
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q34 A A*01:01 A*24:02 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
5 Q34 B B*51:01 B*57:01 B*51:01:01G B*57:01:01G B*51:01:01G B*57:01:01G
5 Q34 C C*02:02 C*06:02 C*02:02:02G C*06:02:01G C*02:02:02G C*06:02:01G
5 Q34 DRB1 DRB1*07:01 DRB1*11:01 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
5 Q34 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
5 Q34 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q34 DRB5
5 Q35 A A*03:01 A*24:02 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
5 Q35 B B*07:02 B*18:01 B*07:02:01G B*18:01:01G B*07:02:01G B*18:01:01G
5 Q35 C C*07:02 C*12:03 C*07:02:01G C*12:03:01G C*07:02:01G C*12:03:01G
5 Q35 DRB1 DRB1*11:04 DRB1*15:01 DRB1*11:04:01 DRB1*15:01:01G DRB1*11:04:01i DRB1*15:01:01i
5 Q35 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
5 Q35 DRB4
5 Q35 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
5 Q36 A A*03:01 A*03:01 A*03:01:01G A*03:01:01G A*03:01:01G A*03:01:01G
5 Q36 B B*14:02 B*35:03 B*14:02:01 B*35:03:01G B*14:02:01 B*35:03:01G
5 Q36 C C*07:02 C*08:02 C*07:02:01G C*08:02:01G C*07:02:01G C*08:02:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
5 Q36 DRB1 DRB1*04:05 DRB1*13:02 DRB1*04:05:01 DRB1*13:02:01 DRB1*04:05:01i DRB1*13:02:01
5 Q36 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
5 Q36 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
5 Q36 DRB5
6 Q1 A A*24:02 A*34:01 A*24:02:01G A*34:01:01 A*24:02:01G A*34:01:01
6 Q1 B B*38:02 B*48:01 B*38:02:01G B*48:01:01G B*38:02:01G B*48:01:01G
6 Q1 C C*07:02 C*08:01 C*07:02:01G C*08:01:01G C*07:02:01G C*08:01:01G
6 Q1 DRB1 DRB1*14:06 DRB1*15:02 DRB1*14:06:01 DRB1*15:02:01 DRB1*14:06:01 DRB1*15:02:01
6 Q1 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
6 Q1 DRB4
6 Q1 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
6 Q2 A A*02:06 A*24:02 A*02:06:01G A*24:02:01G A*02:06:01G A*24:02:01G
6 Q2 B B*51:01 B*54:01 B*51:01:01G B*54:01:01G B*51:01:01G B*54:01:01G
6 Q2 C C*01:02 C*14:02 C*01:02:01G C*14:02:01G C*01:02:01G C*14:02:01G
6 Q2 DRB1 DRB1*04:05 DRB1*14:03 DRB1*04:05:01 DRB1*14:03:01 DRB1*04:05:01i DRB1*04:05:01i
6 Q2 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
6 Q2 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q2 DRB5
6 Q3 A A*02:01 A*02:05 A*02:01:01G A*02:05:01G A*02:01:01G A*02:05:01G
6 Q3 B B*35:02 B*51:01 B*35:02:01G B*51:01:01G B*35:02:01G B*51:01:01G
6 Q3 C C*04:01 C*14:02 C*04:01:01G C*14:02:01G C*04:01:01G C*14:02:01G
6 Q3 DRB1 DRB1*11:04 DRB1*11:04 DRB1*11:04:01 DRB1*11:04:01 DRB1*11:04:01i DRB1*11:04:01i
6 Q3 DRB3 DRB3*02:02 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
6 Q3 DRB4
6 Q3 DRB5
6 Q4 A A*30:01 A*33:03 A*30:01:01G A*33:03:01G A*30:01:01G A*33:03:01G
6 Q4 B B*42:01 B*53:01 B*42:01:01 B*53:01:01G B*42:01:01 B*53:01:01G
6 Q4 C C*04:01 C*17:01 C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
6 Q4 DRB1 DRB1*03:02 DRB1*13:02 DRB1*03:02:01 DRB1*13:02:01 DRB1*03:02:01 DRB1*13:02:01
6 Q4 DRB3 DRB3*01:01 DRB3*03:01 DRB3*01:01:02G DRB3*03:01:01G DRB3*01:01:02G DRB3*03:01:01G
6 Q4 DRB4
6 Q4 DRB5
6 Q5 A A*01:02 A*68:02 A*01:02 A*68:02:01G A*01:02 A*68:02:01G
6 Q5 B B*15:10 B*58:02 B*15:10:01 B*58:02 B*15:10:01 B*58:02
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q5 C C*03:04 C*06:02 C*03:04:02 C*06:02:01G C*03:04:02 C*06:02:01G
6 Q5 DRB1 DRB1*03:01 DRB1*12:01 DRB1*03:01:01G DRB1*12:01:01G DRB1*03:01:01i DRB1*12:01:01G
6 Q5 DRB3 DRB3*02:02 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
6 Q5 DRB4
6 Q5 DRB5
6 Q6 A A*11:01 A*32:01 A*11:01:01G A*32:01:01G A*11:01:01G A*32:01:01G
6 Q6 B B*35:01 B*41:01 B*35:01:01G B*41:01:01 B*35:01:01G B*41:01:01
6 Q6 C C*04:01 C*07:01 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
6 Q6 DRB1 DRB1*01:01 DRB1*13:05 DRB1*01:01:01G DRB1*13:05:01 DRB1*01:01:01i DRB1*13:05:01
6 Q6 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q6 DRB4
6 Q6 DRB5
6 Q7 A A*02:06 A*11:02 A*02:06:01G A*11:02:01G A*02:06:01G A*11:02:01G
6 Q7 B B*15:11 B*27:04 B*15:11:01G B*27:04:01G B*15:11:01G B*27:04:01G
6 Q7 C C*03:03 C*12:02 C*03:03:01G C*12:02:01G C*03:03:01G C*12:02:01G
6 Q7 DRB1 DRB1*04:03 DRB1*08:03 DRB1*04:03:01 DRB1*08:03:02 DRB1*04:03:01i DRB1*08:03:02
6 Q7 DRB3
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q7 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q7 DRB5
6 Q8 A A*34:01 A*34:01 A*34:01:01 A*34:01:01 A*34:01:01 A*34:01:01
6 Q8 B B*15:21 B*40:01 B*15:21 B*40:01:01G B*15:21 B*40:01:01G
6 Q8 C C*04:03 C*12:03 C*04:03:01 C*12:03:01G C*04:03:01 C*12:03:01G
6 Q8 DRB1 DRB1*04:05 DRB1*15:02 DRB1*04:05:01 DRB1*15:02:01 DRB1*04:05:01i DRB1*15:02:01
6 Q8 DRB3
6 Q8 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q8 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
6 Q9 A A*36:01 A*69:01 A*36:01 A*69:01 A*36:01 A*69:01
6 Q9 B B*07:02 B*55:01 B*07:02:01G B*55:01:01G B*07:02:01G B*55:01:01G
6 Q9 C C*01:02 C*07:02 C*01:02:01G C*07:02:01G C*01:02:01G C*07:02:01G
6 Q9 DRB1 DRB1*11:01 DRB1*15:03 DRB1*11:01:01G DRB1*15:03:01G DRB1*11:01:01i DRB1*15:03:01G
6 Q9 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q9 DRB4
6 Q9 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
6 Q10 A A*02:01 A*23:01 A*02:01:01G A*23:01:01G A*02:01:01G A*23:01:01G
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q10 B B*14:01 B*15:01 B*14:01:01 B*15:01:01G B*14:01:01 B*15:01:01G
6 Q10 C C*03:04 C*08:02 C*03:04:01G C*08:02:01G C*03:04:01G C*08:02:01G
6 Q10 DRB1 DRB1*04:01 DRB1*13:01 DRB1*04:01:01 DRB1*13:01:01G DRB1*04:01:01 DRB1*13:01:01i
6 Q10 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q10 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q10 DRB5
6 Q11 A A*23:01 A*66:02 A*23:01:01G A*66:02 A*23:01:01G A*66:02
6 Q11 B B*42:02 B*57:03 B*42:02 B*57:03:01 B*42:02 B*57:03:01
6 Q11 C C*17:01 C*18:01 C*17:01:01G C*18:01:01G C*17:01:01G C*18:01:01G
6 Q11 DRB1 DRB1*12:01 DRB1*16:02 DRB1*12:01:01G DRB1*16:02:01 DRB1*12:01:01G DRB1*16:02:01
6 Q11 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
6 Q11 DRB4
6 Q11 DRB5 DRB5*02:02 DRB5*02:02:01G DRB5*02:02:01G
6 Q12 A A*29:02 A*68:01 A*29:02:01G A*68:01:02G A*29:02:01G A*68:01:02G
6 Q12 B B*44:02 B*44:03 B*44:02:01G B*44:03:01G B*44:02:01G B*44:03:01G
6 Q12 C C*07:04 C*16:01 C*07:04:01G C*16:01:01G C*07:04:01G C*16:01:01G
6 Q12 DRB1 DRB1*07:01 DRB1*13:02 DRB1*07:01:01G DRB1*13:02:01 DRB1*07:01:01G DRB1*13:02:01
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q12 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
6 Q12 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q12 DRB5
6 Q13 A A*03:01 A*23:01 A*03:01:01G A*23:01:01G A*03:01:01G A*23:01:01G
6 Q13 B B*27:02 B*27:02 B*27:02:01 B*27:02:01 B*27:02:01 B*27:02:01
6 Q13 C C*02:02 C*02:02 C*02:02:02G C*02:02:02G C*02:02:02G C*02:02:02G
6 Q13 DRB1 DRB1*11:04 DRB1*16:01 DRB1*11:04:01 DRB1*16:01:01 DRB1*11:04:01i DRB1*11:04:01i
6 Q13 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q13 DRB4
6 Q13 DRB5 DRB5*02:02 DRB5*02:02:01G DRB5*02:02:01G
6 Q14 A A*01:01 A*03:01 A*03:01:01G A*29:32 A*03:01:01G A*29:32
6 Q14 B B*39:20 B*55:01 B*39:20 B*55:01:01G B*39:20 B*55:01:01G
6 Q14 C C*03:03 C*12:03 C*03:03:01G C*12:03:01G C*03:03:01G C*12:03:01G
6 Q14 DRB1 DRB1*08:04 DRB1*14:01 DRB1*08:04:01 DRB1*14:01:01G DRB1*08:04:01 DRB1*14:01:01i
6 Q14 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q14 DRB4
6 Q14 DRB5
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q15 A A*03:01 A*30:04 A*03:01:01G A*30:04:01G A*03:01:01G A*30:04:01G
6 Q15 B B*14:01 B*37:01 B*14:01:01 B*37:01:01G B*14:01:01 B*37:01:01G
6 Q15 C C*06:02 C*08:02 C*06:02:01G C*08:02:01G C*06:02:01G C*08:02:01G
6 Q15 DRB1 DRB1*03:01 DRB1*15:01 DRB1*03:01:01G DRB1*15:01:01G DRB1*03:01:01i DRB1*15:01:01i
6 Q15 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
6 Q15 DRB4
6 Q15 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
6 Q16 A A*30:02 A*34:02 A*30:02:01G A*34:02:01 A*30:02:01G A*34:02:01
6 Q16 B B*49:01 B*53:01 B*49:01:01G B*53:01:01G B*49:01:01G B*53:01:01G
6 Q16 C C*04:01 C*07:01 C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
6 Q16 DRB1 DRB1*01:01 DRB1*04:05 DRB1*01:01:02 DRB1*04:05:01 DRB1*01:01:02 DRB1*04:05:01i
6 Q16 DRB3
6 Q16 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q16 DRB5
6 Q17 A A*02:01 A*68:03 A*02:01:01G A*68:03:01 A*02:01:01G A*68:03:01
6 Q17 B B*39:05 B*51:01 B*39:05:01 B*51:01:01G B*39:05:01 B*51:01:01G
6 Q17 C C*02:02 C*07:02 C*02:02:02G C*07:02:01G C*02:02:02G C*07:02:01G
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q17 DRB1 DRB1*04:04 DRB1*04:07 DRB1*04:04:01 DRB1*04:07:01G DRB1*04:04:01 DRB1*04:07:01G
6 Q17 DRB3
6 Q17 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
6 Q17 DRB5
6 Q18 A A*02:01 A*29:02 A*02:01:01G A*29:02:01G A*02:01:01G A*29:02:01G
6 Q18 B B*15:30 B*44:03 B*15:30 B*44:03:01G B*15:30 B*44:03:01G
6 Q18 C C*01:02 C*04:01 C*01:02:01G C*04:01:01G C*01:02:01G C*04:01:01G
6 Q18 DRB1 DRB1*01:03 DRB1*04:03 DRB1*01:03 DRB1*04:03:01 DRB1*01:03 DRB1*04:03:01i
6 Q18 DRB3
6 Q18 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q18 DRB5
6 Q19 A A*11:01 A*74:01 A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
6 Q19 B B*07:02 B*53:01 B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
6 Q19 C C*04:01 C*07:02 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
6 Q19 DRB1 DRB1*04:01 DRB1*13:02 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
6 Q19 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
6 Q19 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q19 DRB5
6 Q20 A A*02:01 A*32:01 A*02:01:01G A*32:01:01G A*02:01:01G A*32:01:01G
6 Q20 B B*35:01 B*52:01 B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
6 Q20 C C*03:04 C*12:02 C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
6 Q20 DRB1 DRB1*04:07 DRB1*15:02 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
6 Q20 DRB3
6 Q20 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q20 DRB5 DRB5*01:02 DRB5*01:02:01G DRB5*01:02:01G
6 Q21 A A*03:01 A*25:01 A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
6 Q21 B B*18:01 B*35:01 B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
6 Q21 C C*04:01 C*12:03 C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G




6 Q22 A A*01:01 A*01:01 A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
6 Q22 B B*08:01 B*18:01 B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q22 C C*07:01 C*07:01 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
6 Q22 DRB1 DRB1*03:01 DRB1*11:04 DRB1*03:01:01G DRB1*11:04:01 DRB1*03:01:01i DRB1*11:04:01i
6 Q22 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
6 Q22 DRB4
6 Q22 DRB5
6 Q23 A A*31:01 A*34:01 A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
6 Q23 B B*13:01 B*49:01 B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
6 Q23 C C*07:01 C*12:03 C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
6 Q23 DRB1 DRB1*01:02 DRB1*14:01 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
6 Q23 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q23 DRB4
6 Q23 DRB5
6 Q24 A A*03:01 A*29:02 A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
6 Q24 B B*07:02 B*44:03 B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
6 Q24 C C*07:02 C*16:01 C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
6 Q24 DRB1 DRB1*14:01 DRB1*15:01 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
6 Q24 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q24 DRB4
6 Q24 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
6 Q25 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
6 Q25 B B*15:25 B*54:01 B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
6 Q25 C C*01:02 C*04:03 C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
6 Q25 DRB1 DRB1*04:05 DRB1*11:06 DRB1*04:05:01 DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
6 Q25 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q25 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q25 DRB5
6 Q26 A A*01:01 A*29:02 A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
6 Q26 B B*44:03 B*58:01 B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
6 Q26 C C*07:01 C*16:01 C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
6 Q26 DRB1 DRB1*07:01 DRB1*11:01 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
6 Q26 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q26 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q26 DRB5
6 Q27 A A*02:02 A*30:02 A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q27 B B*15:03 B*57:02 B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
6 Q27 C C*02:10 C*18:01 C*02:10 C*18:01:01G C*02:10 C*18:01:01G
6 Q27 DRB1 DRB1*07:01 DRB1*10:01 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
6 Q27 DRB3
6 Q27 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q27 DRB5
6 Q28 A A*68:01 A*68:03 A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
6 Q28 B B*35:01 B*40:02 B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
6 Q28 C C*03:05 C*04:01 C*03:05 C*04:01:01G C*03:05 C*04:01:01G
6 Q28 DRB1 DRB1*04:07 DRB1*14:02 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
6 Q28 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
6 Q28 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q28 DRB5
6 Q29 A A*02:01 A*31:02 A*02:01:01G A*31:02 A*02:01:01G A*31:02
6 Q29 B B*15:15 B*51:01 B*15:15 B*51:01:01G B*15:15 B*51:01:01G
6 Q29 C C*01:02 C*15:02 C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
6 Q29 DRB1 DRB1*04:07 DRB1*08:02 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q29 DRB3
6 Q29 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q29 DRB5
6 Q30 A A*23:01 A*30:01 A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
6 Q30 B B*49:01 B*49:01 B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
6 Q30 C C*07:01 C*07:01 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
6 Q30 DRB1 DRB1*11:01 DRB1*15:01 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
6 Q30 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q30 DRB4
6 Q30 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
6 Q31 A A*02:01 A*32:01 A*02:01:01G A*32:01:01G A*02:01:01G A*32:01:01G
6 Q31 B B*27:05 B*73:01 B*27:05:02G B*73:01 B*27:05:02G B*73:01
6 Q31 C C*02:02 C*15:05 C*02:02:02G C*15:05:01G C*02:02:02G C*15:05:01G
6 Q31 DRB1 DRB1*08:04 DRB1*14:02 DRB1*08:04:01 DRB1*14:02:01 DRB1*08:04:01 DRB1*14:02:01
6 Q31 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
6 Q31 DRB4
6 Q31 DRB5
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q32 A A*02:01 A*26:01 A*02:01:01G A*26:01:01G A*02:01:01G A*26:01:01G
6 Q32 B B*37:01 B*58:01 B*37:01:01G B*58:01:01G B*37:01:01G B*58:01:01G
6 Q32 C C*03:02 C*06:02 C*03:02:01G C*06:02:01G C*03:02:01G C*06:02:01G
6 Q32 DRB1 DRB1*10:01 DRB1*13:02 DRB1*10:01:01 DRB1*13:02:01 DRB1*10:01:01 DRB1*13:02:01
6 Q32 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
6 Q32 DRB4
6 Q32 DRB5
6 Q33 A A*01:01 A*32:01 A*01:01:01G A*32:01:01G A*01:01:01G A*32:01:01G
6 Q33 B B*08:01 B*15:01 B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
6 Q33 C C*03:03 C*07:01 C*03:03:01G C*07:01:01G C*03:03:01G C*07:01:01G
6 Q33 DRB1 DRB1*03:01 DRB1*14:07 DRB1*03:01:01G DRB1*14:07:02 DRB1*03:01:01i DRB1*14:07:02
6 Q33 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
6 Q33 DRB4
6 Q33 DRB5
6 Q34 A A*01:01 A*24:02 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
6 Q34 B B*51:01 B*57:01 B*51:01:01G B*57:01:01G B*51:01:01G B*57:01:01G
6 Q34 C C*02:02 C*06:02 C*02:02:02G C*06:02:01G C*02:02:02G C*06:02:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q34 DRB1 DRB1*07:01 DRB1*11:01 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
6 Q34 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q34 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
6 Q34 DRB5
6 Q35 A A*03:01 A*24:02 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
6 Q35 B B*07:02 B*18:01 B*07:02:01G B*18:01:01G B*07:02:01G B*18:01:01G
6 Q35 C C*07:02 C*12:03 C*07:02:01G C*12:03:01G C*07:02:01G C*12:03:01G
6 Q35 DRB1 DRB1*11:04 DRB1*15:01 DRB1*11:04:01 DRB1*15:01:01G DRB1*11:04:01i DRB1*15:01:01i
6 Q35 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
6 Q35 DRB4
6 Q35 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
6 Q36 A A*03:01 A*03:01 A*03:01:01G A*03:01:01G A*03:01:01G A*03:01:01G
6 Q36 B B*14:02 B*35:03 B*14:02:01 B*35:03:01G B*14:02:01 B*35:03:01G
6 Q36 C C*07:02 C*08:02 C*07:02:01G C*08:02:01G C*07:02:01G C*08:02:01G
6 Q36 DRB1 DRB1*04:05 DRB1*13:02 DRB1*04:05:01 DRB1*13:02:01 DRB1*04:05:01i DRB1*13:02:01
6 Q36 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
6 Q36 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
6 Q36 DRB5
7 Q37 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
7 Q37 B B*15:21 B*15:35 B*15:21 B*15:35 B*15:21 B*15:35
7 Q37 C C*04:03 C*07:02 C*04:03:01 C*07:02:01G C*04:03:01 C*07:02:01G
7 Q37 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
7 Q37 DQB1 DQB1*05:02 DQB1*06:01 DQB1*05:02:01i DQB1*06:01:01i DQB1*05:02:01i DQB1*06:01:01i
7 Q37 DRB1 DRB1*08:03 DRB1*15:02 DRB1*08:03:02 DRB1*15:02:01 DRB1*08:03:02 DRB1*15:02:01
7 Q37 DRB3
7 Q37 DRB4
7 Q37 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
7 Q38 A A*02:01 A*30:01 A*02:01:01G A*30:01:01G A*02:01:01G A*30:01:01G
7 Q38 B B*15:03 B*42:01 B*15:03:01G B*42:01:01 B*15:03:01G B*42:01:01
7 Q38 C C*02:10 C*17:01 C*02:10 C*17:01:01G C*02:10 C*17:01:01G
7 Q38 DPB1 DPB1*01:01 DPB1*04:01 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
7 Q38 DQB1 DQB1*04:02 DQB1*06:02 DQB1*04:02:01i DQB1*06:02:01i DQB1*04:02:01i DQB1*06:02:01i
7 Q38 DRB1 DRB1*03:02 DRB1*15:03 DRB1*03:02:01 DRB1*15:03:01G DRB1*03:02:01 DRB1*15:03:01G
7 Q38 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
7 Q38 DRB4
7 Q38 DRB5
7 Q39 A A*02:01 A*02:01 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
7 Q39 B B*44:02 B*57:03 B*44:02:01G B*57:03:01 B*44:02:01G B*57:03:01
7 Q39 C C*05:01 C*07:01 C*05:01:01G C*07:01:01G C*05:01:01G C*07:01:01G
7 Q39 DPB1 DPB1*01:01 DPB1*17:01 DPB1*01:01:01 DPB1*17:01:01G DPB1*01:01:01 DPB1*17:01:01G
7 Q39 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i
7 Q39 DRB1 DRB1*04:01 DRB1*13:03 DRB1*04:01:01 DRB1*13:03:01 DRB1*04:01:01 DRB1*13:03:01
7 Q39 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
7 Q39 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
7 Q39 DRB5
7 Q40 A A*11:02 A*26:01 A*11:02:01G A*26:01:01G A*11:02:01G A*26:01:01G
7 Q40 B B*15:02 B*27:04 B*15:02:01G B*27:04:01G B*15:02:01G B*27:04:01G
7 Q40 C C*08:01 C*12:02 C*08:01:01G C*12:02:01G C*08:01:01G C*12:02:01G
7 Q40 DPB1 DPB1*02:01 DPB1*19:01 DPB1*02:01:02G DPB1*19:01:01G DPB1*02:01:02G DPB1*19:01:01G
7 Q40 DQB1 DQB1*03:01 DQB1*05:02 DQB1*03:01:01i DQB1*05:02:01i DQB1*03:01:01i DQB1*05:02:01i
7 Q40 DRB1 DRB1*12:02 DRB1*15:01 DRB1*12:02:01 DRB1*15:01:01G DRB1*12:02:01 DRB1*15:01:01i
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
7 Q40 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
7 Q40 DRB4
7 Q40 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
7 Q41 A A*01:01 A*30:02 A*01:01:01G A*30:02:01G A*01:01:01G A*30:02:01G
7 Q41 B B*08:01 B*15:03 B*08:01:01G B*15:03:01G B*08:01:01G B*15:03:01G
7 Q41 C C*02:10 C*07:01 C*02:10 C*07:01:01G C*02:10 C*07:01:01G
7 Q41 DPB1 DPB1*01:01 DPB1*02:02 DPB1*01:01:01 DPB1*02:02 DPB1*01:01:01 DPB1*02:02
7 Q41 DQB1 DQB1*02:01 DQB1*02:02 DQB1*02:01:01i DQB1*02:02:01i DQB1*02:01:01i DQB1*02:02:01i
7 Q41 DRB1 DRB1*03:01 DRB1*07:01 DRB1*03:01:01G DRB1*07:01:01G DRB1*03:01:01i DRB1*07:01:01G
7 Q41 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
7 Q41 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
7 Q41 DRB5
7 Q42 A A*24:02 A*31:01 A*24:02:01G A*31:01:02G A*24:02:01G A*31:01:02G
7 Q42 B B*38:01 B*51:01 B*38:01:01 B*51:01:01G B*38:01:01 B*51:01:01G
7 Q42 C C*12:03 C*14:02 C*12:03:01G C*14:02:01G C*12:03:01G C*14:02:01G
7 Q42 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
7 Q42 DQB1 DQB1*03:01 DQB1*03:03 DQB1*03:01:01i DQB1*03:03:02i DQB1*03:01:01i DQB1*03:03:02i
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
7 Q42 DRB1 DRB1*04:01 DRB1*09:01 DRB1*04:01:01 DRB1*09:01:02G DRB1*04:01:01 DRB1*09:01:02G
7 Q42 DRB3
7 Q42 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
7 Q42 DRB5
7 Q43 A A*03:01 A*03:01 A*03:01:01G A*03:01:01G A*03:136 A*03:189
7 Q43 B B*07:02 B*41:02 B*07:02:01G B*41:02:01 B*07:02:01G B*41:02:01
7 Q43 C C*07:02 C*17:01 C*07:02:01G C*17:01:01G C*07:02:01G C*17:01:01G
7 Q43 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
7 Q43 DQB1 DQB1*03:01 DQB1*06:04 DQB1*03:01:01i DQB1*06:04:01i DQB1*03:01:01i DQB1*06:04:01i
7 Q43 DRB1 DRB1*13:02 DRB1*13:03 DRB1*13:02:01 DRB1*13:03:01 DRB1*13:02:01 DRB1*13:03:01
7 Q43 DRB3 DRB3*01:01 DRB3*03:01 DRB3*01:01:02G DRB3*03:01:01G DRB3*01:01:02G DRB3*03:01:01G
7 Q43 DRB4
7 Q43 DRB5
7 Q44 A A*03:01 A*32:01 A*03:01:01G A*32:01:01G A*03:01:01G A*32:01:01G
7 Q44 B B*37:01 B*57:01 B*37:01:01G B*57:01:01G B*37:01:01G B*57:01:01G
7 Q44 C C*06:02 C*06:02 C*06:02:01G C*06:02:01G C*06:02:01G C*06:02:01G
7 Q44 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
7 Q44 DQB1 DQB1*02:02 DQB1*05:01 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
7 Q44 DRB1 DRB1*07:01 DRB1*10:01 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
7 Q44 DRB3
7 Q44 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
7 Q44 DRB5
7 Q45 A A*24:02 A*33:01 A*24:02:01G A*33:01:01 A*24:02:01G A*33:01:01
7 Q45 B B*14:02 B*35:01 B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
7 Q45 C C*04:01 C*08:02 C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
7 Q45 DPB1 DPB1*04:02 DPB1*04:01 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
7 Q45 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i
7 Q45 DRB1 DRB1*11:01 DRB1*14:02 DRB1*11:01:01G DRB1*14:02:01 DRB1*11:01:01i DRB1*14:02:01
7 Q45 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
7 Q45 DRB4
7 Q45 DRB5
7 Q46 A A*02:01 A*33:03 A*02:01:01G A*33:03:01G A*02:01:01G A*33:03:01G
7 Q46 B B*44:03 B*57:01 B*44:03:02 B*57:01:01G B*44:03:02 B*57:01:01G
7 Q46 C C*07:01 C*07:01 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
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7 Q46 DPB1 DPB1*04:01 DPB1*03:01 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
7 Q46 DQB1 DQB1*02:02 DQB1*03:03 DQB1*02:02:01i DQB1*03:03:02i DQB1*02:02:01i DQB1*03:03:02i
7 Q46 DRB1 DRB1*07:01 DRB1*07:01 DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G
7 Q46 DRB3
7 Q46 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
7 Q46 DRB5
7 Q47 A A*02:01 A*03:01 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
7 Q47 B B*35:01 B*44:02 B*35:01:01G B*44:02:01G B*35:01:01G B*44:02:01G
7 Q47 C C*04:01 C*05:01 C*04:01:01G C*05:01:01G C*04:01:01G C*05:01:01G
7 Q47 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
7 Q47 DQB1 DQB1*02:01 DQB1*03:01 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
7 Q47 DRB1 DRB1*03:01 DRB1*04:01 DRB1*04:01:01 DRB1*04:01:01 DRB1*03:01:01i DRB1*04:01:01
7 Q47 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
7 Q47 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
7 Q47 DRB5
7 Q48 A A*02:01 A*24:02 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
7 Q48 B B*15:03 B*51:02 B*15:03:01G B*51:02:01 B*15:03:01G B*51:02:01
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
7 Q48 C C*02:10 C*08:01 C*02:10 C*08:01:01G C*02:10 C*08:01:01G
7 Q48 DPB1 DPB1*01:01 DPB1*04:01 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
7 Q48 DQB1 DQB1*03:01 DQB1*05:01 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
7 Q48 DRB1 DRB1*01:02 DRB1*14:02 DRB1*01:02:01 DRB1*14:02:01 DRB1*01:02:01 DRB1*14:02:01
7 Q48 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
7 Q48 DRB4
7 Q48 DRB5
7 Q49 A A*02:01 A*02:06 A*02:01:01G A*02:06:01G A*02:01:01G A*02:06:01G
7 Q49 B B*07:02 B*40:02 B*07:02:01G B*40:02:01G B*07:02:01G B*40:02:01G
7 Q49 C C*03:08 C*07:02 C*03:08 C*07:02:01G C*03:08 C*07:02:01G
7 Q49 DPB1 DPB1*04:01 DPB1*04:02 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
7 Q49 DQB1 DQB1*03:02 DQB1*06:02 DQB1*03:02:01i DQB1*06:02:01i DQB1*03:02:01i DQB1*06:02:01i
7 Q49 DRB1 DRB1*04:11 DRB1*15:01 DRB1*04:11:01 DRB1*15:01:01G DRB1*04:11:01 DRB1*15:01:01i
7 Q49 DRB3
7 Q49 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
7 Q49 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
7 Q50 A A*01:01 A*02:01 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
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7 Q50 B B*35:01 B*37:01 B*35:01:01G B*37:01:01G B*35:01:01G B*37:01:01G
7 Q50 C C*04:01 C*06:02 C*04:01:01G C*06:02:01G C*04:01:01G C*06:02:01G
7 Q50 DPB1 DPB1*02:01 DPB1*13:01 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
7 Q50 DQB1 DQB1*05:01 DQB1*06:02 DQB1*05:01:01i DQB1*06:02:01i DQB1*05:01:01i DQB1*06:02:01i
7 Q50 DRB1 DRB1*10:01 DRB1*15:03 DRB1*10:01:01 DRB1*15:03:01G DRB1*10:01:01 DRB1*15:03:01G
7 Q50 DRB3
7 Q50 DRB4
7 Q50 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
7 Q51 A A*02:05 A*02:05 A*02:05:01G A*02:05:01G A*02:05:01G A*02:05:01G
7 Q51 B B*50:01 B*50:01 B*50:01:01G B*50:01:01G B*50:01:01G B*50:01:01G
7 Q51 C C*06:02 C*06:02 C*06:02:01G C*06:02:01G C*06:02:01G C*06:02:01G
7 Q51 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
7 Q51 DQB1 DQB1*02:02 DQB1*02:02 DQB1*02:02:01i DQB1*02:02:01i DQB1*02:02:01i DQB1*02:02:01i
7 Q51 DRB1 DRB1*07:01 DRB1*07:01 DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G
7 Q51 DRB3
7 Q51 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
7 Q51 DRB5
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
7 Q52 A A*31:01 A*33:03 A*31:01:02G A*33:03:01G A*31:01:02G A*33:03:01G
7 Q52 B B*40:02 B*58:01 B*40:02:01G B*58:01:01G B*40:02:01G B*58:01:01G
7 Q52 C C*03:02 C*03:04 C*03:02:01G C*03:04:01G C*03:02:01G C*03:04:01G
7 Q52 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
7 Q52 DQB1 DQB1*03:01 DQB1*06:09 DQB1*03:01:01i DQB1*06:09:01 DQB1*03:01:01i DQB1*06:09:01
7 Q52 DRB1 DRB1*11:01 DRB1*13:02 DRB1*11:01:01G DRB1*13:02:01 DRB1*11:01:01i DRB1*13:02:01
7 Q52 DRB3 DRB3*02:02 DRB3*03:01 DRB3*02:02:01G DRB3*03:01:01G DRB3*02:02:01G DRB3*03:01:01G
7 Q52 DRB4
7 Q52 DRB5
7 Q53 A A*02:07 A*33:03 A*02:07:01G A*33:03:01G A*02:07:01G A*33:03:01G
7 Q53 B B*46:01 B*58:01 B*46:01:01G B*58:01:01G B*46:01:01G B*58:01:01G
7 Q53 C C*01:02 C*03:02 C*01:02:01G C*03:02:01G C*01:02:01G C*03:02:01G
7 Q53 DPB1 DPB1*01:01 DPB1*04:02 DPB1*01:01:01 DPB1*04:02:01G DPB1*01:01:01 DPB1*04:02:01G
7 Q53 DQB1 DQB1*02:01 DQB1*04:01 DQB1*02:01:01i DQB1*04:01:01 DQB1*02:01:01i DQB1*04:01:01
7 Q53 DRB1 DRB1*03:01 DRB1*04:05 DRB1*03:01:01G DRB1*04:05:01 DRB1*03:01:01i DRB1*04:05:01i
7 Q53 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
7 Q53 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
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7 Q53 DRB5
7 Q54 A A*01:01 A*24:02 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
7 Q54 B B*08:01 B*40:01 B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
7 Q54 C C*03:04 C*07:01 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
7 Q54 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
7 Q54 DQB1 DQB1*02:01 DQB1*03:01 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
7 Q54 DRB1 DRB1*03:01 DRB1*12:01 DRB1*03:01:01G DRB1*12:01:01G DRB1*03:01:01i DRB1*12:01:01G
7 Q54 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
7 Q54 DRB4
7 Q54 DRB5
8 Q37 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
8 Q37 B B*15:21 B*15:35 B*15:21 B*15:35 B*15:21 B*15:35
8 Q37 C C*04:03 C*07:02 C*04:03:01 C*07:02:01G C*04:03:01 C*07:02:01G
8 Q37 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
8 Q37 DQB1 DQB1*05:02 DQB1*06:01 DQB1*05:02:01i DQB1*06:01:01i DQB1*05:02:01i DQB1*06:01:01i
8 Q37 DRB1 DRB1*08:03 DRB1*15:02 DRB1*15:02:01 DRB1*15:02:01 DRB1*08:03:02 DRB1*15:02:01
8 Q37 DRB3
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8 Q37 DRB4
8 Q37 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01 DRB5*01:01:01
8 Q38 A A*02:01 A*30:01 A*02:01:01G A*02:01:01G A*02:01:01G A*30:01:01G
8 Q38 B B*15:03 B*42:01 B*15:03:01G B*42:01:01 B*15:03:01G B*42:01:01
8 Q38 C C*02:10 C*17:01 C*02:10 C*17:01:01G C*02:10 C*17:01:01G
8 Q38 DPB1 DPB1*01:01 DPB1*04:01 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
8 Q38 DQB1 DQB1*04:02 DQB1*06:02 DQB1*04:02:01i DQB1*06:02:01i DQB1*04:02:01i DQB1*06:02:01i
8 Q38 DRB1 DRB1*03:02 DRB1*15:03 DRB1*03:02:01 DRB1*15:03:01G DRB1*03:02:01 DRB1*15:03:01G
8 Q38 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
8 Q38 DRB4
8 Q38 DRB5
8 Q39 A A*02:01 A*02:01 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
8 Q39 B B*44:02 B*57:03 B*44:02:01G B*57:03:01 B*44:02:01G B*57:03:01
8 Q39 C C*05:01 C*07:01 C*05:01:01G C*07:01:01G C*05:01:01G C*07:01:01G
8 Q39 DPB1 DPB1*01:01 DPB1*17:01 DPB1*01:01:01 DPB1*17:01:01G DPB1*01:01:01 DPB1*17:01:01G
8 Q39 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:116i DQB1*03:116i
8 Q39 DRB1 DRB1*04:01 DRB1*13:03 DRB1*04:01:01 DRB1*04:01:01 DRB1*04:01:01 DRB1*04:01:01
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8 Q39 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
8 Q39 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
8 Q39 DRB5
8 Q40 A A*11:02 A*26:01 A*11:02:01G A*26:01:01G A*11:02:01G A*26:01:01G
8 Q40 B B*15:02 B*27:04 B*15:02:01G B*27:04:01G B*15:02:01G B*27:04:01G
8 Q40 C C*08:01 C*12:02 C*08:01:01G C*12:02:01G C*08:01:01G C*12:02:01G
8 Q40 DPB1 DPB1*02:01 DPB1*19:01 DPB1*02:01:02G DPB1*19:01:01G DPB1*02:01:02G DPB1*19:01:01G
8 Q40 DQB1 DQB1*03:01 DQB1*05:02 DQB1*03:01:01i DQB1*05:02:01i DQB1*03:116i DQB1*05:02:01i
8 Q40 DRB1 DRB1*12:02 DRB1*15:01 DRB1*12:02:01 DRB1*12:02:01 DRB1*12:02:01 DRB1*12:12
8 Q40 DRB3 DRB3*02:02 DRB3*02:02:01G
8 Q40 DRB4
8 Q40 DRB5 DRB5*01:01 DRB5*01:01:01
8 Q41 A A*01:01 A*30:02 A*01:01:01G A*30:02:01G A*01:01:01G A*30:02:01G
8 Q41 B B*08:01 B*15:03 B*08:01:01G B*15:03:01G B*08:01:01G B*15:03:01G
8 Q41 C C*02:10 C*07:01 C*02:10 C*07:01:01G C*02:10 C*07:01:01G
8 Q41 DPB1 DPB1*01:01 DPB1*02:02 DPB1*01:01:01 DPB1*02:02 DPB1*01:01:01 DPB1*02:02
8 Q41 DQB1 DQB1*02:01 DQB1*02:02 DQB1*02:01:01i DQB1*02:02:01i DQB1*02:01:01i DQB1*02:02:01i
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8 Q41 DRB1 DRB1*03:01 DRB1*07:01 DRB1*03:01:01G DRB1*07:01:01G DRB1*03:01:01i DRB1*07:01:01G
8 Q41 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
8 Q41 DRB4 DRB4*01:01
8 Q41 DRB5
8 Q42 A A*24:02 A*31:01 A*24:02:01G A*31:01:02G A*24:02:01G A*31:01:02G
8 Q42 B B*38:01 B*51:01 B*38:01:01 B*51:01:01G B*38:01:01 B*51:01:01G
8 Q42 C C*12:03 C*14:02 C*12:03:01G C*14:02:01G C*12:03:01G C*14:02:01G
8 Q42 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
8 Q42 DQB1 DQB1*03:01 DQB1*03:03 DQB1*03:01:01i DQB1*03:03:02i DQB1*03:01:01i DQB1*03:03:02i
8 Q42 DRB1 DRB1*04:01 DRB1*09:01 DRB1*04:01:01 DRB1*09:01:02G DRB1*04:01:01 DRB1*09:01:02G
8 Q42 DRB3
8 Q42 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
8 Q42 DRB5
8 Q43 A A*03:01 A*03:01 A*03:01:01G A*03:01:01G A*03:01:01G A*03:01:01G
8 Q43 B B*07:02 B*41:02 B*07:02:01G B*41:02:01 B*07:02:01G B*41:02:01
8 Q43 C C*07:02 C*17:01 C*07:02:01G C*17:01:01G C*07:02:01G C*17:01:01G
8 Q43 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
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8 Q43 DQB1 DQB1*03:01 DQB1*06:04 DQB1*03:01:01i DQB1*06:04:01i DQB1*03:01:01i DQB1*06:04:01i
8 Q43 DRB1 DRB1*13:02 DRB1*13:03 DRB1*13:02:01 DRB1*13:03:01 DRB1*13:02:01 DRB1*13:03:01
8 Q43 DRB3 DRB3*01:01 DRB3*03:01 DRB3*01:01:02G DRB3*03:01:01G DRB3*01:01:02G DRB3*03:01:01G
8 Q43 DRB4
8 Q43 DRB5
8 Q44 A A*03:01 A*32:01 A*03:01:01G A*32:01:01G A*03:01:01G A*32:01:01G
8 Q44 B B*37:01 B*57:01 B*37:01:01G B*57:01:01G B*37:01:01G B*57:01:01G
8 Q44 C C*06:02 C*06:02 C*06:02:01G C*06:02:01G C*06:02:01G C*06:02:01G
8 Q44 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
8 Q44 DQB1 DQB1*02:02 DQB1*05:01 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
8 Q44 DRB1 DRB1*07:01 DRB1*10:01 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
8 Q44 DRB3
8 Q44 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
8 Q44 DRB5
8 Q45 A A*24:02 A*33:01 A*24:02:01G A*33:01:01 A*24:02:01G A*33:01:01
8 Q45 B B*14:02 B*35:01 B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
8 Q45 C C*04:01 C*08:02 C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
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8 Q45 DPB1 DPB1*04:02 DPB1*04:01 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
8 Q45 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:116i DQB1*03:116i
8 Q45 DRB1 DRB1*11:01 DRB1*14:02 DRB1*11:01:01G DRB1*14:02:01 DRB1*11:01:01i DRB1*14:02:01
8 Q45 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
8 Q45 DRB4
8 Q45 DRB5
8 Q46 A A*02:01 A*33:03 A*02:01:01G A*33:03:01G A*02:01:01G A*33:03:01G
8 Q46 B B*44:03 B*57:01 B*44:03:02 B*57:01:01G B*44:03:02 B*57:01:01G
8 Q46 C C*07:01 C*07:01 C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
8 Q46 DPB1 DPB1*04:01 DPB1*03:01 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
8 Q46 DQB1 DQB1*02:02 DQB1*03:03 DQB1*02:02:01i DQB1*03:03:02i DQB1*02:02:01i DQB1*03:03:02i
8 Q46 DRB1 DRB1*07:01 DRB1*07:01 DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G
8 Q46 DRB3
8 Q46 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
8 Q46 DRB5
8 Q47 A A*02:01 A*03:01 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
8 Q47 B B*35:01 B*44:02 B*35:01:01G B*44:02:01G B*35:01:01G B*44:02:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
8 Q47 C C*04:01 C*05:01 C*04:01:01G C*05:01:01G C*04:01:01G C*05:01:01G
8 Q47 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
8 Q47 DQB1 DQB1*02:01 DQB1*03:01 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
8 Q47 DRB1 DRB1*03:01 DRB1*04:01 DRB1*03:01:01G DRB1*04:01:01 DRB1*03:01:01i DRB1*04:01:01
8 Q47 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
8 Q47 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
8 Q47 DRB5
8 Q48 A A*02:01 A*24:02 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
8 Q48 B B*15:03 B*51:02 B*15:03:01G B*51:02:01 B*15:03:01G B*51:02:01
8 Q48 C C*02:10 C*08:01 C*02:10 C*08:01:01G C*02:10 C*08:01:01G
8 Q48 DPB1 DPB1*01:01 DPB1*04:01 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
8 Q48 DQB1 DQB1*03:01 DQB1*05:01 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
8 Q48 DRB1 DRB1*01:02 DRB1*14:02 DRB1*14:02:01 DRB1*14:02:01 DRB1*14:02:01 DRB1*14:02:01
8 Q48 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
8 Q48 DRB4
8 Q48 DRB5
8 Q49 A A*02:01 A*02:06 A*02:01:01G A*02:06:01G A*02:01:01G A*02:06:01G
High confidence Medium confidence Low confidence Discordant call
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. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
8 Q49 B B*07:02 B*40:02 B*07:02:01G B*40:02:01G B*07:02:01G B*40:02:01G
8 Q49 C C*03:08 C*07:02 C*03:08 C*07:02:01G C*03:08 C*07:02:01G
8 Q49 DPB1 DPB1*04:01 DPB1*04:02 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
8 Q49 DQB1 DQB1*03:02 DQB1*06:02 DQB1*03:02:01i DQB1*06:02:01i DQB1*03:02:01i DQB1*06:02:01i
8 Q49 DRB1 DRB1*04:11 DRB1*15:01 DRB1*04:11:01 DRB1*15:01:01G DRB1*04:11:01 DRB1*15:01:01i
8 Q49 DRB3
8 Q49 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
8 Q49 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
8 Q50 A A*01:01 A*02:01 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
8 Q50 B B*35:01 B*37:01 B*35:01:01G B*37:01:01G B*35:01:01G B*37:01:01G
8 Q50 C C*04:01 C*06:02 C*04:01:01G C*06:02:01G C*04:01:01G C*06:02:01G
8 Q50 DPB1 DPB1*02:01 DPB1*13:01 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
8 Q50 DQB1 DQB1*05:01 DQB1*06:02 DQB1*05:01:01i DQB1*06:02:01i DQB1*05:01:01i DQB1*06:02:01i
8 Q50 DRB1 DRB1*10:01 DRB1*15:03 DRB1*10:01:01 DRB1*15:03:01G DRB1*10:01:01 DRB1*15:03:01G
8 Q50 DRB3
8 Q50 DRB4
8 Q50 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
High confidence Medium confidence Low confidence Discordant call
continued . . .
239
B. Allele calls from UCLA QAP samples
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
8 Q51 A A*02:05 A*02:05 A*02:05:01G A*02:05:01G A*02:05:01G A*02:05:01G
8 Q51 B B*50:01 B*50:01 B*50:01:01G B*50:01:01G B*50:01:01G B*50:01:01G
8 Q51 C C*06:02 C*06:02 C*06:02:01G C*06:02:01G C*06:02:01G C*06:02:01G
8 Q51 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
8 Q51 DQB1 DQB1*02:02 DQB1*02:02 DQB1*02:02:01i DQB1*02:02:01i DQB1*02:02:01i DQB1*02:02:01i
8 Q51 DRB1 DRB1*07:01 DRB1*07:01 DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G
8 Q51 DRB3
8 Q51 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
8 Q51 DRB5
8 Q52 A A*31:01 A*33:03 A*31:01:02G A*33:03:01G A*31:01:02G A*33:03:01G
8 Q52 B B*40:02 B*58:01 B*40:02:01G B*58:01:01G B*40:02:01G B*58:01:01G
8 Q52 C C*03:02 C*03:04 C*03:02:01G C*03:04:01G C*03:02:01G C*03:04:01G
8 Q52 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
8 Q52 DQB1 DQB1*03:01 DQB1*06:09 DQB1*03:01:01i DQB1*06:09:01 DQB1*03:01:01i DQB1*06:09:01
8 Q52 DRB1 DRB1*11:01 DRB1*13:02 DRB1*13:02:01 DRB1*13:23:02 DRB1*13:02:01 DRB1*13:02:01
8 Q52 DRB3 DRB3*02:02 DRB3*03:01 DRB3*02:02:01G DRB3*03:01:01G DRB3*02:02:01G DRB3*03:01:01G
8 Q52 DRB4
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
8 Q52 DRB5
8 Q53 A A*02:07 A*33:03 A*02:07:01G A*33:03:01G A*02:07:01G A*33:03:01G
8 Q53 B B*46:01 B*58:01 B*46:01:01G B*58:01:01G B*46:01:01G B*58:01:01G
8 Q53 C C*01:02 C*03:02 C*01:02:01G C*03:02:01G C*01:02:01G C*03:02:01G
8 Q53 DPB1 DPB1*01:01 DPB1*04:02 DPB1*01:01:01 DPB1*04:02:01G DPB1*01:01:01 DPB1*04:02:01G
8 Q53 DQB1 DQB1*02:01 DQB1*04:01 DQB1*02:01:01i DQB1*04:01:01 DQB1*02:01:01i DQB1*04:01:01
8 Q53 DRB1 DRB1*03:01 DRB1*04:05 DRB1*03:01:01G DRB1*04:05:01 DRB1*03:01:01i DRB1*04:05:01i
8 Q53 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
8 Q53 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
8 Q53 DRB5
8 Q54 A A*01:01 A*24:02 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
8 Q54 B B*08:01 B*40:01 B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
8 Q54 C C*03:04 C*07:01 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
8 Q54 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
8 Q54 DQB1 DQB1*02:01 DQB1*03:01 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
8 Q54 DRB1 DRB1*03:01 DRB1*12:01 DRB1*03:01:01G DRB1*12:01:01G DRB1*03:01:01i DRB1*12:01:01G
8 Q54 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
8 Q54 DRB4
8 Q54 DRB5
9 Q55 A A*02:01 A*30:01 A*02:01:01G A*30:01:01G A*02:01:01G A*30:01:01G
9 Q55 B B*42:01 B*49:01 B*42:01:01 B*49:01:01G B*42:01:01 B*49:01:01G
9 Q55 C C*07:01 C*17:01 C*07:01:01G C*17:01:01G C*07:01:01G C*17:01:01G
9 Q55 DPB1 DPB1*01:01 DPB1*04:01 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
9 Q55 DQB1 DQB1*03:02 DQB1*06:09 DQB1*03:02:01i DQB1*06:09:01 DQB1*03:02:01i DQB1*06:09:01
9 Q55 DRB1 DRB1*04:04 DRB1*13:02 DRB1*04:04:01 DRB1*13:02:01 DRB1*04:04:01 DRB1*13:02:01
9 Q55 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
9 Q55 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
9 Q55 DRB5
9 Q56 A A*31:01 A*68:01 A*31:01:02G A*68:01:02G A*31:01:02G A*68:01:02G
9 Q56 B B*15:15 B*39:06 B*15:15 B*39:06:02 B*15:15 B*39:06:02
9 Q56 C C*01:02 C*07:02 C*01:02:01G C*07:02:01G C*01:02:01G C*07:02:01G
9 Q56 DPB1 DPB1*04:01 DPB1*04:02 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
9 Q56 DQB1 DQB1*03:01 DQB1*04:02 DQB1*03:01:01i DQB1*04:02:01i DQB1*03:01:01i DQB1*04:02:01i
9 Q56 DRB1 DRB1*08:02 DRB1*14:06 DRB1*08:02:01 DRB1*14:06:01 DRB1*08:02:01 DRB1*14:06:01
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
9 Q56 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
9 Q56 DRB4
9 Q56 DRB5
9 Q57 A A*24:02 A*31:01 A*24:02:01G A*31:01:02G A*24:02:01G A*31:01:02G
9 Q57 B B*39:02 B*39:06 B*39:02:02 B*39:06:02 B*39:02:02 B*39:06:02
9 Q57 C C*07:02 C*07:02 C*07:02:01G C*07:02:01G C*07:02:01G C*07:02:01G
9 Q57 DPB1 DPB1*04:02 DPB1*11:01 DPB1*04:02:01G DPB1*11:01:01 DPB1*04:02:01G DPB1*11:01:01
9 Q57 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i
9 Q57 DRB1 DRB1*14:06 DRB1*16:02 DRB1*14:06:01 DRB1*16:02:01 DRB1*14:06:01 DRB1*16:02:01
9 Q57 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
9 Q57 DRB4
9 Q57 DRB5 DRB5*02:02 DRB5*02:02:01G DRB5*02:02:01G
9 Q58 A A*02:01 A*11:01 A*02:01:01G A*11:01:01G A*02:01:01G A*11:01:01G
9 Q58 B B*40:01 B*55:01 B*40:01:01G B*55:01:01G B*40:01:01G B*55:01:01G
9 Q58 C C*03:03 C*03:04 C*03:03:01G C*03:04:01G C*03:03:01G C*03:03:01G
9 Q58 DPB1 DPB1*03:01 DPB1*04:02 DPB1*03:01:01G DPB1*04:02:01G DPB1*03:01:01G DPB1*04:02:01G
9 Q58 DQB1 DQB1*05:01 DQB1*06:04 DQB1*05:01:01i DQB1*06:04:01i DQB1*05:01:01i DQB1*06:04:01i
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
9 Q58 DRB1 DRB1*01:01 DRB1*13:02 DRB1*01:01:01G DRB1*13:02:01 DRB1*01:01:01i DRB1*13:02:01
9 Q58 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
9 Q58 DRB4
9 Q58 DRB5
9 Q59 A A*23:01 A*31:01 A*23:01:01G A*31:01:02G A*23:01:01G A*31:01:02G
9 Q59 B B*15:10 B*35:17 B*15:10:01 B*35:17:01 B*15:10:01 B*35:17:01
9 Q59 C C*03:04 C*04:01 C*03:04:02 C*04:01:01G C*03:04:02 C*04:01:01G
9 Q59 DPB1 DPB1*01:01 DPB1*04:02 DPB1*01:01:01 DPB1*04:02:01G DPB1*01:01:01 DPB1*04:02:01G
9 Q59 DQB1 DQB1*04:02 DQB1*05:01 DQB1*04:02:01i DQB1*05:01:01i DQB1*04:02:01i DQB1*05:01:01i




9 Q60 A A*02:01 A*68:01 A*02:01:01G A*68:01:02G A*02:01:01G A*68:01:02G
9 Q60 B B*15:01 B*35:03 B*15:01:01G B*35:03:01G B*15:01:01G B*35:03:01G
9 Q60 C C*03:03 C*12:03 C*03:03:01G C*12:03:01G C*03:03:01G C*12:03:01G
9 Q60 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
9 Q60 DQB1 DQB1*03:02 DQB1*05:03 DQB1*03:02:01i DQB1*05:03:01i DQB1*03:02:01i DQB1*05:03:01i
9 Q60 DRB1 DRB1*04:04 DRB1*14:01 DRB1*04:04:01 DRB1*14:01:01G DRB1*04:04:01 DRB1*14:01:01i
9 Q60 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
9 Q60 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
9 Q60 DRB5
9 Q61 A A*24:02 A*32:01 A*24:02:01G A*32:01:01G A*24:02:01G A*32:01:01G
9 Q61 B B*14:01 B*55:01 B*14:01:01 B*55:01:01G B*14:01:01 B*55:01:01G
9 Q61 C C*03:03 C*08:02 C*03:03:01G C*08:02:01G C*03:03:01G C*08:02:01G
9 Q61 DPB1 DPB1*02:01 DPB1*03:01 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
9 Q61 DQB1 DQB1*02:02 DQB1*05:03 DQB1*02:02:01i DQB1*05:03:01i DQB1*02:02:01i DQB1*05:03:01i
9 Q61 DRB1 DRB1*07:01 DRB1*14:01 DRB1*07:01:01G DRB1*14:01:01G DRB1*07:01:01G DRB1*14:01:01i
9 Q61 DRB3 DRB3*02:02 DRB3*02:02:01G
9 Q61 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
9 Q61 DRB5
9 Q62 A A*02:05 A*03:01 A*02:05:01G A*03:01:01G A*02:05:01G A*03:01:01G
9 Q62 B B*15:03 B*52:01 B*15:03:01G B*52:01:02 B*15:03:01G B*52:01:02
9 Q62 C C*02:10 C*16:01 C*02:10 C*16:01:01G C*02:10 C*16:01:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
9 Q62 DPB1 DPB1*04:02 DPB1*17:01 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
9 Q62 DQB1 DQB1*02:02 DQB1*03:01 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
9 Q62 DRB1 DRB1*07:01 DRB1*13:03 DRB1*07:01:01G DRB1*13:03:01 DRB1*07:01:01G DRB1*13:03:01
9 Q62 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
9 Q62 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
9 Q62 DRB5
9 Q63 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
9 Q63 B B*15:01 B*48:01 B*15:01:01G B*48:01:01G B*15:01:01G B*48:01:01G
9 Q63 C C*01:02 C*08:01:01G C*01:02:01G C*08:01:01G C*01:02:01G C*08:01:01G
9 Q63 DPB1 DPB1*04:02 DPB1*05:01 DPB1*04:02:01G DPB1*05:01:01G DPB1*04:02:01G DPB1*05:01:01G
9 Q63 DQB1 DQB1*03:01 DQB1*03:03 DQB1*03:01:01i DQB1*03:03:02i DQB1*03:01:01i DQB1*03:03:02i
9 Q63 DRB1 DRB1*09:01 DRB1*11:01 DRB1*09:01:02G DRB1*11:01:01G DRB1*09:01:02G DRB1*11:01:01i
9 Q63 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
9 Q63 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
9 Q63 DRB5
9 Q64 A A*02:01 A*02:06 A*02:01:01G A*02:06:01G A*02:01:01G A*02:06:01G
9 Q64 B B*35:47 B*52:01 B*35:47 B*52:01:02 B*35:47 B*52:01:02
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
9 Q64 C C*03:03 C*04:01 C*03:03:01G C*04:01:01G C*03:03:01G C*04:01:01G
9 Q64 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
9 Q64 DQB1 DQB1*03:02 DQB1*04:02 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
9 Q64 DRB1 DRB1*04:04 DRB1*04:07 DRB1*04:04:01 DRB1*04:07:01G DRB1*04:04:01 DRB1*04:07:01G
9 Q64 DRB3
9 Q64 DRB4 DRB4*01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
9 Q64 DRB5
9 Q65 A A*24:02 A*34:02 A*24:02:01G A*34:02:01 A*24:02:01G A*34:02:01
9 Q65 B B*13:02 B*14:02 B*13:02:01G B*14:02:01 B*13:02:01G B*14:02:01
9 Q65 C C*06:02 C*08:02 C*06:02:01G C*08:02:01G C*06:02:01G C*08:02:01G
9 Q65 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
9 Q65 DQB1 DQB1*02:02 DQB1*05:03 DQB1*02:02:01i DQB1*05:03:01i DQB1*02:02:01i DQB1*05:03:01i
9 Q65 DRB1 DRB1*07:01 DRB1*14:01 DRB1*07:01:01G DRB1*14:01:01G DRB1*07:01:01G DRB1*14:01:01i
9 Q65 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
9 Q65 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
9 Q65 DRB5
9 Q66 A A*02:01 A*26:01 A*02:01:01G A*26:01:01G A*02:01:01G A*26:01:01G
High confidence Medium confidence Low confidence Discordant call
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9 Q66 B B*07:02 B*35:01 B*07:02:01G B*35:01:01G B*07:02:01G B*35:01:01G
9 Q66 C C*04:01 C*07:02 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
9 Q66 DPB1 DPB1*03:01 DPB1*04:01 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
9 Q66 DQB1 DQB1*06:02 DQB1*06:04 DQB1*06:02:01i DQB1*06:04:01i DQB1*06:02:01i DQB1*06:04:01i
9 Q66 DRB1 DRB1*13:02 DRB1*15:01 DRB1*13:02:01 DRB1*15:01:01G DRB1*13:02:01 DRB1*15:01:01i
9 Q66 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
9 Q66 DRB4
9 Q66 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
9 Q67 A A*02:01 A*02:03 A*02:01:01G A*02:03:01G A*02:01:01G A*02:03:01G
9 Q67 B B*46:01 B*51:01 B*46:01:01G B*51:01:01G B*46:01:01G B*51:01:01G
9 Q67 C C*01:02 C*14:02 C*01:02:01G C*14:02:01G C*01:02:01G C*14:02:01G
9 Q67 DPB1 DPB1*03:01 DPB1*04:02 DPB1*03:01:01G DPB1*04:02:01G DPB1*03:01:01G DPB1*04:02:01G
9 Q67 DQB1 DQB1*03:01 DQB1*03:02 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
9 Q67 DRB1 DRB1*04:03 DRB1*11:04 DRB1*04:03:01 DRB1*11:04:01 DRB1*04:03:01i DRB1*11:04:01i
9 Q67 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
9 Q67 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
9 Q67 DRB5
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
9 Q68 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
9 Q68 B B*08:01 B*52:01 B*08:01:01G B*52:01:01G B*08:01:01G B*52:01:01G
9 Q68 C C*07:02 C*12:02 C*07:02:01G C*12:02:01G C*07:02:01G C*12:02:01G
9 Q68 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
9 Q68 DQB1 DQB1*02:01 DQB1*06:01 DQB1*02:01:01i DQB1*06:01:01i DQB1*02:01:01i DQB1*06:01:01i
9 Q68 DRB1 DRB1*03:01 DRB1*15:02 DRB1*03:01:01G DRB1*15:02:01 DRB1*03:01:01i DRB1*15:02:01
9 Q68 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
9 Q68 DRB4
9 Q68 DRB5 DRB5*01:02 DRB5*01:02:01G DRB5*01:02:01G
9 Q69 A A*03:01 A*24:02 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
9 Q69 B B*07:02 B*57:01 B*07:02:01G B*57:01:01G B*07:02:01G B*57:01:01G
9 Q69 C C*06:02 C*07:02 C*06:02:01G C*07:02:01G C*06:02:01G C*07:02:01G
9 Q69 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
9 Q69 DQB1 DQB1*03:03 DQB1*06:02 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
9 Q69 DRB1 DRB1*07:01 DRB1*15:01 DRB1*07:01:01G DRB1*15:01:01G DRB1*07:01:01G DRB1*15:01:01i
9 Q69 DRB3
9 Q69 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
9 Q69 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
9 Q70 A A*03:01 A*33:01 A*03:01:01G A*33:01:01 A*03:01:01G A*33:01:01
9 Q70 B B*15:10 B*45:01 B*15:10:01 B*45:01:01G B*15:10:01 B*45:01:01G
9 Q70 C C*03:04 C*06:02 C*03:04:02 C*06:02:01G C*03:04:02 C*06:02:01G
9 Q70 DPB1 DPB1*01:01 DPB1*03:01 DPB1*01:01:01 DPB1*03:01:01G DPB1*01:01:01 DPB1*03:01:01G
9 Q70 DQB1 DQB1*04:02 DQB1*05:01 DQB1*04:02:01i DQB1*05:01:01i DQB1*04:02:01i DQB1*05:01:01i




9 Q71 A A*02:01 A*02:01 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
9 Q71 B B*45:01 B*53:01 B*45:01:01G B*53:01:01G B*45:01:01G B*53:01:01G
9 Q71 C C*04:01 C*16:01 C*04:01:01G C*16:01:01G C*04:01:01G C*16:01:01G
9 Q71 DPB1 DPB1*01:01 DPB1*01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
9 Q71 DQB1 DQB1*04:02 DQB1*05:01 DQB1*04:02:01i DQB1*05:01:01i DQB1*04:02:01i DQB1*05:01:01i
9 Q71 DRB1 DRB1*01:02 DRB1*03:02 DRB1*01:02:01 DRB1*03:02:01 DRB1*01:02:01 DRB1*03:02:01
9 Q71 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
9 Q71 DRB4
9 Q71 DRB5
9 Q72 A A*24:02 A*68:03 A*24:02:01G A*68:03:01 A*24:02:01G A*68:03:01
9 Q72 B B*35:43 B*39:06 B*35:43:01G B*39:06:02 B*35:43:01G B*39:06:02
9 Q72 C C*01:02 C*07:02 C*01:02:01G C*07:02:01G C*01:02:01G C*07:02:01G
9 Q72 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
9 Q72 DQB1 DQB1*03:01 DQB1*03:02 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
9 Q72 DRB1 DRB1*04:03 DRB1*14:06 DRB1*04:03:01 DRB1*14:06:01 DRB1*04:03:01i DRB1*14:06:01
9 Q72 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
9 Q72 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
9 Q72 DRB5
10 Q73 A A*11:01 A*25:01
10 Q73 B B*07:02 B*40:02 B*07:02:01G B*40:02:01G B*07:02:01G B*40:02:01G
10 Q73 C C*02:02 C*07:02 C*02:02:02G C*07:02:01G C*02:02:02G C*07:02:01G
10 Q73 DPB1 DPB1*04:01 DPB1*19:01 DPB1*04:01:01G DPB1*19:01:01G DPB1*04:01:01G DPB1*19:01:01G
10 Q73 DQB1 DQB1*02:02 DQB1*03:01 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
10 Q73 DRB1 DRB1*07:01 DRB1*13:05 DRB1*07:01:01G DRB1*13:05:01 DRB1*07:01:01G DRB1*13:05:01
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10 Q73 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
10 Q73 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
10 Q73 DRB5
10 Q74 A A*30:01 A*30:02 A*30:01:01G A*30:02:01G A*30:01:01G A*30:02:01G
10 Q74 B B*14:02 B*53:01 B*14:02:01 B*53:01:01G B*14:02:01 B*53:01:01G
10 Q74 C C*04:13 C*08:02 C*04:13 C*08:02:01G C*04:13 C*08:02:01G
10 Q74 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
10 Q74 DQB1 DQB1*02:03 DQB1*06:02 DQB1*02:03 DQB1*06:02:01i DQB1*02:03 DQB1*06:02:01i
10 Q74 DRB1 DRB1*03:02 DRB1*15:03 DRB1*03:02:01 DRB1*15:03:01G DRB1*03:02:01 DRB1*15:03:01G
10 Q74 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
10 Q74 DRB4
10 Q74 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
10 Q75 A A*02:01 A*02:06 A*02:01:01G A*02:06:01G A*02:01:01G A*02:06:01G
10 Q75 B B*15:01 B*40:02 B*15:01:01G B*40:02:01G B*15:01:01G B*40:02:01G
10 Q75 C C*03:04 C*08:01 C*03:04:01G C*08:01:01G C*03:04:01G C*08:01:01G
10 Q75 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
10 Q75 DQB1 DQB1*03:01 DQB1*06:02 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
High confidence Medium confidence Low confidence Discordant call
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10 Q75 DRB1 DRB1*12:01 DRB1*15:01 DRB1*12:01:01G DRB1*15:01:01G DRB1*12:01:01G DRB1*15:01:01i
10 Q75 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
10 Q75 DRB4
10 Q75 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
10 Q76 A A*02:01 A*30:02 A*02:01:01G A*30:02:01G A*02:01:01G A*30:02:01G
10 Q76 B B*38:01 B*57:01 B*38:01:01 B*57:01:01G B*38:01:01 B*57:01:01G
10 Q76 C C*06:02 C*12:03 C*06:02:38 C*12:03:08 C*06:02:01G C*12:03:01G
10 Q76 DPB1 DPB1*02:01 DPB1*03:01 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
10 Q76 DQB1 DQB1*03:03 DQB1*03:03 DQB1*03:03:02i DQB1*03:40 DQB1*03:03:02i DQB1*03:40
10 Q76 DRB1 DRB1*07:01 DRB1*09:01 DRB1*07:01:01G DRB1*09:01:02G DRB1*07:01:01G DRB1*09:01:02G
10 Q76 DRB3
10 Q76 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
10 Q76 DRB5
10 Q77 A A*02:02 A*33:01 A*02:02:01 A*33:01:01 A*02:02:01 A*33:01:01
10 Q77 B B*42:01 B*78:01 B*42:01:01 B*78:01:01 B*42:01:01 B*78:01:01
10 Q77 C C*16:01 C*17:01 C*16:01:01G C*17:01:01G C*16:01:01G C*17:01:01G
10 Q77 DPB1 DPB1*01:01 DPB1*02:01 DPB1*01:01:02G DPB1*02:01:02G DPB1*01:01:02G DPB1*02:01:02G
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10 Q77 DQB1 DQB1*03:01 DQB1*06:02 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
10 Q77 DRB1 DRB1*08:04 DRB1*15:03 DRB1*08:04:01 DRB1*15:03:01G DRB1*15:03:01G DRB1*15:03:01G
10 Q77 DRB3
10 Q77 DRB4
10 Q77 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01 DRB5*01:01:01
10 Q78 A A*02:06 A*30:02 A*02:06:01G A*30:02:01G A*02:06:01G A*30:02:01G
10 Q78 B B*27:05 B*35:14 B*27:05:02G B*35:14:01 B*27:05:02G B*35:14:01
10 Q78 C C*02:02 C*04:01 C*02:02:02G C*04:01:01G C*02:02:02G C*04:01:01G
10 Q78 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
10 Q78 DQB1 DQB1*03:01 DQB1*06:02 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
10 Q78 DRB1 DRB1*15:01 DRB1*16:02 DRB1*15:01:01G DRB1*16:02:01 DRB1*15:01:01i DRB1*16:02:01
10 Q78 DRB3
10 Q78 DRB4
10 Q78 DRB5 DRB5*01:01 DRB5*02:02 DRB5*01:01:01 DRB5*02:02:01G DRB5*01:01:01 DRB5*02:02:01G
11 Q31 A A*02:01 A*32:01 A*02:01:01G A*32:01:01G A*02:01:01G A*32:01:01G
11 Q31 B B*27:05 B*73:01 B*27:05:02G B*27:05:02G B*27:05:05 B*27:85
11 Q31 C C*02:02 C*15:05 C*02:02:02G C*15:05:01G C*02:02:02G C*15:05:01G
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11 Q31 DPB1 DPB1*02:01 DPB1*03:01 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
11 Q31 DQB1 DQB1*03:01 DQB1*04:02 DQB1*03:01:01i DQB1*04:02:01i DQB1*03:01:01i DQB1*04:02:01i
11 Q31 DRB1 DRB1*08:04 DRB1*14:02 DRB1*08:04:01 DRB1*14:02:01 DRB1*08:04:01 DRB1*14:02:01
11 Q31 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q31 DRB4
11 Q31 DRB5
11 Q32 A A*02:01 A*26:01 A*02:01:01G A*26:01:01G A*02:01:01G A*26:01:01G
11 Q32 B B*37:01 B*58:01 B*37:01:01G B*58:01:01G B*37:01:01G B*58:01:01G
11 Q32 C C*03:02 C*06:02 C*03:02:01G C*06:02:01G C*03:02:01G C*06:02:01G
11 Q32 DPB1 DPB1*02:01 DPB1*02:02 DPB1*02:01:02G DPB1*02:02 DPB1*02:01:02G DPB1*02:02
11 Q32 DQB1 DQB1*05:01 DQB1*06:09 DQB1*05:01:01i DQB1*06:09:01 DQB1*05:01:01i DQB1*06:09:01
11 Q32 DRB1 DRB1*10:01 DRB1*13:02 DRB1*10:01:01 DRB1*13:02:01 DRB1*10:01:01 DRB1*13:02:01
11 Q32 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
11 Q32 DRB4
11 Q32 DRB5
11 Q34 A A*01:01 A*24:02 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
11 Q34 B B*51:01 B*57:01 B*51:01:01G B*57:01:01G B*51:01:01G B*57:01:01G
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11 Q34 C C*02:02 C*06:02 C*02:02:02G C*06:02:01G C*02:02:02G C*06:02:01G
11 Q34 DPB1 DPB1*02:01 DPB1*04:02 DPB1*02:01:02G DPB1*04:02:01G DPB1*02:01:02G DPB1*04:02:01G
11 Q34 DQB1 DQB1*03:01 DQB1*03:03 DQB1*03:01:01i DQB1*03:03:02i DQB1*03:01:01i DQB1*03:03:02i
11 Q34 DRB1 DRB1*07:01 DRB1*11:01 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
11 Q34 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
11 Q34 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q34 DRB5
11 Q35 A A*03:01 A*24:02 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
11 Q35 B B*07:02 B*18:01 B*07:02:01G B*18:01:01G B*07:02:01G B*18:01:01G
11 Q35 C C*07:02 C*12:03 C*07:02:01G C*12:03:01G C*07:02:01G C*12:03:01G
11 Q35 DPB1 DPB1*04:01 DPB1*14:01 DPB1*04:01:01G DPB1*14:01 DPB1*04:01:01G DPB1*14:01
11 Q35 DQB1 DQB1*03:01 DQB1*06:02 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
11 Q35 DRB1 DRB1*11:04 DRB1*15:01 DRB1*11:04:01 DRB1*11:04:01 DRB1*11:04:01i DRB1*11:04:01i
11 Q35 DRB3 DRB3*02:02 DRB3*02:02:01G
11 Q35 DRB4
11 Q35 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
11 Q37 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
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11 Q37 B B*15:21 B*15:35 B*15:21 B*15:35 B*15:21 B*15:35
11 Q37 C C*04:03 C*07:02 C*04:03:01 C*07:02:01G C*04:03:01 C*07:02:01G
11 Q37 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
11 Q37 DQB1 DQB1*05:02 DQB1*06:01 DQB1*05:02:01i DQB1*06:01:01i DQB1*05:02:01i DQB1*06:01:01i
11 Q37 DRB1 DRB1*08:03 DRB1*15:02 DRB1*08:03:02 DRB1*15:02:01 DRB1*08:03:02 DRB1*15:02:01
11 Q37 DRB3
11 Q37 DRB4
11 Q37 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
11 Q38 A A*02:01 A*30:01 A*02:01:01G A*30:01:01G A*02:01:01G A*30:01:01G
11 Q38 B B*15:03 B*42:01 B*15:03:01G B*42:01:01 B*15:03:01G B*42:01:01
11 Q38 C C*02:10 C*17:01 C*02:10 C*17:01:01G C*02:10 C*17:01:01G
11 Q38 DPB1 DPB1*01:01 DPB1*04:01 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
11 Q38 DQB1 DQB1*04:02 DQB1*06:02 DQB1*04:02:01i DQB1*06:02:01i DQB1*04:02:01i DQB1*06:02:01i
11 Q38 DRB1 DRB1*03:02 DRB1*15:03 DRB1*03:02:01 DRB1*15:03:01G DRB1*03:02:01 DRB1*15:03:01G
11 Q38 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q38 DRB4
11 Q38 DRB5
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q39 A A*02:01 A*02:01 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
11 Q39 B B*44:02 B*57:03 B*44:02:01G B*57:03:01 B*44:02:01G B*57:03:01
11 Q39 C C*05:01 C*07:01 C*05:01:01G C*07:01:01G C*05:01:01G C*07:01:01G
11 Q39 DPB1 DPB1*01:01 DPB1*17:01 DPB1*01:01:01 DPB1*17:01:01G DPB1*01:01:01 DPB1*17:01:01G
11 Q39 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i
11 Q39 DRB1 DRB1*04:01 DRB1*13:03 DRB1*04:01:01 DRB1*13:03:01 DRB1*04:01:01 DRB1*13:03:01
11 Q39 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q39 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q39 DRB5
11 Q40 A A*11:02 A*26:01 A*11:02:01G A*26:01:01G A*11:02:01G A*26:01:01G
11 Q40 B B*15:02 B*27:04 B*15:02:01G B*27:04:01G B*15:02:01G B*27:04:01G
11 Q40 C C*08:01 C*12:02 C*08:01:01G C*12:02:01G C*08:01:01G C*12:02:01G
11 Q40 DPB1 DPB1*02:01 DPB1*19:01 DPB1*02:01:02G DPB1*19:01:01G DPB1*02:01:02G DPB1*19:01:01G
11 Q40 DQB1 DQB1*03:01 DQB1*05:02 DQB1*03:01:01i DQB1*05:02:01i DQB1*03:01:01i DQB1*05:02:01i
11 Q40 DRB1 DRB1*12:02 DRB1*15:01 DRB1*12:02:01 DRB1*12:02:01 DRB1*12:02:01 DRB1*12:02:01
11 Q40 DRB3 DRB3*02:02 DRB3*02:02:01G
11 Q40 DRB4
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q40 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
11 Q41 A A*01:01 A*30:02 A*01:01:01G A*30:02:01G A*01:01:01G A*30:02:01G
11 Q41 B B*08:01 B*15:03 B*08:01:01G B*15:03:01G B*08:01:01G B*15:03:01G
11 Q41 C C*02:10 C*07:01 C*02:10 C*07:01:01G C*02:10 C*07:01:01G
11 Q41 DPB1 DPB1*01:01 DPB1*02:02 DPB1*01:01:01 DPB1*02:02 DPB1*01:01:01 DPB1*02:02
11 Q41 DQB1 DQB1*02:01 DQB1*02:02 DQB1*02:01:01i DQB1*02:02:01i DQB1*02:01:01i DQB1*02:02:01i
11 Q41 DRB1 DRB1*03:01 DRB1*07:01 DRB1*03:01:01G DRB1*07:01:01G DRB1*03:01:01i DRB1*07:01:01G
11 Q41 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q41 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q41 DRB5
11 Q42 A A*24:02 A*31:01 A*24:02:01G A*31:01:02G A*24:02:01G A*31:01:02G
11 Q42 B B*38:01 B*51:01 B*38:01:01 B*51:01:01G B*38:01:01 B*51:01:01G
11 Q42 C C*12:03 C*14:02 C*12:03:01G C*14:02:01G C*12:03:01G C*14:02:01G
11 Q42 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
11 Q42 DQB1 DQB1*03:01 DQB1*03:03 DQB1*03:01:01i DQB1*03:03:02i DQB1*03:01:01i DQB1*03:03:02i
11 Q42 DRB1 DRB1*04:01 DRB1*09:01 DRB1*04:01:01 DRB1*09:01:02G DRB1*04:01:01 DRB1*09:01:02G
11 Q42 DRB3
High confidence Medium confidence Low confidence Discordant call
continued . . .
259
B. Allele calls from UCLA QAP samples
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q42 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
11 Q42 DRB5
11 Q43 A A*03:01 A*03:01 A*03:01:01G A*03:01:01G A*03:01:01G A*03:01:01G
11 Q43 B B*07:02 B*41:02 B*07:02:01G B*41:02:01 B*07:02:01G B*41:02:01
11 Q43 C C*07:02 C*17:01 C*07:02:01G C*17:01:01G C*07:02:01G C*17:01:01G
11 Q43 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
11 Q43 DQB1 DQB1*03:01 DQB1*06:04 DQB1*03:01:01i DQB1*06:04:01i DQB1*03:01:01i DQB1*06:04:01i
11 Q43 DRB1 DRB1*13:02 DRB1*13:03 DRB1*13:02:01 DRB1*13:03:01 DRB1*13:02:01 DRB1*13:03:01
11 Q43 DRB3 DRB3*01:01 DRB3*03:01 DRB3*01:01:02G DRB3*03:01:01G DRB3*01:01:02G DRB3*03:01:01G
11 Q43 DRB4
11 Q43 DRB5
11 Q44 A A*03:01 A*32:01 A*03:01:01G A*32:01:01G A*03:01:01G A*32:01:01G
11 Q44 B B*37:01 B*57:01 B*37:01:01G B*57:01:01G B*37:01:01G B*57:01:01G
11 Q44 C C*06:02 C*06:02 C*06:02:01G C*06:02:01G C*06:02:01G C*06:02:01G
11 Q44 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
11 Q44 DQB1 DQB1*02:02 DQB1*05:01 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
11 Q44 DRB1 DRB1*07:01 DRB1*10:01 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q44 DRB3
11 Q44 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q44 DRB5
11 Q45 A A*24:02 A*33:01 A*24:02:01G A*33:01:01 A*24:02:01G A*33:01:01
11 Q45 B B*14:02 B*35:01 B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
11 Q45 C C*04:01 C*08:02 C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
11 Q45 DPB1 DPB1*04:02 DPB1*04:01 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
11 Q45 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i
11 Q45 DRB1 DRB1*11:01 DRB1*14:02 DRB1*11:01:01G DRB1*14:02:01 DRB1*11:01:01i DRB1*14:02:01
11 Q45 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
11 Q45 DRB4
11 Q45 DRB5
11 Q46 A A*02:01 A*33:03 A*02:01:01G A*02:01:01G
11 Q46 B B*44:03 B*57:01
11 Q46 C C*07:01 C*07:01
11 Q46 DPB1 DPB1*04:01 DPB1*03:01 DPB1*03:01:01G DPB1*03:01:01G
11 Q46 DQB1 DQB1*02:02 DQB1*03:03 DQB1*02:02:01i DQB1*03:03:02i DQB1*02:02:01i DQB1*03:03:02i
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q46 DRB1 DRB1*07:01 DRB1*07:01
11 Q46 DRB3
11 Q46 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G
11 Q46 DRB5
11 Q47 A A*02:01 A*03:01 A*02:01:01G A*03:01:01G A*02:01:01G A*03:01:01G
11 Q47 B B*35:01 B*44:02 B*35:01:01G B*44:02:01G B*35:01:01G B*44:02:01G
11 Q47 C C*04:01 C*05:01 C*04:01:01G C*05:01:01G C*04:01:01G C*05:01:01G
11 Q47 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
11 Q47 DQB1 DQB1*02:01 DQB1*03:01 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
11 Q47 DRB1 DRB1*03:01 DRB1*04:01 DRB1*03:01:01G DRB1*04:01:01 DRB1*03:01:01i DRB1*04:01:01
11 Q47 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q47 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q47 DRB5
11 Q48 A A*02:01 A*24:02 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
11 Q48 B B*15:03 B*51:02 B*15:03:01G B*51:02:01 B*15:03:01G B*51:02:01
11 Q48 C C*02:10 C*08:01 C*02:10 C*08:01:01G C*02:10 C*08:01:01G
11 Q48 DPB1 DPB1*01:01 DPB1*04:01 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q48 DQB1 DQB1*03:01 DQB1*05:01 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
11 Q48 DRB1 DRB1*01:02 DRB1*14:02 DRB1*01:02:01 DRB1*14:02:01 DRB1*01:02:01 DRB1*14:02:01
11 Q48 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q48 DRB4 DRB4*01:01:01G
11 Q48 DRB5
11 Q49 A A*02:01 A*02:06 A*02:06:01G A*02:65 A*02:06:01G A*02:65
11 Q49 B B*07:02 B*40:02 B*07:02:01G B*40:02:01G B*07:02:01G B*40:02:01G
11 Q49 C C*03:08 C*07:02 C*03:08 C*07:02:01G C*03:08 C*07:02:01G
11 Q49 DPB1 DPB1*04:01 DPB1*04:02 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
11 Q49 DQB1 DQB1*03:02 DQB1*06:02 DQB1*03:02:01i DQB1*06:02:01i DQB1*03:02:01i DQB1*06:02:01i
11 Q49 DRB1 DRB1*04:11 DRB1*15:01 DRB1*04:11:01 DRB1*15:01:01G DRB1*04:11:01 DRB1*15:01:01i
11 Q49 DRB3
11 Q49 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q49 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
11 Q50 A A*01:01 A*02:01 A*01:01:01G A*02:01:01G A*01:01:01G A*02:01:01G
11 Q50 B B*35:01 B*37:01 B*35:01:01G B*37:01:01G B*35:01:01G B*37:01:01G
11 Q50 C C*04:01 C*06:02 C*04:01:01G C*06:02:01G C*04:01:01G C*06:02:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q50 DPB1 DPB1*02:01 DPB1*13:01 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
11 Q50 DQB1 DQB1*05:01 DQB1*06:02 DQB1*05:01:01i DQB1*06:02:01i DQB1*05:01:01i DQB1*06:02:01i
11 Q50 DRB1 DRB1*10:01 DRB1*15:03 DRB1*10:01:01 DRB1*15:03:01G DRB1*10:01:01 DRB1*10:01:01
11 Q50 DRB3
11 Q50 DRB4
11 Q50 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
11 Q51 A A*02:05 A*02:05 A*02:05:01G A*02:05:01G A*02:05:01G A*02:05:01G
11 Q51 B B*50:01 B*50:01 B*50:01:01G B*50:01:01G B*50:01:01G B*50:01:01G
11 Q51 C C*06:02 C*06:02 C*06:02:01G C*06:02:01G C*06:02:01G C*06:02:01G
11 Q51 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
11 Q51 DQB1 DQB1*02:02 DQB1*02:02 DQB1*02:02:01i DQB1*02:02:01i DQB1*02:01:19 DQB1*02:02:01i
11 Q51 DRB1 DRB1*07:01 DRB1*07:01 DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G
11 Q51 DRB3
11 Q51 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
11 Q51 DRB5
11 Q52 A A*31:01 A*33:03 A*31:01:02G A*33:03:01G A*31:01:02G A*33:03:01G
11 Q52 B B*40:02 B*58:01 B*40:02:01G B*58:01:01G B*40:02:01G B*58:01:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q52 C C*03:02 C*03:04 C*03:02:01G C*03:04:01G C*03:02:01G C*03:04:01G
11 Q52 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
11 Q52 DQB1 DQB1*03:01 DQB1*06:09 DQB1*03:01:01i DQB1*06:09:01 DQB1*03:01:01i DQB1*06:09:01
11 Q52 DRB1 DRB1*11:01 DRB1*13:02 DRB1*11:01:01G DRB1*13:02:01 DRB1*11:01:01i DRB1*13:02:01
11 Q52 DRB3 DRB3*02:02 DRB3*03:01 DRB3*02:26 DRB3*03:01:01G DRB3*03:01:01G DRB3*03:01:01G
11 Q52 DRB4
11 Q52 DRB5
11 Q53 A A*02:07 A*33:03 A*02:07:01G A*33:03:01G A*02:07:01G A*33:03:01G
11 Q53 B B*46:01 B*58:01 B*46:01:01G B*58:01:01G B*46:01:01G B*58:01:01G
11 Q53 C C*01:02 C*03:02 C*01:02:01G C*03:02:01G C*01:02:01G C*03:02:01G
11 Q53 DPB1 DPB1*01:01 DPB1*04:02 DPB1*01:01:01 DPB1*04:02:01G DPB1*01:01:01 DPB1*04:02:01G
11 Q53 DQB1 DQB1*02:01 DQB1*04:01 DQB1*02:01:01i DQB1*04:01:01 DQB1*02:01:01i DQB1*04:01:01
11 Q53 DRB1 DRB1*03:01 DRB1*04:05 DRB1*03:01:01G DRB1*04:05:01 DRB1*03:01:01i DRB1*04:05:01i
11 Q53 DRB3 DRB3*02:02
11 Q53 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q53 DRB5
11 Q54 A A*01:01 A*24:02 A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q54 B B*08:01 B*40:01 B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
11 Q54 C C*03:04 C*07:01 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
11 Q54 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
11 Q54 DQB1 DQB1*02:01 DQB1*03:01 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
11 Q54 DRB1 DRB1*03:01 DRB1*12:01 DRB1*03:01:01G DRB1*12:01:01G DRB1*03:01:01i DRB1*12:01:01G
11 Q54 DRB3 DRB3*01:01 DRB3*02:02 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
11 Q54 DRB4
11 Q54 DRB5
11 Q55 A A*02:01 A*30:01 A*02:01:01G A*30:01:01G A*02:01:01G A*30:01:01G
11 Q55 B B*42:01 B*49:01 B*42:01:01 B*49:01:01G B*42:01:01 B*49:01:01G
11 Q55 C C*07:01 C*17:01 C*07:01:01G C*17:01:01G C*07:01:01G C*17:01:01G
11 Q55 DPB1 DPB1*01:01 DPB1*04:01 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
11 Q55 DQB1 DQB1*03:02 DQB1*06:09 DQB1*03:02:01i DQB1*06:09:01 DQB1*03:02:01i DQB1*06:09:01
11 Q55 DRB1 DRB1*04:04 DRB1*13:02 DRB1*04:04:01 DRB1*13:02:01 DRB1*04:04:01 DRB1*13:02:01
11 Q55 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
11 Q55 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q55 DRB5
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q56 A A*31:01 A*68:01 A*31:01:02G A*68:01:02G A*31:01:02G A*68:01:02G
11 Q56 B B*15:15 B*39:06 B*15:15 B*39:06:02 B*15:15 B*39:06:02
11 Q56 C C*01:02 C*07:02 C*01:02:01G C*07:02:01G C*01:02:01G C*07:02:01G
11 Q56 DPB1 DPB1*04:01 DPB1*04:02 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
11 Q56 DQB1 DQB1*03:01 DQB1*04:02 DQB1*03:01:01i DQB1*04:02:01i DQB1*03:01:01i DQB1*04:02:01i
11 Q56 DRB1 DRB1*08:02 DRB1*14:06 DRB1*08:02:01 DRB1*14:06:01 DRB1*08:02:01 DRB1*14:06:01
11 Q56 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q56 DRB4
11 Q56 DRB5
11 Q57 A A*24:02 A*31:01 A*24:02:01G A*31:01:02G A*24:02:01G A*31:01:02G
11 Q57 B B*39:02 B*39:06 B*39:02:02 B*39:06:02 B*39:02:02 B*39:06:02
11 Q57 C C*07:02 C*07:02 C*07:02:01G C*07:02:01G C*07:02:01G C*07:02:01G
11 Q57 DPB1 DPB1*04:02 DPB1*11:01 DPB1*04:02:01G DPB1*11:01:01 DPB1*04:02:01G DPB1*11:01:01
11 Q57 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i
11 Q57 DRB1 DRB1*14:06 DRB1*16:02 DRB1*14:06:01 DRB1*16:02:01 DRB1*14:06:01 DRB1*16:02:01
11 Q57 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q57 DRB4
High confidence Medium confidence Low confidence Discordant call
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q57 DRB5 DRB5*02:02 DRB5*02:02:01G DRB5*02:02:01G
11 Q58 A A*02:01 A*11:01 A*02:01:01G A*11:01:01G A*02:01:01G A*11:01:01G
11 Q58 B B*40:01 B*55:01 B*40:01:01G B*55:01:01G B*40:01:01G B*55:01:01G
11 Q58 C C*03:03 C*03:04 C*03:03:01G C*03:04:01G C*03:03:01G C*03:03:01G
11 Q58 DPB1 DPB1*03:01 DPB1*04:02 DPB1*03:01:01G DPB1*04:02:01G DPB1*03:01:01G DPB1*04:02:01G
11 Q58 DQB1 DQB1*05:01 DQB1*06:04 DQB1*05:01:01i DQB1*06:04:01i DQB1*05:01:01i DQB1*06:04:01i
11 Q58 DRB1 DRB1*01:01 DRB1*13:02 DRB1*01:01:01G DRB1*13:02:01 DRB1*01:01:01i DRB1*13:02:01
11 Q58 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
11 Q58 DRB4
11 Q58 DRB5
11 Q59 A A*23:01 A*31:01 A*23:01:01G A*31:01:02G A*23:01:01G A*31:01:02G
11 Q59 B B*15:10 B*35:17 B*15:10:01 B*35:17:01 B*15:10:01 B*35:17:01
11 Q59 C C*03:04 C*04:01 C*03:04:02 C*04:01:01G C*03:04:02 C*04:01:01G
11 Q59 DPB1 DPB1*01:01 DPB1*04:02 DPB1*01:01:01 DPB1*04:02:01G DPB1*01:01:01 DPB1*04:02:01G
11 Q59 DQB1 DQB1*04:02 DQB1*05:01 DQB1*04:02:01i DQB1*05:01:01i DQB1*04:02:01i DQB1*05:01:01i
11 Q59 DRB1 DRB1*08:02 DRB1*10:01 DRB1*08:02:01 DRB1*10:01:01 DRB1*08:02:01 DRB1*10:01:01
11 Q59 DRB3
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q59 DRB4
11 Q59 DRB5
11 Q60 A A*02:01 A*68:01 A*02:01:01G A*68:01:02G A*02:01:01G A*68:01:02G
11 Q60 B B*15:01 B*35:03 B*15:01:01G B*35:03:01G B*15:01:01G B*35:03:01G
11 Q60 C C*03:03 C*12:03 C*03:03:01G C*12:03:01G C*03:03:01G C*12:03:01G
11 Q60 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
11 Q60 DQB1 DQB1*03:02 DQB1*05:03 DQB1*03:02:01i DQB1*05:03:01i DQB1*03:02:01i DQB1*05:03:01i
11 Q60 DRB1 DRB1*04:04 DRB1*14:01 DRB1*04:04:01 DRB1*14:01:01G DRB1*04:04:01 DRB1*14:01:01i
11 Q60 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
11 Q60 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q60 DRB5
11 Q61 A A*24:02 A*32:01 A*24:02:01G A*32:01:01G A*24:02:01G A*32:01:01G
11 Q61 B B*14:01 B*55:01 B*14:01:01 B*55:01:01G B*14:01:01 B*55:01:01G
11 Q61 C C*03:03 C*08:02 C*03:03:01G C*08:02:01G C*03:03:01G C*08:02:01G
11 Q61 DPB1 DPB1*02:01 DPB1*03:01 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
11 Q61 DQB1 DQB1*02:02 DQB1*05:03 DQB1*02:02:01i DQB1*05:03:01i DQB1*02:02:01i DQB1*05:03:01i
11 Q61 DRB1 DRB1*07:01 DRB1*14:01 DRB1*07:01:01G DRB1*14:01:01G DRB1*07:01:01G DRB1*14:01:01i
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q61 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
11 Q61 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q61 DRB5
11 Q62 A A*02:05 A*03:01 A*02:05:01G A*03:01:01G A*02:05:01G A*03:01:01G
11 Q62 B B*15:03 B*52:01 B*15:03:01G B*52:01:02 B*15:03:01G B*52:01:02
11 Q62 C C*02:10 C*16:01 C*02:10 C*16:01:01G C*02:10 C*16:01:01G
11 Q62 DPB1 DPB1*04:02 DPB1*17:01 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
11 Q62 DQB1 DQB1*02:02 DQB1*03:01 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
11 Q62 DRB1 DRB1*07:01 DRB1*13:03 DRB1*07:01:01G DRB1*13:03:01 DRB1*07:01:01G DRB1*13:03:01
11 Q62 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q62 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q62 DRB5
11 Q63 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
11 Q63 B B*15:01 B*48:01 B*15:01:01G B*48:01:01G B*15:01:01G B*48:01:01G
11 Q63 C C*01:02 C*08:01:01G C*01:02:01G C*08:01:01G C*01:02:01G C*08:01:01G
11 Q63 DPB1 DPB1*04:02 DPB1*05:01 DPB1*04:02:01G DPB1*05:01:01G DPB1*04:02:01G DPB1*05:01:01G
11 Q63 DQB1 DQB1*03:01 DQB1*03:03 DQB1*03:01:01i DQB1*03:03:02i DQB1*03:01:01i DQB1*03:03:02i
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q63 DRB1 DRB1*09:01 DRB1*11:01 DRB1*09:01:02G DRB1*11:01:01G DRB1*09:01:02G DRB1*11:01:01i
11 Q63 DRB3 DRB3*02:02
11 Q63 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q63 DRB5
11 Q64 A A*02:01 A*02:06 A*02:01:01G A*02:06:01G A*02:01:01G A*02:06:01G
11 Q64 B B*35:47 B*52:01 B*35:47 B*52:01:02 B*35:47 B*52:01:02
11 Q64 C C*03:03 C*04:01 C*03:03:01G C*04:01:01G C*03:03:01G C*04:01:01G
11 Q64 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
11 Q64 DQB1 DQB1*03:02 DQB1*04:02 DQB1*04:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
11 Q64 DRB1 DRB1*04:04 DRB1*04:07 DRB1*04:04:01 DRB1*04:07:01G DRB1*04:04:01 DRB1*04:07:01G
11 Q64 DRB3
11 Q64 DRB4 DRB4*01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
11 Q64 DRB5
11 Q65 A A*24:02 A*34:02 A*24:02:01G A*34:02:01 A*24:02:01G A*34:02:01
11 Q65 B B*13:02 B*14:02 B*13:02:01G B*14:02:01 B*13:02:01G B*14:02:01
11 Q65 C C*06:02 C*08:02 C*06:02:01G C*08:02:01G C*06:02:01G C*08:02:01G
11 Q65 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q65 DQB1 DQB1*02:02 DQB1*05:03 DQB1*02:02:01i DQB1*05:03:01i DQB1*02:02:01i DQB1*05:03:01i
11 Q65 DRB1 DRB1*07:01 DRB1*14:01 DRB1*07:01:01G DRB1*14:01:01G DRB1*07:01:01G DRB1*14:01:01i
11 Q65 DRB3 DRB3*02:02 DRB3*02:02:01G
11 Q65 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q65 DRB5
11 Q66 A A*02:01 A*26:01 A*02:01:01G A*26:01:01G A*02:01:01G A*26:01:01G
11 Q66 B B*07:02 B*35:01 B*07:02:01G B*35:01:01G B*07:02:01G B*35:01:01G
11 Q66 C C*04:01 C*07:02 C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
11 Q66 DPB1 DPB1*03:01 DPB1*04:01 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
11 Q66 DQB1 DQB1*06:02 DQB1*06:04 DQB1*06:02:01i DQB1*06:04:01i DQB1*06:02:01i DQB1*06:04:01i
11 Q66 DRB1 DRB1*13:02 DRB1*15:01 DRB1*13:02:01 DRB1*15:01:01G DRB1*13:02:01 DRB1*13:02:01
11 Q66 DRB3 DRB3*03:01 DRB3*03:01:01G DRB3*03:01:01G
11 Q66 DRB4
11 Q66 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
11 Q67 A A*02:01 A*02:03 A*02:01:01G A*02:03:01G A*02:01:01G A*02:03:01G
11 Q67 B B*46:01 B*51:01 B*46:01:01G B*51:01:01G B*46:01:01G B*51:01:01G
11 Q67 C C*01:02 C*14:02 C*01:02:01G C*14:02:01G C*01:02:01G C*14:02:01G
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q67 DPB1 DPB1*03:01 DPB1*04:02 DPB1*03:01:01G DPB1*04:02:01G DPB1*03:01:01G DPB1*04:02:01G
11 Q67 DQB1 DQB1*03:01 DQB1*03:02 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
11 Q67 DRB1 DRB1*04:03 DRB1*11:04 DRB1*04:03:01 DRB1*11:04:01 DRB1*04:03:01i DRB1*11:04:01i
11 Q67 DRB3 DRB3*02:02
11 Q67 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q67 DRB5
11 Q68 A A*11:01 A*24:02 A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
11 Q68 B B*08:01 B*52:01 B*08:01:01G B*52:01:01G B*08:01:01G B*52:01:01G
11 Q68 C C*07:02 C*12:02 C*07:02:01G C*12:02:01G C*07:02:01G C*12:02:01G
11 Q68 DPB1 DPB1*02:01 DPB1*04:01 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
11 Q68 DQB1 DQB1*02:01 DQB1*06:01 DQB1*02:01:01i DQB1*06:01:01i DQB1*02:01:01i DQB1*06:01:01i
11 Q68 DRB1 DRB1*03:01 DRB1*15:02 DRB1*03:01:01G DRB1*03:63 DRB1*03:01:01i DRB1*03:01:01i
11 Q68 DRB3 DRB3*02:02
11 Q68 DRB4
11 Q68 DRB5 DRB5*01:02 DRB5*01:02:01G DRB5*01:02:01G
11 Q69 A A*03:01 A*24:02 A*03:01:01G A*24:02:01G A*03:01:01G A*24:02:01G
11 Q69 B B*07:02 B*57:01 B*07:02:01G B*57:01:01G B*07:02:01G B*57:01:01G
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q69 C C*06:02 C*07:02 C*06:02:01G C*07:02:01G C*06:02:01G C*07:02:01G
11 Q69 DPB1 DPB1*04:01 DPB1*04:01 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
11 Q69 DQB1 DQB1*03:03 DQB1*06:02 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
11 Q69 DRB1 DRB1*07:01 DRB1*15:01 DRB1*07:01:01G DRB1*15:01:01G DRB1*07:01:01G DRB1*07:01:01G
11 Q69 DRB3
11 Q69 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q69 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
11 Q70 A A*03:01 A*33:01 A*03:01:01G A*33:01:01 A*03:01:01G A*33:01:01
11 Q70 B B*15:10 B*45:01 B*15:10:01 B*45:01:01G B*15:10:01 B*45:01:01G
11 Q70 C C*03:04 C*06:02 C*03:04:02 C*06:02:01G C*03:04:02 C*06:02:01G
11 Q70 DPB1 DPB1*01:01 DPB1*03:01 DPB1*01:01:01 DPB1*03:01:01G DPB1*01:01:01 DPB1*03:01:01G
11 Q70 DQB1 DQB1*04:02 DQB1*05:01 DQB1*04:02:01i DQB1*05:01:01i DQB1*04:02:01i DQB1*05:01:01i




11 Q71 A A*02:01 A*02:01 A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q71 B B*45:01 B*53:01 B*45:01:01G B*53:01:01G B*45:01:01G B*53:01:01G
11 Q71 C C*04:01 C*16:01 C*04:01:01G C*16:01:01G C*04:01:01G C*16:01:01G
11 Q71 DPB1 DPB1*01:01 DPB1*01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
11 Q71 DQB1 DQB1*04:02 DQB1*05:01 DQB1*04:02:01i DQB1*05:01:01i DQB1*04:02:01i DQB1*05:01:01i
11 Q71 DRB1 DRB1*01:02 DRB1*03:02 DRB1*01:02:01 DRB1*03:02:01 DRB1*01:02:01 DRB1*03:02:01
11 Q71 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q71 DRB4
11 Q71 DRB5
11 Q72 A A*24:02 A*68:03 A*24:02:01G A*68:03:01 A*24:02:01G A*68:03:01
11 Q72 B B*35:43 B*39:06 B*35:43:01G B*39:06:02 B*35:43:01G B*39:06:02
11 Q72 C C*01:02 C*07:02 C*01:02:01G C*07:02:01G C*01:02:01G C*07:02:01G
11 Q72 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
11 Q72 DQB1 DQB1*03:01 DQB1*03:02 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
11 Q72 DRB1 DRB1*04:03 DRB1*14:06 DRB1*04:03:01 DRB1*14:06:01 DRB1*04:03:01i DRB1*14:06:01
11 Q72 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q72 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q72 DRB5
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q79 A A*02:01 A*33:01 A*02:01:01G A*33:01:01 A*02:01:01G A*33:01:01
11 Q79 B B*14:02 B*35:12 B*14:02:01 B*35:12:01 B*14:02:01 B*35:12:01
11 Q79 C C*04:01 C*08:02
11 Q79 DPB1 DPB1*04:01 DPB1*04:02 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
11 Q79 DQB1 DQB1*03:01 DQB1*04:02 DQB1*03:01:01i DQB1*04:02:01i DQB1*03:01:01i DQB1*04:02:01i
11 Q79 DRB1 DRB1*08:02 DRB1*11:01 DRB1*08:02:01 DRB1*11:01:01G DRB1*08:02:01 DRB1*11:01:01i
11 Q79 DRB3 DRB3*02:02 DRB3*02:02:01G
11 Q79 DRB4
11 Q79 DRB5
11 Q80 A A*02:07 A*03:01 A*02:07:01G A*03:01:01G A*02:07:01G A*03:01:01G
11 Q80 B B*27:05 B*46:01 B*27:05:02G B*46:01:01G B*27:05:02G B*46:01:01G
11 Q80 C C*01:02 C*02:02 C*01:02:01G C*02:02:02G C*01:02:01G C*02:02:02G
11 Q80 DPB1 DPB1*02:02 DPB1*04:01 DPB1*02:02 DPB1*04:01:01G DPB1*02:02 DPB1*04:01:01G
11 Q80 DQB1 DQB1*05:01 DQB1*06:01 DQB1*05:01:01i DQB1*06:01:01i DQB1*05:01:01i DQB1*06:01:01i
11 Q80 DRB1 DRB1*01:01 DRB1*08:03 DRB1*01:01:01G DRB1*08:03:02 DRB1*01:01:01i DRB1*08:03:02
11 Q80 DRB3
11 Q80 DRB4 DRB4*01:01:01G
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q80 DRB5
11 Q81 A A*25:01 A*30:01 A*25:01:01G A*30:01:01G A*25:01:01G A*30:01:01G
11 Q81 B B*13:02 B*18:01 B*13:02:01G B*18:01:01G B*13:02:01G B*18:01:01G
11 Q81 C C*06:02 C*12:03 C*07:76:02 C*12:03:08
11 Q81 DPB1 DPB1*03:01:01G DPB1*17:01 DPB1*03:01:01G DPB1*17:01:01G DPB1*03:01:01G DPB1*17:01:01G
11 Q81 DQB1 DQB1*02:02 DQB1*02:02 DQB1*02:02:01i DQB1*02:02:01i DQB1*02:01:19 DQB1*02:02:01i
11 Q81 DRB1 DRB1*07:01 DRB1*07:01 DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G DRB1*07:01:01G
11 Q81 DRB3
11 Q81 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
11 Q81 DRB5
11 Q82 A A*03:02 A*68:02 A*03:02:01 A*68:02:01G A*03:02:01 A*68:02:01G
11 Q82 B B*15:17 B*49:01 B*15:17:01G B*49:01:01G B*15:17:01G B*49:01:01G
11 Q82 C C*05:01 C*05:01 C*05:01:01G C*05:01:01G C*05:01:01G C*05:01:01G
11 Q82 DPB1 DPB1*02:01 DPB1*14:01 DPB1*02:01:02G DPB1*14:01 DPB1*02:01:02G DPB1*14:01
11 Q82 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i
11 Q82 DRB1 DRB1*11:02 DRB1*13:03 DRB1*11:02:01 DRB1*13:03:01 DRB1*11:02:01 DRB1*13:03:01
11 Q82 DRB3 DRB3*02:02 DRB3*03:01 DRB3*02:02:01G DRB3*03:01:01G DRB3*02:02:01G DRB3*03:01:01G
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Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q82 DRB4
11 Q82 DRB5
11 Q83 A A*01:01 A*26:01 A*01:01:01G A*26:01:01G A*01:01:01G A*26:01:01G
11 Q83 B B*45:01 B*51:01 B*45:01:01G B*51:01:01G B*45:01:01G B*51:01:01G
11 Q83 C C*06:02 C*15:02 C*06:02:01G C*15:02:01G C*06:02:01G C*15:02:01G
11 Q83 DPB1 DPB1*19:01 DPB1*20:01 DPB1*19:01:01G DPB1*20:01:01 DPB1*19:01:01G DPB1*20:01:01
11 Q83 DQB1 DQB1*02:02 DQB1*06:03 DQB1*02:02:01i DQB1*06:03:01i DQB1*02:02:01i DQB1*06:03:01i
11 Q83 DRB1 DRB1*07:01 DRB1*13:01 DRB1*07:01:01G DRB1*13:01:01G DRB1*07:01:01G DRB1*13:01:01i
11 Q83 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
11 Q83 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
11 Q83 DRB5
11 Q84 A A*03:01 A*30:02 A*03:01:01G A*30:02:01G A*03:01:01G A*30:02:01G
11 Q84 B B*40:01 B*58:01 B*40:01:01G B*58:01:01G B*40:01:01G B*58:01:01G
11 Q84 C C*03:04 C*07:01 C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
11 Q84 DPB1 DPB1*03:01 DPB1*11:01 DPB1*03:01:01G DPB1*11:01:01 DPB1*03:01:01G DPB1*11:01:01
11 Q84 DQB1 DQB1*03:01 DQB1*06:04 DQB1*03:01:01i DQB1*06:04:01i DQB1*03:01:01i DQB1*06:04:01i
11 Q84 DRB1 DRB1*13:02 DRB1*13:03 DRB1*13:02:01 DRB1*13:03:01 DRB1*13:02:01 DRB1*13:03:01
High confidence Medium confidence Low confidence Discordant call
continued . . .
278
B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
11 Q84 DRB3 DRB3*01:01 DRB3*03:01 DRB3*01:01:02G DRB3*03:01:01G DRB3*01:01:02G DRB3*03:01:01G
11 Q84 DRB4
11 Q84 DRB5
12 Q85 A A*66:01 A*74:01 A*66:01:01G A*74:01:01G A*66:01:01G A*74:01:01G
12 Q85 B B*42:01 B*58:02 B*42:01:01 B*58:02 B*42:01:01 B*58:02
12 Q85 C C*06:02 C*17:01 C*06:02:01G C*17:01:01G C*06:02:01G C*12:04:01
12 Q85 DPB1 DPB1*01:01 DPB1*11:01 DPB1*01:01:01 DPB1*11:01:01 DPB1*01:01:01 DPB1*11:01:01
12 Q85 DQB1 DQB1*02:02 DQB1*04:02 DQB1*02:02:01i DQB1*04:02:01i DQB1*02:02:01i DQB1*04:02:01i
12 Q85 DRB1 DRB1*03:02 DRB1*07:01 DRB1*03:02:01 DRB1*07:01:01G DRB1*03:02:01 DRB1*07:01:01G
12 Q85 DRB3 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G
12 Q85 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
12 Q85 DRB5
12 Q86 A A*30:02 A*36:01 A*30:02:01G A*36:01 A*30:02:01G A*36:01
12 Q86 B B*50:01 B*53:01 B*50:01:01G B*53:01:01G B*50:01:01G B*53:01:01G
12 Q86 C C*04:01 C*06:02 C*04:01:01G C*06:02:01G C*04:01:01G C*06:02:01G
12 Q86 DPB1 DPB1*02:01 DPB1*17:01 DPB1*02:01:02G DPB1*17:01:01G DPB1*02:01:02G DPB1*17:01:01G
12 Q86 DQB1 DQB1*03:01 DQB1*06:02 DQB1*03:01:04i DQB1*06:02:01i DQB1*03:01:04i DQB1*06:02:01i
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
12 Q86 DRB1 DRB1*08:04 DRB1*11:01 DRB1*08:04:01 DRB1*11:01:02 DRB1*08:04:01 DRB1*11:01:02
12 Q86 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
12 Q86 DRB4 DRB4*01:01:01G
12 Q86 DRB5
12 Q87 A A*02:01 A*34:02 A*02:01:01G A*34:02:01 A*02:01:01G A*34:02:01
12 Q87 B B*15:03 B*81:01 B*15:03:01G B*81:01:01G B*15:03:01G B*81:01:01G
12 Q87 C C*04:01 C*18:01 C*04:01:01G C*18:01:01G C*04:01:01G C*18:01:01G
12 Q87 DPB1 DPB1*01:01 DPB1*18:01 DPB1*01:01:02G DPB1*18:01 DPB1*01:01:02G DPB1*18:01
12 Q87 DQB1 DQB1*02:01 DQB1*06:08 DQB1*02:01:01i DQB1*06:08:01 DQB1*02:01:01i DQB1*06:08:01
12 Q87 DRB1 DRB1*03:01 DRB1*13:01 DRB1*03:01:01G DRB1*13:01:01G DRB1*03:01:01i DRB1*13:01:01i
12 Q87 DRB3 DRB3*02:02 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
12 Q87 DRB4
12 Q87 DRB5
12 Q88 A A*24:02 A*31:01 A*24:02:01G A*31:01:02G A*24:02:01G A*31:01:02G
12 Q88 B B*38:01 B*51:01 B*38:01:01 B*51:01:01G B*38:01:01 B*51:01:01G
12 Q88 C C*12:03 C*14:02 C*12:03:01G C*12:03:01G
12 Q88 DPB1 DPB1*02:01 DPB1*05:01 DPB1*02:01:02G DPB1*05:01:01G DPB1*02:01:02G DPB1*05:01:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
12 Q88 DQB1 DQB1*03:01 DQB1*03:03 DQB1*03:01:01i DQB1*03:03:02i DQB1*03:01:01i DQB1*03:03:02i
12 Q88 DRB1 DRB1*04:01 DRB1*09:01 DRB1*04:01:01 DRB1*09:01:02G DRB1*04:01:01 DRB1*09:01:02G
12 Q88 DRB3
12 Q88 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
12 Q88 DRB5
12 Q89 A A*24:02 A*24:02 A*24:02:01G A*24:02:01G A*24:02:01G A*24:02:01G
12 Q89 B B*39:06 B*39:06 B*39:06:02 B*39:06:02 B*39:06:02 B*39:06:02
12 Q89 C C*07:02 C*07:02 C*07:02:01G C*07:02:01G C*07:02:01G C*07:02:01G
12 Q89 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
12 Q89 DQB1 DQB1*03:01 DQB1*03:01 DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i DQB1*03:01:01i
12 Q89 DRB1 DRB1*14:06 DRB1*14:06 DRB1*14:06:01 DRB1*14:06:01 DRB1*14:06:01 DRB1*14:06:01
12 Q89 DRB3 DRB3*01:01 DRB3*01:01 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
12 Q89 DRB4
12 Q89 DRB5
12 Q90 A A*11:01 A*11:01 A*11:01:01G A*11:01:01G A*11:01:01G A*11:01:01G
12 Q90 B B*40:01 B*46:01 B*40:01:01G B*46:01:01G B*40:01:01G B*46:01:01G
12 Q90 C C*01:02 C*07:02 C*01:02:01G C*07:02:01G C*01:02:01G C*07:02:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
12 Q90 DPB1 DPB1*05:01 DPB1*05:01 DPB1*05:01:01G DPB1*05:01:01G DPB1*05:01:01G DPB1*05:01:01G
12 Q90 DQB1 DQB1*03:02 DQB1*03:03 DQB1*03:02:01i DQB1*03:03:02i DQB1*03:02:01i DQB1*03:40
12 Q90 DRB1 DRB1*04:05 DRB1*09:01 DRB1*04:05:01 DRB1*09:01:02G DRB1*04:05:01i DRB1*09:01:02G
12 Q90 DRB3
12 Q90 DRB4 DRB4*01:01 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G DRB4*01:01:01G
12 Q90 DRB5
13 Q91 A A*02:01 A*02:05 A*02:01:01G A*02:05:01G A*02:01:01G A*02:05:01G
13 Q91 B B*41:01 B*56:01 B*41:01:01 B*56:01:01G B*41:01:01 B*56:01:01G
13 Q91 C C*01:02 C*07:01 C*01:02:01G C*07:01:01G C*01:02:01G C*07:01:01G
13 Q91 DPB1 DPB1*04:01 DPB1*06:01 DPB1*04:01:01G DPB1*06:01 DPB1*04:01:01G DPB1*06:01
13 Q91 DQB1 DQB1*03:01 DQB1*05:01 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:116i DQB1*05:01:01i
13 Q91 DRB1 DRB1*01:01 DRB1*13:05 DRB1*01:01:01G DRB1*13:05:01 DRB1*01:01:01i DRB1*13:05:01
13 Q91 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
13 Q91 DRB4
13 Q91 DRB5
13 Q92 A A*34:02 A*74:01 A*34:02:01 A*74:01:01G A*34:02:01 A*74:01:01G
13 Q92 B B*15:31 B*58:01 B*15:31 B*58:01:01G B*15:31 B*58:01:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
13 Q92 C C*02:10 C*04:07 C*02:10 C*02:10
13 Q92 DPB1 DPB1*02:01 DPB1*04:02 DPB1*02:01:02G DPB1*04:02:01G DPB1*02:01:02G DPB1*04:02:01G
13 Q92 DQB1 DQB1*03:03 DQB1*06:02 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
13 Q92 DRB1 DRB1*07:01 DRB1*15:03 DRB1*07:01:01G DRB1*15:03:01G DRB1*07:01:01G DRB1*15:03:01G
13 Q92 DRB3
13 Q92 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
13 Q92 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
13 Q93 A A*24:02 A*25:01 A*24:02:01G A*25:01:01G A*24:02:01G A*25:01:01G
13 Q93 B B*39:02 B*44:03 B*39:02:02 B*44:03:01G B*39:02:02 B*44:03:01G
13 Q93 C C*03:04 C*16:01 C*03:04:01G C*16:01:01G C*03:04:01G C*16:01:01G
13 Q93 DPB1 DPB1*04:02 DPB1*14:01 DPB1*14:01 DPB1*14:01 DPB1*04:02:01G DPB1*14:01
13 Q93 DQB1 DQB1*03:02 DQB1*06:02 DQB1*03:02:01i DQB1*06:02:01i DQB1*03:02:01i DQB1*06:02:01i
13 Q93 DRB1 DRB1*04:04 DRB1*15:01 DRB1*04:04:01 DRB1*15:01:01G DRB1*04:04:01 DRB1*15:01:01i
13 Q93 DRB3
13 Q93 DRB4 DRB4*01:01 DRB4*01:01:01G DRB4*01:01:01G
13 Q93 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
13 Q94 A A*68:02 A*74:01 A*68:02:01G A*74:01:01G A*68:02:01G A*74:01:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
13 Q94 B B*53:01 B*58:02 B*53:01:01G B*58:02 B*53:01:01G B*58:02
13 Q94 C C*04:01 C*06:02 C*04:01:01G C*06:02:01G C*04:01:01G C*06:02:01G
13 Q94 DPB1 DPB1*04:02 DPB1*04:02 DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G DPB1*04:02:01G
13 Q94 DQB1 DQB1*03:01 DQB1*06:02 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
13 Q94 DRB1 DRB1*11:02 DRB1*15:03 DRB1*11:02:01 DRB1*15:03:01G DRB1*11:02:01 DRB1*15:03:01G
13 Q94 DRB3 DRB3*02:02 DRB3*02:02:01G DRB3*02:02:01G
13 Q94 DRB4
13 Q94 DRB5 DRB5*01:01 DRB5*01:01:01 DRB5*01:01:01
13 Q95 A A*02:07 A*24:02 A*02:07:01G A*24:02:01G A*02:07:01G A*24:02:01G
13 Q95 B B*38:02 B*38:02 B*38:02:01G B*38:02:01G B*38:02:01G B*38:02:01G
13 Q95 C C*07:02 C*08:01 C*07:02:01G C*08:01:01G C*07:02:01G C*08:01:01G
13 Q95 DPB1 DPB1*02:02 DPB1*17:01 DPB1*02:02 DPB1*17:01:01G DPB1*02:02 DPB1*17:01:01G
13 Q95 DQB1 DQB1*05:01 DQB1*05:02 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
13 Q95 DRB1 DRB1*15:02 DRB1*16:02 DRB1*15:02:01 DRB1*16:02:01 DRB1*15:02:01 DRB1*16:02:01
13 Q95 DRB3
13 Q95 DRB4
13 Q95 DRB5 DRB5*01:01 DRB5*01:02 DRB5*01:01:01 DRB5*01:02:01G DRB5*01:01:01 DRB5*01:02:01G
High confidence Medium confidence Low confidence Discordant call
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B. Allele calls from UCLA QAP samples
. . . QAP results continued
Run Id Locus Allele 1 Allele 2 Expectation 1 Expectation 2 Clustering 1 Clustering 2
13 Q96 A A*02:01 A*24:02 A*02:01:01G A*24:02:01G A*02:01:01G A*24:02:01G
13 Q96 B B*15:01 B*15:01 B*15:01:01G B*15:01:01G B*15:01:01G B*15:01:01G
13 Q96 C C*03:03 C*03:03 C*03:03:01G C*03:03:01G C*03:03:01G C*03:03:01G
13 Q96 DPB1 DPB1*04:01 DPB1*10:01 DPB1*04:01:01G DPB1*10:01 DPB1*04:01:01G DPB1*10:01
13 Q96 DQB1 DQB1*05:01 DQB1*06:01 DQB1*05:01:01i DQB1*06:01:01i DQB1*05:01:01i DQB1*06:01:01i
13 Q96 DRB1 DRB1*01:01 DRB1*15:02 DRB1*01:01:01G DRB1*15:02:01 DRB1*01:01:01i DRB1*15:02:01
13 Q96 DRB3
13 Q96 DRB4
13 Q96 DRB5 DRB5*01:02 DRB5*01:02:01G DRB5*01:02:01G
Table B.1.: Allele calls for the UCLA QAP dataset [2]. Allele 1 and Allele 2 are the calls made by UCLA. Expectation 1 and 2 are the allele calls
made from the FLX 454 data using the allele caller based on expectation. Clustering 1 and 2 are the allele calls made from the FLX 454
data using the allele caller based on clustering. The font color of allele calls represents ’High’, ’Medium’ and ’Low’ confidence calls,
and background shading represents discordance with the UCLA calls. As IMGT G groups are based on sequencing only exon 2 for
HLA-DQB1, they could not be used for this dataset, which also included partial sequencing of exon 3. Instead i groups were created
which group alleles that can-not be differentiated based on the sequenced regions for exon 2 and 3.
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C. Allele calls from MiSeq sequencing data
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
1 100,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
1 100,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
1 100,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
1 100,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
1 100,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01
1 100,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
1 100,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M1 DRB5
1 200,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
1 200,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
1 200,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
1 200,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
1 200,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
1 200,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
1 200,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M1 DRB5
1 500,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
1 500,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
1 500,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
1 500,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
1 500,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
1 500,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
1 500,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
1 500,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M1 DRB5
2 100,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
2 100,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
2 100,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
2 100,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
2 100,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
2 100,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
2 100,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M1 DRB5
2 200,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
2 200,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
2 200,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
2 200,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
2 200,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
2 200,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
2 200,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
2 200,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M1 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
2 500,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
2 500,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
2 500,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
2 500,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
2 500,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
2 500,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
2 500,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M1 DRB5
3 100,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
3 100,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
3 100,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
3 100,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
3 100,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
3 100,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
3 100,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
3 100,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M1 DRB5
3 200,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
3 200,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
3 200,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
3 200,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
3 200,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
3 200,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
3 200,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
3 200,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M1 DRB5
3 500,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
3 500,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
3 500,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
3 500,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
3 500,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
3 500,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
3 500,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M1 DRB5
4 100,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
4 100,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
4 100,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
4 100,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
4 100,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
4 100,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
4 100,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
4 100,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M1 DRB5
4 200,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
4 200,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
4 200,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
4 200,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
4 200,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
4 200,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
4 200,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M1 DRB5
4 500,000 M1 A A*11:01:01G A*74:01:01G A*11:01:01G A*74:01:01G
4 500,000 M1 B B*07:02:01G B*53:01:01G B*07:02:01G B*53:01:01G
4 500,000 M1 C C*04:01:01G C*07:02:01G C*04:01:01G C*07:02:01G
4 500,000 M1 DPB1 DPB1*04:01:01G DPB1*13:01:01G DPB1*04:01:01G DPB1*13:01:01G
4 500,000 M1 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
4 500,000 M1 DRB1 DRB1*04:01:01 DRB1*13:02:01 DRB1*04:01:01 DRB1*13:02:01
4 500,000 M1 DRB3 DRB3*03:01:01G DRB3*03:01:01G
4 500,000 M1 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M1 DRB5
1 100,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
1 100,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
1 100,000 M2 C C*03:04:01G C*12:02:01G
1 100,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
1 100,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
1 100,000 M2 DRB3
1 100,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
1 200,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
1 200,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
1 200,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*03:04:01G
1 200,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
1 200,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
1 200,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
1 200,000 M2 DRB3
1 200,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
1 500,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
1 500,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
1 500,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
1 500,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
1 500,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
1 500,000 M2 DRB3
1 500,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
2 100,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
2 100,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
2 100,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
2 100,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
2 100,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
2 100,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*15:02:01 DRB1*15:02:01
2 100,000 M2 DRB3
2 100,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
2 200,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
2 200,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
2 200,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
2 200,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
2 200,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*15:02:01 DRB1*15:02:01
2 200,000 M2 DRB3
2 200,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
2 500,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
2 500,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
2 500,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
2 500,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
2 500,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
2 500,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
2 500,000 M2 DRB3
2 500,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
3 100,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
3 100,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M2 C C*03:04:01G C*12:02:01G C*12:02:01G C*12:02:01G
3 100,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
3 100,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
3 100,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*04:07:01G
3 100,000 M2 DRB3
3 100,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
3 200,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
3 200,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
3 200,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
3 200,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
3 200,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
3 200,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*04:07:01G
3 200,000 M2 DRB3
3 200,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
3 500,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
3 500,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
3 500,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
3 500,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
3 500,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
3 500,000 M2 DRB3
3 500,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
4 100,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
4 100,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
4 100,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
4 100,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
4 100,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
4 100,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
4 100,000 M2 DRB3
4 100,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
4 200,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
4 200,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
4 200,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
4 200,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
4 200,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
4 200,000 M2 DRB3
4 200,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
4 500,000 M2 A A*02:01:01G A*32:01:01G A*02:01:01G A*02:65
4 500,000 M2 B B*35:01:01G B*52:01:01G B*35:01:01G B*52:01:01G
4 500,000 M2 C C*03:04:01G C*12:02:01G C*03:04:01G C*12:02:01G
4 500,000 M2 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
4 500,000 M2 DQB1 DQB1*03:02:01i DQB1*06:01:01i DQB1*03:02:01i DQB1*06:01:01i
4 500,000 M2 DRB1 DRB1*04:07:01G DRB1*15:02:01 DRB1*04:07:01G DRB1*15:02:01
4 500,000 M2 DRB3
4 500,000 M2 DRB4 DRB4*01:01:01G DRB4*01:01:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M2 DRB5 DRB5*01:02:01G DRB5*01:02:01G
1 100,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
1 100,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
1 100,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
1 100,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
1 100,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
1 100,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01G
1 100,000 M3 DRB3
1 100,000 M3 DRB4
1 100,000 M3 DRB5
1 200,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
1 200,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
1 200,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
1 200,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
1 200,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
1 200,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
1 200,000 M3 DRB3
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M3 DRB4
1 200,000 M3 DRB5
1 500,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
1 500,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
1 500,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
1 500,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
1 500,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
1 500,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01G
1 500,000 M3 DRB3
1 500,000 M3 DRB4
1 500,000 M3 DRB5
2 100,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
2 100,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
2 100,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
2 100,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
2 100,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
2 100,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M3 DRB3
2 100,000 M3 DRB4
2 100,000 M3 DRB5
2 200,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
2 200,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
2 200,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
2 200,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
2 200,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
2 200,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
2 200,000 M3 DRB3
2 200,000 M3 DRB4
2 200,000 M3 DRB5
2 500,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
2 500,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
2 500,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
2 500,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
2 500,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
High confidence Medium confidence Low confidence Discordant call
continued . . .
301
C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
2 500,000 M3 DRB3
2 500,000 M3 DRB4
2 500,000 M3 DRB5
3 100,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
3 100,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
3 100,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
3 100,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
3 100,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
3 100,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
3 100,000 M3 DRB3
3 100,000 M3 DRB4
3 100,000 M3 DRB5
3 200,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
3 200,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
3 200,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
3 200,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
3 200,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
3 200,000 M3 DRB3
3 200,000 M3 DRB4
3 200,000 M3 DRB5
3 500,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
3 500,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
3 500,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
3 500,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
3 500,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
3 500,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
3 500,000 M3 DRB3
3 500,000 M3 DRB4
3 500,000 M3 DRB5
4 100,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
4 100,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
4 100,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
4 100,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
4 100,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
4 100,000 M3 DRB3
4 100,000 M3 DRB4
4 100,000 M3 DRB5
4 200,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
4 200,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
4 200,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
4 200,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
4 200,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
4 200,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
4 200,000 M3 DRB3
4 200,000 M3 DRB4
4 200,000 M3 DRB5
4 500,000 M3 A A*03:01:01G A*25:01:01G A*03:01:01G A*25:01:01G
4 500,000 M3 B B*18:01:01G B*35:01:01G B*18:01:01G B*35:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M3 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
4 500,000 M3 DPB1 DPB1*04:02:01G DPB1*17:01:01G DPB1*04:02:01G DPB1*17:01:01G
4 500,000 M3 DQB1 DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i DQB1*05:01:01i
4 500,000 M3 DRB1 DRB1*01:01:01G DRB1*01:01:01G DRB1*01:01:01i DRB1*01:01:01i
4 500,000 M3 DRB3
4 500,000 M3 DRB4
4 500,000 M3 DRB5
1 100,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
1 100,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
1 100,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 100,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
1 100,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
1 100,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
1 100,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
1 100,000 M4 DRB4
1 100,000 M4 DRB5
1 200,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
1 200,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 200,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
1 200,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
1 200,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
1 200,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
1 200,000 M4 DRB4
1 200,000 M4 DRB5
1 500,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
1 500,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
1 500,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 500,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
1 500,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
1 500,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01G DRB1*11:04:01i
1 500,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
1 500,000 M4 DRB4
1 500,000 M4 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
2 100,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
2 100,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
2 100,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
2 100,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
2 100,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01G DRB1*11:04:01i
2 100,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
2 100,000 M4 DRB4
2 100,000 M4 DRB5
2 200,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
2 200,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
2 200,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
2 200,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
2 200,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
2 200,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
2 200,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
2 200,000 M4 DRB4
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M4 DRB5
2 500,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
2 500,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
2 500,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
2 500,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
2 500,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
2 500,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
2 500,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
2 500,000 M4 DRB4
2 500,000 M4 DRB5
3 100,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
3 100,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
3 100,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
3 100,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
3 100,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
3 100,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
3 100,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*01:01:02G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M4 DRB4
3 100,000 M4 DRB5
3 200,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
3 200,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
3 200,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
3 200,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
3 200,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
3 200,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
3 200,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
3 200,000 M4 DRB4
3 200,000 M4 DRB5
3 500,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
3 500,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
3 500,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
3 500,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
3 500,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
3 500,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
3 500,000 M4 DRB4
3 500,000 M4 DRB5
4 100,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
4 100,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
4 100,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
4 100,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
4 100,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
4 100,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
4 100,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
4 100,000 M4 DRB4
4 100,000 M4 DRB5
4 200,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
4 200,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
4 200,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
4 200,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
4 200,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
4 200,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
4 200,000 M4 DRB4
4 200,000 M4 DRB5
4 500,000 M4 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
4 500,000 M4 B B*08:01:01G B*18:01:01G B*08:01:01G B*18:01:01G
4 500,000 M4 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
4 500,000 M4 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
4 500,000 M4 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
4 500,000 M4 DRB1 DRB1*03:01:01G DRB1*11:04:01i DRB1*03:01:01i DRB1*11:04:01i
4 500,000 M4 DRB3 DRB3*01:01:02G DRB3*02:02:01G DRB3*01:01:02G DRB3*02:02:01G
4 500,000 M4 DRB4
4 500,000 M4 DRB5
1 100,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
1 100,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
1 100,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
1 100,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:01:01i
1 100,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01G
1 100,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 100,000 M5 DRB4
1 100,000 M5 DRB5
1 200,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
1 200,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
1 200,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
1 200,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
1 200,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
1 200,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
1 200,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 200,000 M5 DRB4
1 200,000 M5 DRB5
1 500,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
1 500,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
1 500,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
1 500,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
1 500,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01G
1 500,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 500,000 M5 DRB4
1 500,000 M5 DRB5
2 100,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
2 100,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
2 100,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
2 100,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
2 100,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
2 100,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
2 100,000 M5 DRB3 DRB3*02:02:01G
2 100,000 M5 DRB4
2 100,000 M5 DRB5
2 200,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
2 200,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
2 200,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
2 200,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
2 200,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
2 200,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 200,000 M5 DRB4
2 200,000 M5 DRB5
2 500,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
2 500,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
2 500,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
2 500,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
2 500,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
2 500,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
2 500,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 500,000 M5 DRB4
2 500,000 M5 DRB5
3 100,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
3 100,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
3 100,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
3 100,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
3 100,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
3 100,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 100,000 M5 DRB4
3 100,000 M5 DRB5
3 200,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
3 200,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
3 200,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
3 200,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
3 200,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
3 200,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
3 200,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 200,000 M5 DRB4
3 200,000 M5 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
3 500,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
3 500,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
3 500,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
3 500,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
3 500,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
3 500,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 500,000 M5 DRB4
3 500,000 M5 DRB5
4 100,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
4 100,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
4 100,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
4 100,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
4 100,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
4 100,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
4 100,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 100,000 M5 DRB4
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M5 DRB5
4 200,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
4 200,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
4 200,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
4 200,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
4 200,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
4 200,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
4 200,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 200,000 M5 DRB4
4 200,000 M5 DRB5
4 500,000 M5 A A*31:01:02G A*34:01:01 A*31:01:02G A*34:01:01
4 500,000 M5 B B*13:01:01G B*49:01:01G B*13:01:01G B*49:01:01G
4 500,000 M5 C C*07:01:01G C*12:03:01G C*07:01:01G C*12:03:01G
4 500,000 M5 DPB1 DPB1*01:01:01 DPB1*04:01:01G DPB1*01:01:01 DPB1*04:01:01G
4 500,000 M5 DQB1 DQB1*05:01:01i DQB1*05:02:01i DQB1*05:01:01i DQB1*05:02:01i
4 500,000 M5 DRB1 DRB1*01:02:01 DRB1*14:01:01G DRB1*01:02:01 DRB1*14:01:01i
4 500,000 M5 DRB3 DRB3*02:02:01G DRB3*02:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M5 DRB4
4 500,000 M5 DRB5
1 100,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
1 100,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
1 100,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
1 100,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 100,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
1 100,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
1 100,000 M6 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 100,000 M6 DRB4
1 100,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 200,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
1 200,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
1 200,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
1 200,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 200,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
1 200,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M6 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 200,000 M6 DRB4
1 200,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 500,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
1 500,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
1 500,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
1 500,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 500,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
1 500,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01G
1 500,000 M6 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 500,000 M6 DRB4
1 500,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 100,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
2 100,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
2 100,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
2 100,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 100,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
2 100,000 M6 DRB3 DRB3*02:02:01G
2 100,000 M6 DRB4
2 100,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 200,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
2 200,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
2 200,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
2 200,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 200,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
2 200,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
2 200,000 M6 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 200,000 M6 DRB4
2 200,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 500,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
2 500,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
2 500,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
2 500,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
2 500,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
2 500,000 M6 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 500,000 M6 DRB4
2 500,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 100,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
3 100,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
3 100,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
3 100,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 100,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
3 100,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
3 100,000 M6 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 100,000 M6 DRB4
3 100,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 200,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
3 200,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
3 200,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 200,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
3 200,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
3 200,000 M6 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 200,000 M6 DRB4
3 200,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 500,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
3 500,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
3 500,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
3 500,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 500,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
3 500,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
3 500,000 M6 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 500,000 M6 DRB4
3 500,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 100,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
4 100,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
4 100,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 100,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
4 100,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
4 100,000 M6 DRB3 DRB3*02:02:01G
4 100,000 M6 DRB4
4 100,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 200,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
4 200,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
4 200,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
4 200,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 200,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
4 200,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
4 200,000 M6 DRB3 DRB3*02:02:01G
4 200,000 M6 DRB4
4 200,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 500,000 M6 A A*03:01:01G A*29:02:01G A*03:01:01G A*29:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M6 B B*07:02:01G B*44:03:01G B*07:02:01G B*44:03:01G
4 500,000 M6 C C*07:02:01G C*16:01:01G C*07:02:01G C*16:01:01G
4 500,000 M6 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 500,000 M6 DQB1 DQB1*05:03:01i DQB1*06:02:01i DQB1*05:03:01i DQB1*06:02:01i
4 500,000 M6 DRB1 DRB1*14:01:01G DRB1*15:01:01G DRB1*14:01:01i DRB1*15:01:01i
4 500,000 M6 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 500,000 M6 DRB4
4 500,000 M6 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 100,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
1 100,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
1 100,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
1 100,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
1 100,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
1 100,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
1 100,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 100,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M7 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
1 200,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
1 200,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
1 200,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
1 200,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
1 200,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
1 200,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 200,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M7 DRB5
1 500,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
1 500,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
1 500,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
1 500,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
1 500,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
1 500,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
1 500,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 500,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M7 DRB5
2 100,000 M7 A A*11:01:01G A*24:02:01G A*24:02:01G A*24:02:01G
2 100,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
2 100,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
2 100,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
2 100,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
2 100,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G
2 100,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 100,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M7 DRB5
2 200,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
2 200,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
2 200,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
2 200,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
2 200,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
2 200,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
2 200,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M7 DRB5
2 500,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
2 500,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
2 500,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
2 500,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
2 500,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
2 500,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
2 500,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 500,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M7 DRB5
3 100,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
3 100,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
3 100,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
3 100,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
3 100,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
3 100,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 100,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M7 DRB5
3 200,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
3 200,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
3 200,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
3 200,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
3 200,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
3 200,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*11:06:01G DRB1*11:06:01G
3 200,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 200,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M7 DRB5
3 500,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
3 500,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
3 500,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
3 500,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
3 500,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
High confidence Medium confidence Low confidence Discordant call
continued . . .
328
C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
3 500,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 500,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M7 DRB5
4 100,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
4 100,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
4 100,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
4 100,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
4 100,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
4 100,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
4 100,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 100,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M7 DRB5
4 200,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
4 200,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
4 200,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
4 200,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
4 200,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
4 200,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 200,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M7 DRB5
4 500,000 M7 A A*11:01:01G A*24:02:01G A*11:01:01G A*24:02:01G
4 500,000 M7 B B*15:25:01G B*54:01:01G B*15:25:01G B*54:01:01G
4 500,000 M7 C C*01:02:01G C*04:03:01 C*01:02:01G C*04:03:01
4 500,000 M7 DPB1 DPB1*05:01:01G DPB1*28:01:01G DPB1*05:01:01G DPB1*28:01:01G
4 500,000 M7 DQB1 DQB1*03:01:01i DQB1*04:01:01 DQB1*03:01:01i DQB1*04:01:01
4 500,000 M7 DRB1 DRB1*04:05:01i DRB1*11:06:01G DRB1*04:05:01i DRB1*11:06:01G
4 500,000 M7 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 500,000 M7 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M7 DRB5
1 100,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
1 100,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
1 100,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
1 100,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
1 100,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
1 100,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 100,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M8 DRB5
1 200,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
1 200,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
1 200,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
1 200,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
1 200,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
1 200,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
1 200,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 200,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M8 DRB5
1 500,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
1 500,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
1 500,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
1 500,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
1 500,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
1 500,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 500,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M8 DRB5
2 100,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
2 100,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
2 100,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
2 100,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
2 100,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
2 100,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01G
2 100,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 100,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M8 DRB5
2 200,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
2 200,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
2 200,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
2 200,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
2 200,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
2 200,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 200,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M8 DRB5
2 500,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
2 500,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
2 500,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
2 500,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
2 500,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
2 500,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
2 500,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 500,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M8 DRB5
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
3 100,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
3 100,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
3 100,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
3 100,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
3 100,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
3 100,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 100,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M8 DRB5
3 200,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
3 200,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
3 200,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
3 200,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
3 200,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
3 200,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
3 200,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 200,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M8 DRB5
3 500,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
3 500,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
3 500,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
3 500,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
3 500,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
3 500,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
3 500,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 500,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M8 DRB5
4 100,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
4 100,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
4 100,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
4 100,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
4 100,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
4 100,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
4 100,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M8 DRB5
4 200,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
4 200,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
4 200,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
4 200,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
4 200,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
4 200,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
4 200,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 200,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M8 DRB5
4 500,000 M8 A A*01:01:01G A*29:02:01G A*01:01:01G A*29:02:01G
4 500,000 M8 B B*44:03:01G B*58:01:01G B*44:03:01G B*58:01:01G
4 500,000 M8 C C*07:01:01G C*16:01:01G C*07:01:01G C*16:01:01G
4 500,000 M8 DPB1 DPB1*05:01:01G DPB1*11:01:01 DPB1*05:01:01G DPB1*11:01:01
4 500,000 M8 DQB1 DQB1*02:02:01i DQB1*03:01:01i DQB1*02:02:01i DQB1*03:01:01i
4 500,000 M8 DRB1 DRB1*07:01:01G DRB1*11:01:01G DRB1*07:01:01G DRB1*11:01:01i
High confidence Medium confidence Low confidence Discordant call
continued . . .
336
C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M8 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 500,000 M8 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M8 DRB5
1 100,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
1 100,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
1 100,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
1 100,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
1 100,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
1 100,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
1 100,000 M9 DRB3
1 100,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M9 DRB5
1 200,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
1 200,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
1 200,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
1 200,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
1 200,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
1 200,000 M9 DRB3
1 200,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M9 DRB5
1 500,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
1 500,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
1 500,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
1 500,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
1 500,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
1 500,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
1 500,000 M9 DRB3
1 500,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M9 DRB5
2 100,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
2 100,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
2 100,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
2 100,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
2 100,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
2 100,000 M9 DRB3
2 100,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M9 DRB5
2 200,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
2 200,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
2 200,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
2 200,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
2 200,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
2 200,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
2 200,000 M9 DRB3
2 200,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M9 DRB5
2 500,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
2 500,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
2 500,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
2 500,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
2 500,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
2 500,000 M9 DRB3
2 500,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M9 DRB5
3 100,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
3 100,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
3 100,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
3 100,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
3 100,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
3 100,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
3 100,000 M9 DRB3
3 100,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M9 DRB5
3 200,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
3 200,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
3 200,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
3 200,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
3 200,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
3 200,000 M9 DRB3
3 200,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M9 DRB5
3 500,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
3 500,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
3 500,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
3 500,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
3 500,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
3 500,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
3 500,000 M9 DRB3
3 500,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M9 DRB5
4 100,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
4 100,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
4 100,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
4 100,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
4 100,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
4 100,000 M9 DRB3
4 100,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M9 DRB5
4 200,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
4 200,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
4 200,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
4 200,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
4 200,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
4 200,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
4 200,000 M9 DRB3
4 200,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M9 DRB5
High confidence Medium confidence Low confidence Discordant call
continued . . .
342
C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M9 A A*02:02:01 A*30:02:01G A*02:02:01 A*30:02:01G
4 500,000 M9 B B*15:03:01G B*57:02:01 B*15:03:01G B*57:02:01
4 500,000 M9 C C*02:10 C*18:01:01G C*02:10 C*18:01:01G
4 500,000 M9 DPB1 DPB1*04:01:01G DPB1*17:01:01G DPB1*04:01:01G DPB1*17:01:01G
4 500,000 M9 DQB1 DQB1*02:02:01i DQB1*05:01:01i DQB1*02:02:01i DQB1*05:01:01i
4 500,000 M9 DRB1 DRB1*07:01:01G DRB1*10:01:01 DRB1*07:01:01G DRB1*10:01:01
4 500,000 M9 DRB3
4 500,000 M9 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M9 DRB5
1 100,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
1 100,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
1 100,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
1 100,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
1 100,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
1 100,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01
1 100,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 100,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M10 DRB5
1 200,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
1 200,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
1 200,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
1 200,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
1 200,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
1 200,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
1 200,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 200,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M10 DRB5
1 500,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
1 500,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
1 500,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
1 500,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
1 500,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
1 500,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
1 500,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M10 DRB5
2 100,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
2 100,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
2 100,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
2 100,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
2 100,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
2 100,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01
2 100,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 100,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M10 DRB5
2 200,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
2 200,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
2 200,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
2 200,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
2 200,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
2 200,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 200,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M10 DRB5
2 500,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
2 500,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
2 500,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
2 500,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
2 500,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
2 500,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
2 500,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 500,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M10 DRB5
3 100,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
3 100,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
3 100,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
3 100,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
3 100,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
3 100,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 100,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M10 DRB5
3 200,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
3 200,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
3 200,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
3 200,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
3 200,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
3 200,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
3 200,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 200,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M10 DRB5
3 500,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
3 500,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
3 500,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
3 500,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
3 500,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
3 500,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 500,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M10 DRB5
4 100,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
4 100,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
4 100,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
4 100,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
4 100,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
4 100,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*14:02:01 DRB1*14:02:01
4 100,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 100,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M10 DRB5
4 200,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
4 200,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
4 200,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
4 200,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
4 200,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*14:02:01 DRB1*14:02:01
4 200,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 200,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M10 DRB5
4 500,000 M10 A A*68:01:02G A*68:03:01 A*68:01:02G A*68:03:01
4 500,000 M10 B B*35:01:01G B*40:02:01G B*35:01:01G B*40:02:01G
4 500,000 M10 C C*03:05 C*04:01:01G C*03:05 C*04:01:01G
4 500,000 M10 DPB1 DPB1*04:02:01G DPB1*14:01 DPB1*04:02:01G DPB1*14:01
4 500,000 M10 DQB1 DQB1*03:01:01i DQB1*03:02:01i DQB1*03:01:01i DQB1*03:02:01i
4 500,000 M10 DRB1 DRB1*04:07:01G DRB1*14:02:01 DRB1*04:07:01G DRB1*14:02:01
4 500,000 M10 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 500,000 M10 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M10 DRB5
1 100,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
1 100,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
1 100,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 100,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i
1 100,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*08:02:01 DRB1*08:02:01
1 100,000 M11 DRB3
1 100,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M11 DRB5
1 200,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
1 200,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
1 200,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
1 200,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 200,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*03:02:01i
1 200,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
1 200,000 M11 DRB3
1 200,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M11 DRB5
1 500,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
1 500,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
1 500,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 500,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
1 500,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
1 500,000 M11 DRB3
1 500,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M11 DRB5
2 100,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
2 100,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
2 100,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*01:02:01G
2 100,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 100,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
2 100,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
2 100,000 M11 DRB3
2 100,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M11 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
2 200,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
2 200,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
2 200,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 200,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
2 200,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
2 200,000 M11 DRB3
2 200,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M11 DRB5
2 500,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
2 500,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
2 500,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
2 500,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 500,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
2 500,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
2 500,000 M11 DRB3
2 500,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M11 DRB5
3 100,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
3 100,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
3 100,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
3 100,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 100,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
3 100,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
3 100,000 M11 DRB3
3 100,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M11 DRB5
3 200,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
3 200,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
3 200,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
3 200,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 200,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
3 200,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
3 200,000 M11 DRB3
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M11 DRB5
3 500,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
3 500,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
3 500,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
3 500,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 500,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
3 500,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
3 500,000 M11 DRB3
3 500,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M11 DRB5
4 100,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
4 100,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
4 100,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
4 100,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 100,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
4 100,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M11 DRB3
4 100,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M11 DRB5
4 200,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
4 200,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
4 200,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
4 200,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 200,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
4 200,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
4 200,000 M11 DRB3
4 200,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M11 DRB5
4 500,000 M11 A A*02:01:01G A*31:02 A*02:01:01G A*31:02
4 500,000 M11 B B*15:15 B*51:01:01G B*15:15 B*51:01:01G
4 500,000 M11 C C*01:02:01G C*15:02:01G C*01:02:01G C*15:02:01G
4 500,000 M11 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 500,000 M11 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M11 DRB1 DRB1*04:07:01G DRB1*08:02:01 DRB1*04:07:01G DRB1*08:02:01
4 500,000 M11 DRB3
4 500,000 M11 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M11 DRB5
1 100,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
1 100,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
1 100,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 100,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 100,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
1 100,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01G
1 100,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 100,000 M12 DRB4
1 100,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 200,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
1 200,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
1 200,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 200,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
1 200,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
1 200,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 200,000 M12 DRB4
1 200,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 500,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
1 500,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
1 500,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 500,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 500,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
1 500,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01G
1 500,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
1 500,000 M12 DRB4
1 500,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 100,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
2 100,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
2 100,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 100,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
2 100,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*15:01:01G DRB1*15:01:01G
2 100,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 100,000 M12 DRB4
2 100,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 200,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
2 200,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
2 200,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
2 200,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 200,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
2 200,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
2 200,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 200,000 M12 DRB4
2 200,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 500,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
2 500,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
2 500,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 500,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
2 500,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
2 500,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
2 500,000 M12 DRB4
2 500,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 100,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
3 100,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
3 100,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
3 100,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 100,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
3 100,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
3 100,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 100,000 M12 DRB4
3 100,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 200,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
3 200,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
3 200,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 200,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
3 200,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
3 200,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 200,000 M12 DRB4
3 200,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 500,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
3 500,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
3 500,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
3 500,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 500,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
3 500,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
3 500,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
3 500,000 M12 DRB4
3 500,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
4 100,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
4 100,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
4 100,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 100,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
4 100,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
4 100,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 100,000 M12 DRB4
4 100,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 200,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
4 200,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
4 200,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
4 200,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 200,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
4 200,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
4 200,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 200,000 M12 DRB4
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 500,000 M12 A A*23:01:01G A*30:01:01G A*23:01:01G A*30:01:01G
4 500,000 M12 B B*49:01:01G B*49:01:01G B*49:01:01G B*49:01:01G
4 500,000 M12 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
4 500,000 M12 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 500,000 M12 DQB1 DQB1*03:01:01i DQB1*06:02:01i DQB1*03:01:01i DQB1*06:02:01i
4 500,000 M12 DRB1 DRB1*11:01:01G DRB1*15:01:01G DRB1*11:01:01i DRB1*15:01:01i
4 500,000 M12 DRB3 DRB3*02:02:01G DRB3*02:02:01G
4 500,000 M12 DRB4
4 500,000 M12 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 100,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
1 100,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
1 100,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
1 100,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
1 100,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
1 100,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
1 100,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M13 DRB4
1 100,000 M13 DRB5
1 200,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
1 200,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
1 200,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
1 200,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
1 200,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
1 200,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
1 200,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
1 200,000 M13 DRB4
1 200,000 M13 DRB5
1 500,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
1 500,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
1 500,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
1 500,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
1 500,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
1 500,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
1 500,000 M13 DRB4
1 500,000 M13 DRB5
2 100,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
2 100,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
2 100,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
2 100,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
2 100,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
2 100,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
2 100,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
2 100,000 M13 DRB4
2 100,000 M13 DRB5
2 200,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
2 200,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
2 200,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
2 200,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
2 200,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
2 200,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
2 200,000 M13 DRB4
2 200,000 M13 DRB5
2 500,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
2 500,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
2 500,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
2 500,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
2 500,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
2 500,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
2 500,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
2 500,000 M13 DRB4
2 500,000 M13 DRB5
3 100,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
3 100,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
3 100,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
3 100,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
3 100,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
3 100,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
3 100,000 M13 DRB4
3 100,000 M13 DRB5
3 200,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
3 200,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
3 200,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
3 200,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
3 200,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
3 200,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
3 200,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
3 200,000 M13 DRB4
3 200,000 M13 DRB5
3 500,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
3 500,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
3 500,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
3 500,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
3 500,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
3 500,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
3 500,000 M13 DRB4
3 500,000 M13 DRB5
4 100,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
4 100,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
4 100,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
4 100,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
4 100,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
4 100,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
4 100,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
4 100,000 M13 DRB4
4 100,000 M13 DRB5
4 200,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
4 200,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
4 200,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
4 200,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
4 200,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
4 200,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
4 200,000 M13 DRB4
4 200,000 M13 DRB5
4 500,000 M13 A A*24:02:01G A*26:01:01G A*24:02:01G A*26:01:01G
4 500,000 M13 B B*51:06:01 B*51:06:01 B*51:06:01 B*51:06:01
4 500,000 M13 C C*12:04:02 C*12:04:02 C*12:04:02 C*12:04:02
4 500,000 M13 DPB1 DPB1*04:01:01G DPB1*26:01:02 DPB1*04:01:01G DPB1*26:01:02
4 500,000 M13 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
4 500,000 M13 DRB1 DRB1*10:01:01 DRB1*12:02:01 DRB1*10:01:01 DRB1*12:02:01
4 500,000 M13 DRB3 DRB3*03:01:01G DRB3*03:01:01G
4 500,000 M13 DRB4
4 500,000 M13 DRB5
1 100,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
1 100,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
1 100,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
1 100,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
1 100,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
1 100,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 100,000 M14 DRB4
1 100,000 M14 DRB5
1 200,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
1 200,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
1 200,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
1 200,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
1 200,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
1 200,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
1 200,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 200,000 M14 DRB4
1 200,000 M14 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
1 500,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
1 500,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
1 500,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
1 500,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
1 500,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01G DRB1*13:03:01
1 500,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 500,000 M14 DRB4
1 500,000 M14 DRB5
2 100,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
2 100,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
2 100,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
2 100,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
2 100,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
2 100,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01G DRB1*13:03:01
2 100,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 100,000 M14 DRB4
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M14 DRB5
2 200,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
2 200,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
2 200,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
2 200,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
2 200,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
2 200,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
2 200,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 200,000 M14 DRB4
2 200,000 M14 DRB5
2 500,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
2 500,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
2 500,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
2 500,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
2 500,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
2 500,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
2 500,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M14 DRB4
2 500,000 M14 DRB5
3 100,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
3 100,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
3 100,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
3 100,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
3 100,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
3 100,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
3 100,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 100,000 M14 DRB4
3 100,000 M14 DRB5
3 200,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
3 200,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
3 200,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
3 200,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
3 200,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
3 200,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 200,000 M14 DRB4
3 200,000 M14 DRB5
3 500,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
3 500,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
3 500,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
3 500,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
3 500,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
3 500,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
3 500,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 500,000 M14 DRB4
3 500,000 M14 DRB5
4 100,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
4 100,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
4 100,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
4 100,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
4 100,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
4 100,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 100,000 M14 DRB4
4 100,000 M14 DRB5
4 200,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
4 200,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
4 200,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
4 200,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
4 200,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
4 200,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
4 200,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 200,000 M14 DRB4
4 200,000 M14 DRB5
4 500,000 M14 A A*03:01:01G A*66:01:01G A*03:01:01G A*66:01:01G
4 500,000 M14 B B*35:01:01G B*41:02:01 B*35:01:01G B*41:02:01
4 500,000 M14 C C*04:01:01G C*17:01:01G C*04:01:01G C*17:01:01G
4 500,000 M14 DPB1 DPB1*04:01:01G DPB1*04:02:01G DPB1*04:01:01G DPB1*04:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M14 DQB1 DQB1*03:01:01i DQB1*05:01:01i DQB1*03:01:01i DQB1*05:01:01i
4 500,000 M14 DRB1 DRB1*01:01:01G DRB1*13:03:01 DRB1*01:01:01i DRB1*13:03:01
4 500,000 M14 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 500,000 M14 DRB4
4 500,000 M14 DRB5
1 100,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
1 100,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
1 100,000 M15 C C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
1 100,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
1 100,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
1 100,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01G
1 100,000 M15 DRB3
1 100,000 M15 DRB4
1 100,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 200,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
1 200,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
1 200,000 M15 C C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
1 200,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
1 200,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01i
1 200,000 M15 DRB3
1 200,000 M15 DRB4
1 200,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 500,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
1 500,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
1 500,000 M15 C C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
1 500,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
1 500,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
1 500,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01G
1 500,000 M15 DRB3
1 500,000 M15 DRB4
1 500,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 100,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
2 100,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
High confidence Medium confidence Low confidence Discordant call
continued . . .
376
C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M15 C C*07:01:01G C*07:02:01G C*07:01:01G C*07:19
2 100,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
2 100,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
2 100,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01G
2 100,000 M15 DRB3
2 100,000 M15 DRB4
2 100,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 200,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
2 200,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
2 200,000 M15 C C*07:01:01G C*07:02:01G C*07:01:01G C*07:19
2 200,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
2 200,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
2 200,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01i
2 200,000 M15 DRB3
2 200,000 M15 DRB4
2 200,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 500,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
2 500,000 M15 C C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
2 500,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
2 500,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
2 500,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01i
2 500,000 M15 DRB3
2 500,000 M15 DRB4
2 500,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 100,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
3 100,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
3 100,000 M15 C C*07:01:01G C*07:02:01G C*07:01:01G C*07:19
3 100,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
3 100,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
3 100,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01i
3 100,000 M15 DRB3
3 100,000 M15 DRB4
3 100,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
3 200,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
3 200,000 M15 C C*07:01:01G C*07:02:01G C*07:02:01G C*07:27:01
3 200,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
3 200,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
3 200,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01i
3 200,000 M15 DRB3
3 200,000 M15 DRB4
3 200,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 500,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
3 500,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
3 500,000 M15 C C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
3 500,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
3 500,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
3 500,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01i
3 500,000 M15 DRB3
3 500,000 M15 DRB4
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 100,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
4 100,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
4 100,000 M15 C C*07:01:01G C*07:02:01G C*07:02:01G C*07:19
4 100,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
4 100,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
4 100,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01i
4 100,000 M15 DRB3
4 100,000 M15 DRB4
4 100,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 200,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
4 200,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
4 200,000 M15 C C*07:01:01G C*07:02:01G C*07:02:01G C*07:19
4 200,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
4 200,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
4 200,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01i
4 200,000 M15 DRB3
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M15 DRB4
4 200,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 500,000 M15 A A*03:01:01G A*26:01:01G A*03:01:01G A*26:01:01G
4 500,000 M15 B B*07:02:01G B*49:01:01G B*07:02:01G B*49:01:01G
4 500,000 M15 C C*07:01:01G C*07:02:01G C*07:01:01G C*07:02:01G
4 500,000 M15 DPB1 DPB1*03:01:01G DPB1*04:01:01G DPB1*03:01:01G DPB1*04:01:01G
4 500,000 M15 DQB1 DQB1*05:04 DQB1*06:02:01i DQB1*05:04 DQB1*06:02:01i
4 500,000 M15 DRB1 DRB1*01:01:01G DRB1*15:01:01G DRB1*01:01:01i DRB1*15:01:01i
4 500,000 M15 DRB3
4 500,000 M15 DRB4
4 500,000 M15 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 100,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
1 100,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
1 100,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
1 100,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
1 100,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
1 100,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*01:02:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M16 DRB3
1 100,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M16 DRB5
1 200,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
1 200,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
1 200,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
1 200,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
1 200,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
1 200,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
1 200,000 M16 DRB3
1 200,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M16 DRB5
1 500,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
1 500,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
1 500,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
1 500,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
1 500,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
1 500,000 M16 DRB3
1 500,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M16 DRB5
2 100,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
2 100,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
2 100,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
2 100,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
2 100,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
2 100,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
2 100,000 M16 DRB3
2 100,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M16 DRB5
2 200,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
2 200,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
2 200,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
2 200,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
2 200,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
2 200,000 M16 DRB3
2 200,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M16 DRB5
2 500,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
2 500,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
2 500,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
2 500,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
2 500,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
2 500,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
2 500,000 M16 DRB3
2 500,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M16 DRB5
3 100,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
3 100,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
3 100,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
3 100,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
3 100,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
3 100,000 M16 DRB3
3 100,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M16 DRB5
3 200,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
3 200,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
3 200,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
3 200,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
3 200,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
3 200,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
3 200,000 M16 DRB3
3 200,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M16 DRB5
3 500,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
3 500,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
3 500,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
3 500,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
3 500,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
3 500,000 M16 DRB3
3 500,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M16 DRB5
4 100,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
4 100,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
4 100,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
4 100,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
4 100,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
4 100,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
4 100,000 M16 DRB3
4 100,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M16 DRB5
4 200,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
4 200,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
4 200,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
4 200,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
4 200,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
4 200,000 M16 DRB3
4 200,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M16 DRB5
4 500,000 M16 A A*26:01:01G A*33:01:01 A*26:01:01G A*33:01:01
4 500,000 M16 B B*14:02:01 B*35:01:01G B*14:02:01 B*35:01:01G
4 500,000 M16 C C*04:01:01G C*08:02:01G C*04:01:01G C*08:02:01G
4 500,000 M16 DPB1 DPB1*02:01:02G DPB1*03:01:01G DPB1*02:01:02G DPB1*03:01:01G
4 500,000 M16 DQB1 DQB1*03:02:01i DQB1*05:01:01i DQB1*03:02:01i DQB1*05:01:01i
4 500,000 M16 DRB1 DRB1*01:02:01 DRB1*04:02:01 DRB1*01:02:01 DRB1*04:02:01
4 500,000 M16 DRB3
4 500,000 M16 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M16 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
1 100,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
1 100,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
1 100,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
1 100,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
1 100,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01G DRB1*04:04:01
1 100,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 100,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M17 DRB5
1 200,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
1 200,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
1 200,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
1 200,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
1 200,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
1 200,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*04:04:01
1 200,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 200,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M17 DRB5
1 500,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
1 500,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
1 500,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
1 500,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
1 500,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
1 500,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01G DRB1*04:04:01
1 500,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 500,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M17 DRB5
2 100,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
2 100,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
2 100,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
2 100,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
2 100,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
2 100,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*04:04:01
2 100,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M17 DRB5
2 200,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
2 200,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
2 200,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
2 200,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
2 200,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
2 200,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*04:04:01
2 200,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 200,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M17 DRB5
2 500,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
2 500,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
2 500,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
2 500,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
2 500,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
2 500,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*04:04:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 500,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M17 DRB5
3 100,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
3 100,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
3 100,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
3 100,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
3 100,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
3 100,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*03:01:01i
3 100,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 100,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M17 DRB5
3 200,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
3 200,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
3 200,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
3 200,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
3 200,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*04:04:01
3 200,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 200,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M17 DRB5
3 500,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
3 500,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
3 500,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
3 500,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
3 500,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
3 500,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*04:04:01
3 500,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 500,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M17 DRB5
4 100,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
4 100,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
4 100,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
4 100,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
High confidence Medium confidence Low confidence Discordant call
continued . . .
392
C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
4 100,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*04:04:01
4 100,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 100,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M17 DRB5
4 200,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
4 200,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
4 200,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
4 200,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
4 200,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
4 200,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*04:04:01
4 200,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 200,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M17 DRB5
4 500,000 M17 A A*01:01:01G A*31:01:02G A*01:01:01G A*31:01:02G
4 500,000 M17 B B*08:01:01G B*40:01:01G B*08:01:01G B*40:01:01G
4 500,000 M17 C C*03:04:01G C*07:01:01G C*03:04:01G C*07:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M17 DPB1 DPB1*02:01:02G DPB1*04:01:01G DPB1*02:01:02G DPB1*04:01:01G
4 500,000 M17 DQB1 DQB1*02:01:01i DQB1*03:02:01i DQB1*02:01:01i DQB1*03:02:01i
4 500,000 M17 DRB1 DRB1*03:01:01G DRB1*04:04:01 DRB1*03:01:01i DRB1*04:04:01
4 500,000 M17 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 500,000 M17 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M17 DRB5
1 100,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
1 100,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
1 100,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
1 100,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
1 100,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
1 100,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
1 100,000 M18 DRB3
1 100,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M18 DRB5
1 200,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
1 200,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
1 200,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
1 200,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
1 200,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
1 200,000 M18 DRB3
1 200,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M18 DRB5
1 500,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
1 500,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
1 500,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
1 500,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
1 500,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
1 500,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
1 500,000 M18 DRB3
1 500,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M18 DRB5
2 100,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
2 100,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
2 100,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
2 100,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
2 100,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
2 100,000 M18 DRB3
2 100,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M18 DRB5
2 200,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
2 200,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
2 200,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
2 200,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
2 200,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
2 200,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
2 200,000 M18 DRB3
2 200,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M18 DRB5
High confidence Medium confidence Low confidence Discordant call
continued . . .
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
2 500,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
2 500,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
2 500,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
2 500,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
2 500,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
2 500,000 M18 DRB3
2 500,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M18 DRB5
3 100,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
3 100,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
3 100,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
3 100,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
3 100,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
3 100,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
3 100,000 M18 DRB3
3 100,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M18 DRB5
3 200,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
3 200,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
3 200,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
3 200,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
3 200,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
3 200,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
3 200,000 M18 DRB3
3 200,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M18 DRB5
3 500,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
3 500,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
3 500,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
3 500,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
3 500,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
3 500,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
3 500,000 M18 DRB3
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M18 DRB5
4 100,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
4 100,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
4 100,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
4 100,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
4 100,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
4 100,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
4 100,000 M18 DRB3
4 100,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M18 DRB5
4 200,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
4 200,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
4 200,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
4 200,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
4 200,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
4 200,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
High confidence Medium confidence Low confidence Discordant call
continued . . .
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M18 DRB3
4 200,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M18 DRB5
4 500,000 M18 A A*02:01:01G A*02:01:01G A*02:01:01G A*02:01:01G
4 500,000 M18 B B*07:02:01G B*15:01:01G B*07:02:01G B*15:01:01G
4 500,000 M18 C C*03:04:01G C*07:02:01G C*03:04:01G C*07:02:01G
4 500,000 M18 DPB1 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01 DPB1*01:01:01
4 500,000 M18 DQB1 DQB1*03:02:01i DQB1*04:02:01i DQB1*03:02:01i DQB1*04:02:01i
4 500,000 M18 DRB1 DRB1*04:01:01 DRB1*08:01:01G DRB1*04:01:01 DRB1*08:01:01G
4 500,000 M18 DRB3
4 500,000 M18 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M18 DRB5
1 100,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
1 100,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
1 100,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 100,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 100,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01G
1 100,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
1 100,000 M19 DRB4
1 100,000 M19 DRB5
1 200,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
1 200,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
1 200,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 200,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 200,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
1 200,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01i DRB1*03:01:01i
1 200,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
1 200,000 M19 DRB4
1 200,000 M19 DRB5
1 500,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
1 500,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
1 500,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
1 500,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
1 500,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01G
1 500,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
1 500,000 M19 DRB4
1 500,000 M19 DRB5
2 100,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
2 100,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
2 100,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
2 100,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 100,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
2 100,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01G
2 100,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
2 100,000 M19 DRB4
2 100,000 M19 DRB5
2 200,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
2 200,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
2 200,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 200,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
2 200,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01i DRB1*03:01:01i
2 200,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
2 200,000 M19 DRB4
2 200,000 M19 DRB5
2 500,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
2 500,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
2 500,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
2 500,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 500,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
2 500,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01i DRB1*03:01:01i
2 500,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
2 500,000 M19 DRB4
2 500,000 M19 DRB5
3 100,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
3 100,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
3 100,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 100,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
3 100,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01i DRB1*03:01:01i
3 100,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
3 100,000 M19 DRB4
3 100,000 M19 DRB5
3 200,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
3 200,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
3 200,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
3 200,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 200,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
3 200,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01i DRB1*03:01:01i
3 200,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
3 200,000 M19 DRB4
3 200,000 M19 DRB5
3 500,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
High confidence Medium confidence Low confidence Discordant call
continued . . .
404
C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
3 500,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
3 500,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 500,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
3 500,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01i DRB1*03:01:01i
3 500,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:14
3 500,000 M19 DRB4
3 500,000 M19 DRB5
4 100,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
4 100,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
4 100,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
4 100,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 100,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
4 100,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01i DRB1*03:01:01i
4 100,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
4 100,000 M19 DRB4
4 100,000 M19 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
4 200,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
4 200,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
4 200,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 200,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
4 200,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01i DRB1*03:01:01i
4 200,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
4 200,000 M19 DRB4
4 200,000 M19 DRB5
4 500,000 M19 A A*01:01:01G A*01:01:01G A*01:01:01G A*01:01:01G
4 500,000 M19 B B*08:01:01G B*08:01:01G B*08:01:01G B*08:01:01G
4 500,000 M19 C C*07:01:01G C*07:01:01G C*07:01:01G C*07:01:01G
4 500,000 M19 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 500,000 M19 DQB1 DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i DQB1*02:01:01i
4 500,000 M19 DRB1 DRB1*03:01:01G DRB1*03:01:01G DRB1*03:01:01i DRB1*03:01:01i
4 500,000 M19 DRB3 DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G DRB3*01:01:02G
4 500,000 M19 DRB4
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M19 DRB5
1 100,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
1 100,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
1 100,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
1 100,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 100,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
1 100,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01G
1 100,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
1 100,000 M20 DRB4
1 100,000 M20 DRB5
1 200,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
1 200,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
1 200,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
1 200,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 200,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
1 200,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01i
1 200,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M20 DRB4
1 200,000 M20 DRB5
1 500,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
1 500,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
1 500,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
1 500,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
1 500,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
1 500,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01G DRB1*11:01:01i
1 500,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
1 500,000 M20 DRB4
1 500,000 M20 DRB5
2 100,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
2 100,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
2 100,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
2 100,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 100,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
2 100,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
2 100,000 M20 DRB4
2 100,000 M20 DRB5
2 200,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
2 200,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
2 200,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
2 200,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 200,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
2 200,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01i
2 200,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
2 200,000 M20 DRB4
2 200,000 M20 DRB5
2 500,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
2 500,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
2 500,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
2 500,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
2 500,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01i
2 500,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
2 500,000 M20 DRB4
2 500,000 M20 DRB5
3 100,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
3 100,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
3 100,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
3 100,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 100,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
3 100,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01i
3 100,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
3 100,000 M20 DRB4
3 100,000 M20 DRB5
3 200,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
3 200,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
3 200,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
3 200,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
3 200,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01i
3 200,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
3 200,000 M20 DRB4
3 200,000 M20 DRB5
3 500,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
3 500,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
3 500,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
3 500,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
3 500,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
3 500,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01i
3 500,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
3 500,000 M20 DRB4
3 500,000 M20 DRB5
4 100,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
4 100,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
4 100,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 100,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
4 100,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01i
4 100,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
4 100,000 M20 DRB4
4 100,000 M20 DRB5
4 200,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
4 200,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
4 200,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
4 200,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 200,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
4 200,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01i
4 200,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
4 200,000 M20 DRB4
4 200,000 M20 DRB5
4 500,000 M20 A A*24:02:01G A*33:03:01G A*24:02:01G A*33:03:01G
4 500,000 M20 B B*40:06:01G B*58:01:01G B*40:06:01G B*58:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M20 C C*03:02:01G C*15:02:01G C*03:02:01G C*15:02:01G
4 500,000 M20 DPB1 DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G DPB1*04:01:01G
4 500,000 M20 DQB1 DQB1*02:01:01i DQB1*03:01:01i DQB1*02:01:01i DQB1*03:01:01i
4 500,000 M20 DRB1 DRB1*03:01:01G DRB1*11:01:01G DRB1*03:01:01i DRB1*11:01:01i
4 500,000 M20 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
4 500,000 M20 DRB4
4 500,000 M20 DRB5
1 100,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
1 100,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
1 100,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
1 100,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
1 100,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
1 100,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01G
1 100,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 100,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M21 DRB5
1 200,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
1 200,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
1 200,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
1 200,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
1 200,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01i
1 200,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 200,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M21 DRB5
1 500,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
1 500,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
1 500,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
1 500,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
1 500,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
1 500,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01G
1 500,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
1 500,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M21 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
2 100,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
2 100,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
2 100,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
2 100,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
2 100,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01G
2 100,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 100,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M21 DRB5
2 200,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
2 200,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
2 200,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
2 200,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
2 200,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
2 200,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01i
2 200,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 200,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M21 DRB5
2 500,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
2 500,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
2 500,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
2 500,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
2 500,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
2 500,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01i
2 500,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
2 500,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M21 DRB5
3 100,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
3 100,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
3 100,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
3 100,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
3 100,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
3 100,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01i
3 100,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M21 DRB5
3 200,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
3 200,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
3 200,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
3 200,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
3 200,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
3 200,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01i
3 200,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 200,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M21 DRB5
3 500,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
3 500,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
3 500,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
3 500,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
3 500,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
3 500,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
3 500,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M21 DRB5
4 100,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
4 100,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
4 100,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
4 100,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
4 100,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
4 100,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01i
4 100,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 100,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M21 DRB5
4 200,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
4 200,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
4 200,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
4 200,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
4 200,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 200,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01i
4 200,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 200,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M21 DRB5
4 500,000 M21 A A*31:01:02G A*68:01:01G A*31:01:02G A*68:01:01G
4 500,000 M21 B B*51:01:01G B*51:01:01G B*51:01:01G B*51:01:01G
4 500,000 M21 C C*15:02:01G C*15:02:01G C*15:02:01G C*15:02:01G
4 500,000 M21 DPB1 DPB1*02:01:02G DPB1*13:01:01G DPB1*02:01:02G DPB1*13:01:01G
4 500,000 M21 DQB1 DQB1*03:02:01i DQB1*06:03:01i DQB1*03:02:01i DQB1*06:03:01i
4 500,000 M21 DRB1 DRB1*04:03:01i DRB1*13:01:01G DRB1*04:03:01i DRB1*13:01:01i
4 500,000 M21 DRB3 DRB3*01:01:02G DRB3*01:01:02G
4 500,000 M21 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M21 DRB5
1 100,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
1 100,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
1 100,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
1 100,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
High confidence Medium confidence Low confidence Discordant call
continued . . .
419
C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 100,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
1 100,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01G
1 100,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
1 100,000 M22 DRB4
1 100,000 M22 DRB5
1 200,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
1 200,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
1 200,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
1 200,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
1 200,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
1 200,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
1 200,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
1 200,000 M22 DRB4
1 200,000 M22 DRB5
1 500,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
1 500,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
1 500,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 500,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
1 500,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
1 500,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
1 500,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
1 500,000 M22 DRB4
1 500,000 M22 DRB5
2 100,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
2 100,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
2 100,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
2 100,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
2 100,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
2 100,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01G DRB1*14:01:01i
2 100,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
2 100,000 M22 DRB4
2 100,000 M22 DRB5
2 200,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
2 200,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 200,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
2 200,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
2 200,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
2 200,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
2 200,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
2 200,000 M22 DRB4
2 200,000 M22 DRB5
2 500,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
2 500,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
2 500,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
2 500,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
2 500,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
2 500,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
2 500,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
2 500,000 M22 DRB4
2 500,000 M22 DRB5
3 100,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 100,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
3 100,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
3 100,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
3 100,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
3 100,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
3 100,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
3 100,000 M22 DRB4
3 100,000 M22 DRB5
3 200,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
3 200,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
3 200,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
3 200,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
3 200,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
3 200,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
3 200,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
3 200,000 M22 DRB4
3 200,000 M22 DRB5
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 500,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
3 500,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
3 500,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
3 500,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
3 500,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
3 500,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
3 500,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
3 500,000 M22 DRB4
3 500,000 M22 DRB5
4 100,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
4 100,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
4 100,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
4 100,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
4 100,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
4 100,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
4 100,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
4 100,000 M22 DRB4
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M22 DRB5
4 200,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
4 200,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
4 200,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
4 200,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
4 200,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
4 200,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
4 200,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
4 200,000 M22 DRB4
4 200,000 M22 DRB5
4 500,000 M22 A A*32:01:01G A*32:01:01G A*32:01:01G A*32:01:01G
4 500,000 M22 B B*35:01:01G B*39:01:01G B*35:01:01G B*39:01:01G
4 500,000 M22 C C*04:01:01G C*12:03:01G C*04:01:01G C*12:03:01G
4 500,000 M22 DPB1 DPB1*05:01:01G DPB1*10:01 DPB1*05:01:01G DPB1*10:01
4 500,000 M22 DQB1 DQB1*03:01:01i DQB1*05:03:01i DQB1*03:01:01i DQB1*05:03:01i
4 500,000 M22 DRB1 DRB1*11:01:01G DRB1*14:01:01G DRB1*11:01:01i DRB1*14:01:01i
4 500,000 M22 DRB3 DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G DRB3*02:02:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M22 DRB4
4 500,000 M22 DRB5
1 100,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
1 100,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
1 100,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:73
1 100,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
1 100,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
1 100,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01G
1 100,000 M23 DRB3
1 100,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 100,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 200,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
1 200,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
1 200,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
1 200,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
1 200,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
1 200,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
1 200,000 M23 DRB3
1 200,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 200,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
1 500,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
1 500,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
1 500,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
1 500,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
1 500,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
1 500,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01G
1 500,000 M23 DRB3
1 500,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
1 500,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 100,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
2 100,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
2 100,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
2 100,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
2 100,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 100,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01G
2 100,000 M23 DRB3
2 100,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 100,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 200,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
2 200,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
2 200,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
2 200,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
2 200,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
2 200,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01i
2 200,000 M23 DRB3
2 200,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 200,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
2 500,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
2 500,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
2 500,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
2 500,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
2 500,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
2 500,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01i
2 500,000 M23 DRB3
2 500,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
2 500,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 100,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
3 100,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
3 100,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
3 100,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
3 100,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
3 100,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01i
3 100,000 M23 DRB3
3 100,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 100,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 200,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
3 200,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
3 200,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
3 200,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
3 200,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
3 200,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01i
3 200,000 M23 DRB3
3 200,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 200,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
3 500,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
3 500,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
3 500,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
3 500,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
3 500,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
3 500,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01i
3 500,000 M23 DRB3
3 500,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
3 500,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 100,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
4 100,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
High confidence Medium confidence Low confidence Discordant call
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 100,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
4 100,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
4 100,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
4 100,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01i
4 100,000 M23 DRB3
4 100,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 100,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 200,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
4 200,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
4 200,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
4 200,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
4 200,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
4 200,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01i
4 200,000 M23 DRB3
4 200,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 200,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
4 500,000 M23 A A*01:01:01G A*24:02:01G A*01:01:01G A*24:02:01G
High confidence Medium confidence Low confidence Discordant call
continued . . .
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C. Allele calls from MiSeq sequencing data
. . . MiSeq results continued
Rep Reads Id Locus Allele 1 Allele 2 Clustering 1 Clustering 2
4 500,000 M23 B B*08:01:01G B*15:01:01G B*08:01:01G B*15:01:01G
4 500,000 M23 C C*04:01:01G C*07:01:01G C*04:01:01G C*07:01:01G
4 500,000 M23 DPB1 DPB1*03:01:01G DPB1*33:01 DPB1*03:01:01G DPB1*33:01
4 500,000 M23 DQB1 DQB1*03:03:02i DQB1*06:02:01i DQB1*03:03:02i DQB1*06:02:01i
4 500,000 M23 DRB1 DRB1*09:01:02G DRB1*15:01:01G DRB1*09:01:02G DRB1*15:01:01i
4 500,000 M23 DRB3
4 500,000 M23 DRB4 DRB4*01:01:01G DRB4*01:01:01G
4 500,000 M23 DRB5 DRB5*01:01:01 DRB5*01:01:01
Table C.1.: Allele calls for the MiSeq dataset. Rep is the repetition of the analysis and Reads is the number of reads used in the analysis. Allele 1
and Allele 2 are the expected alleles. Clustering 1 and 2 are the allele calls made from the MiSeq data using the allele caller based on
clustering. The font color of allele calls represents ’High’, ’Medium’ and ’Low’ confidence calls, and background shading represents
discordance with the reference calls. As IMGT G groups are based on sequencing only exon 2 for HLA-DQB1, they could not be used
for this dataset, which also included partial sequencing of exon 3. Instead i groups were created which group alleles that can-not be
differentiated based on the sequenced regions for exon 2 and 3.
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Structural analysis of an HLA-B27 population variant, B27f. Multiple patterns of
amino acid changes within a single polypeptide segment generate polymorphism
in HLA-B27. J Immunol 139, 831–6 (08/1987) (cit. on p. 14).
82. Erlich, R. et al. Next-generation sequencing for HLA typing of class I loci. BMC
genomics 12, 42 (2011) (cit. on pp. 15, 17, 24, 107).
83. Bentley, G. et al. High-resolution, high-throughput HLA genotyping by next-
generation sequencing. Tissue Antigens 74, 393–403 (11/2009) (cit. on pp. 15,
25, 26, 107, 115).
84. Gabriel, C. et al. Rapid high-throughput human leukocyte antigen typing by
massively parallel pyrosequencing for high-resolution allele identification. Hum
Immunol 70, 960–4 (11/2009) (cit. on pp. 15, 16, 26, 107, 115).
85. Erlich, H. HLA DNA typing: past, present, and future. Tissue Antigens 80, 1–11
(07/2012) (cit. on pp. 15, 107).
439
Bibliography
86. Holcomb, C. L. et al. A multi-site study using high-resolution HLA genotyping
by next generation sequencing. Tissue Antigens 77, 206–17 (03/2011) (cit. on
pp. 16, 107, 115).
87. Skibola, C. et al. Multi-locus HLA class I and II allele and haplotype associations
with follicular lymphoma. Tissue Antigens 79, 279–286 (2012) (cit. on p. 16).
88. Erlich, H. et al. Next generation sequencing reveals the association of DRB3*02:02
with type 1 diabetes. Diabetes 62, 2618–22 (07/2013) (cit. on p. 16).
89. Hajeer, A. H. et al. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype
frequencies in Saudis using next generation sequencing technique. Tissue Antigens
82, 252–8 (10/2013) (cit. on p. 16).
90. Danzer, M. et al. Rapid, scalable and highly automated HLA genotyping using
next-generation sequencing: a transition from research to diagnostics. BMC
Genomics 14, 221 (2013) (cit. on p. 16).
91. Moonsamy, P. et al. High throughput HLA genotyping using 454 sequencing and
the Fluidigm Access Array
TM
system for simplified amplicon library preparation.
Tissue antigens 81, 141–149. issn: 1399-0039 (2013) (cit. on p. 16).
92. Lank, S., Wiseman, R., Dudley, D. & O’Connor, D. A novel single cDNA amplicon
pyrosequencing method for high-throughput, cost-effective sequence-based HLA
class I genotyping. Human Immunology 71, 1011–1017. issn: 01988859 (2010)
(cit. on pp. 16, 107, 115).
93. Grumbt, B., Eck, S. H., Hinrichsen, T. & Hirv, K. Diagnostic applications of
next generation sequencing in immunogenetics and molecular oncology. Transfus
Med Hemother 40, 196–206 (06/2013) (cit. on pp. 17, 107, 115).
94. Lind, C. et al. 137-P: Single molecule real-time sequencing of full length HLA
class I genes–the promise and current reality. Human Immunology 73, 135 (2012)
(cit. on p. 17).
95. Ranade, S. et al. Evaluation of multiplexing strategies for HLA genotyping using
PacBio R©Sequencing technology ASHI 2014 Conference Poster. 10/2014 (cit. on
pp. 17, 107, 115).
96. Roche Diagnostics Corporation. Technical Bulletin; GS FLX System & GS Junior
System; Multiplex Identifier (MID) Adaptors for Rapid Library Preparations
tech. rep. TCB No. 2010-10 (08/2010) (cit. on p. 23).
440
Bibliography
97. Mack, S. J. et al. Common and well-documented HLA alleles: 2012 update to the
CWD catalogue. Tissue Antigens 81, 194–203. issn: 1399-0039 (2013) (cit. on
p. 49).
98. Hartigan, J. A. & Wong, M. A. Algorithm AS 136: A k-means clustering algorithm.
Applied statistics, 100–108 (1979) (cit. on p. 52).
99. Frey, B. J. & Dueck, D. Clustering by passing messages between data points.
Science 315, 972–6 (02/2007) (cit. on pp. 52, 79).
100. European Molecular Biology Laboratory - EBI. IPD - IMGT/HLA Version
Report - 3.16.0 (2014-04) <http://www.ebi.ac.uk/ipd/imgt/hla/docs/
version_r3160.html> (cit. on p. 100).
101. Illumina Inc. MiSeq specifications <http://www.illumina.com/systems/
miseq/performance_specifications.html> (cit. on p. 109).
102. Holland, M. M. & Parsons, T. J. Mitochondrial DNA sequence analysis-validation
and use for forensic casework. Forensic Science Review 11, 21–50 (1999) (cit. on
pp. 117, 118).
103. Gonzales, A., Schofield, R. & Schmitt, G. Lessons learned from 9/11: DNA
identification in mass fatality incidents. NCJ 214781, Washington: National
institute of justice (2006) (cit. on p. 117).
104. Bogenhagen, D. & Clayton, D. A. The number of mitochondrial deoxyribonucleic
acid genomes in mouse L and human HeLa cells. Quantitative isolation of
mitochondrial deoxyribonucleic acid. J Biol Chem 249, 7991–5 (12/1974) (cit. on
p. 117).
105. Hatsch, D., Amory, S., Keyser, C., Hienne, R. & Bertrand, L. A rape case solved
by mitochondrial DNA mixture analysis. J Forensic Sci 52, 891–4 (07/2007)
(cit. on p. 117).
106. Sudoyo, H. et al. DNA analysis in perpetrator identification of terrorism-related
disaster: suicide bombing of the Australian Embassy in Jakarta 2004. Forensic
Sci Int Genet 2, 231–7 (06/2008) (cit. on pp. 117, 118).
107. Holland, M. M., McQuillan, M. R. & O’Hanlon, K. A. Second generation sequen-
cing allows for mtDNA mixture deconvolution and high resolution detection of
heteroplasmy. Croat Med J 52, 299–313 (06/2011) (cit. on pp. 118, 119).
108. Anderson, S. et al. Sequence and organization of the human mitochondrial
genome. Nature 290, 457–65 (04/1981) (cit. on p. 118).
441
Bibliography
109. Budowle, B. et al. Mitochondrial DNA regions HVI and HVII population data.
Forensic Sci Int 103, 23–35 (07/1999) (cit. on p. 118).
110. Salas, A., Lareu, M. V. & Carracedo, A. Heteroplasmy in mtDNA and the weight
of evidence in forensic mtDNA analysis: a case report. Int J Legal Med 114,
186–90 (2001) (cit. on p. 118).
111. Budowle, B., Allard, M. W., Wilson, M. R. & Chakraborty, R. Forensics and
mitochondrial DNA: applications, debates, and foundations. Annu Rev Genomics
Hum Genet 4, 119–41 (2003) (cit. on p. 118).
112. Weir, B. S. et al. Interpreting DNA mixtures. J Forensic Sci 42, 213–22 (03/1997)
(cit. on p. 118).
113. Curran, J. M., Triggs, C. M., Buckleton, J. & Weir, B. S. Interpreting DNA
mixtures in structured populations. J Forensic Sci 44, 987–95 (09/1999) (cit. on
p. 118).
114. Ladd, C., Lee, H. C., Yang, N. & Bieber, F. R. Interpretation of complex forensic
DNA mixtures. Croat Med J 42, 244–6 (06/2001) (cit. on p. 118).
115. Kelly, H., Bright, J.-A., Curran, J. & Buckleton, J. The interpretation of low
level DNA mixtures. Forensic Sci Int Genet 6, 191–7 (03/2012) (cit. on p. 118).
116. Giannelli, P. C. Confirmation Bias. Criminal Justice 22, 60 (2007) (cit. on
p. 118).
117. Balding, D. J. & Buckleton, J. Interpreting low template DNA profiles. Forensic
Sci Int Genet 4, 1–10 (12/2009) (cit. on p. 118).
118. Dror, I. E. & Hampikian, G. Subjectivity and bias in forensic DNA mixture
interpretation. Sci Justice 51, 204–8 (12/2011) (cit. on p. 118).
119. Krane, D. E. et al. Sequential unmasking: a means of minimizing observer effects
in forensic DNA interpretation. J Forensic Sci 53, 1006–7 (07/2008) (cit. on
p. 118).
120. Homer, N. et al. Resolving individuals contributing trace amounts of DNA to
highly complex mixtures using high-density SNP genotyping microarrays. PLoS
Genet 4, e1000167 (08/2008) (cit. on p. 119).
121. Hall, T. A. et al. Base composition profiling of human mitochondrial DNA using
polymerase chain reaction and direct automated electrospray ionization mass
spectrometry. Anal Chem 81, 7515–26 (09/2009) (cit. on p. 119).
442
Bibliography
122. Egeland, T. & Salas, A. A statistical framework for the interpretation of mtDNA
mixtures: forensic and medical applications. PLoS One 6, e26723 (2011) (cit. on
p. 119).
443
